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The present text reports on the data and materials
mainly collected during the period from 1994 
to 1996 in Ecuador, South America
There could be some 12 million Leishmania-infected people in the
world, and 350 million at risk, of whom some 1.5 to 2 million will be
infected each year. Some 90% of the visceral leishmaniasis cases
are reported from two regions - a wide zone in northeast India,
Bangladesh and southern Nepal, and Sudan; and 90% of the cuta-
neous cases are found in Afganistan, Iran, Saudi Arabia and Syria
in the Old World, and Brazil and Peru in the New World.  Smouldering
epidemics of visceral leishmaniasis in the India /Bangladesh /Nepal
focus are thought to be killing 75000 people a year. War and in some
areas military training in forests or deserts is associated with the
disease.  There is also a risk of the urbanization of these principal-
ly rural diseases, particularly where AIDS and leishmaniasis over-
lap. The diversity of the epidemiology of the different forms of the
disease makes it impossible to control leishmaniasis with a single
approach or tool, except perhaps a vaccine...
(Twelfth Programme Report, UNDP/World Bank/WHO Special Programme
for Research and Training in Tropical Diseases -TDR-, 1995,
Leishmaniasis, pp. 135-146)
iCONTENTS
Preface ••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••ix
Members of the research project•••••••••••••••••••••••••••••••••••••••••••••••••••••••••••x
Other contributors••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••xi
Acknowledgements ••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••xii
Introduction •••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••1
Chapter 1. A brief comment on the changing pattern of leishmaniasis in the world •••••••••••••••••2
Chapter 2. Parasitology and vector entomology ••••••••••••••••••••••••••••••••••••••••••••••5
1. Karyotype analysis of Leishmania (Viannia) panamensis
isolated from cutaneous leishmaniasis patients at the Pacific
coastal regions in Ecuador •••••••••••••••••••••••••••••••••••••••••••••••••5
2. Identification of species of Ecuadorian Leishmania isolates
by ELISA using monoclonal antibodies••••••••••••••••••••••••••••••••••••••11
3. Nucleotide sequence variations in the cytochrome c oxidase 
subunit I gene within Leishmania species ••••••••••••••••••••••••••••••••••••21
4. A preliminary study on nucleotide sequence variations of 
Lutzomyia spp. in the cytochrome oxidase subunit I gene •••••••••••••••••••••••25
Chapter 3. Ultrastructural and pathological aspects ••••••••••••••••••••••••••••••••••••••••••28
1.An ultrastructural study of diffuse cutaneous leishmaniasis
caused by Leishmania (Leishmania) mexicana in Ecuador:
the role of parasitophorous vacuole in macrophage-parasite 
interaction •••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••28
2. Diffuse cutaneous leishmaniasis: the pathological difference 
between localized and diffuse forms ••••••••••••••••••••••••••••••••••••••••36
3. Light microscopic and electron microscopic study on patients
with cutaneous leishmaniasis treated with mefloquine
(Mephaquin®) ••••••••••••••••••••••••••••••••••••••••••••••••••••••••••44
Chapter 4. Diagnosis using molecular techniques •••••••••••••••••••••••••••••••••••••••••••53
1. A trial to detect Leishmania parasites in paraffin-embedded skin 
biopsies using polymerase chain reaction ••••••••••••••••••••••••••••••••••••53
2. A comparative study of conventional and PCR-based diagnosis 
of cutaneous leishmaniasis in Ecuador•••••••••••••••••••••••••••••••••••••••69
3. Preliminary studies on diagnosis of cutaneous leishmaniasis
by biopsy specimens using polymerase chain reaction (PCR) ••••••••••••••••••••74
Chapter 5. Clinical and epidemiological  aspects••••••••••••••••••••••••••••••••••••••••••••82
1. Clinical survey of cutaneous leishmaniasis in Ecuador 
for 5 years (1991-1995) ••••••••••••••••••••••••••••••••••••••••••••••••••82
2. Cutaneous leishmaniasis in El Carmen, Province of Manabi, Ecuador •••••••••••••88
Chapter 6. Chemotherapy of leishmaniasis patients ••••••••••••••••••••••••••••••••••••••••••94
1. Oral treatment of New World cutaneous leishmaniasis with 
antimalarial drugs in Ecuador: a preliminary clinical trial •••••••••••••••••••••••94
2. Further studies on the oral treatment of cutaneous leishmaniasis
with antimalarial drug mefloquine (Mephaquin®) in Ecuador •••••••••••••••••••102
ii
3. Studies on the oral treatment of cutaneous leishmaniasis 
with an artemisinin derivative, artesunate (Plasmotrim®) 
in Ecuador ••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••108
4. Clinical observation of topical treatment for cutaneous 
leishmaniasis for 5 years in Ecuador •••••••••••••••••••••••••••••••••••••••114
Chapter 7. Experimental studies on Antileishmanial effects in vitro and in vivo••••••••••••••••••128
1. Effect of plant juices on the growth of Leishmania 
promastigotes in culture •••••••••••••••••••••••••••••••••••••••••••••••••128
2. Effect of mefloquine on visceral leishmaniasis in mice ••••••••••••••••••••••••133
Chapter 8. Leishmaniasis and its related diseases ••••••••••••••••••••••••••••••••••••••••••137
1. Clinical comparisons of cutaneous changes of
patients with diffuse cutaneous leishmaniasis and leprosy
in Ecuador ••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••137
2. A case report of chromomycosis from an endemic area for 
cutaneous leishmaniasis in Ecuador: a differential diagnosis
between leishmaniasis and chromomycosis ••••••••••••••••••••••••••••••••••147
3. Case reports of cutaneous myiasis due to Dermatobia hominis
from an area endemic for cutaneous leishmaniasis in Ecuador ••••••••••••••••••158
Summary •••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••169
Appendix (Abstract of related papers published)••••••••••••••••••••••••••••••••••••••••••••172
1. An epidemiological study of leishmaniasis in a
plantation "Cooperativa 23 de Febrero" newly
established in Ecuador (Jpn J Parasitol, 33, 393-
401, 1984)
2. Infeccion natural de phlebotomus con promastig-
otes de Leishmania braziliensis en una area
endemica de leishmaniasis en Ecuador (Rev Ecuat
Hig Med Trop, 34, 1-20, 1984)
3. Natural infections with promastigotes in man-bit-
ing species of sand flies in leishmaniasis-endem-
ic areas of Ecuador (Am J Trop Med Hyg, 34,
440-446, 1985)
4. Biting activity of two anthropophilic species of
sandflies, Lutzomyia, in an endemic area of
leishmaniasis in Ecuador (Ann Trop Med Parasitol,
79, 533-538, 1985)
5. Leishmania isolated from wild mammals caught in
endemic areas of leishmaniasis in Ecuador (Trans
Roy Soc Trop Med Hyg, 79, 120-121, 1985)
6. A review of leishmaniasis in the New World with
special reference to its transmission mode and epi-
demiology (in Japanese with English summary)
(Jpn J Trop Med Hyg, 13, 205-243, 1985)
7. Primera generacion de phlebotomus de laboratorio
en el Ecuador. El metodo de crianza, manteni-
miento y su contribucion al futuro de la investi-
gacion cientifica en epidemiologia nacional (Rev
Ecuat Hig Med Trop, 36, 3-8, 1986)
8. Leishmaniasis in different altitudes on Andean
slope of Ecuador (Jpn J Trop Med Hyg, 15, 7-15,
1987) 
9. The relationship between severity of ulcerated
lesions and immune responses in the early stage of
cutaneous leishmaniasis in Ecuador (Ann Trop Med
Parasitol, 81, 681-685, 1987)
10. Studies on New World leishmaniasis and its trans-
mission, with particular reference to Ecuador
(Kochi, Japan: Kyowa Printing Co., Research
Report Series, No. 1, 1-174, 1987)
11. The fate of Leishmania braziliensis, L. donovani
and Trypanosoma cruzi in diffusion chambers
implanted into hamsters and mice - a preliminary
study - (Jpn J Trop Med Hyg, 15, 97-104, 1987)
12. Identification, using isoenzyme electrophoresis and
monoclonal antibodies, of Leishmania isolated from
humans and wild animals of Ecuador (Am J Trop
Med Hyg, 40, 154-158, 1989)
13. Observations on the validity of the ovarian acces-
sory glands of seven Ecuadorian sand fly species
(Diptera: Psychodidae) in determining their pari-
ty (Jpn J Trop Med Hyg, 17, 149-155, 1989)
14. A brief review of Central and South American
leishmaniasis, with special reference to Ecuador
(in Japanese) (Nettai, 22, 68-82, 1989)
15. Leishmaniasis research in Central and South
America - Why is it necessary to study parasitic
diseases which are not prevalent in Japan ? - (in
Japanese) (Nihon Iji Shinpo, No. 33397, 59-60,
1989)
16. Epidemiological survey of leishmaniasis using skin
test and ELISA in Ecuador (Jpn J Trop Med Hyg,
17, 331-338, 1989)
17. Las Investigaciones sobre la leishmaniasis en el
Ecuador, 1920-1989 (Bol Of Sanit Panam, 108,
296-307, 1990)
18. Natural infections with Leishmania promastigotes
in Lutzomyia ayacuchensis (Diptera: Psychodidae)
in an Andean focus of Ecuador (J Med Entomol,
27, 701-702, 1990)
19. Phlebotomes of Paraguay: species identification in
three endemic areas (Diptera, Psychodidae and
Phlebotominae) (Ann Rep IICS, Asuncion,
Paraguay, No. 14, 128-133, 1990)
20. Studies on New World leishmaniasis and its trans-
mission, with particular reference to Ecuador
(Kochi, Japan: Kyowa Printing Co., Research
Report Series, No. 2, 1-238, 1990)
21. A review of leishmaniasis in Ecuador (Bull Pan
Am Hlth Org, 25, 64-76, 1991)
22. Evaluation and characterization of partially puri-
fied skin test antigens prepared from Leishmania
panamensis promastigotes (Jpn J Trop Med Hyg,
19, 209-217, 1991)
23. Andean leishmaniasis in Ecuador caused by infec-
tion with Leishmania mexicana and L. major-like
parasites (Am J Trop Med Hyg, 44, 205-217, 1991)
iii
iv
24. Cutaneous leishmaniasis in south-eastern Paraguay:
a study of an endemic area at Limoy (Trans Roy
Soc Trop Med Hyg, 85, 592-594, 1991)
25. Monthly variation in natural infection of the sand-
fly Lutzomyia ayacuchensis with Leishmania mex-
icana in an endemic focus in the Ecuadorian Andes
(Ann Trop Med Parasitol, 85, 407-411, 1991)
26. Description of Leishmania equatorensis sp. n.
(Kinetoplastida: Trypanosomatidae), a new para-
site infecting arboreal mammals in Ecuador (Mem
Inst Osw Cruz, 87, 221-228, 1992)
27. New records of phlebotomine sand flies (Diptera:
Psychodidae) from Ecuador (Mem Inst Osw Cruz,
87, 123-130, 1992)
28. Ultrastructural studies on cutaneous leishmaniasis
in Ecuador (Jpn J Trop Med Hyg, 20, 11-21, 1992)
29. Phlebotomine sandfly species and examinations of
their infection with Leishmania in Paraguay (Ann
Trop Med Parasitol, 86, 175-180, 1992)
30. Studies on New World leishmaniasis and its trans-
mission, with particular reference to Ecuador
(Kochi, Japan: Kyowa Printing Co., Research
Report Series, No. 3, 1-182, 1992)
31. Histopathological observations of Golden hamsters
infected with an Ecuadorian isolate of Leishmania
mexicana (Jpn J Trop Med Hyg, 20, 203-215)
32. The successful treatment of intralesional injections
of megulmine antimonate for cutaneous leishman-
iasis (in Japanese with English summary) (Nishi
Nihon Hihuka, 55, 638-642, 1992)
33. Molecular karyotype characterization of
Leishmania panamensis, Leishmania mexicana, and
Leishmania major-like parasites: agents of cuta-
neous leishmaniasis in Ecuador (Am J Trop Med
Hyg, 48, 707-715, 1993)
34. Histopathological and electron microscopical fea-
tures of skin lesions in a patient with baltonellosis
in Ecuador (J Dermatol, 21, 178-184, 1994)
35. Comparative observations of Golden hamsters
infected with Leishmania (Leishmania) mexicana
from Ecuadorian patient with diffuse and localized
type of cutaneous leishmaniasis (J Pakistan Assoc
Dermatol, 3, 17-32, 1994) 
36. New World leishmaniasis and its transmission, with
particular reference to Andean type of the disease,
Uta (in Japanese with English summary) (Jpn J
Parasitol, 43, 173-186, 1994)
37. Case report of leprosy and a trial of screenings for
the family members in Ecuador (Jpn J Trop Med
Hyg, 22, 219-223, 1994)
38. Seroepidemiological surveys for leprosy in Ecuador
(Jpn J Trop Med Hyg, 22, 179-184, 1994)
39. Studies on New World leishmaniasis and its trans-
mission, with particular reference to Ecuador
(Kochi, Japan: Kyowa Printing Co., Research
Report Series, No. 4, 1-193, 1994) 
40. Oral treatment of New World cutaneous leishman-
iasis with anti-malarial drugs in Ecuador: a pre-
liminary clinical trial (Jpn J Top Med Hyg, 23,
151-157, 1995)
41. A trial of topical treatment using 2% fluorouracil
(5FU) ointment for cutaneous leishmaniasis at the
Pacific coastal lowland of Ecuador (in Japanese)
(Okinawa Med J, 33, 44-47, 1995)
42. Cutaneous leishmaniasis (in Japanese) (Rinsho
Derma, 38, 547-556, 1996)
43. Leishmaniasis (in Japanese with English summa-
ry) (Jpn J Dermatol, 106, 1471-1481, 1996)
44. Leishmaniasis: its changing pattern and importance
as an imported disease (Int Med, 35, 434-435,
1996)
vPlate 1. Landscape of endemic areas of cutaneous leishmaniasis (CL) in Ecuador.  Above: a small Andean
highland village, La Moya, Province of Chimborazo, from where Andean type of CL cases was newly report-
ed.  Below: a lowland endemic area of CL, Zhucay, Province of Cañar, surrounded by dense forest; at this
site many patients with ulcer type of CL were observed, and they were treated orally by Mephaquin®.
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Plate 2. Examinations of patients with leishmaniasis at Hospital El Carmen, Ministry of Public Health, locat-
ed at a town, El Carmen, Province of Manabi, Ecuador.  Above: most of the patients here came to the
examination from remote and mountainous areas.  Below: examination of a patient with ulcer type of CL
on his forearm by Drs. E.A.Gomez L., T. Mimori, M. Carvopiña and Mr. R. Sud A.
vii
Plate 3. Field activities of our research team at endemic areas of cutaneous leishmaniasis (CL) in Ecuador.
Above: An assembly at a primary school of CL-endemic area, La Esmeralda, Province of Los Rios, to give
information on our research.  Below: examination of inhabitants at a primary school, located at a rain for-
est CL-endemic area, La Mamey, Province of Esmeraldas.
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Plate 4. Field activities of our research team in Ecuador.  Above: dissections of vector sandflies by Drs.
E.A.Gomez L., S. Suguri, Y. Hashiguchi and Mr. R. Sud A., at Hotel Majestad, located near CL-endemic
area of Andean slope, La Troncal, Province of Cañar.  Below: our special transportation system of labora-
tory equipments and others.
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Our research activity on leishmaniasis in Ecuador
was started in the year 1982 and continued until 1984,
under the support of the Japan International
Cooperation Agency (JICA) and the Ministry of
Health, Ecuador.  After 1986 to date, our project enti-
tled "Studies on New World leishmaniasis and its
transmission, with paritcular reference to Ecuador"
was financially supported by the Ministry of
Education, Science and Culture, Japan; and invaluable
supports were obtained from Ecuadorian institutions,
such as Catholic University, Guayaquil University and
health centers at different endemic areas of the dis-
ease. During these long research terms, a considerable
information was accumulated, and the details were
reported in our Research Report Series Nos. 1-4 pub-
lished in 1987-1994. 
At the beginning of this project, the isolate and
characterization of Leishmania organisms, the detec-
tion of natural infections of vector sandflies and reser-
voir host mammals, and the evaluation of
immunological tools for diagnosis were made princi-
pally.  In addition, the collection of available infor-
mation on Ecuadorian leishmaniasis and the revision
of leishmaniasis-endemic areas in that country were
also carried out.  
At the second phase of our research, the results
obtained from surveys carried out in different
leishmaniasis-endemic areas of Ecuador, were ana-
lyzed by multi-disciplinary investigators from para-
sitological, epidemiological, vector entomological,
immunological and dermatological points of view.
Particular emphasis was given to a recently discov-
ered autochthonous Andean highland leishmaniasis,
and a comparison of this disease form with others in
the Pacific coast and Amazonian lowland of Ecuador
was done. Moreover, a currently available technique
in molecular biology was briefly reviewed and eval-
uated for the possibility of their application to future
studies of leishmaniasis epidemiology in Ecuador. 
At the third phase, Andean leishmaniasis was
mainly investigated and compared to the lowland
leishmaniasis, from parasitological, entomological and
clinico-epidemiological points of view, employing light
and electron microscopical findings. Local applicat-
tion of ointment and lotion prepared in our project was
tried to use for the treatment of cutaneous leishman-
iasis patients. 
At the fourth phase of the current project, DNA
karyotype of 12 Leishmania isolates from different
areas of the Ecuadorian Andes was examined.
Furthermore, monoclonal antibodies were raised
against newly described Leishmania species, in addi-
tion to various laboratory works using Ecuadorian iso-
lates. Many dermatologic and therapeutic data obtained
from field research were also  accumulated in this
research phase. 
The present report (Research Report Series No. 5)
mentions the results of field and laboratory works done
during 1994 and 1996.  Special emphasis was given
to the oral treatment and its evaluation of cutaneous
leishmaniasis patients with antimalarial drugs, meflo-
quine and artesunate.  Much of the materials and data
collected have yet to be examined and analyzed.  The
results will be published in detail elsewhere, and a fur-
ther investigation will be continued from 1997
onwards, by the financial support of the Ministry of
Education, Science and Culture, Japan.
Yoshihisa Hashiguchi,
Eduardo A. Gomez L.
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Studies on New World Leishmaniasis and
its Transmission, with Particular
Reference to Ecuador
1Leishmaniasis in Ecuador was first reported by
Valenzuela in 1920, about 77 years ago; however it
has remained one of the least studied of Ecuadorian
tropical diseases until recently.  For many years the
principal research activity of leishmaniasis has been
involved with clinical diagnosis and therapy, and this
produced some eventually confirmed case reports.  For
example 260 clinical cases in total were reported in
principal Ecuadorian medical journal during 67 years
from 1920 to 1987.  Only one each of diffuse cuta-
neous leishmaniasis and visceral one were reported,
but no parasitological confirmation was made in both
cases.  Recently, a case of parasitologically confirmed
diffuse cutaneous leishmaniasis was reported by our
research group.  Thus, in Ecuador the variety of cuta-
neous forms of leishmaniasis are prevalent at differ-
ent endemic areas, such as Pacific and Amazonian
regions and the Andes, showing about 95% of total
prevalence.  From 1982 to date, we have studied
almost all of the susceptible endemic foci in that coun-
try.  And it was found that leishmaniasis is widespread
in most provinces and it is a considerable health prob-
lem there; out of the 21 provinces, 15 are reported
as leishmaniasis-endemic areas.  Thus, the disease
occurs in many populations living in rural areas on
both sides of the Andes, including those living in the
Andean plateau.  However, the actual numbers of
leishmaniasis-patients in each endemic area are dif-
ficult to establish, because of insufficient medical
and/or communicative systems in the area.  During our
epidemiological studies from 1982 to date in Ecuador,
we made different types of field works in order to
decide the causative agents, probable vectors and reser-
voir hosts of the disease in each endemic area, in addi-
tion to clinical and therapeutic studies.  In sandfly
collections, for example,  we used several types of
methods, such as Shannon trap, CDC light trap, Caster-
oil trap and protected human-bait collections, depend
on the purpose of research.  To date 70 species were
recorded from different areas of Ecuador, of which
only 4 were incriminated as probable vectors in
Ecuador, isolating Leishmania parasites by fly dis-
section.  At the lowland endemic areas of leishman-
iasis, Lutzomyia trapidoi is the most important vector
in that country, and then followed by Lutzomyia hart-
manni, and Lutzomyia gomezi.  At the highland endem-
ic areas only one species, Lutzomyia ayacuchensis was
proved to be positive for Leishmania organisms.  As
to reservoir hosts of leishmaniasis in Ecuador, 8
species of mammals were incriminated to date; they
are 2 species each  of sloths and squirrels, 1 species
each of anteater, rat, kinkajous and canine, showing
positive for Leishmania parasites in cultures of the
viscera of these mammals.  In Ecuador, 7 species of
the genus Leishmania were isolated from patients,
sandfly vectors or mammalian reservoirs in Ecuador.
In the Pacific lowland areas including Andean slopes,
braziliensis, panamensis and guyanensis of the sub-
genus Viannia, and mexicana, amazonensis and major-
like belonging to the subgenus Leishmania were found.
In the Andean plateau of 1200 m to 2700 m of the alti-
tudes, 2 species, mexicana and major-like, were preva-
lent, and only 1 species, braziliensis was isolated from
patients of different areas of the Ecuadorian Amazon.
The remaining species, equatorensis was described as
a new species of the subgenus Viannia group by our
research group.  This organism was isolated from the
viscera of a sloth and a squirrel caught in humid trop-
ical forest of Ecuador on the Pacific cordillera of about
1000 m  of the altitudes.
Yoshihisa Hashiguchi,
Eduardo A. Gomez L.
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2Leishmaniases are caused by a protozoan para-
site of the genus Leishmania, and transmitted by a tiny
blood feeding insect, sandfly, the genus Phlebotomus
in the Old World and the genus Lutzomyia in the New
World.  About 20 species of Leishmania are respon-
sible for a wide range of clinical manifestations in both
humans and vertebrate animals as zoonosis.  In humans
clinical forms range from a simple, often self heal-
ing cutaneous type to those producing destructive
mucocutaneous ulcers of nasopharynges, uncurative
diffuse cutaneous lesions, and a visceral form known
as kala-azar, the severe chronic infection of the retic-
uloendothelial system, which is often fatal if left
untreated.  Different types of the disease are endem-
ic in many tropical and subtropical regions, and
responsible for increasing health problems in large
parts of the Old and New World, especially in devel-
oping countries.  According to Ashford et al.  (1992),
the number of countries affected by visceral and cuta-
neous forms of leishmaniasis is 67 in total, of which
16 countries are distributed in Asia, 22 in Africa, 21
in Americas and 8 in Europe.  In these affected coun-
tries, about 3 hundreds and 67 millions of people are
estimated as a population at risk.  In this estimation,
it is noticeable that the number at risk with both vis-
ceral and cutaneous forms is extremely high in Asia,
showing 2 hundreds and 71 millions of people.
Futhermore, Ashford et al. (1992) estimated that in
the world about 3 hundreds and 84 thouthands of peo-
ple are annually sufferring from the disease; the high-
est number of annual cases of both visceral and
cutaneous leishmaniasis is found in Asia, and then fol-
lowed by Africa. Many serious problems, especially
with visceral forms of leishmaniasis were reported
in different countries of the world.  For example, in
India drug resistance is now a severe problem caus-
ing high death rates (Dhanda et al., 1996).  In Sudan,
the war zone is probably now the area with the high-
est incidence of the disease in the world (Ziljstra et
al., 1991; Kemp, 1997);  Lockwood (1991) noticed
that visceral leishmaniasis (kala-azar) in the Sudan
should be in the news.
In the New World, leishmaniases are also endem-
ic in many areas of Central and South American coun-
tries, including southern parts of the US and northern
to southern Mexico, and they constitute significant
public health problems in each country. Control of
leishmaniases  in these New World regions is com-
plicated by the variety of different Leishmania species
and their diverse clinical forms, and also complicat-
ed by a unique epidemiological patterns of each
Leishmania species.  Furthermore, in many regions of
the New World, two or more species are often sym-
patric. In the New World 18 species of the genus
Leishmania are reported, and 15 of which are respon-
sible for different types of human leishmaniasis cases
(Grimaldi and Tesh, 1989).  Leishmania species
belonging to the subgenus Viannia, are shown as the
causative agents of cutaneous and mucocutaneous
leishmaniasis.  Among the Viannia group, Leishmania
(Viannia) braziliensis shows the most wide range of
distribution, affecting many populations and causing
cutaneous and mucocutaneous leishmaniasis.  In the
New World endemic areas of leishmaniasis, almost all
forms of the disease are basically zoonoses; and man
is usually an incidental host of the pathogenic
Leishmania species.  Cutaneous forms of leishman-
iasis associated with the subgenus Leishmania group
are also widely prevalent in the New World.  L. (L.)
mexicana is mainly reported from the Central
American countries and from a part of the northern
regions of the South America.  The species, mexicana,
Chapter 1
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3amazonensis and pifanoi are important as causative
agents of diffuse type of cutaneous leishmaniasis; the
clinical form is specifically anergy for Leishmania
antigen, and is highly resistant for available antileish-
manial drugs. In the New World L. (L.) chagasi is
main species which causes the visceral leishmaniasis
with a wide range of distribution from Mexico to
Brazil.  In the case of New World visceral forms, some
records are done based on clinical or serological exam-
inations without confirmation of the parasites on
smears or cultures. For example, in our research field
of Ecuador as mentioned before, 3 years old boy was
reported as visceral leishmaniasis without parasito-
logical confirmation; from our epidemiological sur-
vey in that country, however, we are sure that the
visceral case reported would be misdiagnosed. 
Recently, leishmaniases, especially its visceral
forms are identified and noticed as one of the impor-
tant opportunistic infections of acquired immunode-
ficiency symdrome (AIDS) in several areas of the
world where both diseases distribute sympatrically.
Since the mid-1980s there has been a dramatic increase
in the number of Leishmania infections in human
immunodeficiency virus (HIV) positive patients con-
current with the spread of the viral epidemic to areas
traditionally endemic for leishmaniasis in the world
(Gradoni and Gramiccia, 1994). In southern Europe,
for example, especially in Spain, Italy and France,
leishmaniasis is a growing problem with several hun-
dreds of HIV co-infection cases (Olliaro and Bryceson,
1993). Similar problems are also reported from Asian
countries, such as India, Bangladesh and Nepal where
the severe visceral leishmaniasis is highly prevalent
(WHO, 1995).  In the patients with co-infections of
Leishmania and HIV, clinical manifestations are
unusual and diagnosis difficult, showing atypical sec-
ondary localizations in the gastric mucosa, rectum or
skin, either in lesions or in normal tissue (Gradoni and
Gramiccia, 1994); these patients need prolonged treat-
ment and are liable to relapse (Altes et al., 1991).
In Spain where the disease has been a compulsorily
notifiable disease since 1982, almost 80% of the
Spanish visceral leishmaniasis cases were immun-
odepressed patients, 60% of which were HIV-positives
and the rest were basically divided between haema-
tological disorders of the white blood cells, transplants,
autoimmune disease and alcoholic haepatopathies
(Alvar et al., 1989; Alvar, 1994).  In the endemic area
of leishmaniasis of southern Europe, more than 50%
of visceral leishmaniasis in adults is now related to
infection with HIV, suggesting that Leishmania and
HIV co-infections are becomming more frequent in
areas where both microorganisms are endemic
(Gorgolas and Miles, 1994).  In these areas of Europe,
furthermore, intravenous drug abusers, who repre-
sent 60% of the HIV-positive cases, operate in peri-
urban areas, where the drug traffic is uncontrolled.
Therefore, the opportunity for both diseases, HIV and
leishmaniasis, to overlap in these areas is optimized
(Alvar, 1994).  Tremblay et al. (1996) reviewed
Leishmania and the pathogenesis of HIV infection
based on the recently reported information on the puta-
tive cofactor role that the intracellular pathogen of the
genus Leishmania may play in the pathogenesis of HIV
infection.  They commented that as both Leishmania
and HIV can invade and replicate within macrophages,
it is possible that interactions between both pathogens
may exacerbate the process of Leishmania infection;
thus, co-infection with Leishmania in HIV infected
subjects may affect the pathogenesis of both AIDS and
leishmaniasis diseases.  Therefore, the medical com-
munity should be alerted to the inevitable rise in HIV
and Leishmania co-infections in endemic areas and to
potential interactions between these infectious agents
(Tremblay et al., 1996). 
Yoshihisa Hashiguchi,
Eduardo A. Gomez L.
References
1. Altes, J., Salas, A., Riera, M., Udina, M., Galmes,
A., Balazat, J., Ballesteros, A., Buades, J., Salva,
F. and Villalonga, C., 1991. Visceral leishman-
iasis: another HIV-associated opportunistic infec-
4Trop. Med. Hyg., 41, 687-725.
9. Hashiguchi, Y. , 1996.  Leishmaniasis: its chang-
ing pattern and importance as an imported disease.
Int. Med., 35, 434-435.
10. Kemp, M., 1997. Regulator and effector functions
of T-cell subsets in human Leishmania infections.
Acta Pathol.  Microbiol. Immunol. Scand.
(APMIS), 105, Suppl. No. 68, 1-33.
11. Lockwood, D.N.J., 1991. Sudan: kala-azar should
be in the news. Lancet, 338, 624-625.
12. Olliaro, P.L. and Bryceson, A.D.M., 1993.
Practical progress and new drugs for changing pat-
terns of leishmaniasis. Parasitol. Today, 9, 323-
328.
13. Tremblay, M., Olivier, M. and Bernier, R., 1996.
Leishmania and the pathogenesis of HIV infection.
Parasitol. Today, 12, 257-261.
14. WHO, 1995. Tropical disease research. 10.
Leishmaniasis. TDR Programme Rep., 12, 135-
146.
15. Ziljstra, E.E., Siddig, A.M., El-Hassan, A.M., El-
Toum, I.A., Satti, M., Gharlib, H.W., Sondorp,
E. and Winkler, A., 1991. Kala-azar in displaced
people from southern Sudan: epidemiological, clin-
ical and therapeutic findings.  Trans. Roy. Soc.
Trop. Med. Hyg., 85, 365-369.
tions ? Report of eight cases and review of the lit-
erature. AIDS,  5,  201-207.
2. Alvar, J., 1994. Leishmaniasis and AIDS co-infec-
tion: the Spanish example.  Parasitol. Today, 10,
160-163.
3. Alvar, J., Blazquez, J. and Najera, R., 1989.
Association of visceral leishmaniasis and human
immunodeficiency infections. J. Infect. Dis., 160,
560 (letter).
4. Ashford, R.W., Desjeux, P. and Raadt de, P., 1992.
Estimation of population at risk of infection and
number of cases of leishmaniasis. Parasitol. Today,
8, 104-106.
5. Dhanda, V., Das, P.K. and Lal, R., Srinivasan,
R. and Ramaiah, K.D., 1996. Spread of lymphat-
ic filariasis, re-emergence of leishmaniasis and
threat of babesiosis in India.  Indian J. Med. Res.,
103, 46-54.
6. Gorgolas de, M. and Miles, M.A., 1994. Visceral
leishmaniasis and AIDS. Nature, 372, 33.
7. Gradoni, L. and Gramiccia, M., 1994. Leishmania
infantum tropism: strain genotype or host immune
status ? Parasitol. Today, 10, 264-267.
8. Grimaldi, G. Jr., Tesh, R.B. and McMahon-Pratt,
D., 1989. A review of the geographic distribu-
tion and leishmaniasis in the New World. Am. J.
5Introduction
DNA karyotype analysis is important for under-
standing chromosomal organization in eukaryote cells.
For this purpose pulsed field agarose gel elec-
trophoresis technique has been introduced for sepa-
ration of chromosomal DNAs in yeast (Schwartz and
Cantor, 1984) and parasitic protozoa including
Trypanosoma (Van der Ploeg et al., 1984), Leishmania
(Spithill and Samaras, 1995) and Plasmodium (Kemp
et al., 1985).
In Leishmania, DNA karyotype is, in general, high-
ly variable between species and strains (reviewed by
Bastien et al., 1992; Lighthall and Giannini, 1992).
Nevertheless, when molecular karyotype of certain
strains showed extensive similarity, karyotype analy-
sis is still useful for identification of Leishmania
species and grouping of different isolates.  In this
respect we have reported on karyotype homogeneity
among L. (L.) mexicana isolates in the Andean moun-
tain regions in Ecuador (Katakura et al., 1993, 1994),
strongly suggesting a common geographic origin of
the parasites.  On the contrary, DNA karyotypes of L.
(V.) panamensis strains in the Pacific coastal regions
in Ecuador were variable although we examined only
three isolates from different areas of the northern part
of Ecuador; Quininde, Zapallo Grande and Santo
Domingo (Katakura et al., 1992, 1993).  The results
indicated the complexity and diversity of L. (V.) pana-
mensis in the Pacific coast of Ecuador.  In this study
we analyzed additional 14 Leishmania isolates from
patients at 6 different new endemic areas for further
understanding of distribution and variation of
Leishmania species in the Pacific coastal regions in
Ecuador.
Chapter 2
Parasitology and Vector Entomology
1. Karyotype Analysis of Leishmania (Viannia) panamensis Isolated 
from Cutaneous Leishmaniasis Patients at the Pacific Coastal 
Regions in Ecuador
ABSTRACT. DNA karyotype of Leishmania isolates from cutaneous leishmaniasis patients at nine
endemic areas in the Pacific coast of Ecuador was analyzed by pulsed field gel electrophoresis.  All
of 17 isolates, even isolates at the same endemic area exhibited different chromosomal DNA banding
patterns.  The size variation in the chromosomal DNAs was evident particularly in chromosomes between
400 and 800 kb.  However, DNA bands of approximately 230, 350, 800 and 850 kb appeared to be
conserved among these isolates.  Since a similar DNA karyotype has been reported for the Leishmania
(Viannia) braziliensis complex as well as three Ecuadorian L. (V.) panamensis isolates previously iden-
tified, these isolates in this study probably belong to L. (V.) panamensis.  With regard to DNA kary-
otypes in Leishmania in Ecuador, it is worth to note that karyotype variation was evident among L.
(V.) panamensis isolates in the Pacific coastal regions while karyotype homogeneity was detected in
L. (L.) mexicana isolates in the Andes mountain regions (Katakura et al., 1993, 1994).
Table 1.1.1. Leishmania isolates used in the present study
Species Designation Geographic origin Abbreviation
Ecuadorian isolates
L. (V.) panamensis
MHOM/EC/87/G05 Quininde (QN) G5
MHOM/EC/87/G06 Zapallo Grande (ZG) G6
MHOM/EC/87/G07 Santo Domingo (SD) G7
L. (V.) panamensis?
MHOM/EC/90/EM50 El Moral (EM) EM50
MHOM/EC/90/EM52 El Moral EM52
MHOM/EC/90/PE130 Paraiso Escondido (PE) PE130
MHOM/EC/90/PQ91 Puerto Quito (PQ) PQ91
MHOM/EC/90/PR88 Paraiso (PR) PR88
MHOM/EC/90/PV1 Portoviejo (PV) PV1
MHOM/EC/90/PV10 Portoviejo PV10
MHOM/EC/90/PV12 Portoviejo PV12
MHOM/EC/90/PV19 Portoviejo PV19
MHOM/EC/90/PV156 Portoviejo PV156
MHOM/EC/90/PV158 Portoviejo PV158
MHOM/EC/90/PV159 Portoviejo PV159
MHOM/EC/90/SG13 San Gabriel (SG) SG13
MHOM/EC/90/SG16 San Gabriel SG16
WHO reference strains
L. (V.) panamensis MHOM/PA/71/LS94 Canal Zone, Panama LS94
L. (V.) guyanensis MHOM/BR75/M4147 Para, Brazil M4147
L. (V.) braziliensis MHOM/BR/75/M2904 Para, Brazil M2904
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Materials and Methods
Parasites
Detail designations and geographic origins of
Leishmania isolates in Ecuador and WHO reference
strains used in the present study are shown in Table
1.1.1 and Figure. 1.1.1.  Three Ecuadorian isolates,
MHOM/EC/87/G05, G06 and G07 have been previ-
ously identified as L. (V.) panamensis by isoenzyme
electrophoresis, monoclonal antibodies and kinetoplast
DNA fingerprints (Mimori et al., 1989, 1990).  Parasite
isolation was performed by aspiration of the margins
of active skin lesions from patients followed by inoc-
ulation of the biopsy samples into culture tubes with
biphasic human blood agar based USAMRU medium
(Difco blood agar medium).  Promastigotes grown in
the medium at 25? were collected after several pas-
sages and cryopreserved in the liquid nitrogen before
use.
Figure 1.1.1. Geographic locations of Leishmania
isolates in Ecuador used in this study. The shaded area
on map indicates the Andean highland region more
than 1000 meters above sea level. EM, El Moral; PE,
Paraiso Escondido; PQ, Puerto Quito; PR, Paraiso; PV,
Portoviejo; QN, Quininde; SD, Santo Domingo; SG,
San Gabriel; ZG, Zapallo Grande
7Pulsed field agarose gel electrophoresis (PFGE)
Pulsed field agarose gel electrophoresis was per-
formed as described previously (Katakura et al., 1992,
1993).  Cryopreserved promastigotes were thawed and
grown in USAMRU medium.  An agarose block con-
taining 1 x 107 promastigotes was made and treated
with 1 mg/ml proteinase K (Sigma, St.  Louis, MO)
and 1% sarcosyl (Sigma, St.  Louis, MO) in 0.5 M
EDTA, pH 8.0 at 50? for 2 days.  The resultant
agarose blocks were electrophoresed in 1.5 % agarose
at 180 V in 0.5 x TBE (TBE = 90 mM Tris, 90 mM
boric acid and 2 mM EDTA, pH 8.0) at 12? with a
pulse interval of 60s for 36 hr using a turn-table type
pulsed field gel electrophoresis apparatus (ATTO
Corp., Tokyo, Japan).  The gel was stained with 0.5
?g/ml ethidium bromide in 0.5 x TBE for 20 min,
destained with 0.5 x TBE for 30 min and photographed.
Yeast chromosomal DNAs of Saccharomyces cerevisiae
(FMC, Rockland, ME) were used as the molecular
standard.  Diagrams of DNA karyotypes of the iso-
lates were designed by analyzing photographs of PFGE
gels.
Results
Chromosomal DNAs under 1000 kb were resolved
in our pulsed field gel electrophoresis conditions.  The
PFGE revealed chromosomal DNAs of 14 Leishmania
isolates at six endemic areas in the Pacific coastal
regions; El Moral, Paraiso Escondido, Puerto Quito,
Paraiso, Portoviejo and San Gabriel (Figs. 1.1.1 and
1.1.2).  Diagrams of chromosomal DNA bands of a
total of 19 Leishmania isolates including three
Ecuadorian L. (V.) panamensis isolates (MHOM/EC
/87/G05, G06 and G07) and three WHO reference
strains such as L. (V.) panamensis (MHOM/PA/71
/LS94), L. (V.) guyanensis (MHOM/BR/75/M4147)
and L. (V.) braziliensis (MHOM/BR/75/M2904) are
presented in Figure 1.1.3.  A diagram of DNA bands
of the PV10 isolate was not shown because of poor
separation (Fig. 1.1.2).
Small chromosomes under 400 kb were well sep-
arated and two chromosomal bands of approximately
230 and 350 kb appeared to be common among
Ecuadorian isolates as well as L. (V.) panamensis and
L. (V.) guyanensis reference stains (arrows in Fig.
1.1.3).  A small DNA band under 200 kb was observed
in four isolates of PV12, PE 130, EM50 and SG16
as well as L. (V.) braziliensis M2904.  In L. (V.) pana-
mensis G5 and G7, the smallest chromosomal band
formed a doublet (Fig. 1.1.3; Katakura et al., 1993).  
Medium-sized DNA bands of 400-800 kb were
variable in size among isolates and showed the size
complexity.  However, the DNA banding patterns of
the isolates from the same endemic area were much
similar than those from different areas, as seen in iso-
Figure 1.1.2. Separation of chromosomal DNAs of
Leishmania isolates by pulsed field gel electrophore-
sis using 1.5% agarose gel run at 180 V with a 60-sec
pulse time for 36 hr.
PV1, MHOM/EC/90/PV1; PV10, MHOM/EC/90/PV10;
PV12, MHOM/EC/90/PV12; PV19, MHOM/EC/90/
PV19; PV156, MHOM/EC/90 /PV156; PV158, MHOM/
EC/90/PV158; PV159, MHOM/EC/90/PV159; EM50,
MHOM/EC/90/EM50; EM52, MHOM/EC/90/EM52;
SG16, MHOM/EC/90 /SG16; SG13, MHOM/EC/90/
SG13; LS94, L. (V.) panamensis (MHOM/PA/71/
LS94); M4147, L. (V.) guyanensis (MHOM/BR75/
M4147); M2904, L. (V.) braziliensis (MHOM/BR/75/
M2904); PE130, MHOM /EC/90/PE130; PQ91, MHOM/
EC/90/PQ91; PR88, MHOM/EC/90/PR88; G6, L. (V.)
panamensis (MHOM /EC/90/G06); M, Saccharomyces
cerevisiae as the molecular standard.
8in this study were very similar to those of L. (V.) pana-
mensis isolated from Panama and Ecuador, thereby
these isolates appear to belong to L. (V.) panamen-
sis.  ELISA analysis of sera from the leishmaniasis
patients also suggested that the patients were infect-
ed with L. (V.) panamensis (see Chapter 2-2 in this
text).  Furthermore, isoenzyme analysis was unable to
distinguish L. (V.) panamensis from L. (V.) guyanen-
sis isolates in Ecuador (unpublished data).
Intraspecific karyotype variation is a common fea-
ture in almost all Leishmania species including L. (L.)
major (Giannini et al., 1986), L. (L.) infantum (Bishop
and Miles, 1987; Pages et al., 1989), L. (L.) donovani
(Bishop and Miles, 1987), L. (L.) chagasi (Bishop and
Miles, 1987), L. (V.) panamensis (Giannini et al.,
1986), L. (L.) amazonensis (Scholler et al., 1986) and
L. (V.) peruviana (Dujardin et al., 1993b).  DNA kary-
otype variation of L. (V.) panamensis isolates in the
Pacific coastal regions in Ecuador also indicated the
genetic diversity of this species.  A great diversity
of mammalian reservoir hosts and possible sand fly
vectors in the lowlands in Ecuador may be related to
the diversity of the parasites (Hashiguchi and Gomez,
1991).  However, mechanisms of polymorphisms on
the size and number of the chromosomal bands
between different strains are poorly understood
Figure 1.1.3. Diagrams of chromosomal DNAs of Leishmania isolates. For designations of each isolate,
see Table 1.1.1 and Figure 1.1.2. M, the molecular standard.
lates of PV1, PV12, PV19, PV156, PV158 and PV159
at Portoviejo (Figs. 1.1.2 and 1.1.3).  In addition, two
DNA bands of approximately 800 and 850 kb were
clearly separated and seem to be conserved in all iso-
lates (arrow heads in Fig. 1.1.3).
Discussion
In this study we examined DNA karyotypes of a
total of 17 Leishmania isolates from cutaneous
leishmaniasis patients at 9 endemic areas of the cen-
tral and northern part of the Pacific coastal regions
in Ecuador (Fig. 1.1.1).  The results revealed that DNA
karyotypes of the isolates were variable but chromo-
somal DNA bands of approximately 230, 350, 800 and
850 kb seem to be common to all isolates (Fig. 1.1.3).
Sizes of conserved chromosomal bands are somewhat
smaller than those reported by Dujardin et al.  (1993a),
who analysed molecular karyotype of 45 reference
strains and stocks representative of the New World
Leishmania by pulsed field gel electrophoresis.  They
found a unique set of size-conserved chromosomal
bands of 295, 405 and 900 kb in the braziliensis com-
plex and of 350 and 930 kb in the mexicana com-
plex.  The DNA karyotypes of Leishmania isolates
9although DNA deletion and amplification may account
for some of DNA size modification (Bastien et al.,
1992).
Ken Katakura,
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Introduction
In Ecuador, New World leishmaniases are wide-
ly distributed in areas from the Pacific coastal and
Amazonian lowland regions to the Andean highland
regions.  In our consecutive survey of the disease, the
first Leishmania strain was isolated from wild mam-
mals in 1982 (Hashiguchi et al., 1985).  During the
past 14 years, 125 Leishmania strains have been iso-
lated from patients, reservoir hosts and sandfly vec-
tors in the 13 different provinces of this country.
Among these stocks, 30 isolates have been already
identified as L. (Leishmania) amazonensis, L. (L.) mex-
icana, L. (Viannia) braziliensis, L. (V.) panamensis, L.
(L.) major-like, and L. (V.) equatorensis by zymodeme,
schizodeme and serodeme analyses (Mimori et al., 1989;
Hashiguchi et al., 1991; Grimaldi et al., 1992; Katakura
et al., 1993, 1994).  However, the classification of
species of most isolates has been left unsolved.
Species- and/or subspecies-specific monoclonal
antibodies have been developed for characterization
and identification of Leishmania species (McMahon-
Pratt and David, 1981; McMahon-Pratt et al., 1982,
1985; Anthony et al., 1985; Grimaldi et al., 1987).
Thus, we took advantage of the serodeme analysis
by ELISA for classification of Ecuadorian isolates.
The present paper deals with the reactivities of 125
Ecuadorian stocks to species-specific monoclonal anti-
bodies.
Materials and Methods
Parasites
As standard strains, 7 WHO reference strains of
New World Leishmania and 2 Ecuadorian reference
strains, L. (V.) equatorensis and L. (L.) major-like,
were also used in this experiment (Table 2.2.1).
Ecuadorian isolates used in this experiment were as
follows: 111 isolates from patients; 6 from wild mam-
mals and a domestic dog; and 8 from sand flies.  The
clinical and epidemiological data of these isolates
are given in Tables 2.2.2 to 2.2.4.
Preparation of antigens for ELISA
The isolates were cultured with Schneider's medi-
um containing 15% heat-inactivated fetal bovine
serum.  The harvested promastigotes were washed
by centrifugation with phosphate buffered saline solu-
tion.  The washed parasites were immediately sus-
pended in lysis buffer (10 mM Tris-HCl, pH 7.5;
containing 2 mM EDTA, 1.6 mM phenyl methyl sul-
fonyl fluoride, 2 mM iodoacetoamide, 100?g/ml leu-
peptin).  After sonication of the material for one min,
the cell homogenate was centrifuged at 1600 x g for
10 min.  The supernatant was adjusted to 10?g pro-
tein concentration per ml with coating buffer.
Monoclonal antibodies
Eight monoclonal antibodies, namely B4, B11,
B16, B18, B19, M8, T3/M13, and 7H9, were used in
2. Identification of Species of Ecuadorian Leishmania 
Isolates by ELISA using Monoclonal Antibodies
ABSTRACT. One hundred twenty five Ecuadorian Leishmania stocks isolated from human, reservoir hosts
and sandfly vectors at 40 different areas of the 13 provinces were classified into 7 groups with 9 species-
specific monoclonal antibodies and ELISA technique.  Eighty nine of 125 isolates were identified as Leishmania
(Viannia) panamensis, 15 strains as L. (Leishmania) mexicana, 4 strains as L. (L.) amazonensis, 4 strains as
L. (V.) braziliensis, 3 strains as L. (L.) major-like, and 3 strains as L. (V.) equatorensis.  Clear-cut answer
on the classification was not obtained from 7 isolates.
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this experiment.  Furthermore, A1 monoclonal anti-
body was newly prepared in our laboratory accord-
ing to the Köhler and Milstein method (1975), using
P3U1 myeloma cells.  The specificity and character-
ization of A1 monoclonal antibody will be described
elsewhere.
ELISA
ELISA was carried out with the microwell ELISA
mate® Kit for peroxidase conjugate (Kirkegaard &
Perry Laboratory, USA).  The wells of 96-well poly-
styrene microplate (Falcon, USA) were coated with
100?l of the antigen solutions at 4? overnight.  After
blocking with BSA solution of the Kit, each well was
incubated with 9 monoclonal antibodies at 37? for
1hr.  The wells were then washed 5 times with wash
solution of the Kit by microplate washer, automati-
cally, and 100?l of peroxidase conjugated rabbit anti-
mouse immunoglobulins (Dako, Denmark) was applied
each well.  The plate was incubated for 1 hr at 37?.
After washing, the mixture of ABTS peroxidase sub-
strate and H2O2 solution of the Kit was added to each
well, and incubated 30 min at 37?.  The reaction was
stopped by adding of stop solution of the Kit.  The
absorbent at 405 nm was measured using microplate
reader and the relative ratio against negative control
was calculated.  Values over 10 were considered pos-
itive.
Results
In the first step of this study, the reactivities of 9
monoclonal antibodies in total to WHO and Ecuadorian
reference strains were examined by ELISA.  The
results are shown in Table 2.2.1.  The monoclonal anti-
bodies used in this study showed a high and consis-
tent qualitative specificity at species level of reference
strains.  For instant, B4 and B11 for L. (V.) pana-
mensis; B16 and B18 for L. (V.) braziliensis; B19 for
L. (V.) guyanensis; A1 for L. (L.) amazonensis; M8
for L. (L.) mexicana; 7H9 for L. (V.) equatorensis.  On
the other hand, all monoclonal antibodies, except for
T3/M13, used in this study did not show a high and
consistent qualitative specificity against L. (L.) major-
like strains.
To check the availability of these monoclonal anti-
bodies to Ecuadorian parasites, the reactivities of these
monoclonal antibodies against 30 known Ecuadorian
strains, which have been previously identified as L.
(L.) amazonensis, L. (L.) mexicana, L. (V.) brazilien-
sis, L. (V.) panamensis, L. (L.) major-like, and L. (V.)
equatorensis, were also tested.  The species-specificity
of the present monoclonal antibodies against the
Ecuadorian strains was very high as well as that against
the reference stains, except for 5 L. (L.) mexicana
strains.
Based on the reactive pattern of reference strains
to these monoclonal antibodies, 125 isolates were clas-
sified by ELISA tests.  As shown in Tables 2.2.1 to
2.2.4,  89 of 125 isolates were classified as L. (V.)
panamensis, 15 strains as L. (L.) mexicana, 4 strains
as L. (L.) amazonensis,  4 strains as L. (V.) brazilien-
sis, 3 strains as L. (L.) major-like, and 3 strains as
L. (V.) equatorensis.  Other 7 isolates did not give a
clear answer on the classification in this experiment.
In Ecuadorian L. (V.) panamensis strains, two reac-
tive patterns were observed.  One was very similar
to that of the reference strain, the other  reacted only
with B4.  Ratio of the latter reactive pattern was 6.7%
(6/89).  No or low reactivity of B18 monoclonal anti-
body was confirmed in 4 Ecuadorian L. (V.) brazilien-
sis strains.  B19 monoclonal antibody was very specific
for L. (V.) guyanensis of reference strain (Table 2.2.1).
However, no Ecuadorian isolates reacted with this anti-
body.  Consistent qualitative specificity of 7H9 mono-
clonal antibody was very high against L. (V.)
equatorensis of Ecuadorian reference strain. Three iso-
lates  reacted with this antibody. The two were iso-
lated from reservoir hosts, and the other one from
sandfly vector.  G-02 strain of L. (L.) amazonensis
reacted A1 and T3/M13 monoclonal antibodies.
However, other 3 strains, G-03, G-04, and INH-690,
reacted with both A1 and M8 monoclonal antibod-
ies.
Distribution of Leishmania parasites isolated from
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40 different endemic areas was summarized in Table
2.2.2. In Tables 2.2.3 and 2.2.4, furthermore, the sum-
mary of all the isolates obtained were arranged by the
clinical and parasitological data of patients, and the
species and isolation areas (locations)  of reservoir
hosts and sandfly vectors.
Discussion
A variety of molecular and biochemical methods
have been used for characterization and identification
of Leishmania species.  Species- and/or subspecies-
specific monoclonal antibodies have been developed
to characterize and identify the New World species of
Leishmania (McMahon-Pratt and David, 1981;
McMahon-Pratt et al., 1982, 1985;  Anthony et al.,
1985;  Grimaldi et al., 1987).  In this study, 9 mono-
clonal antibodies were used to classify Ecuadorian
Leishmania isolates by ELISA method. Among these
monoclonal antibodies, the availability  of B4, B11,
B16, B18, B19 and M8 monoclonal antibodies against
Table 2.2.1. Reactivities of Leishmania species-specific monoclonal antibodies to reference strains and 
selected Ecuadorian Leishmania isolates
Monoclonal antibodies
Designation Species B4 B11 B16 B18 B19 A1 M8 7H9 T3/M13
WHO reference strains
MHOM/BR/75/M2904 L. (V.) braziliensis 0.9 0.4 48.8 44.7 1.4 0.4 1.3 8.2 8.1
MHOM/PA/71/LS94 L. (V.) panamensis 52.3 39.3 2.8 0.3 1.1 0.1 0.9 0.7 6.4
MHOM/BR/75/M4147 L. (V.) guyanensis 1.1 0.8 5.0 1.1 31.7 0.4 1.0 0.8 7.7
MHOM/BR/73/M2269 L. (L.) amazonensis 0.1 0.3 1.7 0.1 0.3 19.5 1.3 1.0 4.5
MHYC/BZ/62/M379 L. (L.) mexicana 0.1 0.1 0.8 0.1 0.1 0.3 25.2 0.1 31.0
MHOM/BR/74/PP75 L. (L.) chagasi 0.3 0.2 3.7 0.3 1.0 0.2 0.7 1.6 5.8
MHOM/SU/73/5ASKH L. (L.) major 1.0 0.6 7.7 1.5 3.2 0.7 4.1 1.8 59.2
Ecuadorian reference stains
MCHO/EC/82/Lsp-1 L. (V.) equatorensis 0.1 0.1 0.7 0.1 0.1 0.1 0.1 35.1 36.7
MHOM/EC/87/G-09 L. (L.) major-like 0.6 0.1 3.1 0.8 1.4 0.1 1.1 0.4 55.9
Ecuadorian isolates
MHOM/EC/87/G-07 L. (V.) panamensis 56.7 51.2 4.4 1.5 2.5 0.7 1.6 2.1 6.4
MHOM/EC/90/SG-13 L. (V.) panamensis 53.5 28.1 5.4 0.8 1.8 0.2 0.9 1.4 5.5
MHOM/EC/90/PV-158 L. (V.) panamensis 30.5 6.1 5.7 1.3 2.3 0.2 0.8 1.2 3.7
MHOM/EC/88/TA-1 L. (V.) braziliensis 6.1 1.5 28.9 1.8 1.5 1.6 2.1 2.1 1.8
MHOM/EC/88/INH-03 L. (V.) braziliensis 5.8 1.8 27.3 8.0 2.1 1.3 1.4 2.2 2.5
MHOM/EC/90/EC-50 L. (V.) braziliensis 3.4 1.1 46.5 2.7 4.0 1.1 2.9 0.9 1.6
MSCI/EC/87/G-02 L. (L.) amazonensis 0.9 1.1 2.0 1.2 1.6 14.8 3.2 9.2 14.1
MPOT/EC/87/G-03 L. (L.) amazonensis 1.2 0.4 2.8 0.9 1.7 55.6 16.4 1.0 6.5
MHOM/EC/88/PT-001 L. (L.) mexicana 1.1 0.6 4.9 1.0 1.0 1.7 30.0 1.0 35.8
MHOM/EC/89/AL-1 L. (L.) mexicana 1.3 1.4 3.8 1.6 1.7 1.9 11.3 4.5 58.0
MHOM/EC/92/HU-01 L. (L.) mexicana 1.5 1.3 2.7 1.4 1.5 1.8 7.3 1.4 19.3
MHOM/EC/88/PT-115 L. (L.) major-like 1.2 1.4 3.1 1.5 1.7 2.0 3.1 1.8 24.3
IHAR/EC/93/OC-4 L. (V.) equatorensis 1.7 1.9 1.8 1.6 2.6 1.1 2.2 47.6 58.2
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Table 2.2.2. Leishmania species isolated from the 13 different provinces and its provenance
details
Province Species Locality (No. of isolates)
ESMERALDAS
L. (L.) amazonensis Muisne(1)
L. (V.) panamensis Quininde(1), Zapallo Grande(1), 5 de Junio(1)
L. (L.) major-like Quininde(1)
MANABI
L. (V.) panamensis Calceta(3), Calderon(2), El Calmen(1),
El Moral(13), H. Vasquez(1), Portoviejo(6),
Progreso(7), San Gabriel(19), San Placido(1),
San Sebastian(2)
LOS RIOS
L. (V.) panamensis 6 de Agosto(1), Quevedo(1)
L. (L.) amazonensis Palenque(2)
GUAYAS
L. (V.) panamensis El Triunfo(1), Manglaralto(1), Milagro(1),
Naranjal(6), Olon(4), Pascuales(1), Puerto Inca(1)
L. (V.) equatorensis Naranjal(2)
EL ORO
L. (V.) panamensis Santa Rosa(1)
PICHINCHA
L. (V.) panamensis Sto. Domingo(1), Puerto Quito(4), Paraiso(1),
24 de Mayo(4)
BOLIVAR
L. (L.) amazonensis Echeandia(1)
L. (V.) panamensis Caluma(1)
CHIMBORAZO
L. (L.) mexicana Alausi(2), Huigra(2)
? Alausi(1), Huigra(3)
CAÑAR
L. (V.) equatorensis Ocaña(1)
? Ocaña(2)
AZUAY L. (L.) mexicana Dug Dug(1), Paute(10)
L. (L.) major-like Paute(2)
? Paute(1)
NAPO
L. (V.) braziliensis El Coca(1)
MORONA SANTIAGO 
L. (V.) braziliensis Taisha(1)
ZAMORA CHINCHIPE
L. (V.) braziliensis El Chorro(1), La Chonta(1)
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L. (V.) panamensis, L. (L.) mexicana and L. (L.) major-
like species of Ecuadorian strains has been demon-
strated by Mimori et al. (1989) and Hashiguchi et al.
(1991), using indirect radioimmune binding assay tech-
nique.  Species specificity of 7H9 monoclonal anti-
body to L. (V.) equatorensis has been also reported by
Terabe et al. (1994), using ELISA method.  From
our experiment used 30 known Ecuadorian strains
which have been identified at species level by other
methods, it was appeared that the present monoclonal
antibodies were useful for classification of Ecuadorian
Leishmania parasites.  Based on the results obtained
from ELISA-monoclonal antibodies technique, 119 of
125 isolates were classified as L. (V.) panamensis,
L. (L.) mexicana, L. (L.) amazonensis, L. (V.) brazilien-
sis, L. (L.) major-like, and L. (V.) equatorensis.  On
the other hand, only 7 isolates did not give a clear
answer on the classification in this experiment.
However, from the reactive pattern in ELISA and iso-
lation area of these 7 organisms, it is assumed that
they belong to L. (L.) mexicana or L. (L.) major-like.
For further clarification of species of the isolates,  the
preparation of  monoclonal antibody to L. (L.) major-
like is now in progress.
In the column of “species by ELISA”,  Lm-l: L. (L.) major-like, Lp: L. (V.) panamensis, Lb: L. (V.) brazilien-
sis, La: L. (L.) amazonensis, Lm: L. (L.) mexicana, Leq: L. (V.) equatorensis. In the column of “site of lesions”,
FA: face, A: arm, A(w): arm (wrist), A(b) : arm (back side), H: hand, FO: foot, FO(b): foot (back side), S:
shoulder, BO: body, BO(b): body (back side), N: neck, N(b): neck (back side).  In the column of “type of
lesions”, U: ulcer, N: nodule, E: erythema, P: papule, L: lymphadenopathy, NF: not found of lymphadenopathy,
NM: not measured, ND: not done.
Table 2.2.3. Summary of  clinical and parasitological data of  patients from whom Leishmania stocks
were isolated at different endemic areas in Ecuador
MHOM/EC/86/Paute Lm-l 4 M 1 3x5 A U, L:NF 5 + Paute
MHOM/EC/87/G-05 Lp 20 F 2 10x8,15x12 A U, 4 + Quininde
L:generalized
MHOM/EC/87/G-06 Lp 21 M 1 25x9 A U, L:NF 2 + Zapallo Grande
MHOM/EC/87/G-07 Lp 38 F 1 30x27 A U, L:NF 3 + Sto. Domingo
MHOM/EC/87/G-09 Lm-l 18 F 1 10x10 FO U, L:NF 4 + Quininde
MHOM/EC/88/INH-01 Lp 27 M 1 30x30 A U, L:localized 2.5 + Naranjal
MHOM/EC/88/INH-02 Lp 41 M 1 10x10 H U, L:generalized 4 + Santa Rosa
(large)
MHOM/EC/88/INH-03 Lb 23 M 1 30x30 A U, L:NF 3 + El Coca
MHOM/EC/88/INH-04 Lp 17 M 7 40x40, 30x30, FA, S, U L:NF 1.5 + Puerto Inca
10x10(4), BO(b),
15x15 FO(b)
MHOM/EC/88/INH-08 Lp 25 F 1 30x17 A(w) U, L:positive 3 + 5 de Junio
MHOM/EC/88/INH-10 Lp 19 M 1 25x20 A(w) U, L:positive 3 ND Olon
MHOM/EC/88/INH-11 Lp 22 M 1 30x30 A(w) U, L:positive 4 ND Olon
MHOM/EC/88/INH-12 Lp 21 M 1 20x15 A(w) U, L:NF 4 ND Olon
MHOM/EC/88/INH-13 Lp 21 M 4 20x30(3), A, FO U, L:NF 4 ND Olon
10x10
Designation Age
Species
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No. and size
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MHOM/EC/88/INH-17 Lp 30 M 2 20x15, 15x15 BO U, L:NF 3 ND Puerto Quito
MHOM/EC/88/INH-21 Lp 16 M 5 10x10, 5x5(2), H U, L:positive 1 ND El Triunfo
3x3(2) (axilla)
MHOM/EC/88/INH-23 LP 28 F 11 40x40, 20x30, FA, BO, U, E 2 ND Pascuales
20x20, less than A(b)
5x5(8)
MHOM/EC/88/INH-29 LP 28 F 2 21x15, 15x15 FO U, L:NF 4 ND 6 de Agosto
MHOM/EC/88/INH-30 Lp 22 M 2 35x25, 25x15 FO, FA U, L:NF 3 ND EL Carmen
MHOM/EC/88/INH-36 Lp 1 F 1 5x5 H U, L:NF 1 ND Milagro
MHOM/EC/88/INH-37 Lp 25 M 2 10x13, 8x5 H, FO U, L:localized 2 ND Quevedo
MHOM/EC/88/INH-38 Lp 29 M 7 5x5(7) FA, H, U, L:NF 3 ND Caluma
FO
MHOM/EC/88/PT-001 Lm 5M M 2 4x3, 5x4 FA N, L:NF 4 ND Paute
MHOM/EC/88/PT-006 Lm 11M M 1 15x10 FA U, L:NF 7 ND Paute
MHOM/EC/88/PT-007 Lm 11M F 1 3x7 FA P, L:NF 9 ND Paute
MHOM/EC/88/PT-023 Lm 10M M 4 5x5, 2x2, 1x1(2) FA P, L:NF 4 + Paute
MHOM/EC/88/PT-024 Lm 11M M 2 2x2(2) FA P, L:NF 9 ND Paute
MHOM/EC/88/PT-025 Lm 5M M 1 2x3 FA P, L:NF 4 ND Paute
MHOM/EC/88/PT-027 Lm 10M F 3 3x3(3) FA P, L:NF 8 ND Paute
MHOM/EC/88/PT-027 Lm 10M F 3 3x3(3) FA P, L:NF 8 ND Paute
MHOM/EC/88/PT-029 Lm 9M F 5 4x4, 2x2(2), FA P, L:NF 2 ND Paute
1x1(2)
MHOM/EC/88/PT-103 Lm 5 F 1 3x3 FA P, L:NF 4 ND Paute
MHOM/EC/88/PT-115 Lm-l 8 M 1 4x4 FA P, L:NF 5 ND Paute
MHOM/EC/88/TA-1 Lb 13 M 1 25x25 FA U, L:localized 1 ND Taisha
MHOM/EC/89/AL-1 Lm Alausi
MHOM/EC/90/DD-35 Lm 1 M 1 4x3 FA N, L:NF 6 ND Dug Dug
MHOM/EC/90/EC-50 Lb 40 M 1 40x60 A(b) N, L:NF 1 ND El Chorro
MHOM/EC/90/EM-49 Lp 8 M 1 NM FO U, L:NF 2 ND El Moral
MHOM/EC/90/EM-52 Lp 4 M 1 NM FO U, L:NF 3 ND El Moral
MHOM/EC/90/EM-53 Lp 6 MM 3 NM FA U, L:NF 3 ND El Moral
MHOM/EC/90/EM-54 Lp 18 F 10 NM FA, A, E U, L:NF 2 ND El Moral
MHOM/EC/90/EM-55 Lp 15 F 5 NM A, FO, U, L:NF 1 ND El Moral
BO, E
MHOM/EC/90/EM-57 Lp 17 F 2 NM A U, L:NF 0.5 ND El Moral
MHOM/EC/90/EM-58 Lp 15 F 2 NM FO U, L:NF 2 ND El Moral
MHOM/EC/90/EM-59 Lp 30 F 2 NM FA, U, L:NF 3 ND El Moral
BO(b)
MHOM/EC/90/EM-60 Lp 19 F 2 NM A, FO U, L:NF 6 ND El Moral
Designation Age
Species
by
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MHOM/EC/90/EM-64 Lp 10 M 1 NM FA U, L:NF 1 ND El Moral
MHOM/EC/90/INH-690 La 19 M lot all U, N(diffuse) - Muisne
MHOM/EC/90/INH-785 Lp 23 M 3 13x13, 5x5, FA, N, U, L:NF ? + Manglaralto
3x3 A(w)
MHOM/EC/90/INH-932 Lp
MHOM/EC/90/LC-47 Lb 35 M 1 60x70 BO(b) U, L:positive 5 ND La Chonta
MHOM/EC/90/P0-02 Lp 7 M 2 10x5, 5x5 H U, L:localized 2 ND H. Vasquez
MHOM/EC/90/PE-130 Lp 4M F 4 10x5(4) A, FO U, L:NF 2 ND Puerto Quito
MHOM/EC/90/PQ-91 Lp 18 F 1 10x15 A U, L:NF 3 + Puerto Quito
MHOM/EC/90/PR-88 Lp 10 M 1 10x10 A U, L:NF 8 ND Paraiso  
MHOM/EC/90/PV-001 Lp 13 F 2 15x10, 5x5 FA, FO U, L:NF 2 ND El Moral
MHOM/EC/90/PV-002 Lp 7 F 2 10x5, 5x5 H U, L:localized 2 ND El Moral
MHOM/EC/90/PV-004 Lp 1 M 3 10x15, 5x5, 2x3 FA, H U, L:positive 3 ND El Moral
MHOM/EC/90/PV-006 Lp ? F 7 NM FA, A U, L:NF 0.5 ND San Gabriel
MHOM/EC/90/PV-010 Lp 20 M 1 10x20 A U, L:positive 3 ND Calderon
MHOM/EC/90/PV-012 Lp 28 F 1 20x15 A U, L:NF 1 ND Progreso
MHOM/EC/90/PV-018 Lp 45 F 3 20x10, 1x1, 3x2 ? U, L:NF 0.5 ND Calderon
MHOM/EC/90/PV-019 Lp 21 M 2 10x10, 6x5 ? U, L:NF 2 ND San Placido
MHOM/EC/90/PV-156 Lp 55 F 1 5x3 A U, L:NF 1 ND Portoviejo
MHOM/EC/90/PV-157 Lp 20 M 6 10x4(3), 7x5, A, FO U, L:NF 1 ND Portoviejo
5x3, 3x2
MHOM/EC/90/PV-158 Lp 20 F 2 20x10, 10x5 FA, U, L:NF 1 ND Calceta
BO(b)
MHOM/EC/90/PV-159 Lp 25 F 1 5x7 FO U, L:NF 4 ND Portoviejo
MHOM/EC/90/PV-160 Lp 16 M 1 10x7 A U, L:NF 2 ND Portoviejo
MHOM/EC/90/PV-161 Lp 17 M 1 3x4 A U, L:NF 1 ND Calceta
MHOM/EC/90/PV-162 Lp 22 M 3 15x7, 5x3, 3x2 A U, L:NF 3 ND Calceta
MHOM/EC/90/SG-04 Lp 5 F 23 NM FA, A, U, L:NF 8 ND San Gabriel
FO
MHOM/EC/90/SG-13 Lp 21 F 1 NM A U, L:positive 3 ND San Gabriel
MHOM/EC/90/SG-14 Lp 11 M 3 NM FA, A U, L:NF 2 ND San Gabriel
MHOM/EC/90/SG-16 Lp 7 F 5 NM FO, BO U, L:NF 3 ND San Gabriel
MHOM/EC/90/SG-17 Lp 14 M 3 NM A, BO U, L:NF 3 ND San Gabriel
MHOM/EC/90/SG-23 Lp 48 F 2 NM A(b) U, L:NF 2 ND San Gabriel
MHOM/EC/90/SG-24 Lp 15 F 3 NM FA, A U, L:NF 1 ND San Gabriel
MHOM/EC/90/SG-26 Lp 9 MM 4 NM FA, FO U, L:NF 2 ND San Gabriel
MHOM/EC/90/SG-27 Lp 10 F 1 NM FA U, L:NF 2 ND San Gabriel
MHOM/EC/90/SG-33 Lp 9 F 2 NM A U, L:NF 5 ND San Gabriel
MHOM/EC/90/SG-34 Lp 11 F 5 NM FA, FO U, L:NF 5 ND San Gabriel
Designation Age
Species
by
ELISA
Sex
No. size(mm)
No. and size
of lesions
Site
of
lesions
Type of
lesions and
lymphadenopathy
Duration
time
(months)
Skin
test Locality
Table 2.2.3. continued
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MHOM/EC/90/SG-35 Lp 7 M 1 NM H U, L:NF ? ND San Gabriel
MHOM/EC/90/SG-37 Lp 26 F 3 NM A(b) U, L:NF 1 ND San Gabriel
MHOM/EC/90/SG-39 Lp 1 F 1 NM FA U, L:NF 1 ND San Gabriel
MHOM/EC/90/SG-40 Lp 32 F 1 NM BO U, L:NF 2 ND San Gabriel
MHOM/EC/90/SG-44 Lp 35 M 4 NM A U, L:NF 3 ND San Gabriel
MHOM/EC/90/SG-45 Lp 12 M 1 NM FA U, L:positive 1 ND San Gabriel
MHOM/EC/90/SG-46 Lp 20 M 2 NM A U, L:NF 3 ND San Gabriel
MHOM/EC/90/VC-096 Lp 37 M 1 10x10 A U, L:NF 6 + 24 de Majo
MHOM/EC/90/VC-097 Lp 8 M 1 5x5 A U, L:localized 12 + 24 de Majo
MHOM/EC/90/VC-098 Lp 1 2M 2 3x4, 4x4 A U, L:NF 12 + 24 de Majo
MHOM/EC/90/VC-127 Lp 30 M 1 5x5 H U, L:NF 1 ND 24 de Majo
MHOM/EC/91/PV-136 Lp 45 F 1 25x20 A U, L:NF 3 + Portoviejo
MHOM/EC/91/PV-141 Lp 8 M 1 13x15 BO(b) U, L:NF 4 + Progreso
MHOM/EC/91/PV-142 Lp 8 M 4 10x8, 8x8, FA, A U, L:NF 3 + Progreso
8x7, 5x5
MHOM/EC/91/PV-143 Lp 36 F 1 35x30 FO U, L:positive 2 + San Sebastian
MHOM/EC/91/PV-144 Lp 18 F 2 25x15, 4x5 FA, A U, L:NF 7 + Portoviejo
MHOM/EC/91/PV-149 Lp 9 M 2 8x8, 3x3 FA U, L:NF 1 + Progreso
MHOM/EC/91/PV-158 Lp ND Progreso
MHOM/EC/91/PV-160 Lp ND Progreso
MHOM/EC/91/PV-172 Lp 7 M 2 12x10, 5x7 BO, FO U, L:positive 5 ND Progreso
MHOM/EC/91/PV-043 Lp 25 F 2 15x10, 10x10 A U, L:localized 4 + San Sebastian
MHOM/EC/91/PV-093 Lp ? M 1 40x30 H U, L:NF 2 + San Sebastian
MHOM/EC/92/HU-01 Lm 1 F 2 10x10, 5x5 FA U, L:NF 4 + Huigra
MHOM/EC/92/HU-03 Lm 2 F 3 5x5, 1x1(2) FA U, L:NF 18 + Huigra
MHOM/EC/92/HU-04 ? 9 MM 4 5x5, 3x3(3) FA P, L:NF 3 + Huigra
MHOM/EC/92/HU-06 ? 2 M 1 3x2 A U, L:NF 8 ? Huigra
MHOM/EC/95/NA-03 Lp 27 M 8 15x10, 5x5, A(b), L:generalized ? ND Naranjal
4x4, 3x3, N(b),
2x2(2), U, N, P,
1x1(2) E
MHOM/EC/95/NA-04 Lp 38 M 2 5x8, 20x15 A, N(b) U, L:NF ? ND Naranjal
MHOM/EC/95/NA-06 LP 32 M 2 10x15, 10x10 A(b) U, L:NF ? ND Naranjal
MHOM/EC/95/NA-08 Lp 28 M 4 15x10(2), A, A(b) U, L:NF ? ND Naranjal
NM(2)
MHOM/EC/95/NA-09 Lp 25 M 1 10x5 A(b) U, L:NF ? ND Naranjal
Designation Age
Species
by
ELISA
Sex
No. size(mm)
No. and size
of lesions
Site
of
lesions
Type of
lesions and
lymphadenopathy
Duration
time
(months)
Skin
test Locality
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MCHO/EC/82/Lsp-1 Leq Choloepus hoffmani didactylus Naranjal
MSCI/EC/82/Lsp-2 Leq Sciurus vulgaris Naranjal
MSCI/EC/87/G-02 La Sciurus vulgaris Palenque
MPOT/EC/87/G-03 La Potos flavus Palenque
MTAM/EC/87/G-04 La Tamandua tetradactyla Echeandia
MCAN/EC/88/INU-2 Lm Canis familiaris Paute
IAYA/EC/89/PAI-1 ? Lutzomyia ayacuchensis Paute
ITRA/EC/90/PQI-1 Lp Lutzomyia trapidoi Puerto Quito
IAYA/EC/92/ALI-3 ? Lutzomyia ayacuchensis Alausi
IAYA/EC/92/ALI-4 Lm Lutzomyia ayacuchensis Alausi
IAYA/EC/92/HUI-1 ? Lutzomyia ayacuchensis Huigra
IHAR/EC/93/OC-2 ? Lutzomyia hartmanni Ocaña
IHAR/EC/93/OC-3 ? Lutzomyia hartmanni Ocaña
IHAR/EC/93/OC-4 Leq Lutzomyia hartmanni Ocaña
Table 2.2.4. Summary of Leishmania species  isolated from reservoir hosts and sandfly vectors at differ-
ent endemic areas in Ecuador
Designation
?La: L. (L.) amazonensis, Lm: L. (L.) mexicana, Lp: L. (V.) panamensis, Leq: L. (V.) equatorensis.
Species?
by
ELISA
Reservoir hosts
or
sandfly vectors
Locality
Until now, a little information on Leishmania
species at every endemic foci has been available
(Mimori et al., 1989; Hashiguchi et al., 1991; Katakura
et al., 1994; Le Pont et al., 1994).  Armijos and oth-
ers (1991) have reported on Leishmania species
obtained from 6 different provinces located at north
of the country. From our results and other reports, it
is suggested that there is a principal distribution pat-
tern of Ecuadorian Leishmania species as follows.  The
major Leishmania species of the Pacific coastal low-
land area is L. (V.) panamensis.  L. (L.) amazonen-
sis, L. (V.) panamensis and L. (V.) equatorensis
distribute in the subtropical regions of the west Andean
slopes extending from north to south of this country.
In the Andean highland regions, L. (L.) mexicana and
L. (L.) major-like parasites distribute. L. (V.) brazilien-
sis is mainly found in the Amazonian regions.
Masato Furuya,
Yoko Akimaru,
Tatsuyuki Mimori,
Motonari Shiraishi,
Eduardo A. Gomez L.,
Shigeo Nonaka
Yoshihisa Hashiguchi
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Introduction
The species identification among the genus
Leishmania had been performed by zymodeme,
serodeme, schizodeme and karyodeme analyses.
Recently, molecular biological techniques have been
rapidly developed and the sequences of various genes
have been used for molecular phylogenetic studies
of different organisms.  We have been trying to apply
the nucleotide sequence of the cytochrome c oxidase
subunit I gene for the identification of parasite and
insect species, i. e., Paragonimus, Dirofilaria,
Anopheles? and etc.
The mitochondrial DNA (mtDNA) of animals is a
relatively small molecule, usually shorter than 16kb
long and generally encodes 13 proteins, two riboso-
mal RNA and 22 tRNA.  The small size, relatively
rapid rate of evolutionary change, and maternal hap-
loid inheritance of mtDNA make it suitable for exam-
ining population history and structure among closely
related taxa.  For example, cytochrome c oxidase sub-
unit I and II (COI and COII) genes have been used
to study the phylogenetic relationships of honeybee or
the land snail (Crozier et al., 1989; Lecanidou et al.,
1994).  In the present study, we sequenced segments
of the COI gene (391bp out of about 1500bp) to exam-
ine the intraspecific variation of the genus Leishmania.
Materials and Methods
Parasites
All the isolates of Leishmania were obtained from
the collection of Kochi Medical School.  Species name
and designation of the isolates used are shown in Table
2.3.1.  Eight species of Leishmania organisms were
cultured in Schneider's  drosophila medium contain-
ing 15% heat-inactivated fetal bovine serum.  The har-
vested promastigotes were washed two times by
centrifugation with phosphate buffered saline.  The
washed parasites were immediately fixed with and
reserved in absolute ethanol.  The materials were kept
in refrigerator until used for DNA extraction.
Preparation of DNA
Total DNA was prepared from the materials pre-
served in absolute ethanol. Extraction buffer consist-
ed of 50 mM Tris-HCl (pH 9.0) containing 10 mM
EDTA, 200 mM NaCl, 0.5% (w/v) SDS and 200?g/ml
proteinase K.  The resultant viscous solution was
extracted several times with an equal volume of phe-
nol that had been equilibrated with 1M Tris-HCl (pH
8.0) and then extracted 2 or 3 times with phenol/chlo-
roform (1:1) and once with chloroform-isoamyl-alco-
hol (24:1).  After an additional chloroform extraction,
the nucleic acid was precipitated with 2.5 volumes
of cold absolute ethanol containing 300 mM sodium
acetate and then chilled at -80? overnight.  After cen-
trifugation at 14000 rpm for 30 min at 0?, the pel-
let was dissolved in 200?1 of TE buffer (10 mM
Tris-HCl (pH 7.6), 1 mM EDTA).
Sequencing strategies
3.  Nucleotide Sequence Variations in the Cytochrome C Oxidase
Subunit I Gene within Leishmania Species
ABSTRACT. Determination of partial nucleotide sequences of COI genes of eight species of
Leishmania, i e., L. (Leishmania) amazonensis, L. (Viannia) equatorensis, L. (L.) major-like, L. (L.)
mexicana, L. (L.) major, L. (V.) guyanensis, L. (V.) braziliensis and L. (V.) panamensis was tried by
a PCR method using primers designed for planarian COI genes.  The present study showed that the
primers are useful for the amplification of COI genes of four  species, i. e., L. (L.) major, L. (V.) guya-
nensis, L. (V.) braziliensis and  L. (V.) panamensis. A partial sequence of COI genes of the four species
was determined. 
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PCR products were sequenced from both ends
using a dye-primer cycle sequencing kit and a Model
377 DNA sequencer (Applied Biosystems).  Double-
stranded PCRs were performed to prepare insertions
for clonings.  The sequences of the primers used in
the PCR were as follows: pri-a 5' TGG TTT TTT GTG
CAT CCT GAG GTT TA3' and pri-b 5' AGA AAG
AAC GTA ATG AAA ATG AGC AAC3'.  These
primers were originally designed for amplification
of the planarian COI gene (Bessho et al., 1992a,b).
PCR amplifications were performed according to the
manufactures' instructions, with denaturation at 94?
for 1 min  (except for the first cycle for 4 min), anneal-
ing at 45? for 1 min and extension at 72? for 30
cycles, followed by final extension step of 7 min at
72?.  The PCR products were electrophoresed in 1%
agarose 1600 gel in TAE buffer at 100 v for 30 min.
Bands of about 450 bp were carried out by knife cut-
ting under ultraviolet illumination.  QIAquick spin
PCR purification kit (Qiagen) was used for the extrac-
tion of PCR products.  The extracted PCR products
were ligated in pT7blue T-vector plasmid, and the vec-
tors were transformed in NovaBlue competent cells
with pT7blue T-vector kit (Novagen).  The amplified
plasmids were extracted with Wizard miniprep purifi-
cation kit (Promega).  Sequencing reactions were car-
ried out with dye-primer cycle sequencing kit (Applied
Biosystems and Amersham).  The dye-primers used
were T7 promoter primer and U-19 mer primer and
the thermocycling was done at the condition of denat-
uration at 95? for 10 sec, annealing at 55? for 30
sec and extension at 70? for 1 min for 15 cycles
followed with another 15 cycles of denaturation at
95? for 10 min and extension at 1 min.  Sequence
analysis was performed using a Model 377 DNA
autosequencer (Applied Biosystems).  DNA sequence
data were aligned and analyzed using GENTYX com-
puter software (Higgins et al., 1992).  The nucleotide
sequence of each species was basically determined
with the accordance of three clone sequences read from
both ends.
Results and Discussion
Eight species materials of Leishmania were used
for PCR and only four showed a single PCR product
with the expected size (about 450 bp) in ethidium-bro-
mide stained agarose gel, i. e., L. (V.) panamensis,
L. (V.) guyanensis, L. (V.) braziliensis and L. (L.)
major. No PCR product was observed in other species.
The reason why PCR products could not be found in
the remaining species is not clear.  The difference of
these results may depend on the peculiar editing mech-
anism in trypanosomatid mitochondria.  Clarifying the
editing mechanism of each species may show the rea-
son, but it was shown that the present primers are use-
ful for PCR at least in the four species of Leishmania
mentioned above.
Nucleotide sequences of 438 bp in the four species,
in which  whole sequences were amplified by the first
PCR, were generally obtained (Fig 2.3.1).  Some
intraspecific differences in nucleotide sequences were
observed in each species.  Heterogeneity of cytochrome
c oxidase subunit 1 gene sequences has been report-
ed in the freshwater planarian having asexual repro-
duction (Bessho et al., 1992a,b).  In planarians, not
only interindividual heterogeneity but also hetero-
plasmy within an individual was reported.  Further
such a study will clarify the variation of the sequences
in the genus Leishmania.  Out of the 438 surveyed
nucleotide positions, 42 variant nucleotide positions
were found.  The numbers of variant positions between
two species are shown in Table 2.3.1.  The closest pos-
sitive identical sequence of the present four species
was that of kinetoplast of L. tarentole in the GeneBank
nucleic acid sequence database.  The poisson proba-
bilities with L. (V.) braziliensis, L. (V.) panamensis,
L. (V.) guyanensis and L. (L.) major were 1.7e-114,
1.0e-113, 7.0e-112 and 2.2e-103, respectively.  The
secondary identical sequence was that of Trypanosoma
brucei mitochondrial maxicircle DNA.  The poisson
probabilities were: L.(V.) braziliensis, 2.8e-103; L. (V.)
panamensis, 5.3e-102; L. (V.) guyanensis, 9.8e-99; and
L. (L.) major, 4.5e-91.  Further studies will be done
to compare the nucleotide sequence of some pre-
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L. panamensis 1:TGGTTTTTTGTGCATCCTGAGGTTTACA-TTATTTTACTGCCTGTATKTGGACTTATTTC 59
L. guyanensis 1:............................-..................T.........W.. 59
L. braziliensis 1:............................-..........A.......T............ 59
L. major 1:..........C.................T.WW.KW............T.........W.. 60
1:********** **************** *  * **** ******* ********* **
L. panamensis 60:TTCAATTATTGAAGTATTAGGATTTYGATGTGTATTTAGTACAGTTGCAATGATCTATTC 119
L. guyanensis 60:........................CC...................A.............. 119
L. braziliensis 60:.........................C.................................. 119
L. major 61:.Y.................R...KCC..............R....A.............. 120
00:* ***************** ***   ************** **** **************
L. panamensis 120:TATGGTTTTAATTGCTATTTTAGGTATGTTTGTTTGAGCGCACCACATGTTTGTTGTTGG 179
L. guyanensis 120:........................G..............A.................... 179
L. braziliensis 120:........................C................................... 179
L. major 121:........................G..............A.................... 180
000:************************ ************** ********************
L. panamensis 180:TATGGATGTTGACTCTAGAGCATACTTTGGTGGTGTATCTATACTTATAGGGCTACCTAC 239
L. guyanensis 180:...................................................A........ 239
L. braziliensis 180:...................................................A........ 239
L. major 181:.................S.................................A........ 240
000:***************** ********************************* ********
L. panamensis 240:ATGTGTAAAACTTTTTAATTGGATCTATAGTTTTTTATACACTGACATTGTTATTTTATT 299
L. guyanensis 240:.....................A...................................... 299
L. braziliensis 240:.....................A...........................A.......... 299
L. major 241:..............K....W.A.............Y.......................Y 300
000:************** **** * ************ ************* *********
L. panamensis 300:TGAAATATATTTTGTAATTATGTTTATTTTTATGTTTTTAATAGGTGCAGTTACTGGTCT 359
L. guyanensis 300:............................................................ 359
L. braziliensis 300:C............A.........................H.................... 359
L. major 301:.....................................H...........R.......... 360
000:************ *********************** * ********* **********
L. panamensis 360:TTTTCTATCTAATGTTGGTATTGATATAATGTTACATGACACTTATTTTGTDGTTGCTCA 419
L. guyanensis 360:...............................KK............C...R.TSY...... 419
L. braziliensis 360:.............................................C.....T........ 419
L. major 361:..K............Y..Y.............Y............C.....T........ 420
000:** ************ ** ************  ************ *** *   ******
L. panamensis 420:TTTTCATTACGTTCTTTCT        438
L. guyanensis 420:..K.S..............        438
L. braziliensis 420:...................        438
L. major 421:...................        439
000:** * **************
Figure 2.3.1. Nucleotide sequences of a 438 bp fragment of the mitochondrial COI gene from
four species of Leishmania (W:A/T, R:A/G, M:A/C, K:T/G, Y:T/C, S:G/C. H:A/T/C).
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Species Name Designation
Leishmania (L.) amazonensis MHOM/BR/73/M2269
Leishmania (V.) equatorensis MCHO/EC/82/Lsp1
Leishmania (L.) major-like MHOM/EC/87/G-09
Leishmania (L.) mexicana MHYC/BZ/62/M379
Leishmania (L.) major MHOM/SU/73/5ASKH
Leishmania (V.) guyanensis MHOM/BR/75/M4147
Leishmania (V.) braziliensis MHOM/BR/75/M2904
Leishmania (V.) panamensis MHOM/PA/71/LS94
Table 2.3.1. Leishmania isolates used in the present study
Table 2.3.2. Numbers of variant positions of nucleotide sequences between two species of Leishmania
Species L. (V.) panamensis L. (V.) guyanensis L. (V.) braziliensis L. (L.) major
L. (V.) guyanensis 7 ? ? ?
L. (V.) braziliensis 7 7 ? ?
L. (L.) major 9 2 10 ?
ferrable genes for the establishment of species iden-
tification in the genus Leishmania.
Setsuo Suguri,
Masakazu Harada,
Masato Furuya,
Atsushi Hosokawa,
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Introduction
Species identification among the genus Lutzomyia
has been mainly done based on external and internal
morphological features.  Recently, methods using
isozyme electrophoresis patterns and karyotype have
been also introduced for the species characterization
of the organisms.  Moreover, the sequences of vari-
ous genes have been used for molecular phylogenet-
ic studies.  We have been trying to apply the nucleotide
sequence of the cytochorome c oxidase subunit I gene
for the identification of parasite and insect species.  In
the present study, we sequenced segments of the COI
gene (441 bp out of about 1500 bp) to examine the
intraspecific variation of the genus Lutzomyia.
Materials and Methods
Insects
All the adult flies collected by a protected human-
bait method in Ecuador were preserved in 100%
ethanol and were brought back to Japan.  The mate-
rials were kept in refrigerator until required for DNA
extraction.  Sandfly species and their collection sites
are shown in Table 2.4.1.
Preparation of DNA
Total DNA was prepared from the materials pre-
served in absolute ethanol. Extraction buffer consist-
ed of 10 mM Tris-HCl (pH8.0) containing 10 mM
EDTA, 150 mM NaCl, 0.1% (w/v) SDS and 200?g/ml
proteinase K. Each sandfly was homogenated with the
200?l of extraction buffer.  The resultant viscous solu-
tion was extracted twice with equal volume of phe-
nol-chloroform-isoamyl alcohol (25:24:1). The phenol
had been equilibrated with 1 M Tris-HCl (pH8.0).  The
nucleic acids were precipitated with 500?l of cold
absolute ethanol containing 20?l of 3 M sodium
acetate and then chilled at -80? over night. After cen-
trifugation at 14000 rpm for 30 min at 4?, the pel-
lets were washed with 1000?l of 70% ethanol and
dissolved in 20?l of TE buffer (10 mM Tris-HCl
(pH7.6), 1 mM EDTA).
Sequencing strategies
See Chapter 2.3 in this text.
Results and Discussion
Three species of the genus Lutzomyia, L.
ayacuchensis, L. hartmanni and L. trapidoi  were used
for PCR and all the species showed a single PCR prod-
uct with the expected size (about 450 bp) in ethidium-
bromide stained agarose gel. The same primers had
been also useful in PCR of Anopheles mosquitoes.
Therefore, these primers may be one of the most pre-
ferrable for PCR amplifications of insect COI genes.
Nucleotide sequences of 441 bp in the three species,
in which whole sequences were amplified by the first
PCR, were generally obtained (Fig. 2.4.1).  A few
4.  A Preliminary Study on Nucleotide Sequence Variations of 
Lutzomyia spp. in the Cytochrome C
Oxidase Subunit I Gene
ABSTRACT. Partial nucleotide sequences of COI genes of the following three species: Lutzomyia
ayacuchensis, L. hartmanni and L. trapidoi were determined by PCR method using primers designed
for planarian COI genes. The results obtained showed that the primers were useful for the amplifica-
tion of COI genes of these sandfly species. In the current study, a partial sequences of COI genes of
the three species (441 bp) was determined.
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Lut ayac 1:TGGTTTTTTGTGCATCCTGAGGTTTATATTTTAATTTTACCAGGATTCGGTATAATTTCT 60
Lut hart 1:....................................C.T........T..A......... 60
Lut trap 1:....................................C.T........T..A......... 60
0:************************************ * ******** ** *********
Lut ayac 61:CATATTATTAGAAATGAAAGAGGGAAAAAAGAAACCTTCGGAACATTAGGAATAATTTAT 120
Lut hart 61:.......................A...........A..T..T..T.......Y....... 120
Lut trap 61:.......................A...........A..T..T..T............... 120
00:*********************** *********** ** ** ** ******* *******
Lut ayac 121:GCTATACTTGCTATTGGACTTTTAGGATTTATTGTTTGAGCTCATCATATATTTACAGTT 180
Lut hart 121:...........A.....TT.A..............A.....A..C..C........T..A 180
Lut trap 121:........K..A.....TK.A.......K......A.....A..Y..C....K...T..A 180
000:******** ** *****  * ******* ****** ***** ** ** **** *** ** 
Lut ayac 181:GGAATAGATGTAGATACTCGGGCCTATTTTACCTCTGCTACAATAATTATTGCTGTTCCA 240
Lut hart 181:...........T........A..A..C.....T..A..A.................A..T 240
Lut trap 181:...........T........A..A..C.....T..W..A..R..............A..T 240
000:*********** ******** ** ** ***** ** ** ** ************** ** 
Lut ayac 241:ACAGGAATTAAAATTTTTAGATGATTAGCAACTATCCATGGATATCAATTAAAGTATTCC 300
Lut hart 241:..T..............C......C.T.....A..T........C........A.....T 300
Lut trap 241:..T..............C......C.T.....A..T........C........R.....T 300
000:** ************** ****** * ***** ** ******** ******** ***** 
Lut ayac 301:CCTGCCCTACTCTGAACCCTTGGATTTATTTTCTTATTTACTGTAGGAGGATTAACGGGA 360
Lut hart 301:..C..TT....A.....AT.A..T........T.....C.....T...........A... 360
Lut trap 301:..C..TT....A.....AT.A..T........T.....C.....T...........A... 360
000:** **  **** *****  * ** ******** ***** ***** *********** ***
Lut ayac 361:GTAATTCTTGCTAATTCATCTGTAGACATTATTCTACATGACACCTATTATGTCGTTGCT 420
Lut hart 361:..T...T.A.....C..T.....T..T........T.....T..A........T...... 420
Lut trap 361:..T...T.A.....C..T.....T..T........T.....T..A........T...... 420
000:** *** * ***** ** ***** ** ******** ***** ** ******** ******
Lut ayac 421:CATTTTCATTACGTTCTTTCT          441
Lut hart 421:.....................          441
Lut trap 421:.....................          441
000:*********************
Figure 2.4.1. Nucleotide sequences of a 441 bp fragment of the mitochondrial COI gene from three species
of Lutzomyia, ayacuchensis (Lut ayac), hartmanni (Lut hart) and trapidoi (Lut trap).
Species Place Date (1996)
L. ayacuchensis Huigra August 8
L. hartmanni Ocaña July 27
L. trapidoi Ocaña July 27
Table 2.4.1. Species and collected places of the sandflies used in the present study
Species L. ayacuchensis L. hartmanni
L. hartmanni 60 ?
L. trapidoi 56 8
Table 2.4.2. Numbers of variant positions of nucleotide sequences between two species of Lutzomyia
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intraspecific difference in nucleotide sequences were
observed in each species.  Out of the 441 surveyed
nucleotide positions, 65 variant nucleotide positions
were found. The numbers of variant positions between
two species are shown in Table 2.4.1.  The nearest
positive identical sequence of L. ayacuchensis was that
of Drosophila melanogaster mitochondria in the
GeneBank nucleic acid sequence database with an
identity of 83% (poisson probability: 4.2e-121).  On
the other hand, in the cases of L. hartmanni and L.
trapidoi, the nearest positive identical sequence was
that of Feltia jaculifera (dingy cutworm) COI gene;
the identities were 85% and 84% with the poisson
probabilities, 6.2e-127 and 5.4e-127, respectively.
Further studies on other species of the genus Lutzomyia
will be done.  The differences of nucleotide sequences
of genes will be applied for the establishment of
species identification and phylogenetic studies of the
genus Lutzomyia in the future.
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Masakazu Harada,
Motoyoshi Maruno,
Atsushi Hosokawa,
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Introduction
Cutaneous leishmaniasis is a parasitic disease
caused by various types of Leishmania spp.  Man and
domestic animals are infected by sandfly, a vector,
with Leishmania parasites in their promastigote forms.
Promastigotes are taken in the macrophages and then
transform into the form of amastigotes.  Amastigotes
are reproduced by binary fission inside parasitophorous
vacuoles (PVs) of the host macrophage.  Light-micro-
scopically, diffuse cutaneous leishmaniasis (DCL)
shows numerous Leishmania parasites in specimens
taken from the skin lesions of leishmaniasis.  On the
contrary, in localized cutaneous leishmaniasis (LCL),
few Leishmania parasites can be seen in specimens
taken from the skin lesions.  Ultrastructural observa-
tion shows one parasitophorous vacuole in one
Leishmania parasitized macrophage.  Veress et al.
(1994) pointed out the possibility that the presense
or absense of a PV was the morphological sign of par-
asite survival.  DCL is resistant to the traditional treat-
ments, but LCL has a good response to them.  LCL
also shows natural healing.  It may be difficult for
Leishmania parasites to survive in LCL.  To investi-
gate difference in PV-parasite interaction between DCL
and LCL, we performed the ultrastructural observa-
tion using the skin samples taken from DCL and LCL
patients.
Materials and Methods
Patient history
A DCL patient, caused by L. (Leishmania) mexi-
cana, was a 24-year-old male, having suffered from it
for 8 years.  The lesions were present almost all over
the body, and revealed typical clinical features of DCL.
The lesions showed papules, infiltrated plaques and
nodules without ulcerations.  The lesions immediate-
ly improved after treatments with Glucantime®, but
relapsed intermittently with five or six months inter-
vals after clinical improvement (Reyna et al., 1994).  
A LCL patient, caused by L. (Viannia) panamen-
Chapter 3
Ultrastructural and Pathological Aspects
1.  An Ultrastructural Study of Diffuse Cutaneous Leishmaniasis 
Caused by Leishmania (Leishmania) mexicana in Ecuador: 
the Role of Parasitophorous Vacuole 
in Macrophage-Parasite Interaction
ABSTRACT. In the current study, an electron microscopic observation was done on the skin biopsy
materials taken from  a diffuse cutaneous leishmaniasis (DCL) and a localized cutaneous leishmaniasis
(LCL) patients in Ecuador. Large parasitophorous vacuoles (PVs) and disconnected cell membranes of
Leishmania amastigotes were observed only in DCL.  The margin of the cell membrane of disconnected
site was bended outward.  These findings support that proteo-high-molecular weight phosphoglycan
(proteo-HMWPG) was released from the disconnected site of the membranes of the amastigotes, and
that production of proteo-HMWPG was accelerated in DCL more than in LCL.
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sis, was a 13-year-old male, having suffered from it
for 3 months.  The lesions showed single ulcer on
the dorsum of the right hand, and revealed typical clin-
ical features of LCL.  (see Chapter 3. 2 about the clin-
ical photographs of DCL and LCL cases in this text).
Electron microscopy
The tissue samples were biopsied from a nodule
of the DCL patient and from the margin of the ulcer
of the LCL patient.  The samples were cut into small
pieces, and fixed in phosphate-buffered 2? glu-
taraldehyde solution for electron microscopy.  The
samples were washed with phosphate-buffered 1?
osmium tetroxide, and then dehydrated with an ethanol
series and propylene oxide, and embedded in Epon
812 resin.  Ultrathin sections of the samples were
stained with uranyl acetate and lead citrate, then
observed by JEOL 2000 electron microscopy.
Results
DCL
Macrophages attached closely with each other.
A few lymphocytes and plasma cells were observed
among the macrophages.  Most of the macrophages
showed various sized PVs.  One large PV contained
several Leishmania amastigotes, while another small
PV contained one or two (Fig. 3.1.1A) .  The shapes
of Leishmania amastigotes were round and their diam-
eters ranged from 2.1 to 3.5?m.  Each amastigote had
a nucleus.  The cell organells of the parasites showed
well developed (Fig. 3.1.1B).  The PV was filled with
electron dense granules and a notch like structure was
found in the PV (Fig. 3.1.1C).  The cell membranes
of Leishmania amastigotes in the PV disconnected at
some places.  The margin of the cell membrane at
the disconnected site was bended outward of the
amastigotes (Fig. 3.1.1D, E).
LCL
Amastigotes-phagocyted macrophages were scat-
terezd in the dermis.  Several lymphocytes were
observed gathering around the macrophage (Fig. 3.1.
2A).  Amastigotes showed round or oval shape and
their diameters were 2.1 to 2.8 ?m.  The cell organells
of the amastigotes were well developed.  No discon-
necected site of the cell membrane of the amastig-
otes was found.  Rough endoplasmic reticulums
(RERs) of the macrophages in LCL were enlarged
more than those in DCL (Fig. 3.1.2B).  The cytoplasms
of some macrophages showed degenerative appear-
ances (Fig. 3.1.2C).  No large PV could be observed
(see Chapter 3. 2 about H. E. staining findings of DCL
and LCL in this text).
Discussion
The mechanism(s) of survival of Leishmania
amastigote is still unknown though PV is thought to
be a morphological sign of parasite survival.  It was
reported that PV was common structure of parasitized
macrophage not in human but also in hamster (Veress
et al., 1981), and that no large PVs had been observed
in human cutaneous leishmaniasis by any investiga-
tors.  Nor we could find the papers describing large
PV in LCL cases to our knowledge.  However, Schurr
et al.  (1987) reported that the macrophages of DCL
showed larger PVs than those of LCL.  In our DCL
case, large PVs were observed in numerous number
of the macrophages, light- and electron-microscopi-
cally.  Several experiments showed that large PVs of
macrophages were found in animal models treated with
inoculation of Leishmania parasites derived from
human cutaneous leishmaniasis including DCL and
LCL patients (Chang et al., 1987; Bretana et al., 1983;
Bhutto et al., 1994).  Thus, large PV formation may
be resulted not to the factors in Leishmania parasite
side but in host side.
In Leishmania (L.) mexicana, the amasigotes
secrete proteo-phosphoglycan from the flagellar pock-
ets (Fig. 3.1.3).  Proteo-high-molecular weight phos-
phoglycan (proteo-HMWPG) appears to be a characteristic
secretory product of L. (L.) mexicana amastigotes,
which is released into the PV of the macrophages (Ilg
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Figure 3.1.1A. Various sized PVs are found in macrophages in DCL. Each
PV contains several numbers of Leishmania amastigotes. Arrow, PV; arrow
head, Leishmania amastigotes; M, macrophage; P, plasma cell. Bar?5?m.
Figure 3.1.1B. Leishmania amastigotes show round shapes and their diame-
ters ranged from 2.1 to 3.5?m. MN, Nucleus of macrophage. Bar?1?m.
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Figure 3.1.1C. The PV was filled with electron dense granules and a notch-
like structure (arrow) was found in PV. Bar?1?m.
Figure 3.1.1D. The cell membranes of Leishmania amastigotes in PV were
disconnected at some places.  The margin of the cell membrane at the site
was bended outward. Bar?200 nm.
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Figure 3.1.1E. See Figure 3.1.1D.
Figure 3.1.2A. Amastigotes-phagocyted macrophages are found in LCL.  Several
lymphocytes gather around the macrophage. M, macrophage; L, lymphocyte.
Bar?2?m.
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Figure 3.1.2B. Amastigotes show round or oval shape and their diameters are
2.1 to 2.8 ?m.  The cell organells of amastigotes are well developed.  RERs
of the macrophages are enlarged. MN, nucleus of macrophage; arrow, RER.
Bar?500 nm.
Figure 3.1.2C. Asterisk shows degenerated macrophage. Bar?1?m.
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et al., 1994).  Our electron microscopic observations
revealed that the cell membranes of amastigotes in
large PV of DCL were disconnected and the margin
of the membrane was bended outward.  Furthermore,
no large PV or disconnected cell membrane of amastig-
otes were found in LCL.  These findings support that
the secretion of proteo-HMWPG from Leishmania
amastigotes is accelerated in DCL more than in LCL.
DCL is considered to be manifestations of specific
T cell anergy, and also known as split tolerance (Ulrich
et al., 1995).  It is well known that IL-1 produced
by T cells activates macrophages.  Our previous
immunohistochemical study using anti-T cell antibody
revealed that T cells gathered not around Leishmania
parasitized macrophages in DCL but around those in
LCL, and that the macrophages in DCL were acti-
vated less than those in LCL (see Chapter 3. 2 about
the immunohistochemical study in this text).  It is
unknown whether large PV formation is inhibited by
activation of macrophages or not.  C3H/HeN mice are
naturally resistant to cutaneous and systemic infec-
tions with the protozoan parasites.  In previous exper-
iment using Leishmania parasitized mice, anti-IFN-?
-treated C3H/HeN mice developed cutaneous lesions,
and the parasites spreaded to the regional lymph nodes,
and then metastasized to the spleens and livers
(Belosevic et al., 1989).  As a further experiment, rela-
tionship between PV formation and macrophage acti-
vating factor, such as IFN-?, should be investigated.  
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Introduction
Cutaneous leishmaniasis is clinically divided into
classical, diffuse and disseminated types.  Clinical
manifestations of diffuse cutaneous leishmaniasis
(DCL) show so many nodules and papules on the
whole body, but no ulcer.  Those of localized cuta-
neous leishmaniasis (LCL), on the contrary, show one
or several papules, nodules and ulcers, of which mar-
gin elevates like bank (Hashiguchi, 1996).  Leishmania
parasites are seen countlessly in DCL, in contrast to
this, very few Leishmania parasites can be seen in LCL
(Carvalho et al., 1994).  Leishmania parasites prolif-
erate in the cytoplasm of the host macrophage, but
Leishmania parasite-macrophage interaction is not well
known.  We performed immunohistochemical study
with anti-lysozyme antibody to investigate the activ-
ities of the macrophages in DCL and LCL specimens
and also performed immunohistochemical study with
anti-T cell and B cell antibodies to investigate their
relationship with macrophages.  We compared the
macrophages in both cases electron-microscopically.  
Materials and Methods
The tissue samples were biopsied from one case
of the DCL patient (Fig. 3.2.1A, B) and two cases of
the LCL patients (Fig. 3.2.1C) in Ecuador, South
America.  The samples were taken from the center
of the nodule in the DCL patient and taken from the
margin of the ulcer in the LCL patients.  The sam-
ples were cut into two pieces.  One was fixed in 10?
formalin solution for light microscopy.  The other was
cut into small pieces, and fixed in phosphate-buffered
2? glutaraldehyde solution for electron microscopic
examination.
Light microscopy
The tissue samples were dehydrated in an ethanol
series, and embedded in paraffin.  The samples were
sectioned 4?m thickness for H. E. staining and
immunohistochemical staining with anti-lysozyme anti-
body, anti-human T cell, CD45R0 antibody and anti-
human B cell, CD20 antibody (Dako, Kyoto, Japan).
Immunohistochemical staining was performed with
DAKO LSAB kit (Dako, Kyoto, Japan).  Steps in stain-
ing of dehydrated sections were as follows: 1) block-
ing with 3? hydrogen peroxidase; 2) incubation with
diluted normal bovine serum for 5 min to block non-
specific reactions; 3) incubation with each first
antibody for overnight at 4? ; 4) incubation with
biotinylated anti-mouse IgG for 10 min at room tem-
perature; 5) incubation with avidine-biotine-peroxi-
dase complex for 10 min at room temperature; 6)
placement in streptavidine in Tris-HCl buffer; 7) color
development by immersion in the AEC solution con-
taining 0.005? H2O2 for 30 sec at room tempera-
ture; 8) counterstaining of sections with hematoxyline;
9) coverslipping with AQUATEX solution (Merck Co.,
Tokyo, Japan).
2.  Diffuse Cutaneous Leishmaniasis: the Pathological 
Difference Between Localized and Diffuse Forms
ABSTRACT.  A case of diffuse cutaneous leishmaniasis (DCL) and two cases of localized cutaneous leishmaniasis
(LCL) were examined immunohistochemically by using anti-T cell, CD45RO antibody and anti-lysozyme antibody.
T-lymphocytes infiltrated throughout the dermis and were observed surrounding the macrophages in the LCL lesions.
In contrast to this, the macrophages in the DCL lesions were not activated in comparison with those in the LCL
lesions.  It is suggested that the macrophages may not play their role as antigen presenting cells in the DCL lesions.
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Electron microscopy 
The samples were washed with phosphate-buffered
1? osmium tetroxide, and then dehydrated with an
ethanol series and propylene oxide, and embedded in
Epon 812 resin.  Ultrathin sections of the samples were
stained with uranyl acetate and lead citrate, then
observed by JEOL 2000 EX electron microscopy.
Results
H.E.  staining
DCL
No cell infiltration into the epidermis was seen,
though the epidermis was slightly thin.  Dense cell
infiltration was observed down to the lower dermis
through clear zone which existed just beneath the epi-
dermis (Fig. 3.2.2A).  Dense cell infiltration consist-
ed of lymphocytes, a few plasma cells and numerous
macrophages with big vacuoles.  Most of the
macrophages contained one or several parasites with-
in their vacuoles (Fig. 3.2.2B).
LCL
The epidermis showed parakeratosis, hyperker-
atosis and cell infiltration of lymphocytes.  Dense cell
infiltration was observed throughout the dermis with-
out clear zone as seen in DCL (Fig. 3.2.2C).  Dense
cell infiltration consisted of lymphocytes, plasma cells
and macrophages without big vacuoles.  Parasites were
observed only in a few macrophages.
Immunohistochemical staining
DCL
Anti-lysozyme positive cells were observed
throughout the dermis (Fig. 3.2.3A), but each
macrophage was weakly stained.  By the both anti-B
cell and anti-T cell antibody staining, the majority
of positive cells existed at the lower dermis but a
few among the group of the macrophages (Fig. 3.2.3B).
LCL
Anti-lysozyme positive cells were scattered
throughout the dermis, and each macrophage was
stained more strongly than that of DCL (Fig. 3.2.3C).
Positive cells to anti-B cell and anti-T cell antibody
were observed throughout the dermis and T lympho-
cytes infiltrated to the epidermis (Fig. 3.2.3D, E) .
Electron microscopy
DCL
Macrophages attached closely with each other.
Lymphocyte and plasma cell were observed between
the macrophages.  Most of the macrophages showed
various sized parasitophorous vacuoles (PVs).  The
big PV contained several Leishmania parasites, while
the small PV contained one or two.  The PV was filled
with low electron dense granules and the space was
observed at some area.  The lack of cell membrane
of Leishmania parasite in PV was observed.
LCL
Leishmania parasites could be seen in the
macrophages, but the number of parasites was too less
than those of DCL.  In addition, the PVs were so small
to be seen clearly.
Discussion
Histopathologically in cutaneous leishmaniasis,
varying numbers of lymphocytes, plasma cells and
macrophages infiltrate the lesions.  Eventually the
lesions become granulomatous.  Numerous numbers
of Leishmania parasites are present in DCL lesions,
but few in LCL tissue.  The epidermis have a nor-
mal appearance in DCL nodule (Bittencourt et al.,
1992).  Our DCL epidermis was also showed almost
normal appearance but cell infiltration was shown in
LCL epidermis.  DCL is considered to be manifesta-
tions of specific T cell anergy, also known as split tol-
erance (Bittencourt et al., 1992).  The previous report
has described that IL-1? mRNA was expressed in
LCL epidermis but abscent in most DCL samples using
the RT-PCR, and has also described that DCL epi-
Figure 3.2.1B. Clinical appearance of the DCL patient's foot.
Figure 3.2.1C. Clinical appearance of the LCL patient' forearm patient's fore-
arm.
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Figure 3.2.1A. Clinical appearance of the DCL patient's body.
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Figure 3.2.2A. H. E. staining of the DCL lesion,
asterisk: clear zone (?40).
Figure 3.2.2B. H. E. staining of the DCL ???????
Leishmania ?????????????????????????????????????????
???????????????????????
Figure 3.2.3A. Anti-lysozyme antibody staining of the DCL lesion, arrow:
Leishmania parasites (?400).
Figure 3.2.2C. H. E. staining of the LCL
lesion (?100).
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Figure 3.2.3C. Anti-lysozyme antibody staining of the LCL lesion, arrow:
Leishmania parasites. Note the intensity of the staining, compared with Figure
3.2.3A (?400).
Figure 3.2.3B. Anti-T lymphocyte antibody staining of the DCL lesion (?400).
Figure 3.2.3D. Anti-T lymphocyte antibody staining of the LCL lesion, arrow:
macrophage. T lymphocytes were observed surrounding the macrophage (?400).
Figure 3.2.3E. Anti-T lymphocyte antibody staining of the LCL lesion (?400).
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dermis showed fewer Langerhans cells than LCL epi-
dermis (Caceres-Dittmar et al., 1992, 1993).  In this
immunohistochemical study of anti-T cell antibody, T
lymphocytes infiltrated into the epidermis only in the
LCL lesions.  Thus, it is considered that DCL epi-
dermis does not function fully as an immune response
place.  
In our DCL lesion, a few T lymphocytes infitrat-
ed into the group of the macrophages and the major-
ity of those cells existed at the lower dermis.  In
comparison with anti-lysozyme staining, the
macrophages in LCL lesions were more strongly
stained than DCL lesions.  These results suggest that
the macrophages in DCL lesions are less activated than
those in LCL lesions because few T cells exist near
the DCL macrophages.
Numerous Leishmania parasites were observed
in the DCL patient.  Leishmania parasites proliferate
in host macrophage and are present at amastigote form.
The another difference in H.E.  section between our
DCL lesions and LCL lesions was that the clear zone
just beneath the epidermis was present in DCL lesions.  
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Introduction
Many drugs are used for treatments of cutaneous
leishmaniasis. However, each treatment contains some
problems such as adverse reactions and economical
costs.  Mefloquine, an anti-malarial drug for multi-
ple drug-resistant malaria, is schizonticidal, and
destroys the erythrocytic, asexual forms of the
Plasmodium parasites in man (Desjardins et al., 1979).
Caillard et al. (1995) reported that mefloquine acted
on the midterm trophozoites in malaria and that
Plasmodium parasites at this stage in mice were imme-
diately destroyed by the drug. If mefloquine is effc-
tive on Leishmania parasites, we could obtain one
more alternative for the treatment of cutaneous
leishmaniasis.
Sixteen patients with cutaneous leishmaniasis were
treated with the administration of mefloquine in
Ecuador, South America by Gomez et al.  (1995).  As
a result, nine of them had been clinically cured with-
in 3 weeks of the drug administration; six of them
within 4-6 weeks; one patient after 8 weeks.  No spe-
cific adverse reactions were observed during the treat-
ment.  The mechanism how mefloquine affects
Leishmania parasites is unknown. It is, however, spec-
ulated that mefloquine may inhibit amastigote-
macrophage interactions and/or directly act on the
parasite in leishmaniasis with the same manner as in
malaria. Electron microscopic study on a patient with
cutaneous leishmaniasis was performed to investigate
how Leishmania parasites and macrophages would
change before and after the treatment. 
Materials and Methods
Mefloquine (Mephaquin®, Mepha Ltd., Switzerland)
was administered orally with the dose of 4.2 mg/kg/day
for 6 days to cutaneous leishmanial patients.  The
administration was repeated with 3 weeks intervals
depending on the degree of recovery of each patient.
The specimens used in this study were taken from a
41-year-old male cutaneous leishmanial patient treat-
ed with this method.  A total of four specimens were
taken from the margin of the ulcer sized 35?25 mm
with one specimen each at a time, at four different
times: before the oral treatment, 2 weeks, 4 weeks and
6 weeks after the treatment.  Each specimen was cut
into two pieces: one for light microscopic examina-
tion and the other for electron microscopic one.  The
former was stained with two different methods: hema-
toxilin-eosine (H. E.) staining and immunohisto-
chemical staining with anti-asialo GM1 antibody. 
3.  Light Microscopic and Electron Microscopic Study on Patients 
with Cutaneous Leishmaniasis Treated 
with Mefloquine  (Mephaquin®)
ABSTRACT. A 41-year-old man with cutaneous leishmaniasis was treated with a dose of 4.2 mg/kg/day
for 6 days of mefloquine (Mephaquin®).  His ulcer was completely cured within 6 weeks of the med-
ication. The specimens taken from the patient treated with mefloquine were observed light-micro-
scopically and electron-microscopically. After the treatment, it was found that in the specimens with
H. E.  staining, inflammatory cell infiltration was remarkably decreased, that no leishmanial parasite
was observed, and also that in the specimen with anti-asialo GM1 antibody staining, the activity and
cytotoxicity of macrophages were remarkably diminished.  Electron microscopic study which revealed
degeneration of macrophages after the treatment supported the light microscopic findings.  The leish-
manicidal effectiveness of mefloquine may be related to macrophage-mefloquine interactions. 
45
Light microscopy
The tissue samples were fixed in 10? formalin
solution, and embedded in paraffin. The samples were
sectioned for both H. E. staining and immunohisto-
chemical staining with anti-asialo GM1 antibody.
Immunohistochemical staining was performed with
DAKO LSAB kit (Dako Co., Kyoto, Japan).  Steps
in staining of dehydrated sections were as follows:
1) blocking with 3? hydrogen peroxidase; 2) incu-
bation with diluted normal bovine serum for 5 min
to block non-specific reactions; 3) incubation with rab-
bit anti-asialo GM1 antibody (Wako Chemicals, Osaka,
Japan) for overnight at 4?; 4) incubation with biotiny-
lated anti-mouse IgG for 10 min at room temperature;
5) incubation with avidine-biotine-peroxidase complex
for 10 min at room temperature; 6) placement in strep-
tavidine in Tris-HCl buffer; 7) color development by
immersion in the AEC solution containing 0.005?
H2O2 for 30 sec at room temperature; 8) counter-
staining of sections with hematoxyline; 9) coverslip-
ping with AQUATEX solution (Merck Co., Tokyo,
Japan). 
Electron microscopy 
The tissue samples were cut into small pieces,
fixed in phosphate-buffered 2? glutaraldehyde solu-
tion, washed with phosphate-buffered 1? osmium
tetroxide. The samples were then dehydrated with an
ethanol series and propylene oxide, and embedded in
Epon 812 resin.  Ultrathin sections of the samples were
stained with uranyl acetate and lead citrate, then
observed by JEOL 2000 EX electron microscopy.
Results
H.E.  staining
The specimens taken from the patient before the
oral treatment with Mephaquin® showed epidermal
hyperplasia and mild exocytosis of lymphoid cells,
while those taken 6 weeks after the treatment revealed
the almost normal epidermis (Fig. 3.3.1A, B).  The
former showed dense infiltration of lymphocytes, plas-
ma cells and macrophages throughout the dermis
together with Leishmania parasites both inside and
outside of the macrophages (Fig. 3.3.2A).  In contrast
to this, the latter showed localized infiltration of lym-
phocytes, plasma cells and giant cells around the ves-
sels without Leishmania parasites (Fig. 3.3.2B). 
Immunohistochemical staining
Immunohistochemical study revealed the follow-
ing: in the specimens before the treatment, the anti-
asialo GM1 antibody positive, light-brownish cells
were observed throughout the dermis.  Each positive
cell was larger than lymphocyte which was not stained
by the anti-asialo GM1 antibody (Fig. 3.3.3A).  These
findings in the specimens before the treatment indi-
cated that most of macrophages were activated and
cytotoxic.  On the other hand, the specimens taken 6
weeks after the treatment showed only the anti-asia-
lo GM1 antibody negative cells which were present
only around the vessels.  These cells consisted of
macrophages, plasma cells and lymphocytes (Fig.
3.3.3B).  It was speculated that macrophages in the
specimen 6 weeks after the treatment lost their activ-
ities and cytotoxicity.
Electron microscopy
Electron microscopic study revealed the follow-
ing: in the specimen before the treatment, the
macrophages attached with each other.  The cell
organells within those were well developped (Fig.
3.3.4A).  In the specimen taken from 6 weeks after the
treatment, however, the intercellular spaces between
the macrophages were enlarged.  The cytoplasms of
these cells showed vacuolar degeneration and the cell
membranes appeared degenerated (Fig. 3.3.4B).  The
rough endoplasmic reticulums (RERs) of the plasma
cells were significantly enlarged in the specimen before
the treatment.  This indicated that plasma cells were
active making proteins (Fig. 3.3.5A).
On the contrary, RERs of the plasma cells in the
specimen 6 weeks after the treatment were almost nor-
malized, which indicated that the activities found in
the specimens before the treatment diminished (Fig.
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Figure 3.3.1A. H. E.  stained features before the treatment.  Epidermal hyper-
plasia and mild exocytosis of lymphoid cell are shown. Dense cellular infil-
tration is remarkable throughout the dermis. 
Figure 3.3.1B. H. E.  stained features 6 weeks after the treatment.  Epidermis is
almost normalized. Cellular infiltration is localized around the vessels.
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Figure 3.3.2A. High magnification view stained by H. E.  before the treatment. Dense
cellular infiltration consists of lymphocytes, plasma cells and macrophages. Leishmania
parasites are observed both inside and outside the macrophages. 
Figure 3.3.2B. High magnification view stained by H.E.  6 weeks after the treatment.
Leishmania parasites are not observed.
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Figure 3.3.3A. Anti-asialo GM1 antibody stained features before the treat-
ment.  Positive cells are shown throughout the dermis. 
Figure 3.3.3B. Anti-asialo GM1 antibody stained features 6 weeks after the
treatment.  Positive cells are seen only around the blood vessels. 
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Figure 3.3.4A. Electron microscopic features before the treatment.
Macrophages attach with each other and the cell-organells are well developped.
(MP: macrophage, Bar=2?m) 
Figure 3.3.4B. Electron microscopic features 6 weeks after the treatment.
Intercellular spaces between the macrophages are enlarged.  Macrophages show
vacuolar degeneration.  (MP: macrophage, Bar=2?m) 
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Figure 3.3.5A. Electron microscopic features before the treatment.  RERs
of the plasma cells are significantly enlarged.  (P: plasma cell, Bar=2?m) 
Figure 3.3.5B. Electron microscopic features 6 weeks after the treatment.
RERs of the plasma cells are almost normalized.  The intercellular spaces
between the plasma cells are enlarged.  (P: plasma cell, Bar=2?m) 
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3.3.5B).  The plasma cells attached with each other
before the treatment, while the intercellular spaces
between plasma cells were enlarged in the specimen
6 weeks after the treatment, the similar findings as
in the macrophages (Fig. 3.3.5B).  No Leishmania par-
asites were observed in macrophages 6 weeks after the
treatment.
Discussion
The results of the treatment with mefloquine
(Mephaquin®) against cutaneous leishmaniasis patients
in Ecuador showed 100? cure rate (Gomez et al.,
1995).  In this study, macrophages, plasma cells and
Leishmania parasites were observed light-microscop-
ically and electron-microscopically to investigate the
effect of mefloquine against cutaneous leishmaniasis.
The findings such as decreased cellular infiltration and
disapperance of Leishmania parasites in the specimen
after the treatment did not contradict the clinical heal-
ing of cutaneous leishmaniasis.
Previous reports showed that macrophages in cuta-
neous leishmaniasis were activated (Ridley, 1987;
Gaafar et al., 1995).  Those reports hypothesized two
mechanisms for the elimination of the parasites: 1)
intact macrophages are activated and destroy the par-
asitized macrophages; 2) the parasitized macrophages
are destroyed by a necrotizing process.  The latter is
believed to be more efficient for parasite elimina-
tion.  Anti-asialo GM1 antibody positive cells are
thought to be cytotoxic macrophages from the results
that the cytotoxicity of the in vitro activated
macrophages was reduced by the treatment with anti-
asialo GM1 plus complement (Akagawa et al., 1982).
So we performed immunohistochemical staining with
anti-asialo GM1 antibody as a marker for activation
of the macrophages.  The presence of anti-asialo GM1
antibody positive macrophages indicates that the con-
ditions to eliminate Leishmania parasites are in active
phase.  The finding that only anti-asialo GM1 anti-
body negative cells were observed in the specimen
after the treatment, may suggest that Leishmania par-
asites were eliminated after the treatment with meflo-
quine and that it was no longer necessary for
macrophages to become activated. 
Some reporters have described about the ultra-
structural morphology of parasitized macrophages in
leishmaniasis (Akiyama et al., 1972; Alexander et al.,
1975; Chang et al., 1976, 1978; Veress et al., 1981).
According to these reports, the morphological sign
of parasite survival might be considered as the pres-
ence or abscence of parasitophorous vacuole (PV).
PVs are common structures not in human parasitized
macrophages but in hamster parasitized macrophages.
No large PVs have been observed in human cutaneous
leishmaniasis by any investigators.  This difference
between human and hamster parasitized macrophages
may be related to the speculation that the PV results
from the inability of the macrophages to kill the par-
asite.  In our study, we could not observe the
macrophages containing Leishmania parasites in the
specimens after the treatment. That is why we com-
pared electron-microscopically parasite-abscence
macrophages in the specimens before and after the
treatment.  The degenerative appearance of the cyto-
plasm and the cell membrane suggested inactivity of
the macrophage in the specimens after the treatment.
Enlargement of the intercellular space between the
macrophages may also suggest inactivity of those. In
addition, the changes of the plasma cells after the treat-
ment, such as normalization of the RER and enlarge-
ment of intercellular space between plasma cells,
suggested inactivity of those plasma cells.  We con-
sider that the changes shown in the macrophages and
the plasma cells before and after the treatment may be
a result of cure of leishmaniasis.  Thus, mefloquine is
expected to be an effective anti-leishmanial drug. As
a further investigation,  we are planning to test meflo-
quine on leishmanial hamster and to examine electron-
microscopically the stage sensitivity of Leishmania
parasites against the drug in vitro.
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Introduction
Leishmaniasis is divided into four broad divisions:
cutaneous (CL), diffuse cutaneous (DCL), mucocu-
taneous (MCL), and visceral forms (VL). These clin-
ical types are mainly caused by the different species
of the genus Leishmania as follows: CL is caused by
L. (Leishmania) mexicana complex, L. (L.) mexicana,
L. (L.) amazonensis, L. (L.) pifanoi, L. (L.) garnha-
mi and L. (L.) venezuelensis; CL and/or MCL are
caused by L. (Viannia) braziliensis complex, L. (V.)
braziliensis, L. (V.) guyanensis and L. (V.) panamen-
sis; and VL is caused by Leishmania (L.) donovani
complex, L. (L.) donovani, L. (L.) infantum and L. (L.)
chagasi. Traditional methods to detect these
Leishmania protozoans include direct visualization by
Giemza or Wright staining and/or culture of the tis-
sue materials.  Recently, polymerase chain reaction
(PCR) has been established as a reliable method to
detect infectious agents such as protozoans, helminths,
bacilli, and etc.  It is essentially important for der-
matologists to detect Leishmania protozoans in skin
lesions not only for differential diagnoses of ulcer-form-
ing skin diseases but also for investigating relationships
between the clinical manifestations of the disease and
the causative species.  The purpose of this study is
to detect Leishmania amastigotes in skin lesions by
PCR using specific primers of Leishmania that have
been reported so far. In this study, we report the results
of preliminary trials, 1) to detect four Leishmania
species mentioned above by PCR using the specific
primers for their characterization, and 2) to detect
Leishmania amastigotes from formalin-fixed and paraf-
fin-embedded skin specimens by PCR using these
primers.
Materials and Methods
Following four species of the genus Leishmania
were used for genomic DNA extraction in this study:
L. (L.) mexicana (MHOM/EC/88/PT-007), L. (L.) ama-
zonensis (MPOT/EC/87/G-02), L (V.) braziliensis
(MHOM/EC/88/INH-03), and L. (V.) panamensis
(MHOM/EC/88/INH-04).  The biopsy materials used
were ordinarily formalin-fixed and paraffin-embedded
skin specimens taken from 11 patients with cutaneous
leishmaniasis in Ecuador.
Chapter 4
Diagnosis using Molecular Techniques
1. A Trial to Detect Leishmania Parasites in Paraffin-Embedded 
Skin Biopsies using Polymerase Chain Reaction
ABSTRACT. We tried to detect Leishmania amastigotes in 11 skin biopsies, ordinarily formalin-fixed
and paraffin-embedded, from patients with cutaneous leishmaniasis in Ecuador by polymerase chain
reaction (PCR) using specific primers of Leishmania organisms that had been reported so far.  In the
current study, it was not able to confirm the specifically amplified DNA by PCR using the genomic
DNA extracted from Leishmania protozoans.  However, we could only detect the specific DNA in some
of the formalin-fixed and paraffin-embedded skin specimens.  By modifying such a technique, it would
be necessary to establish more convenient and reliable methods to detect Leishmania amastigotes by
PCR using ordinarily formalin-fixed and paraffin-embedded skin specimens in further investigations.
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Extraction of genomic DNA from Leishmania
parasites
The genomic DNA extractions from L. (L.) mex-
icana, L. (L.) amazonensis, L. (V.) braziliensis and
L. (V.) panamensis were performed as follows: pro-
mastigotes from in vitro culture of each Leishmania
species were centrifuged with 3000 r.p.m. for 5 min.
The pellet was incubated in lysis buffer (2% SDS,
10 mM Tris-HCl (pH8.0), 150 mM NaCl, 10 mM
EDTA) which contained proteinase K 500?g/ml at
55? for 24 hrs. Ethanol precipitation was performed
with each pellet after phenol-chloroform extraction
and chloroform-isoamyl-alcohol extraction, respec-
tively.  The product was used as a template after hav-
ing been adjusted to 1?g/?l using dH2O.
Extraction of DNA from paraffin slices
Six or seven paraffin slices, 10?m each in thick-
ness, were cut off from blocks of the ordinarily for-
malin-fixed and paraffin-embedded skin biopsy
specimens. After deparaffinization with xylene-alco-
hol and air dry, the tissues were dissolved in 400?l
of TE (10 mM Tris-1 mM EDTA (pH 7.5) and the
same amount of InstaGeneTMMatrix (BIO-RAD,
USA).  They were incubated at 56? for 2 hrs, and
additionally heated at 100? for 5 min.  Then, ethanol
precipitation was performed after phenol-chloroform
treatment to extract genomic DNA, which was dis-
solved in 20?l of TE.
PCR for Leishmania parasites
The primers used in this study were prepared as
follows: L1 (5'-GAACGGGGTTTCTGTATGG-3') and
L2 (5'-TACTCCCCGACATGCCTCTG-3') for L. (V.)
braziliensis complex; US1 (5'-TTGGCCTGAAAAAT
GGACCCG-3') and LS1 (5'-ACACCCAAACACAAC
CAAACC-3') for L. (L.) mexicana complex; US2 (5'-
GTGGGGGAGGGGCGTTCT-3') and LS2 (5'-ATTT-
TACACCAACCCCCAGTT-3'), which are primers for
a common portion of the two species complexes
(Eshita et al., 1995); 13A (5'-TTGACCCCCAACCA-
CATTATA-3') and 13B (5'-ATATTACACCAACC-
CCCAGTT-3'), which are primers for a common por-
tion of the two species complexes, L. (V.) brazilien-
sis and L. (L.) mexicana (Rodrigues et al., 1994).
Figure 4.1.1 shows the homologies of the primers and
the Leishmania isolates and species used in this study.
As for the reaction conditions for PCR, we followed
those reported by the respective authors  (Eshita et al.,
1995; Rodriguez et al., 1994; Lopez et al., 1993).  The
reaction buffer for PCR consisted of 10 mM Tris-HCl
(pH8.9), 1.5 mM MgCl2, 80 mM KCl, 500?g/ml BSA,
0.1% Sodium Cholate, and 0.1% Triton X-100. The
enzyme dilution buffer contained 10 mM Tris-HCl
(pH7.5), 300 mM KCl, 1 mM DTT, 0.1mM EDTA,
500?g/ml BSA, 50% Glycerol, and 0.1% Triton X-
100. The reaction mixture of those was a total of 100
?l consisting of 1?l of genomic DNA, primer 2?l,
10x buffer 10?l, 5 mM dNTP 4?l, DW 78?l, and
Tth DNA polymerase (TOYOBO Co., Ltd., Japan) 1U/
?l.
Method for PCR using paraffin slice speci-
mens
We used the primers, US2/LS2, under the fol-
lowing conditions: denature 94? 1 min, annealing
47?2 min, extention 72? 3 min, with the number
of cycles of 30 times. The PCR product obtained shows
114 basepairs. As for negative controls, we used
genomic DNA from paraffin slices of a skin specimen
of a healthy individual from Okinawa and dH2O. In
total, two trials of PCR were performed using differ-
ent annealing conditions and different templates. In
the second trial, the annealing conditions were changed
from 47? for 2 min to 43? for 2 min, and the tem-
plate was replaced with 10?l of the first PCR prod-
uct.
We performed nested PCR because the amount
of genomic DNA obtained from the paraffin embed-
ded specimens was little.  The primer used for the nest-
ed PCR was designed choosing the outer base
sequences of US2/LS2 primer.  That is, 5'-TGGTG-
GAAATTGGTGGGAAA-3' for US2 outer primer, and
5'-GGCGGCTGCTCTGGATTAT-3' for LS2 outer
primer were used. After having performed  PCR with
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File name: X54470/L.(V.) guyanesis kinetoplast minicircle DNA, conserved region
Sequence size: 222
L1 primer; sequence size: 19
L2 primer; sequence size: 20
[Accession No.: X54470/222 bp]
001' AATTCTAAATTTCAAGCCTCTTAGAGGCCTATTTCACGGCATTCTAACTCTAGCCGGAGT
061' GCGCGGCCCACTATATTACACCAACCCCTAATTGTGCACGGGGAGGCCAAAAAACGTGAT
121' TTTCGGGGGATTTTTGAACGGGGTTTCTGTATGCCATTTTTCGATTTGCAGAACGCCCCT
000' *******************--------------------------
000' (L1 primr) GAACGGGGTTTCTGTATGC
181' ACCCAGAGGCATGTCGGGGAGTAAAATTTGGTCGCTATTTTT
000' ---********************
000' CAGAGGCATGTCGGGGAGTA  (L2 primer)
PCR 
incubation 94? 2 min.
denature 94? 1 min.
annealing 54? 2 min.
extention 72? 3 min.
cycles 30 cycles
PCR product 72 bp
Figure 4.1.1. The primers and their homologies of Leishmania isolates and species  used in
this study.
these primers, we used 1/10 (10?l) of the amplified
DNA as a template.  Further PCR was performed using
US2/LS2 primer and the template which had been
adjusted to 100?l adding fresh PCR mixture to it.  The
PCR conditions for this time was as follows: incuba-
tion 94? for 2 min, denature 94? for 1 min, anneal-
ing 47? for 2 min, and  extention 77? for 3 min.
The expected amplified DNA size was 184 bp.
Results
The results of PCR using Leishmania parasites
The amplified DNA products were found at the
site of approximately 72 bp in INH-03 and INH-04
with the primers of L1/L2.  No positive bands were
found in PT-007 and G-02 with these primers.  Weakly
positive bands were seen at the site of approximate-
ly 65 bp in PT-007 and G-02 using the primers of
US1/LS1. However, no bands were observed at the
site of 341 bp, which had been reported previously
(Eshita et al., 1995). The amplified DNA products
were found at the site of approximately 114 bp in all
the Leishmania parasites used with the primers of
US2/LS2.  A small amount of extrabands were seen
at the site of 200 bp in PT-007 and G-02 with these
primers. dH2O used as a control showed no bands
(Fig. 4.1.2). The amplified DNA products were rec-
ognized at the site of approximately120 bp with the
primers of 13A/13B in all the four Leishmania species
used as seen with the primers of US2/LS2 (Fig. 4.1.
3).
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File name: M21325/ L.(L.) amazonensis (IFLA/BR/67/PH8) kinetoplast DNA, clone pMAT38
Sequence size: 716
US1 primer; sequence size: 21
LS1 primer; sequence size: 21
[Accession No.: M21325/716 bp]
001' GTGGTTTTTGGCCTGAAAAATGGACCCGCCCAAACTTTCTGCCCGTGGGGGAGGGGCGTT
000' *********************--------------------------------
0' [US1 primer] TTGGCCTGAAAAATGGACCCG
061' CTCAAAATGGCAAAAATGGGTGCAGAAACCCCGTCATATTTTCGGGGAATTCGGGGAATT
000' ------------------------------------------------------------
121' TCGGCTCGGGCGGTGAAAACTGGGGGTTGGTGTAAAATAGGGGCGGCTGCTTCGGGCTTG
000' ------------------------------------------------------------
181' TTTCTTTTTGAGGTCGCGTTTGTTTGGGTATGTACTTGGTGGGTGGTAGTCGAGTTGGTT
000' ------------------------------------------------------------
241' TGTGCCTTGAAAATTGTTTTTATTTTAACTTTATTTTAAAAGTTTGGATTCGATGGATTA
000' ------------------------------------------------------------
301' TAATGTTTGTTTTGCTGTTGGAATGGTGGTTTGGTTGTGTTTGGGTGTTATATGACGTGA
000' ---------------------------*********************
000' GGTTTGGTTGTGTTTGGGTGT  [LS1 primer]
361' TGGTTGCTCGTCTGATTGGTATTGTCTTTGGGGGTCGGAAGTTGGTGTATTTGTGCGGAT
421' GATGAGGCTTACAGTTATAATATAAGTTTATATTGTATTTAATGCCATTTAATGATGTTA
481' TCTGGTTGTATGTAATCTCTTGGGGTTTTTGGTGTGGCCTTGTAGTGGACGGGAATGATT
541' TTTGGATATGATTATAATTTTATTTGAAATGTACATATATTCAATTTCGTTGTTATAATG
601' TTTTTGTTATGTGTGTTTAATTGTTAGATTTATGATGACGTGACAGTACTGTTAGTTAAG
661' GATAGACATGTGTGAGGTAATAGATAGTAGGATTAGGGTGGTGTGAGAGGTGGTTT
PCR
incubation 94? 2 min.
denature 94? 1 min.
annealing 50? 2 min.
extention 72? 3 min.
cycles 30 cycles
PCR product 341 bp
Figure 4.1.1. continued.
The results of PCR using the extracted DNA
from the paraffin slice specimens of the
patients with leishmaniasis
The first trial of PCR showed band only in lane
6 (EC/7/96/8/13) (Fig. 4.1.4). However, the second
trial showed no positive bands in any lane (Fig. 4.1.5).
We performed nested PCR (Blikaytis et al., 1990)
using an outer primer which we designed outside the
primers of US2/LS2. The first step using our own
primers revealed positive band in only one specimen
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File name: U19811/L.(V.) panamensis kinetoplast minicircle, partial sequence, fragment LPAN
Sequence size: 623
US2 primer; sequence size: 18
LS2 primer; sequence size: 21
[Accession No.: U19811/623 bp]
001' AAATTTATTGATATTAATAGTATACTATATGGTGCTGTTATTGTTATCTATTACTGTTCT
061' CGGTTAGCTTTNATATAATATTTACTATATTAGCATTTTATACTTGTATGGTTACGTTGG
121' CTGATTGTGATGGATTTAATAACTTTATTGACTGTAACATTAGCTAAACCTTATTACTAC
181' TCTGTTATGCTCTGTTAGAAATAATATTTTTGTTTATAAAATTCTAAAATTGGGCATAAA
241' ATTCTAAAATTGGGCATAAAATCGTACCACCCGACATGCCTCTGGGTAGGGGCGTTCTGC
000' ******************--
[US2 primer] GTGGGGGAGGGGCGTTCT
301' GGAAAACCGAAAAATGGCATACAGAAACCCCGTTCAAAAATAGCCCGAAAAATCGCGGTT
000' ------------------------------------------------------------
361' TTTTGGGCCTCCCCGTGCACAATTAGGGGTTGGTGTAATATAGTGGGCCGNGCACCCCGA
000' --------------------** * ************* **
000' AACTGGGGGTTGGTGTAAAAT  [LS2 primer]
421' CTCGGGGCTAGCTCTCGTGGAACTANGGNCNCTTAGAGGCTTGATTTATAAATTAAATAT
481' TTTGGATAGATTGTTATTAGCTAATAAAGTTAAATAGTTGTTTGATTAATTGCATTACTA
541' TGTTGCTTACAGTGAATAATTTGGTTATAATTAATTTATTATTACGTTGAATAAATACTC
601' GATAGATACATCATTGAATAATA
PCR
incubation 94? 2 min.
denature 94? 1 min.
annealing 47? 2 min.
extention 72? 3 min.
cycles 30 cycles
PCR product 114 bp
Figure 4.1.1. continued.
(DCL) not at the expected site of 184 bp but at the
site of 480 bp (Fig. 4.1.6). However, the second step
of nested PCR showed no positive reactions.
Discussion
Fast and accurate diagnosis is the first step for a
proper treatment.  Traditional culture methods require
long times for detecting Leishmania parasites, for
example, with a low rate of successful detection of the
organisms.  It is well-known that recently PCR has
been established as a time-saving and reliable method
for the diagnosis of various infectious diseases.
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File name: U19805/L. (V.) braziliensis kinetoplast minicircle, partial sequence, fragment MCLB06
Sequence size: 774
US2 primer; sequence size: 18
LS2 primer; sequence size: 21
[Accession No.: U19805/774 bp]
001' GAAAACCCCCGGACACCAGCCGGTNCCCAAACCNGANCCGCGGGCGNCGGAGTAGANGAA
061' AAAGGGGCCCANGCCCTCCNNNTAAAAAANGGNNGGAAGGGNGGCAGAGAAAANAGNAAC
121' ACANCCCAANCCGCCNACGGGCCCCCAAACNAGACCGGAACANGNACANCCAGGAAAGAG
181' GCGGCACANNAANAGGGAGNCNAAAANACTANNCANGTTANACAACNNCGANACCTAGGA
241' AACTAAGGATATNGCCCATNNAGCTCCNAGNGCTAGATNNCCATAACAGCGCNAGNTTAT
301' TACAAGGNTGNAACCATTATATTANACNAGATACTANTACTAGNCTANTANTTAATNTAA
361' TAATGNTACTTACTCGATACAGCNNTANTATATAACTATGAATAATTGAACTAGTTTGAT
421' TACTAGTATTACATTGATTATAATGAGNTTAANTATATATAANTTTATTTATACTTTACT
481' CAATTATTACACGAGTANTTTTATTATATAGGCTCTCTAATGCACAGTTTAATAATATTG
541' TTAGTAAATAATTTTTAGAAATAATAATTTAATAAAATTTAGTTTTTACTGCGTTATGGT
601' CTAGAAAATTACGATAAAATCGTACTTCCCCGACATGCCTCTGGGTAGGGGCGTTCTGCG
000' *** ***********
000' [US2 primer] GTGGGGGAGGGGCGTTCT---
661' AAATTCGATTTTTGGCATACAGAAACCCCGTTCAAAAAATGCCCAATTTTCACGATTTTT
000' ------------------------------------------------------------
721' GGCCTCCCCGTGCACAATTAGGGGTTGGTGTAATATAGTGGGCCGCGCACCCCG
000' ---------------** * ************* **
000' AACTGGGGGTTGGTGTAAAAT  [LS2 primer]
PCR
incubation 94? 2 min.
denature 94? 1 min.
annealing 47? 2 min.
extention 72? 3 min.
cycles 30 cycles
PCR product 114 bp
Figure 4.1.1. continued.
The total number of reported cases of leishman-
iasis in Japan is yet small (about 20 cases) (Nonaka,
1995). However, a large number of people are  suf-
fering from leishmaniasis as WHO has designated it
as one of 6 TDR's major diseases in the world.
Therefore, it is not difficult to imagine that possibil-
ities we encounter it in the near future will increase
gradually because of the accelerated intercommuni-
cation in the current world.
Leishmaniasis is caused by protozoan parasites that
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File name: U19810/L.(L) amazonensis kinetoplast minicircle, partial sequence, fragment LAMAZ
Sequence size: 599
US2 primer; sequence size: 18
LS2 primer; sequence size: 21
[Accession No.: U19810/599 bp]
001' TTTTTGATTTAGTAGTTAATAGCTGTGTTTATTTGTGTGGGTGGTGGTATGGTGTTACAG
061' AGTTTGGTGGAAATTGGTGGGAAAATGGTCCCGGCCCAAACTTTTCTGCCGTGGGGAGGG
000' US2 outer primer ***********
000' TGGTGGAAATTGGTGGGAAA      [US2 primer] GTGGGGGAGGG
121' GCGTTCTGCGGATTCGGGAAAAATGAGTGCGAAACCCCGGTTCATAATTTGGGGGATTTT
000' *******-----------------------------------------------------
000' GCGTTCT
181' GGAGAATTCCGGCTCCGAGGCTCGAAACTGGGGGTTGGTGTAAAATAGGGGCGGCTGCTC
000' ------------------------*********************** US2 outer primer
000' AAACTGGGGGTTGGTGTAAAATA  GGCGGCTGCTC
000' [LS2 primer]
241' TGGATTATTNATTTTAAAATTAATTATTTTGTTAAAATATATTTTGGTTAGGAATATGTT
000' ********
000' TGGATTAT
301' TTTATTGCTTCTGCATTTGTTAGATTGGCTGATGCTCTGTAGGTTGTTTGTTTTAGGCTC
361' TAGTGGTCTTTTGATTGCGTTCTTTTTCCTTACAATTTGTATTTATATTACATATATTAC
421' TTAGGGGTTATTTGTTTGGTATGAGGTAGGCTGTGTTATGCTCATGAGTTTGTGATATTG
481' TTTAGATTTATAATGTTAGATCGGATTATATGTTCCTCGTTTACTATTTGTGATGTTTGT
541' GCTAATTTGNAATNAATAGTTGGGACGGTTGGACCGGTTGTTNTAAGGATTACATGNGT
PCR
incubation 94? 2 min.
denature 94? 1 min.
annealing 47? 2 min.
extention 72? 3 min.
cycles 30 cycles
PCR product 114 bp (US2/LS2 primer)
184 bp (US2/LS2 outer primer)
Figure 4.1.1. continued.
belong to the Kinetoplastidae that has kineto-
plast DNA.  It is transmitted by the arthropod
vectors, sandflies.  The Kinetoplastidae is sub-
divided into the genera Trypanosoma and
Leishmania.  The two genera have different vec-
tors and different clinical manifestations, but are com-
mon in that both have nucleus and kinetoplast. The
kinetoplast DNA consists of maxicircle and minicir-
cle; the latter occupies most of the DNA. The number
of minicircles is approximately 300 in the genus
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File name: Z11552/L.(L.) mexicana kinetoplast minicircle DNA
Sequence size: 660
US2/primer; sequence size: 18
LS2/primer; sequence size: 21
[Accession No.: Z11552/660 bp]
001' GGACCTTTGATATATGGGCAGGTTCATTGTCTTTTGATATGCGATTTTTGTTTGTTGCTT
061' TTCTGGTGGACGTTGTTGTTGGTTGTGCTGGATTGAGATTGGGTGCCTTACAGAATAAAA
121' GGCCTTTAATTAGGTAAGTGAGGGGTGTGTAATGGTAAGTTTTTGATTCTTGACGTTATA
181' TTTTGGTATACTTTGTTTTAATGTCAGTGATACATGTTACTATTACGATGAATTAATTTC
241' TCTTTATATAAACTGTATACATTGCCTGGTTAAGTGTTGAATGTTTGTGTTAAGGAATGT
301' AATTGTTTTGTACGAGTTAGATGTGGATTTAGTGTGGGTGATGTGTTGGTGGTGATGATT
361' TGGGTTGGGAGTGGGCTTGAAAATAGGGACAAAAAACGAAACTTTTCTGCCCGTGGGGGA
000' ********
000' [US2 primer] GTGGGGGA
421' GGGGCGTTCTGCGAAAATGGCAAAAATGAGTGCAGAAACCCCGTTCATAATTTAGGGGAA
000' **********--------------------------------------------------
000' GGGGCGTTCT
481' TTCCTGGAATTTCAGCTCCGGCGGTGGAAACTGGGGGTTGGTGTAAAATAGTGGGGGTGG
000' ----------------------------*********************
000' AACTGGGGGTTGGTGTAAAAT   [LS2 primer]
541' TGGGGATTTTTATTTTATTTGGAATTGTGAGGGCTTTGTAGGCGTTGTTACACGGCATTC
601' TATTTGTTTTGTTTAGCTGTTCTTTTGTGTGGTTACGTGCGGCTTTGTGTGTTATGAAGG
PCR
incubation 94? 2 min.
denature 94? 1 min.
annealing 47? 2 min.
extention 72? 3 min.
cycles 30 cycles
PCR product 114 bp
Figure 4.1.1. continued.
Trypanosoma, while that in the genus Leishmania is
less than 10. This fact naturally supports an idea and
possibility to identify and classify the Leishmania par-
asites on the basis of kinetoplast DNA.  The kineto-
plast DNA has 2500 basepairs, and the homologies are
less in the genus Leishmania than in the genus
Trypanosoma.  It is expected from these facts that the
Leishmania parasites will be classified according to
differences in base sequences in the near future
(Sugane, 1989).
The Leishmania parasites have been classified into
four groups: L. (L.) donovani complex, L. (L.) tropi-
ca complex, L. (L.) mexicana complex, and L. (V.)
braziliensis complex.  All the Leishmania parasites
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File name : M21326/ L.(L.) amazonensis (MHOM/BR/00/Raimundo) kinetoplast DNA, clone pMAT170
Sequence size: 902
US2 primer; sequence size: 18
LS2 primer; sequence size: 21
[Accssion No.: M21326/902 bp]
001' ATGGTTTTTGGCCTGGAAAAATGGTCCCGGCCCAAACTTTTCTGCCCCGTGGGGGAGGGG
000' ************
000' (US2 primer) GTGGGGGAGGGG
061' CGTTCTGCGGAAACCTCAAAAATGAGTGCAGAAACCCCGTTCATATTTTGGGGGATTTTT
000' ******------------------------------------------------------
000' CGTTCT
121' GGGAATTTCGGTTCGGACGGTGGAAACTGGGGGTTGGTGTAAAATAGGGGCGGCTGCTTC
000' ------------------------*********************
000' AACTGGGGGTTGGTGTAAAAT   (LS2 primer)
181' GGGCTTGTTCCTTTTTGAGGTCGCGTTTGTTTGGGTATGTACTTGGTGGTTGGTAGTCGA
241' GTTGGTTTGTGCCTTGAAATGTTTTTATTTTAACTTTATTTTAAAAGTTTGGATTCAATG
301' GATTATAATGTTTGTTTTGCTGTTGAAATGGTGGTTTGGCTGTGTTTGGGTGTTATATGA
361' CGTGATGGTTGTTCGTCTGATTGGTATTGTCTTTGGGGATCGGAAGTTGGTGTATTTGTG
421' CGGATGGTGAGGCTTACAGTTATAATATAAGTTTATATTGTATTTAATGTCATTTAATGA
481' TGTTATCTGGTTGTGTGTAATCTCTTGGGGTTTTTGGTGTGGCCTTTGTAGTGGGCGGAC
541' TGATTTTTGGATATGATTATAATTTTATTTAAATGTGCATATATTCAATTTCGTTGTTAT
601' AATGTTTTTGTTATGTGTGTTTAATTGTTAGATTTGTGATGACGTGACAGTACTGTTAGT
661' TAAGGATAGACATATGTGAGGTAATAGATAGTAGGATTAGGGTGGTATGAGAGATGGTTT
721' ACTGATTTTTGGATATGATTATAATTTTATTTAAATGTGCATATATTCAATTTCGTTGTT
781' ATAATGTTTTTGTTATGTGTGTTTAATTGTTAGATTTGTGATGACGTGACAGTACTGTTA
841' GTTAAGGATAGACATATGTGAGGTAATAGATAGTAGGATTAGGGTGGTATGAGAGATGGT
901' TT
PCR
incubation 94? 2 min.
denature 94? 1 min.
annealing 47? 2 min.
extention 72? 3 min.
cycles 30 cycles
PCR product 114 bp
Figure 4.1.1. continued.
cause skin lesions, but leishmaniasis, which manifests
skin lesions mostly, is caused by the Leishmania par-
asites other than L. (L.) donovani copmlex that main-
ly causes visceral leishmaniasis (VL).  Major localities
for L.  (L.) tropica complex are Middle East, the
Mediterranean basin, and Africa, while those for L.
(L.) mexicana complex and L. (V.) braziliensis com-
plex are only the New World.  L. (L.) mexicana com-
plex mainly causes cutaneous leishmaniasis (CL), and
L. (V.) braziliensis complex causes CL and mucocu-
taneous leishmaniasis (MCL) (Hashiguchi, 1996).
Therefore, we, dermatologists, are mostly concerned
with L. (L.) tropica complex, L. (L.) mexicana com-
plex and L. (V.) braziliensis complex. Parts of the base
sequences of kinetoplast DNA of those have been
already reported (Rogers, 1988; Samuelson, 1991).
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File name: U19811/L.(V.) panamensis kinetoplast minicircle, partial sequence, fragment LPAN
Sequence size: 623
13B foward primer; sequence size: 18
13A reverse primer; sequence size: 21
[accession No.: U19811/ 623 bp]
001' AAATTTATTGATATTAATAGTATACTATATGGTGCTGTTATTGTTATCTATTACTGTTCT
061' CGGTTAGCTTTNATATAATATTTACTATATTAGCATTTTATACTTGTATGGTTACGTTGG
121' CTGATTGTGATGGATTTAATAACTTTATTGACTGTAACATTAGCTAAACCTTATTACTAC
181' TCTGTTATGCTCTGTTAGAAATAATATTTTTGTTTATAAAATTCTAAAATTGGGCATAAA
241' ATTCTAAAATTGGGCATAAAATCGTACCACCCGACATGCCTCTGGGTAGGGGCGTTCTGC
000' *** ***********--
[13B foward primer] GTGGGGGAGGGGCGTTCT
301' GGAAAACCGAAAAATGGCATACAGAAACCCCGTTCAAAAATAGCCCGAAAAATCGCGGTT
000' ------------------------------------------------------------
361' TTTTGGGCCTCCCCGTGCACAATTAGGGGTTGGTGTAATATAGTGGGCCGNGCACCCCGA
000' --------------------** * ************* **
000' AACTGGGGGTTGGTGTAAAAT
421' CTCGGGGCTAGCTCTCGTGGAACTANGGNCNCTTAGAGGCTTGATTTATAAATTAAATAT
481' TTTGGATAGATTGTTATTAGCTAATAAAGTTAAATAGTTGTTTGATTAATTGCATTACTA
541' TGTTGCTTACAGTGAATAATTTGGTTATAATTAATTTATTATTACGTTGAATAAATACTC
601' GATAGATACATCATTGAATAATA
PCR
incubation 94? 2 min.
denature 94? 1 min.
annealing 50? 2 min.
extention 72? 3 min.
cycles 25 cycles
PCR product 120 bp
Figure 4.1.1. continued.
Montenegro skin test, indirect immunofluorescent anti-
body test, enzyme-linked immunosorbent assay
(ELISA).  However, those methods are not so reliable
because they often show negative results when per-
formed at early stages of infection, or cross reactions
sometimes occur with other pathogens (Manson-Bahr,
1987).  Recently, many reports have appeared to show
Traditional methods to detect the Leishmania par-
asites include direct visualization of the organisms by
Giemsa staining and/or culture of tissue smears, which
were reported by Gomez et al. (1987).  Skin biopsy is
also utilized for this purpose to detect the parasites
within the macrophages in the dermis.  Methods to
indirectly detect leishmaniasis cases include
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File name  : U19805/L.(V.) braziliensis kinetoplast minicircle, partial sequence, fragment MCLB06
Sequence size: 774
13B foward primer; sequence size: 18
13A reverse primer; sequence size: 21
[Accession No.; U19805/774 bp]
001' GAAAACCCCCGGACACCAGCCGGTNCCCAAACCNGANCCGCGGGCGNCGGAGTAGANGAA
061' AAAGGGGCCCANGCCCTCCNNNTAAAAAANGGNNGGAAGGGNGGCAGAGAAAANAGNAAC
121' ACANCCCAANCCGCCNACGGGCCCCCAAACNAGACCGGAACANGNACANCCAGGAAAGAG
181' GCGGCACANNAANAGGGAGNCNAAAANACTANNCANGTTANACAACNNCGANACCTAGGA
241' AACTAAGGATATNGCCCATNNAGCTCCNAGNGCTAGATNNCCATAACAGCGCNAGNTTAT
301' TACAAGGNTGNAACCATTATATTANACNAGATACTANTACTAGNCTANTANTTAATNTAA
361' TAATGNTACTTACTCGATACAGCNNTANTATATAACTATGAATAATTGAACTAGTTTGAT
421' TACTAGTATTACATTGATTATAATGAGNTTAANTATATATAANTTTATTTATACTTTACT
481' CAATTATTACACGAGTANTTTTATTATATAGGCTCTCTAATGCACAGTTTAATAATATTG
541' TTAGTAAATAATTTTTAGAAATAATAATTTAATAAAATTTAGTTTTTACTGCGTTATGGT
601' CTAGAAAATTACGATAAAATCGTACTTCCCCGACATGCCTCTGGGTAGGGGCGTTCTGCG
000' **** **********---
000' [13B foward primer] GTGGGGGAGGGGCGTTCT
661' AAATTCGATTTTTGGCATACAGAAACCCCGTTCAAAAAATGCCCAATTTTCACGATTTTT
001'-------------------------------------------------------------
721' GGCCTCCCCGTGCACAATTAGGGGTTGGTGTAATATAGTGGGCCGCGCACCCCG
000' ---------------** * ************* **
000'                AACTGGGGGTTGGTGTAAAAT   [13A reverse primer]
PCR
incubation 94? 2 min.
denature 94? 1 min.
annealing 50? 2 min.
extention 72? 3 min.
cycles 25 cycles
PCR product 120 bp
Figure 4.1.1. continued.
sis) with the primers of L1/L2.  Negative reactions
were obtained in all the four species with the primers
of US1/LS1, contrary to our expectation that bands
would appear at the site of 341 bp in PT-007.  We
thought that PCR didn't work well for some unknown
reasons.  The amplified DNA products were obtained
in all the four kinds of genomic DNA at the site of
114 bp with the primers of US2/LS2.  Therefore, we
considered that it would be possible to detect leishman-
iasis cases caused by L. (L.) mexicana complex and
L. (V.) braziliensis complex with the primers of
efficacy of PCR to detect the Leishmania parasites
(Rodriguez et al., 1994; Lopez et al., 1993; Brujin
et al., 1993)
As a preliminary trial, we performed the PCR
method for detecting Leishmania, using four species
of the genus Leishmania with a hope of its clinical
application for the diagnosis of leishmaniasis.  The
results showed bands in MHOM/EC/88/INH-03 (L.
(V.) braziliensis) and MHOM/EC/88/INH-04 (L. (V.)
panamensis), but not in MHOM/EC/88/PT-007 (L. (L.)
mexicana) and MSCI/EC/87/G-02 (L. (L.) amazonen-
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File name: U19810/L.(L) amazonensis kinetoplast minicircle, partial sequence, fragment LAMAZ
Sequence size: 599
13B foward primer; sequence size: 18
13A reverse primer; sequence size: 21
[Accession No.: U19810/599 bp]
001' TTTTTGATTTAGTAGTTAATAGCTGTGTTTATTTGTGTGGGTGGTGGTATGGTGTTACAG
061' AGTTTGGTGGAAATTGGTGGGAAAATGGTCCCGGCCCAAACTTTTCTGCCGTGGGGAGGG
000' [13B foward primer] ***********
000' GTGGGGGAGGG
121' GCGTTCTGCGGATTCGGGAAAAATGAGTGCGAAACCCCGGTTCATAATTTGGGGGATTTT
000' *******-----------------------------------------------------
000' GCGTTCT     [13A reverse primer]
181' GGAGAATTCCGGCTCCGAGGCTCGAAACTGGGGGTTGGTGTAAAATAGGGGCGGCTGCTC
000' -------------------------****************** **
000' AACTGGGGGTTGGTGTAATAT  [13A reverse primer]
241' TGGATTATTNATTTTAAAATTAATTATTTTGTTAAAATATATTTTGGTTAGGAATATGTT
301' TTTATTGCTTCTGCATTTGTTAGATTGGCTGATGCTCTGTAGGTTGTTTGTTTTAGGCTC
361' TAGTGGTCTTTTGATTGCGTTCTTTTTCCTTACAATTTGTATTTATATTACATATATTAC
421' TTAGGGGTTATTTGTTTGGTATGAGGTAGGCTGTGTTATGCTCATGAGTTTGTGATATTG
481' TTTAGATTTATAATGTTAGATCGGATTATATGTTCCTCGTTTACTATTTGTGATGTTTGT
541' GCTAATTTGNAATNAATAGTTGGGACGGTTGGACCGGTTGTTNTAAGGATTACATGNGT
PCR
incubation 94? 2 min.
denature 94? 1 min.
annealing 50? 2 min.
extention 72? 3 min.
cycles 25 cycles
PCR product 120 bp
Figure 4.1.1. continued.
US2/LS2 if target Leishmania species were limited.
Laskay et al.  (1995) reported that 7 out of 40 cases
with suspect of leishmaniasis but with negative results
of Leishmania culture showed positive results by PCR,
and stated that it was worth while diagnostically per-
forming PCR especially for the chronic cases.  Our
results with the paraffin-embedded specimens from
the patients with leishmaniasis showed no PCR prod-
ucts except from EC/7/96/8/13.  The reasons for this
might be that the amount of DNA collected from the
paraffin slices was insufficient, or that PCR didn't work
well probably due to paraffin and/or formalin that
might have obstructed the entire courses of PCR, or
that little amount of PCR products might have lead
to false negative results. Considering these possible
reasons, we retried PCR using TAKARA Ex Taq with
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File name: Z11555/L.(L.) mexicana kinetoplast minicircle DNA
Sequence size : 699
13B foward primer; sequence size: 18
13A reverse primer; sequence size: 21
[Accession No.; Z11555/699 bp]
001' GGTCCCGGCCCAAACTTTTCTGCCCCGTGGGGGAGGGGCGTTCTGCGAATTTGGGAAAAA
000' ******************----------------
[13B foward primer] GTGGGGGAGGGGCGTTCT
061' TGAGTGCAGAAACCCCGTTCATATTTTGGGGAATTTTGGGGAATTCCGGCTCCGGCGGTC
000' ------------------------------------------------------------
121' ACAACTGGGGGTTGGTGTAAAATACCCGGTGCGTGGGTATGGTTAGTGGTAGAGCTTTGT
000' ****************** **
000' AACTGGGGGTTGGTGTAATAT   [13A reverse primer]
181' CGTAGGCTTGGTCTTGATGCTTTAGATTAGTTTTGGGCTGGTGAGTTTTGTTTGGTAGAT
241' TTGGTATACATTTTAAATTGTCTGTTATTTGATTTTAATAATCTCTTTGGTATAGTTATT
301' ATTCTATGTGGTATTAGTTTGTTAGGATGTTGTGTGTTGGATTTGGTGTCTTGGATTTGG
361' GCTGCCCGTGGGTTTATATATTTATGGTTGAATAATGGAGATAATATAGAATACTGATAA
421' GTTATATTATATATTATTAGGTGGTAGTGGATTGGATATGGTAATGTGGGGGTTTGTTGC
481' ATTATGTGGTACGTGGATGTTTATGTTGTCTTTCGTATTTATATTTAGCTTTTCGTTTTG
541' AATTTCTGTTTATGTTATTATATCGTTGTGGTCATTGTGATATTTGGGTTATTTGTATGT
601' TCTGGTTTTGAGATATGTGTTTGTTAATTAAAAGATGTTTTGAGGGGATTAGACTTGGTT
661' TGGATATGCTGATTTGGTTAGGAGTTTCTGGGGAAAGTG
PCR
incubation 94? 2 min.
denature 94? 1 min.
annealing 50? 2 min.
extention 72? 3 min.
cycles 25 cycles
PCR product 120 bp
Figure 4.1.1. continued.
TAKARA RN easy Mini Kit (50) to collect DNA, but
no expected PCR products were obtained.
It is necessary for clinicians without a thorough
knowledge of molecular biology to be able to judge
easily the results of PCR to detect Leishmania para-
sites in skin lesions.  In order to attain this purpose,
it is desirable that the primers should amplify spe-
cific portions of Leishmania parasites and that the PCR
products should be located at such a site as the clin-
icians can easily detect them. Because of their short
base sequences in DNA, it is sometimes difficult to
recognize PCR products with the size less than 100
bp when compared with a size marker or a primer.
Among the primers we used in this study, US2/LS2
that form bands at the site of 114 bp is the most use-
ful for clinicians to detect Leishmania infections by
PCR.  However, an ideal method for clinicians is to
detect Leishmania parasites from paraffin slice spec-
imens. However, in the present trials, we have not been
able to establish a method to extract DNA from paraf-
fin slice specimens yet, and, this will be done in the
future.
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Figure 4.1.2. The results of PCR using Leishmania
parasites.
lane 01: size marker; pUC/HapII
primer L1/L2
lane 02: MHOM/EC/88/PT-007(L. (L.) mexicana)
lane 03: MHOM/EC/88/INH-03(L. (V.) braziliensis)
lane 04: MHOM/EC/88/INH-04(L. (V.) panamensis)
lane 05: MPOT/EC/87/G-03(L. (L.) amazonensis)
primer US1/LS1
lane 06: MHOM/EC/88/PT-007(L. (L.) mexicana)
lane 07: MHOM/EC/88/INH-03(L.(V.) braziliensis)
lane 08: MHOM/EC/88/INH-04(L.(V.) panamensis)
lane 09: MSCI/EC/87/G-03(L.(L.) amazonensis)
primer US2/LS2
lane 10; MHOM/EC/88/PT-007(L. (L.) mexicana)
lane 11: MHOM/EC/88/INH-03(L. (V.) braziliensis)
lane 12: MHOM/EC/88/INH-04(L. (V.) panamensis)
lane 13: MSCI/EC/87/G-03(L. (L.) amazonensis)
lane 14: dH2O
lane 15: size marker; pUC/HapII
151413121110987654321 1413121110987654321
54321
Figure 4.1.3. The results with the primers, 13A/
13B.
lane 1: size marker; pUC/ HapII
primer 13A/13B
lane 2: MHOM/EC/88/ PT-007 (L. (L.) mexicana)
lane 3: MHOM/EC/88/ INH-03 (L. (V.) braziliensis)
lane 4: MHOM/EC/88/ INH-04 (L. (V.) panamensis)
lane 5: MSCI/EC/87/G-03 (L. (L.) amazonensis)
Figure 4.1.4. The results of PCR on paraffin-embe-
ded skin tissue from the patients with leishmaniasis.
Lane 6 showed a band (positive).
primer US2/LS2
lane 01: size marker; pUC/HapII
lane 02: EC/3/96/8/13
lane 03: EC/4/96/8/13
lane 04: EC/5/96/8/13
lane 05: EC/6/96/8/13
lane 06: EC/7/96/8/13
lane 07: EC/9/96/8/13
lane 08: EC/11/96/8/13
lane 09: EC/14/96/8/13
lane 10: EC/15/96/8/13
lane 11: EC/16/96/8/13
lane 12: DCL
lane 13: normal skin (Okinawa)
lane 14: dH2O
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1413121110987654321
Figure 4.1.5. The second PCR trial on paraffin-
embedded skin tissue.
primer US2/LS2
lane 01:  size marker; pUC/HapII
lane 02: EC/3/96/8/13
lane 03: EC/4/96/8/13
lane 04: EC/5/96/8/13
lane 05: EC/6/96/8/13
lane 06: EC/7/96/8/13
lane 07: EC/9/96/8/13
lane 08: EC/11/96/8/13
lane 09: EC/14/96/8/13
lane 10: EC/15/96/8/13
lane 11: EC/16/96/8/13
lane 12: DCL
lane 13: normal skin (Okinawa)
lane 14: dH2O
1413121110987654321
Figure 4.1.6. Nested PCR on paraffin-embeded skin
tissue.  Lane 12 (DCL) showed a band (positive).
primer US2/LS2 outer primer
lane 01: size marker; pUC/HapII
lane 02: EC/3/96/8/13
lane 03: EC/4/96/8/13
lane 04: EC/5/96/8/13
lane 05: EC/6/96/8/13
lane 06: EC/7/96/8/13
lane 07: EC/9/96/8/13
lane 08: EC/11/96/8/13
lane 09: EC/14/96/8/13
lane 10: EC/15/96/8/13
lane 11: EC/16/96/8/13
lane 12: DCL
lane 13: normal skin (Okinawa)
lane 14: dH2O
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Introduction
Leishmaniasis is endemic in many areas of tropi-
cal and subtropical America.  At least 24 countries are
affected and it constitutes an important public health
problem in the New World (Grimaldi and Tesh, 1993).
The number of reported human cases of New World
leishmaniasis has increased dramatically in recent years
(Walton et al., 1988).  Although Leishmania (Viannia)
braziliensis and L. (Leishmania) mexicana complex-
es, are responsible for most of the cases in Latin
American countries; the former is by far the most
prevalent (Lopez et al., 1993).
Diagnosis of leishmaniasis is often complicated,
in particular with L. (V.) braziliensis complex, the
number of parasites present in lesions is scarce
(Marsden, 1985).  In endemic Latin American coun-
tries the diagnosis of cutaneous leishmaniasis is usu-
ally made on the basis of clinical manifestations. The
serological tests are not able to discriminate between
past or present infections.  Furthermore, serologic tests
show cross-reactivities with sera from individuals
infected with other diseases such as Chagas disease,
malaria, brucellosis, leprosy and tuberculosis which
co-exist in leishmaniasis endemic regions in the New
World (Guevara et al., 1989).
The laboratory procedures used for diagnosis of
leishmaniasis have been extensively reviewed
(Grimaldi and McMahon-Pratt, 1991; Manson-Bahr,
1987; Palma and Gutierrez, 1991).  The classical meth-
ods used for direct demonstration of the parasite in
tissues or skin lesions include the following: (i) exam-
ination of stained smears or histologic sections; (ii)
inoculations of hamsters with aspirates from infect-
ed tissues or with triturated tissue fragments; (iii) in
vitro culture of tissue homogenates or aspirates in
biphasic media.  A combination of these direct tech-
niques is still the most commonly used method for the
diagnosis of leishmaniasis, especially the cutaneous
form (Grimaldi and McMahon-Pratt, 1991; Navin et
al., 1990).  New approaches for the detection of par-
asites, such as standard DNA hybridization procedures
have been attempted since the early 1980s.  In spite
of their considerable sensitivity, detecting as few as
50-100 parasites (Lopez et al., 1988; Wirth et al.,
1986), and the incorporation of nonradioactive detec-
tion systems (Lopez et al., 1988; Barker, 1989), their
potential use in routine diagnosis has been hampered
by the multiple step nature of standard hybridization
procedures. The development of the polymerase chain
reaction (PCR) (Saiki et al., 1985) has provided a more
2. A Comparative Study of Conventional and 
PCR-Based Diagnosis of Cutaneous 
Leishmaniasis in Ecuador
ABSTRACT. The results of a preliminary trial carried out in an endemic area for cutaneous leishman-
iasis in Ecuador, are reported here.  The diagnostic value of a polymerase chain reaction (PCR) spe-
cific for Leishmania (V.) braziliensis complex was compared with that of currently recommended 3
methods: microscopic examination of dermal scrapings, in vitro culture of patient tissue biopsy and
histopathologic examination.  The outcome of this trial was that PCR was consistently more sensi-
tive than any of the three currently recommended methods of diagnosis. PCR results were much
faster than the culture and histopathologic methods.  The sensitivity of visualizing amastigotes in scrap-
ing samples, which is simple, cheap and conventional method in use reached to only 37.5%. The
current results showed that the PCR technique can provide the means for early and rapid diagnosis
of leishmaniasis in Ecuador.  This should reduce morbidity and treatment costs of cutaneous leishman-
iasis.
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powerful approach to the application of molecular bio-
logic techniques for diagnosis.  Extension primers were
designed to amplify conserved sequences found in
minicircles of kinetoplast DNA (kDNA) of Leishmania
parasites. Such a target is eminently suitable because
the kinetoplast is known to posses thousands of copies
of the minicircular DNA (Simpson, 1987) thereby
enhancing the likelihood of detection of the parasite.
In Ecuador, leishmaniasis is endemic in many
regions including coastal, east jungle and Andean val-
leys (Amunarriz, 1991; Hashiguchi and Gomez, 1992;
Barrera et al., 1994).  In the present study, we select-
ed Leishmania infected patients from El Carmen,
Province of Manabi, Ecuador and compared between
the conventionally recommended methods of visual-
izing amastigotes or promastigotes from human tissue
samples, and the PCR procedure. The finding provides
guidelines for the selection of the most sensitive and
appropriate methods for the diagnosis of cutaneous
leishmaniasis in endemic areas of Ecuador.
Materials and Methods
Patients and study area
A total of 25 patients with skin lesions compati-
ble with cutaneous leishmaniasis were evaluated
between January and May 1997. Patients were enrolled
if the ulcerative, papular, or nodular skin lesions, last-
ing for two or more weeks, were not attributable to
trauma.  All patients are residents in the canton El
Carmen, small town located in the Pacific region,
Province of Manabi, Ecuador at 600 m above sea level.
It has approximately 68,000 inhabitants distributed
into 24 communities.  The samples were taken in a
local hospital and patients were noticed of the purpose
of the study.
Diagnostic procedures
Lesion margins were cleaned and debrided with
70% alcohol and furacin detergent. The dermal scrap-
ings and smears were Giemsa-stained and then exam-
ined for amastigotes at x100 magnification. After
injecting 2% xylocaine, a biopsy was taken at the mar-
gin of the lesion with a 4-mm diameter disposable
punch (Kai, Japan).  The biopsy was divided into three
portions, one was fixed in 10% formalin for
histopathologic examination.  Another part was sec-
tioned in various parts and inoculated into two NNN
culture medium tubes with penicilin and streptomycin,
maintained for 24 hrs at 4?, and then incubated at
27?, were examined every 2-3 days looking for pro-
mastigotes growth under an inverted microscope for
a period of one month, or until positive. The last por-
tion was maintained in 200 ml of TE buffer (Tris-
EDTA) in congelation until DNA extraction.
DNA preparation and PCR assay
Approximately 1 mm3 of the biopsy specimen was
immersed in 100?l of lysis buffer (10 mM Tris-HCl,
pH8.0; 10 mM EDTA; 1?g/?l of proteinase K) and
incubated at 55? for 2 hrs.  The digested tissue was
treated with phenol/chloroform for DNA extraction
and precipitated with sodium acetate. DNA was stored
at -20? until use.
The PCR was performed as described previously
(Lopez et al., 1993).  Briefly, 3?l of purified DNA
samples were added in final volume of a 20?l reac-
tion mixture containing 1?M of each L. (V.) brazilien-
sis complex specific primers (MP1L; 5'-TACTCCCC
GACATGCCTCTG-3' and MP3H; 5'-GAACGGGGT
TTCTGTATGC-3'), and 1 unit of Taq DNA poly-
merase (Perkin-Elmer-Cetus, Norwalk, CT).  In the
first cycle the temperature steps were 3 min at 94?,
followed by 29 cycles each one consisting of 1 min at
94? (denaturation), 1 min at 54? (annealing) and 30
seconds at 72? (elongation).  All tests were carried
out with the following controls: positive control (biop-
sy patients with parasitolgically proven leishmaniasis)
and negative control (skin biopsies from individuals
with ulcerations other than leishmaniasis).  DNAs from
both positive and negative controls were added in
every PCR reaction.  The amplified products were
visualized by ethidium bromide staining, after 1%
agarose gel electrophoresis, under UV light (Fig.
4.2.1).
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1 2 3 4 5 6
Figure 4.2.1. A respective example of the results
obtained using the PCR assay in skin biopsy samples
from Ecuadorian patients suspected of leishmaniasis
are shown.  Lane 1, 2 and 3: PCR products from
leishmaniasis-infected Ecuadorian patients.  Lane 4:
DNA size marker. Lane 5: positive control of
Leishmania (Viannia) braziliensis complex.  Lane 6:
negative control.  One fifth of the PCR product was
electrophoresed in 1% agarose gels, and visualized by
ethidium bromide staining.
Table 4.2.1. Pairwise comparison between PCR method and three standard methods
?ND = not done.
Patient
number
Stained
smear
Culture
Histopathologic
examination
PCR
1 positive positive negative positive
2 positive positive negative positive
3 positive positive negative ND
4 negative negative negative negative
5 positive positive negative positive
6 positive positive negative positive
7 positive positive negative positive
8 ND? positive negative ND
9 negative negative negative negative
10 negative negative negative positive
11 negative positive positive positive
12 negative positive negative positive
13 negative negative negative negative
14 negative positive negative positive
15 negative positive positive positive
16 negative negative negative positive
17 negative negative negative negative
18 negative negative negative negative
19 positive positive negative positive
20 negative positive positive positive
21 negative negative positive positive
22 negative negative negative positive
23 positive negative negative positive
24 positive negative positive positive
25 positive positive positive positive
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Results
The three standard diagnostic methods for
leishmaniasis with which the PCR method is compared
were carried out in an endemic area of cutaneous
leishmaniasis in Ecuador, under field conditions.  The
pairwise comparison between the PCR method and the
three standard diagnostic methods is given in Table
4.2.1.  PCR was consistently more sensitive than smear
examination, histopathologic examination and culture
in specific medium.  PCR detected Leishmania kDNA
in two samples negative for the three other procedures.
Discussion
The three recomended standard diagnostic meth-
ods used in this study are the best currently available.
Hamster inoculation requires animal facilities and this
service is not always available, especially in field con-
ditions.  The limited sensitivity of histopathology
(20%) was probably due to the scarcity of organisms
or shrinkage and/or distortion of amastigotes during
fixing which is consistent with previous reports (Cuba-
Cuba et al., 1984; Salinas et al., 1989; De Brujin et
al., 1993) showing that histopathology has limited sen-
sitivity and, given its low utility in relation to cost,
it is best to use it as a complementary test rather than
as primary diagnostic procedure.
The procedure for immediate diagnosis, dermal
scraping, demonstrated only 37.5% (9/24) of sensi-
tivity.  The dermal scraping method is recommend-
ed, however, for its simplicity and low cost.
Otherwise, 13 (52%) out of 25 biopsy samples
were positive after culture in especific media.
However, there is a high risk of bacterial and/or fun-
gal contamination working in field conditions which
decrease the sensitivity of the test.  Also, cultures
require at least one week for parasite growth.
Although parasite isolation is the gold standard for
leishmaniasis diagnosis, its limitations clearly indicate
that more sensitive methods are needed to increase
sensitivity.
In the contrary, PCR detected Leishmania DNA in
17 (74%) of the 23 samples tested so far.  These results
show PCR to be consistently more sensitive than the
three recommended methods.  The confirmed speci-
ficity for Leishmania (Viannia) species, when crude
samples are used, enhances the utility of PCR for diag-
nosis of cutaneous leishmaniasis in endemic areas.
Also, PCR results are available much faster than those
of the culture-methods.  Further studies to evaluate
the usefulness of PCR to monitor treatment of
Leishmania infected patients are ongoing.
Manuel Calvopiña,
Angel Guevara,
Eduardo A. Gomez L.,
Ronald Guderian,
Tatsuyuki Mimori,
Yoshihisa Hashiguchi
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Introduction
The diagnosis of cutaneous leishmaniasis depends
mainly on the microscopical demonstration of para-
sites from smear specimens or culture. However, in
the case of few parasites in the lesions and for the esti-
mation of successful treatment, more sensitive meth-
ods are required.
Since Rodgers et al. (1990) reported the PCR
method using 13A and 13B primers designed from
kinetoplast minicircle, many methods based on PCR
have been reported. The main target regions to ampli-
fy are kinetoplast minicircle DNA (Smyth et al., 1992;
Lopez et al., 1993; Bhattacharyya et al., 1993;
Rodriguez et al., 1994; Laskay et al., 1995;
Bhattacharyya et al., 1996), small-subunit rRNA gene
(Guevara et al., 1992; Meredith et al., 1993; Mathis
and Deplazes, 1995) and the mini-exon genes repeat
(Hassan et al., 1993; Fernandes et al., 1994; Ramos
and Simpson, 1996). RAPD-PCR (Noyes et al., 1996;
Motazedian et al., 1996) and AP-PCR (Pogue et al.,
1995a, b) were also developed.  However, Dobner et
al.  (1994) reported the presence of intraspecific vari-
ation by the analysis of kinetoplast minicircle DNA.
As the method with high sensitivity and convenience
to mass treatment, enzyme-linked immunosorbent
assay (ELISA) after PCR (Costa et al., 1996) and PCR-
SHELA (Qiao et al., 1995) were reported, but those
methods require each species specific probe to iden-
tify species.  Among the PCR methods of Leishmania
diagnosis, the detection by PCR from patient's mate-
rials was regarded as the most reliable one (Ravel et
al., 1995; Nuzum et al., 1995).  Recently Ramos and
Simpson (1996) proposed the possibility to identify
Leishmania species by the PCR products of conserved
region of the mini-exon repeat using S-1629 and S-
1630 primers.  We report here the results of our pre-
liminary trial on species identification of Leishmania
by PCR using two sets of primers 13A - 13B and S-
1629- S-1630.
Materials and Methods
Template DNAs were prepared from eight
Leishmania species, L. (Leishmania) major, L. (L.)
major-like, L. (L.) mexicana, L. (L.) amazonensis, L.
(V.) braziliensis, L. (V.) guyanensis, L. (V.) panamensis
and L. (V.) equatorensis maintained by culture in
Kochi Medical School.  Cultures containing parasites
were washed by physiological saline and fixed in 100%
ethanol.  A total of 40 ml of suspension were cen-
3.  Preliminary Studies on Diagnosis of Cutaneous 
Leishmaniasis using Skin Biopsy Specimens by 
Polymerase Chain Reaction (PCR)
ABSTRACT. Diagnostic methods of cutaneous leishmaniasis by polymerase chain reaction (PCR)
were studied using cultured parasites and human skin biopsy specimens from Ecuador. Template DNAs
were prepared by boiling for 10 min in 5 % Chelex solutions. Leishmania were detected by PCR
using primers designed from minicircle (13A and 13B) and mini-exon gene (S-1629 and S-1630).  The
former primers amplified non-specific products in human DNA and sensitivity of the reaction was low.
The latter ones never amplified non-specific products even in human template and enabled the sub-
genus level identification.  When sensitivity was increased in the latter system, the results well coin-
cided with those of identifications by smear or culture in the field survey.  Moreover, three unknown
samples by morphological examination were diagnosed to be parasites belonging to subgenus Viannia
by the present PCR method.
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Table 4.3.1. Comparison of PCR results using two primer-sets, 13A-13B and S-1629-S1630
Specimen
Smear or 
culture
Polymerase chain reaction
13A-13B S-1629 S-1630
Huigra 16 ? ? ?
La Moya 2 ? ? ? ???
Alausi 8 ? ? L. (L.) mexicana
Alausi 21 ? ? ? ?
Mil 1 ? ? ? ?
Mil 3 ? ? L. (V.)?
Mil 4 ? ? L. (V.)
Mil 5 ? ? ? ?
Mil 6 ? ? L. (V.)
Mil 7 ? ? L. (V.)
Mil 8 ? ? L. (V.)
Mil 9 ? ? L. (V.)
Mil 10 ? ? ? ?
Mil 11 ? ? ? ?
Mil 12 ? ? L. (V.)
EI Mamey 6 ? ? ? ?
EI Mamey 7 ? ? ? ?
La Moya 1 ? ? ? ?
Zhucay 21 ? ? ? ?
Zhucay 22 ? ? ? ?
Zhucay 23 ? ? ? ?
Zhucay 24 ? ? ? ?
Zhucay 26 ? ? ? ?
Zhucay 27 ?
?L. (V.) represents one or more species belonging to subgenus Viannia.
???; very weak band was observed.
In subgenus Leishmania group, distinct products were
gained in three species; 460 bp and 1000 bp in L.
(L.) major, 360 bp in L. (L.) mexicana and 320 bp and
800 bp in L. (L.) amazonensis although the same prod-
ucts pattern was observed in L. (L.) major and L. (L.)
major-like strain.  However almost the same products
(290 bp and 620 bp) were obtained in three species
belonging to subgenus Viannia, L. (V.) braziliensis, L.
(V.) guyanensis and L. (V.) panamensis, except for 70
bp and 140 bp in L. (V.) equatorensis (Fig. 4.3.3).
In this system no products were amplified in human
DNA.  From these results, it would be possible to iden-
tify species at subgenus level by the present PCR.
Field samples were also analysed by PCR using
mini-exon primers.  Parasites were determined as L.
(L.) mexicana in Alausi 8 and it was thought to be
infected by parasites belonging to subgenus Viannia
in Mil 3, Mil 4, Mil 6 Mil 7, Mil 8, Mil 9 and Mil
12 (Fig. 4.3. 4 and Table 4.3.1). In Huigra 16, La Moya
2, Alausi 21, Mil 1, Mil 5, Mil 10, Mil 11, El Mamey
6, El Mamey 7, La Moya 1, Zhucay 21, Zhucay 22,
Zhucay 23, Zhucay 24, Zhucay 26 and Zhucay 27 PCR
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trifuged at 10000 rpm for 5 min and after the removal
of supernatant precipitates were air-dried in refriger-
ator. Then 200 ml of 5% Chelex 100 resin (Bio Rad
Laboratories, Hercules, CA, USA) solution were added
and mixed to resuspend parasites in the solution. They
were boiled for 10 min and used as a template.
Human skin smear specimens (field samples) were
obtained from inhabitants during field survey, 1992-
1993, in Ecuador.  Samples were smeared on the slide
glasses and fixed with 100% ethanol after dry.  Every
specimens on slide glass were removed by a sterile
cutter knife with 20 ml of re-distilled sterile water and
transferred into a microtube.  After the addition of 240
ml of 5% Chelex 100 resin solution, the tubes were
boiled for 10 min and 1 ml of supernatant was used
as the template.
Polymerase chain reaction (PCR) was performed
using S-1629 and S-1630 primers based on the method
of Ramos and Simpson (1996).  PCR mixture (total
50 ml) contains 200 mM dNTP, Taq polymerase
(Amplitaq, Perkin-Elmer Cetus, Norwalk, CT) 1.25
unit, 10 mM Tris-HCl, pH 8.3, 50 mM KCl, 1.5 mM
MgCl2, 0.001% gelatin, 10 % (0 and 5%) DMSO
(dimethylsulfoxide), each 200 nM primer and 1 ml
template DNA. After 5 cycles of 95? for 1.5 min,
45? for 1 min and 65? for 1.5 min, 35 cycles of
reaction were performed under the condition of 95?
for 1.5 min, 50? for 1 min and 72? for 2 min and
followed by a cycle of 72? for 7 min and stored at
4?. In another experiments, six cycles were increased;
PCR was performed under the condition after first step
of 6 cycles of 95? for 1.5 min, 45? for 1 min and
65? for 1.5 min, and second step of 40 cycles of 95?
for 1.5 min, 50? for 1 min and 72? for 2 min.
In the case of PCR using 13A and 13B primers,
28 cycles of reaction were performed under the con-
ditions of 94? for 1.5 min, 64? for 1.5 min and 72?
for 1.5 min in the same mixtures without DMSO.
Products were electrophoresed in agarose gel, stained
with ethidium bromide and analysed.
Results
The system using 13A and 13B primers ampli-
fied 120 bp products from every Leishmania species,
but products of the same size were obtained in human
template DNA. After the examination of PCR con-
dition to distinguish Leishmania from human, anneal-
ing temperature and cycles were determined to 64?
and 28 cycles, respectively.  In this condition there
are no non-specific amplification when 10 ng human
DNA was used as template (Fig. 4.3.1).  Field sam-
ples were tested by this method. PCR products using
13A-13B primers were detected from samples of
Alausi 8, Mil 3, Mil 4, Mil 6, Mil 7, Mil 8, Mil 9
and Mil 12. The samples of Huigra 16, La Moya 2,
Alausi 21, Mil 1, Mil 5, Mil 10, Mil 11, El Mamay
6, El Mamay 7, La Moya 1, Zhucay 21, Zhucay 22,
Zhucay 23, Zhucay 24, Zhucay 26 and Zhucay 27 were
considered to be negative (Fig. 4.3. 2 and Table 4.3.1).
PCR were performed using the mini-exon primers
(S-1629 and S-1630), 10% DMSO and template DNAs
of L. (L.) major, L. (L.) major-like, L. (L.) mexicana,
L. (L.) amazonensis, L. (V.) braziliensis, L. (V.) guya-
nensis, L. (V.) panamensis and L. (V.) equatorensis.
Figure 4.3.1. PCR products using 13 A - 13 B
primers stained with ethidium bromide after agarose
gel electrophoresis. M; 120 bp marker: Lane 1; L.
(Leishmania) mexicana DNA: Lane 2; human DNA
(10 ng).
M 1 2
120???
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Table 4.3.2. Differences of PCR products according to the difference of DMSO concentration; numbers rep-
resent products size in basepairs
Species
0-4% 5% 8% 10%
DMSO concentration
L. (L.) major 290 (very weak) 290, 500 460, 1,000
L. (L.) major-like 470
L. (L.) mexicana 500 360
L. (L.) amazonensis 320, 800 320, 800
L. (V.) braziliensis 290 290, 600 290, 620
L. (V.) guyanensis 290 290, 600 290, 620
L. (V.) panamensis 290 290, 600 290, 620
L. (V.) equatorensis 100 100 100, 140 70, 140
Human no products no products no products no products
987654321M M87654321
26252423222120191817161514M
120bp?
13121110M
120bp?
Figure 4.3.2. PCR products of skin smear specimens
using 13A-13B primers stained with ethidium bromide
after agarose gel electrophoresis.  M; marker, Lane 1;
Huigra 16, Lane 2; La Moya 2, Lane 3; Alausi 8, Lane
4; Alausi 21, Lane 5; Mil 1, Lane 6; Mil 3, Lane 7;
Mil 4, Lane 8; Mil 5, Lane 9; Mil 6, Lane 10; Mil 7,
Lane 11; Mil 8, Lane 12; Mil 9, Lane 13; Mil 10, Lane
14; Mil 11, Lane 15; Mil 12, Lane16 ; El Mamay 6,
Lane 17; El Mamay 7, Lane 18; La Moya 1, Lane
19; Zhucay 21, Lane 20; Zhucay 22, Lane 21; Zhucay
23, Lane 22; Zhucay 24, Lane 23; Zhucay 26, Lane
24; Zhucay 27, Lane 25; L. (L.) mexicana DNA, Lane
26; human DNA (1 ng).
Figure 4.3.3. Results of PCR with 10 % DMSO
using S-1629 and S-1630 mini-exon primers. Stained
agarose gel with ethidium bromide after elec-
trophoresis. M; marker (1,000, 700, 525 + 500, 400,
300, 200, 100 and 50 bp), Lane 1; L. (L.) major, Lane
2; L. (L.) major-like, Lane 3; L. (L.) mexicana, Lane
4; L. (L.) amazoensis, Lane 5; L. (V.) braziliensis, Lane
6; L. (V.) guyanensis, Lane 7; L. (V.) panamensis, Lane
8; L. (V) equatorensis.
products were not detected. Samples of PCR negative
but diagnosed positive or unknown in Leishmania
infection by smear or culture method were re-exam-
ined by PCR 6 cycles added.  After the modified PCR,
five samples (Mil 5, Mil 10, Mil 11, El Mamey 6 and
Zhucay 22) proved to be positive (parasites belonging
to Viannia) and two samples (La Moya 2 and Zhucay
23) showed very weak band (? ) (belonging to
Viannia).  In samples of Mil 11, El Mamey 6 and
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Zhucay 22, infections were undetermined by smear or
culture method, but they were probably thought to
be positive (parasites belonging to Viannia) by the
results of PCR. However, samples of Alausi 21 and
Mil 1 were still negative (Fig. 4.3.5 and Table 4.3.1).
1413121110987654321M 121110987654321M
1716151413M
M27262524232221201918171615
Figure 4.3.4. Results of PCR with 10% DMSO using
S-1629 and S-1630 mini-exon primers. Stained agarose
gel with ethidium bromide after electrophoresis. M;
marker (1,000, 700, 525 + 500, 400, 300, 200, 100 and
50 bp), Lane 1; Huigra 16, Lane 2; La Moya 2, Lane
3; Alausi 8, Lane 4; Alausi 21, Lane 5; Mil 1, Lane
6; Mil 3, Lane 7; Mil 4, Lane 8; Mil 5, Lane 9; Mil
6, Lane 10; Mil 7, Lane 11; Mil 8, Lane 12; Mil 9,
Lane 13; Mil 10, Lane 14; Mil 11, Lane 15; Mil 12,
Lane16; El Mamay 6, Lane 17; El Mamay 7, Lane 18;
La Moya 1, Lane 19; Zhucay 21, Lane 20; Zhucay 22,
Lane 21; Zhucay 23,Lane 22; Zhucay 24, Lane 23;
Zhucay 26, Lane 24; Zhucay 27, Lane 25; No DNA,
Lane 26; human DNA (10 ng), Lane 27; L. (V.)
brasiliensis DNA.
Figure 4.3.5. Results of PCR with 10 % DMSO
using S-1629 and S-1630 mini-exon primers. Stained
agarose gel with ethidium bromide after elec-
trophoresis. M; marker (1,000, 700, 525 + 500, 400,
300, 200, 100 and 50 bp), Lane 1; L. (V.) brasilien-
sis DNA, Lane 2; La Moya 2, Lane 3; Alausi 21, Lane
4; Mil 1, Lane 5; Mil 5, Lane 6; Mil 10, Lane 7; Mil
11, Lane 8; El Mamay 6, Lane 9; El Mamay 7, Lane
10; La Moya 1, Lane 11;  Zhucay 21, Lane 12; Zhucay
22, Lane 13; Zhucay 23, Lane 14; Zhucay 24, Lane
15; Zhucay 26, Lane16; Zhucay 27, Lane 17; No DNA.
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Discussion
Results of PCR using primers designed from mini-
exon repeat have well coincided with that of histo-
logical or microscopical diagnosis as a whole. Final
accordance rate was 87.5 % (14/16).  As no fales-pos-
itive reactions were observed, positive samples in PCR
were thought to contain Leishmania without doubt.
Accordingly, when samples undetermined by smear
examination or culture method turned positive by PCR,
they should be diagnosed Leishmania positive.
As 13A-13B primers amplified non-specific prod-
ucts in human DNA, the cycles were decreased not
to produce the bands.  So the sensitivity was lowered,
however the specimens diagnosed positive by this sys-
tem were apparently positive ones. Non-specific prod-
ucts were never amplified in PCR systems using
S-1629 and S-1630 primers.  The minimal sensitivi-
ty including whole process was not determined in both
systems using 13A and 13B primers and S-1629 and
S-1630 primers because of the technical difficulties.
In the process of this study using S-1629 and S-
1630 primers, each species has different reactivity to
the concentrations of DMSO. Namely in subgenus
Leishmania, the lower concentration of DMSO, the
less products were detected.  In contrast, in subgenus
Viannia, clear bands were detected even in mixture
without DMSO.  But L. (V.) equatorensis had the pecu-
liar reaction mode that the most abundant products
were obtained in 0% DMSO condition (Table 4.3.2).
So the role of DMSO is not the same in each species
although its function is not clear in PCR. As the small
sized products of PCR using 10% DMSO in L. (V.)
equatorensis were detectable in agarose gel, we applied
that concentration of DMSO in further analysis.
Variations in both the length and primary sequence
of the non-transcribed spacers have been reported in
Leishmania. L. (V.) lainsoni has 157 bp deletions in
non-transcribed spacer of mini-exon gene and showed
32 bp deletion during polymerizing process in PCR
(Fernandes et al., 1994). And Cupolillo et al. (1995)
reported from the analysis of internal transcribed
sequences (ITS) of rRNA gene that L. (V.) lainsoni
and L. (V.) equatorensis were quite separate from other
species and some association in phylogenic position.
So our results in L. (V.) equatorensis suggest the pres-
ence of some deletion in mini-exon genes and artifact
in PCR.
At present the identification of Leishmania by PCR
has not been perfectly established because species in
subgenus cannot be discriminated each other in any
systems.  The efforts to sequence non-transcribed spac-
er in mini-exon gene repeats may enable the complete
identification at species level by simple PCR method.
However, even in the present situation PCR is useful
in diagnosis of Leishmania infection and the evalua-
tion of treatments.
Masakazu Harada,
Setsuo Suguri,
Ken Katakura,
Yuki Eshita,
Masato Furuya,
Eduardo A. Gomez L.,
Yoshihisa Hashiguchi
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Introduction
There are three types of leishmaniasis, that is, cuta-
nenous, mucocutaneous and visceral leishmaniasis.
Cutaneous leishmaniases are classified into four types,
that is, localized, diffuse, recidivans and post kala-
azar (Grevelink et al., 1996). Previously, we report-
ed  several findings on cutaneous manifestations of
leishmaniasis in Ecuador (Nonaka et al., 1990a, b;
Hashiguchi et al., 1992; Reyna et al., 1994).  That
is, there were    marked differences in clinical find-
ings of cutaneous  leishmaniasis between the low-
Chapter 5
Clinical and Epidemiological Aspects
1. Clinical Survey of Cutaneous Leishmaniasis in 
Ecuador for 5 Years (1991-1995)
ABSTRACT. In this study, we analyzed clinical and epidemiological data on cutaneous changes of
leishmaniasis recorded in the period from 1991 to 1995 in Ecuador.  A total of 348 cutaneous leishman-
iasis patients living in Ecuador were examined for this  study.  The study areas were included Provinces
of Manabi, Los Rios, Azuay, and Esmeraldas.  These areas are located in the Pacific coast and the
slope of Andean mountains.  Each patient was thoroughly examined clinically and parasitologically.
The total 348 patients in this study consisted of 204 males  and 144 females.  The mean age of patients
was 21.2  years (? 1.2 s.e.) in males, 18.9 years (? 1.4 s.e.) in females and 20.2 years (? 0.9 s.e.)
in total.  Patients less than 20-year-old occupied more than half of all the patients examined. However,
senior patients more than 50-year-old were seen, namely 15 cases (7.4%) in males, 11 cases (7.7%)
in females and 26 cases (7.5%) in total.  The mean duration period of cutaneous lesions was 5.3 months
(? 0.4 s.e.) in males, 6.3 months (? 0.7 s.e.) in females and 5.7 months (? 0.4 s.e.) in total.  The
number of the patients with the onset of lesions less than 1 month was 18 cases (10.5%) in males, 8
cases (7.0%)  in females and 26 cases (9.1%) in total.  However, there were 8  cases  (4.7%) in
males, 7 cases (6.1%) in females and 15 cases (5.2%)  in total that showed the duration period of lesions
more than 13 months.  The popular types of lesions included ulcer, nodule,  erythematous plaque and
papule.  The most polular type was ulcer formation. The patients with ulcer occupied more than 50%
in total.  More than half of the lesions were located on the face and  the extremities.  The lesions on
the trunk were seen more frequently in male than in female.  On the other hand, the lesions on the
legs were more popular in female.  Almost half of the lesions were solitary, but the remainder were
multiple.  The cases with more than ten multiple lesions were seen in five of the male patients, two
of the female patients and seven of the total patients.  Several species of Leishmania parasites and vec-
tors were reported  in the areas  examined in this study.  Cutaneous manifestations of leishmaniasis
in Ecuador may differ delicately from those in other areas because of the difference of species of the
parasites, various behaviors of the vectors and the different life style of the inhabitants. Therefore.
medical doctors assigned to the treatments for cutaneous leishmaniasis in Ecuador have not only
medical knowledge but also entomological, ecological, environmental and anthropological knowledge.
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land and highland of Ecuador.  The most popular cuta-
neous change was ulcer, but non-ulcered cutaneous
changes such as papules, plaques and nodules were
also seen frequently.  Big ulcers more than 900 mm2
were also seen in 21 (14.7%) of 143 cases of cuta-
neous leishmaniasis.  Lymphnode  swellings were also
seen in half of the patients examined, more frequent-
ly in males than in  females.  One case of general-
ized cutaneous leishmaniasis was reported in Ecuador.
In this study, we analyzed data on cutaneous changes
of patients with leishmaniasis recorded from 1991 to
1995 in Ecuador.   
Materials and Methods
A total of 348 cutaneous leishmaniasis patients
living in Ecuador were analyzed for this study.  The
study areas included Provinces of Manabi, Los Rios,
Azuay and Esmeraldas.  These areas are located in the
Pacific coast and the slope of Andean mountains.  The
period of observation was 5 years from 1991 to 1995.
Before each examination, all the necessary informa-
tion on the patients was recorded on registration cards
by the members of the public health care centers.
Onset of the lesions was recorded by asking the time
when the lesions started.  Each patient was thoroughly
examined clinically and parasitologically.  Smears
were taken from the edge of ulcers and stained with
Giemsa and then examined microscopically using oil
emulsion.  Skin changes of the patients with cutaneous
leishmaniasis were thoroughly examined for charac-
teristics, size, site and number of the lesions.  Skin
test by using Leishmania promastigote antigens pre-
pared by Furuya et al.  (1991) was also performed
on a part of patients as an immunological examina-
tion. 
Results
The results obtained are summerized in Table 5.1.1
to 5.1.5.  The total patients in this study were 348, 204
males and 144 females (Table 5.1.1).  The mean age
of patients was 21.2 years (? 1.2 s.e.) in males, 18.9
years (? 1.4 s.e.) in females and 20.2 years (? 0.9
s.e. ) in total.  Young patients less than 20-year-old
occupied more than half of all the patients examined.
However, senior patients, more than 50-year-old were
seen with  15 cases (7.4%) in males, 11 cases (7.7%)
in females and 26 cases (7.5%) in total.  The mean
duration period of cutaneous lesions was 5.3 months
(? 0.4 s.e.) in males, 6.3 months (? 0.7 s.e.) in
female and 5.7 months (? 0.4 s.e.) in total (Table
5.1.2).  The number of the patients with the onset of
lesions less than 1 month was 18 cases (10.5%) in
males, 8 cases (7.0%) in females and 26 cases (9.1%)
in total.  However, there  were 8 cases (4.7%) in males,
7 cases (6.1%) in females and 15 cases (5.2%) in total
that showed the duration time of lesions more than 13
months.  The popular types of lesions included ulcer,
nodule, erythematous plaque and papule (Table 5.1.3).
The most polular type was ulcer formation.  The
patients with ulcer occupied more than 50% in total.
Distribution of the lesions is shown in Table 5.1.4.
More than half of the lesions were located on the face
and the extremities.  The lesions on the trunk were
seen more frequently in male than in female.  On the
other hand, the lesions on the legs were more popu-
lar in female.  Almost half of the lesions were soli-
tary, but the remainder were multiple (Table 5.1.5).
The cases more than ten multiple lesions were seen in
five of the male patients, two of the female patients
and seven of the total patients.
Discussion
In 1990, we performed a comparative study of skin
changes of cutaneous leishmaniasis between highland
and lowland in  Ecuador (Nonaka et al., 1990a).
There were marked differences between the  two areas.
The mean age of the patients in lowland was 20 years,
but that in highland was low (2 years).  The number
of the lesions was more in lowland than in highland.
Large ulcers were frequently seen in lowland, but those
Table 5.1.1. Summary of patients with cutaneous leishmaniasis
Age (years) Male (%) Female (%) Total (%)
00?05 31 ( 15.2) 29 ( 20.1) 60 ( 17.2)
06?09 28 ( 13.7) 25 ( 17.4) 53 ( 15.2)
10?19 49 ( 24.0) 36 ( 25.0) 85 ( 24.5)
20?29 51 ( 25.0) 22 ( 15.3) 73 ( 21.0)
30?39 19 ( 9.3) 11 ( 7.6) 30 ( 8.6)
40?49 11 ( 5.4) 10 ( 6.9) 21 ( 6.0)
50?59 4 ( 2.0) 6 ( 4.2) 10 ( 2.9)
60?00 11 ( 5.4) 5 ( 3.5) 16 ( 4.6)
Tolal 204 (100.0) 144 (100.0) 348 (100.0)
Time (months) Male (%) Female (%) Total (%)
00?01 18 ( 10.2) 8 ( 7.0) 26 ( 9.1)
02?03 66 ( 38.3) 39 ( 33.9) 53 ( 36.5)
04?06 51 ( 29.6) 35 ( 30.4) 85 ( 30.0)
07?12 29 ( 16.9) 26 ( 22.6) 73 ( 19.2)
13?00 8 ( 4.7) 7 ( 6.1) 30 ( 5.2)
Tolal 172 (100.0) 115 (100.0) 348 (100.0)
Table 5.1.2. The duration time of cutaneous leishmaniasis lesions
Type Male (%) Female (%) Total (%)
Erythema 0 ( 0) 1 ( 0.7) 1 ( 0.3)
Papule 18 ( 8.9) 14 ( 9.8) 32 ( 9.3)
Nodule 26 ( 12.8) 10 ( 7.0) 36 ( 10.4)
Plaque 25 ( 12.4) 17 ( 11.9) 42 ( 12.2)
Scar 9 ( 4.6) 19 ( 13.3) 28 ( 8.1)
Scar with erythema 0 ( 0) 2 ( 1.4) 2 ( 0.6)
Ulcer 123 ( 60.8) 80 ( 55.9) 203 ( 58.8)
Granuloma 1 ( 0.5) 0 ( 0) 1 ( 0.3)
Tolal 202 (100.0) 143 (100.0) 345 (100.0)
Table 5.1.3. The clinical forms of cutaneous leishmaniasis lesions
84
in highland were very small.  The lesions were wet
in lowland, however dry in highland.  Mucocutaneous
leishmaniasis was seen only in lowland and never seen
in highland.  In 1991, we reported Andean leishman-
iasis in Ecuador caused by infection with Leishmania
(Leishania) mexicana and L. (L.) major-like parasites
(Hashiguchi et al., 1991).  Cutaneous  leishmaniasis
in highland was similar to "Uta", a cutaneous form
of the disease described in Peru.  "Uta" is prevalent
among the   inhabitants to the western slopes and val-
ley of the  Peruvian Andes at the elevations between
600 and 3000 meters  above sea level.  This disease
is thought to be caused by L. (Viannia) peruviana
(or a variant of L. (V.) braziliensis).  Therefore, the
parasites of Andean cutaneous leishmaniasis in
Ecuador is different from those in Peru.  It is very
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Table 5.1.4. The site of 391 lesions
Body area Male (%) Female (%) Total (%)
Face 52 ( 21.7) 37 ( 24.6) 89 ( 22.8)
Ear 9 ( 3.7) 2 ( 1.3) 11 ( 2.8)
Neck 6 ( 2.5) 0 ( 0) 6 ( 1.5)
Back 10 ( 4.1) 4 ( 2.7) 14 ( 3.6)
Chest 2 ( 0.8) 0 ( 0) 2 ( 0.5)
Abdomen 1 ( 0.4) 0 ( 0) 1 ( 0.3)
Buttock 1 ( 0.4) 1 ( 0.7) 2 ( 0.5)
Trunk 3 ( 1.2) 0 ( 0) 3 ( 0.8)
Shoulder 1 ( 0.4) 1 ( 0.7) 2 ( 0.5)
Arm 21 ( 8.7) 5 ( 10.0) 36 ( 9.2)
Elbow 5 ( 2.1) 3 ( 2.0) 8 ( 2.0)
Forearm 53 ( 22.1) 22 ( 14.7) 75 ( 19.2)
Hand 8 ( 3.3) 2 ( 1.3) 10 ( 2.6)
Upper extremity 11 ( 4.6) 6 ( 4.0) 17 ( 4.3)
Thigh 10 ( 4.1) 3 ( 2.0) 13 ( 3.3)
Leg 44 ( 18.3) 51 ( 34.0) 95 ( 24.3)
Foot 1 ( 0.4) 0 ( 0) 1 ( 0.3)
Extremities 3 ( 1.2) 3 ( 2.0) 6 ( 1.5)
Tolal 241 (100.0) 150 (100.0) 391 (100.0)
Table 5.1.5. The number of lesions per patient
Number Male (%) Female (%) Total (%)
1 100 ( 50.9) 65 ( 49.3) 165 ( 50.3)
2 41 ( 20.9) 25 ( 19.0) 66 ( 20.1)
3 25 ( 12.8) 18 ( 13.6) 43 ( 13.1)
4 10 ( 5.1) 9 ( 6.8) 19 ( 5.8)
5 6 ( 3.1) 7 ( 5.3) 13 ( 4.0)
06?9 9 ( 4.6) 6 ( 4.5) 15 ( 4.6)
10?0 5 ( 2.6) 2 ( 1.5) 7 ( 2.1)
Tolals 196 (100.0) 132 (100.0) 328 (100.0)
interesting  that clinical features of both types of
leishmaniasis are almost similar disregarding differ-
ent species of parasites and similar environmental con-
ditions of  inhabitants.  Furthermore, we performed
dermatological and parasitological examinations of
cutaneous leishmaniasis in the Pacific coast of Ecuador
(Nonaka  et al., 1992).  The most frequent duration
time of lesions was three months.  Approximately 25%
of the lesions persisted for more than  five  months.
The mean number of cutaneous lesions was 2.7 in both
sexes.  The subjects with single lesion were most fre-
quent, and 40% possessed multiple lesions.  There
were three cases with more than 10 cutaneous lesions
out of 143 patients.  The most frequent sites of lesions
were extremities.  The most popular cutaneous change
was ulcer formation, but non-ulcered cutaneous
Table 5.1.6. The size of lesions
Size of lesions (mm2) Male (%) Female (%) Total (%)
0000?0009 30 ( 8.2) 13 ( 4.8) 43 ( 6.8)
0010?0025 70 ( 19.2) 33 ( 12.2) 103 ( 16.2)
0026?0100 92 ( 25.2) 61 ( 22.5) 153 ( 24.1)
0101?0400 114 ( 31.3) 89 ( 32.8) 203 ( 31.8)
0401?1600 42 ( 11.5) 56 ( 20.7) 98 ( 15.4)
1601?0000 6 ( 1.6) 4 ( 1.5) 10 ( 1.6)
unknown 11 ( 3.0) 15 ( 5.5) 26 ( 4.1)
Tolal 365 (100.0) 271 (100.0) 636 (100.0)
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changes  were also seen.  The lesions with the size
of less than  400 mm2 were frequent.  There were 21
cases with lesions of more than 900 mm2 and all of
them were ulcerated.  In this study, we analyzed 348
patients in total.  The mean age of the patients was
2 years older than that in the previous study (Nonaka
et al., 1990a).  Senior patients  with more than 50 years
of age were more frequent than those  in  the previ-
ous study.  The mean duration period of cutaneous
lesion was 1.5 months longer than that in the previ-
ous study.  The mean number of cutaneous lesions was
2.7.  Seven cases possessed more than 10 lesions.  This
datum showed a similar tendency to that in the pre-
vious report (Nonaka et al., 1990a). The most fre-
quented site was the face following the extremities,
that is, the exposed areas with various stimuli.  This
means that it may be possible for a sand fly to bite for
aspiration of blood from exposed sites of humans.
Several species of parasites and vectors are report-
ed in the areas examined in this study.  Cutaneous
manifestations of leishmaniasis in Ecuador will differ
delicately from those in other areas because of the dif-
ference of species of the parasites, various behaviors
of the vectors and different life style of the inhabi-
tants.  Therefore, medical doctors assigned to the treat-
ments for cutaneous leishmaniasis should have not
only medical knowledge but also entomological, eco-
logical, environmental and anthropological knowledge. 
Shigeo Nonaka,
Atsushi Hosokawa,
Motoyoshi Maruno, 
Roberto Sud A.,
Eduardo A. Gomez L., 
Yoshihisa Hashiguchi
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Introduction
Cutaneous leishmaniasis is an acute or chronic
infection affecting tissues of mammmals, including
man, caused by different species of protozoa of the
genus Leishmania.  The cutaneous form exists in dif-
ferent endemic areas of the world.  In Latin America
it is common in sylvatic focus of all countries with
exception of Chile and Uruguay in South America.
It is endemic in Central and South America reaching
the estuary of Parana river in the east, and occiden-
tal Andean slopes of Peru in the west.  In Ecuador
cutaneous form is the most frequent clinical feature
of the disease, but several cases of the mucocutaneous
leishmaniasis are also seen throughout the year.
Cutaneous leishmaniasis was reported for the first time
by  Valenzuela in 1920 (Rodriguez, 1974).  The first
case of mucocutaneous forms was described in 1924
by Heinert (Rodriguez, 1974).  Since then, many cases
of cutaneous and some of mucocutaneous leishman-
iasis have been  reported every year, and studies on
transmision of the disease with reference to vectors
and reservoirs started in 1982 and continued to date
(Hashiguchi et al., 1987, 1990, 1992, 1994).
The lack of a well structured information system
has not allowed epidemiologists to elaborate on a good
and representative statistic feature of the disease in
Ecuador.  However, there is an important information
that gives an idea on the incidence of leishmaniasis in
the country.  For example, case reports were made
from Ecuador in different years as follows: 1981,  103
cases; 1982, 263 cases; 1983, 284 cases; and 1984,
1316 cases (PAHO, 1984).
In El Carmen Hospital, first case was reported in
1983, and since then, many cases have been registered
every year.  In this paper we reviewed the incidence
of cutaneous leishmaniasis recorded to date in the hos-
pital, and analyzed the results of a therapeutic trial
with five groups of patients who received meglumine
antimonate Glucantime® between 1988 and 1989.
Materials and Methods
The study area, Canton El Carmen, Province of
Manabi was located at the north-western regions of
the Pacific coast of Ecuador (Fig. 5.2.1). The area
includes many   small towns, villages, settlement and
spread farms or field houses at mountainous parts of
the cordillera between Andean slopes and the coast of
the country.  All patients diagnosed with leishman-
iasis during 1988 and 1996 were included in the eval-
uation of general incidence, and a clinical trial of
treatment done in 1988 - 1989 (Garcia and Bastidas,
1991) is reviewed and analyzed.
The used method for diagnosis has been the direct
examination, that is the stained smear of material taken
from the lesions.  Smears were fixed with pure ethanol
and stained with Giemsa or Wright colouring.  We
reviewed data on patients studied in the trial 1988 -
1989 which included procedence, sex, age and living
2.  Cutaneous Leishmaniasis in  El Carmen, 
Province of Manabi, Ecuador
ABSTRACT. Clinical cases of leishmaniasis registered during the period from 1985 to 1996 in a pub-
lic hospital in El Carmen, Province of Manabi, Ecuador were briefly evaluated, in order to get an infor-
mation on the global situation of the disease in the area.  In the hospital a therapeutic trial was done
in 1988-1989 using meglumine antimonate (Glucantime®) with different doses.  The results on the ther-
apy were also analysed and evaluated. The methodology of treatment used and the possibility of even-
tual misdiagnosis in such a rural hospital were taken into consideration, with the intention of improving
medical care system in the endemic area of cutaneous leishmaniasis.
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activity of patients; lesions evaluation by type, loca-
tion, size and total number, time of evolution; and
treatment, healing time and cure rate of lesions.
Probable side effects were also taken into considera-
tion.  Treatment scheme used in the hospital was care-
fully evaluated.  The scheme of treatment was
structured using very low doses for some patients,
because in that time there was no information on the
species of Leishmania existing in the area, and there
was always the possibility of benign leishmaniasis
caused by not so virulent strains.
Treatment trial using meglumine antimonate was
done during 1988 and 1989 as the following sched-
ules in each group, Group A, 5cc (1 ampoule) each
day for 10 days; Group B, 5cc everyday, during 14
days; Group C, 5cc everyday, during 20 days; Group
D, Glucantime®, 60 mg/kg/day, for 10 days; Group E,
Table 5.2.1. Parasitologically confirmed leishmaniasis cases in Hospital El Carmen, Province of Manabi,
Ecuador during 1985 and 1996
Year 1985 1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996
No. of case 10 9 6 89 232 349 124 24 54 104 64 70+
Fig. 5.2.1. Map of the study areas.
Glucantime®, 60 mg/kg/day, for 14 days.
Results
Retrospective epidemiological data analysis
The total numbers of cases of leishmaniasis reg-
istered from 1985 to 1996 in El Carmen Hospital are
shown in Table 5.2.1.  All patients were parasitolog-
ically confirmed by microscopical examination of
smear specimens taken from clinically suspected leish-
manial lesions.  A preliminary trial of treatment with
Glucantime® was done in 1988 - 1989 with 241
patients treated in El Carmen Hospital, Manabi,
Ecuador.  These data are analyzed further as follows.
Age distribution of subjects
Ages of 134 patients (55%) were within 11 and 30
years old, with an age peak within 21 and 30 (69
patients; 28.6%) as shown in Table 5.2.2.
Sex distribution of subjects
Of the total subjects in the present retrospective
study, 144 ( 59.8%) were male and 97 ( 40.2%) were
female, as shown in Table 5.2.3.
Occupation of subjects
Distribution of life activities of patients studied in
1988-1989, is shown in Table 5.2.4.  It is clear that
the highest incidence is seen in those persons with
some kind of field activities, which expose them to
the bite of sandflies, in the forest (Table 5.2.4).
Residence of subjects
Among 241 persons diagnosed as cutaneous
leishmaniasis in El Carmen Hospital, 61 (25.3%) were
from same town (El Carmen) where the hospital is
located (Fig. 5.2.1); 18 (7.4%) came from Rio de Oro;
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No. of lesions No. of patients Percentage (%)
1 134 55.6
2 47 19.5
3 28 11.6
4 1 56.2
5 7 2.9
6 3 1.2
7 2 0.8
9 1 0.4
10 3 1.2
11 1 0.4
Total 241 100.0
Table 5.2.5. Frequency distribution of number of
lesions observed in subjects in this
study
Table 5. 2. 6. Number of lesions observed on the
body surface of subjects
Body area No. of lesions Percentage  (%)
Upper extrem. 148 30.2
Lower extrem. 238 48.6
Face 72 14.7
Thorax 23 4.7
Neck 8 1.6
Total 489 100.0
4 patients (4.9%) came; from each one: La Alegria,
Tres Ranchos, Tigre, Maicito, Venado and Mongoya
3 patients (7.4%) came; from each one: El Rocio,
Puerto Nuevo, La Esperanza, Agua Sucia, Las Delicias,
Km 26, La Crespa, La virgencita and Colonape 2
patients came; from each one: Tripa de Pollo, Las
Vainas, Km 62, Campeche, El Rosario, Limones, Km
58, Piojito, Cohete, La Valencia, Palanca, Tinaja,
Canali, Pita, El Guayabo, Km 40, Km 38, Chontillal,
Campamento, El Achote, La Sandia, La Salvacion, El
Palmar, Km 21, Km 44, Tigrillo, Santa Maria, Chiparo,
Toquilla, Km 32 and La Mediana, 1 patient (12.4%)
came. Some patients also came from other areas
besides Canton El Carmen:10 (4.1%) from Esmeraldas
Province; from each one: Canton Flavio Alfaro,
Pedernales and Santo Domingo de Los Colorados 2
patients (total: 2.4%) came; from each one: Amazonia,
17 (7%) from Pupuza; 15 (6.2%) from Bramadora; 8
(3.3%) from Cajones; 5 (2%) from Chila Guabal; 5
(2%) from Porvenir and 5 (2%) from Mono. From each
one: EL Cedro Chila, Palma Sola and Las Mercedes
Table 5.2.2. Age distribution of subjects registered
at the hospital
Occupation No. of patients Percentage (%)
Agriculture 68 28.2
Not specified 60 24.8
Students 50 20.7
House keeping 40 16.5
Car driver 3 1.2
Business man 3 1.2
Bricklayer 2 0.8
Public employee 2 0.8
Mechanical technician 2 0.8
Teachers 2 0.8
Dressmaker 3 1.2
Tapster 1 0.4
Wood-cutter 1 0.4
Fisher 1 0.4
Hair-dresser 1 0.4
Nursering 1 0.4
Total 241 100.0
Age groups No. of patients Percentage (%)
<1 year 3 1.2
1 - 10 54 22.4
11 - 20 65 26.9
21 - 30 69 28.6
31 - 40 24 9.9
41 - 50 15 6.2
> -  50 11 4.5
Total 241 100.0
Sex No. of patients Percentage (%)
Male 144 59.8
Female 097 40.2
Table 5.2.3. Sex distribution of subjects in this study 
Table 5.2.4. Occupation of subjects found in this
study
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The distribution of cutaneous leishmaniasis lesions
on the body surface of subjects registered in the hos-
pital is shown in Table 5.2.6.
Size of lesions
A total of 489 ulcerous lesions were observed in
the present subjects of cutaneous leishmaniasis.  Of
these, 157 (32.2% ) had a diameter of 2 cm; 133
(27.4%), 1 cm; 112 (23%), 3 cm; the remainings
(17.4%), between 5 and 10 cm.
Duration time of lesions
The majority of duration time of lesions ranged
from 1 month to 5 months at the time of examina-
tion of subjects, before treatment and registered in
1988-1989, as shown in Table 5.2.7.
Results of treatment with Glucantime®
Among 119 patients treated with 5cc (1.5g) of
Glucantime®/day, during 10 days, only 48 (40.2%)
accomplished periodic control attendance to the hos-
pital during three months.  42 were confirmed with
healed lesions, of which one presented reactivation
8 months later.  The other six did not heal lesions dur-
ing observation of three months.  Failure rate in this
group is 14.5% (7 patients).  Cure rate was  85.5%.
Among 49 patients treated with 5cc (1.5g) of
Glucantime®/day, for 14 days, only 15 completed
routinary controls for three months.  Fourteen healed
lesions, with one reactivation 1 month later.  One
patient never healed during the treatment.  Failure rate
was 13.3% (2 patients).  Cure rate was 86.7%.
Among 19 patients treated with 5cc (1.5g) of
Glucantime®/day, for 20 days, only 6 completed three
months control.  One (16.6%) of the six never healed
lesions.  Failure rate was 16.6% (1 patient).  Cure rate
was 83.4%.
Among 40 patients treated with Glucantime®, 60
mg/kg/day for 10 days, only 20 came for controls dur-
ing three months.  All of them healed lesions with-
out reactivation within three months. Cure rate was
100%.
Among 12 patients treated with Glucantime®, 60
Table 5.2.7. Duration time of lesions as of the exam-
ination at El Carmen Hospital
Duration time (month) No. of patients Percentages  (%)
< 1 < 19 7.8
1 74 30.7
2 80 33.1
3 29 12.0
4 18 7.4
5 4 1.6
6 5 2.0
7 6 2.4
8 1 0.4
9 2 0.8
12 1 0.4
18 1 0.4
48 1 0.4
Total 241 100.0
Calceta, Convento, Quinonez, and Chone 1 patient
(total: 2%) came.
Number of lesions found in subjects
Number of lesions observed in patients ranged
from one  to 11.  The distribution of total number of
leishmanial lesions is shown in Table 5.2.5.
Anatomical distribution of lesions
Table 5.2.8. Side effects of subjects treated with
Glucantime® injection
Symptoms No. of patients Percentages (%)
Fever 8 5.4
Dizziness 4 2.7
Rash 2 1.3
Nausea 1 0.6
Headache 1 0.6
Parestesia 1 0.6
Vomiting 1 0.6
Cough 1 0.6
Weakness 1 0.6
Malaise 1 0.6
None 126 85.5
Total 147 100.0
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mg/kg/day for 14 days, only 4 patients completed three
months control.  All of them healed completely.  Cure
rate for 4 patients was 100%.
Probable side effects observed
Only 147 patients could be evaluated for probable
side effects.  Of them, 21 (14.2%) showed slight clin-
ical symptoms as shown in Table 5.2.8.
Discussion
Leishmaniasis was recognized for the first time as
a public health problem in Province of Manabi in 1984
(unpublished data), when a big number of cases
appeared in some areas of the province.  Since then,
epidemiological studies have been done in order to
understand the epidemiological aspects of the dis-
ease (Coronel et al., 1986; Alava et al., 1990).
The clinical cases registered at the El Carmen
Hospital, in our opinion, could be directly correlated
with the reservation of antimonial drugs existing in
the hospital at different seasons.  Because people tends
to avoid looking for medical care, when they know
there is no treatment avaliable.  So, after the breakout
of leishmaniasis in 1984, many cases were not regis-
tered because of the lack of chemotherapy.  And then,
when people realized that medical care was just diag-
nosis and not treatment because of the lack of oppor-
tune provision of drugs, they quiet attendance to
hospitals and try any other ways, such as natural med-
icine, witchery, religious ceremonies etc.  We know
there were hundreds of cases in each of the Cantons
of Manabi Province, but the incidence registered until
1987 does not represent the actual incidence.  In 1988
- 1991, a reasonable amount of drugs was sent to every
medical center in Manabi, and people attending those
centers were so registered, and incidence is more like
reality in this period. In 1992, the lack of antimonial
drugs was again the problem, and it persists to date.
Registered cases are few in the hospital, but we have
found so many cases by active field research during
1986 and 1992 (Nonaka et al., 1992).  About clini-
cal therapeutical trial done in 1988-1989, we can say
that age and sex of patients does not have any sig-
nificance as transmission aspect, but these factors may
represent the social or family problems in the dis-
ease transmission.
Considering the distribution of occupation in
patients in this study, we can clearly see that first of
all, bitting activity of sand flies in this area is most-
ly sylvatic.  Because most of infected patients have
agricultural and unspecific activities, although the
important number of students and housekeepers infect-
ed might suggest domiciliary bitting, at night, when
doing respective works such as late night studies or
breakfast preparation at early dawn.  The poor dis-
tribution of other occupational activities in the rest of
the patients strongly suggests that transmission occurs
mostly in the forest.  Because of many different places
where patients came from, there is no doubt about the
widespread of the disease in the entire Canton El
Carmen and other areas of Manabi and neighbouring
provinces. 
Registered data on number, size and location of
lesions could have been really useful to evaluate effi-
ciency of treatment, if related to the different groups
of the trial.  Unfortunately these aspects were not spec-
ified for each group of patients. Most patients had a
short duration time (between <1 and 4 months), but
this important information was not related or speci-
fied for each group of treated patients neither.  We
must also recognize here that patients with a long dura-
tion time such as the one with four years, were prob-
ably not leishmanial cases, and diagnosis was wrong
considering the lack of experience for diagnosis and
the easy confusion occuring in some rural laboratories
with other skin diseases, once in a while.
First two groups of the trial of treatment received
an insufficient dose of Glucantime®, perhaps due to
the fact that in that time there was no information
about the strain of Leishmania causing the disease in
the area, and low dose could have worked in case of
benign or less virulent strains.  Results clearly show
the efficiency of treatment in the other groups, with
the correct dosage.  About the patient who did not heal
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the lesion in group C, there is again the possibility
of a diagnosis mistake.  It is important to point here,
that the time for follow-up has been too short in this
trial; the minimun should be of one year.  We must
also add that during actual research we are doing in
El Carmen, we have found several cases of false pos-
itive and negative diagnoses of leishmaniasis, con-
firmed by us (unpublished data).  Probable side effects
are the usual with the exception of fever which could
have been caused by septic manipulation of lesions.
In conclusions, evidently, the incidence of
leishmaniasis maintains an important rate in Manabi
Province, specially in those remote areas where med-
ical care is not available neither educational programs
on public health are developed.  Bitting activity and
transmission occur mainly in the forest although there
could be domiciliary transmission, specially in those
areas where houses are surrounded by vegetation.  For
further investigation patients should be grouped by
age, and conditions of lesions (number, size and loca-
tion) for each treatment group.  Good training and
diagnostic conditions should be insured, to avoid mis-
diagnosis.  Isolation of the parasite should be estab-
lished as routinary activity, to know real distribution
of Leishmania species in this province. Schemes of
treatment should be kept as in groups D and E. Follow-
up should be of one year as minimun.  Alternative
treatments with drugs similar to or more efficient than
antimonials, but of easier administration should be
taken into consideration, for field conditions.
R. Wilfrido Garcia V.,
Eduardo A. Gomez L.,
Yoshihisa Hashiguchi
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Introduction
The pentavalent antimonials sodium stibogluconate
and meglumine antimonate remain as the first choice
of drugs in the clinical treatment of different types
of leishmaniasis, such as cutaneous, mucocutaneous
and visceral forms (Bryceson, 1980; WHO, 1990).
Since the introduction of these antimonials more than
50 years ago, many investigations have been done in
order to find more efficient treatment without side
effect for the disease.  No satisfactory effective new
drugs, however, have been developed, though sever-
al important advances have been made (Berman, 1988;
Croft, 1988).  There is, therefore, still a need to search
for a new drug that is fully effective and orally applic-
able for most clinical forms of Old and New World
leishmaniasis.
To date, trials of search for new drugs and treat-
ment have been performed in vitro and in vivo using
experimental animals and/or volunteer patients with
leishmaniasis.  In the present study we tried to treat
cutaneous leishmaniasis patients with two types of
antimalarial drugs, mefloquine and artesunate, which
are clinically being used.  The current paper describes
the antileishmanial activities of these drugs, based
on the data obtained from clinical trials at endemic
areas of Ecuador. 
Materials and Methods
In the present study, a total of 17 patients with
Chapter 6
Chemotherapy of Leishmaniasis Patients
1.  Oral Treatment of New World Cutaneous Leishmaniasis 
with Antimalarial Drugs in Ecuador: a 
Preliminary Clinical Trial
ABSTRACT. The current study was designed to evaluate antileishmanial activity of  mefloquine
hydrochloride (Mephaquin®) and artesunate (Plasmotrim®) which are currently being used as anti-
malarial drugs.  A totoal of 17 patients (volunteers) with cutaneous leishmaniasis were treated with
these drugs in this study.  Of these subjects, 16 were treated by the oral administration of a total dosage
of 1500 mg (1 Lactab each for 6 days) mefloquine, i.e., 4.2 mg/kg/day for 6 days, and if necessary
the dosage was repeated with 3 weeks intervals.  The majority of cutaneous lesions healed within 2
to 3 weeks after the commencement of mefloquine treatment, showing an average of 3.6 weeks of heal-
ing times with 100% cure rate.  One slowly healing within 8 weeks after the commencement was
observed; this case grew worse because of infection with Tunga penetrans at the late healing phase
of leishmaniasis.  The remaining one patient with an  ulcer lesion was treated by the oral administra-
tion of a total dosage of 1200 mg (2 Lactab each for 3 days) artesunate, i.e., 6.7 mg/kg/day for 3
days,  and the same dosage was repeated 2 weeks later.  The lesion healed within 6 weeks after the
commencement of artesunate treatment.  In the present study, all the patients received mefloquine or
artesunate were treated without admission, performing their normal daily activities.  No specified
adverse reaction was noticed.
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cutaneous leishmaniasis were examined.  They came
from different endemic areas, Zhucay and Manta Real
(Province of Cañar), Zapotal (Province of Guayas),
Muisne (Province of Esmeraldas) and Caluma
(Province of Chimborazo).  Of these subjects, 16 were
treated orally with a total dosage of 1500 mg (1
Lactab® each for 6 days) mefloquine (Mephaquin®,
Mepha Ltd., Aesch-Basle, Switzerland; each Lactab®
contains mefloquine hydrochloride corresponding to
250 mg mefloquine base), i.e., 4.2 mg/kg/day for 6
days, and if necessary the dosage was repeated with
3 weeks intervals after the end of initial treatment.  In
patients treated with mefloquine, 13 out of 16 were
male and 3 were female, aged from 2 to 81 years.  The
remaining one patient (14 years old male) was treat-
ed orally with a total dosage of 1200 mg (2 Lactab®
each for 3 days) artesunate (Plasmotrim®, Mepha Ltd;
each Lactab® contains artesunate 200 mg), i.e., 6.7
mg/kg/day for 3 days, and the same dosage was repeat-
ed 2 weeks later.  All the subjects were informed of
the purpose of the study and gave permission for drug
administration and repeated physical examinations.
The patients received treatment during their daily activ-
ities without admission.  Almost all the volunteers
(patients) lived in mountainous and dense forest areas
in which no transportation systems are available (Fig.
6.1.1A).  Their dwellings are located at very remote
areas from our laboratory of health centers in each
endemic area.  All the volunteers were in a very poor
economic condition.  In such a field situation and an
ethical consideration, no placebo treatment was per-
formed in the current trial.
All the cutaneous leishmaniasis patients treated in
this study were diagnosed by the demonstration of
Leishmania  amastigotes in smear specimens from the
lesions.  Treated patients received a follow-up phys-
ical examination every 2 or 3 weeks, and they were
recorded photographically at the same time.  When
their dermal lesions were partially still active in the
examination, an additional administration of the drug
was made as mentioned above.  During the treatment,
the patients were asked for the presence of any com-
plaint, such as vomiting, nausea, diarrhoea, fever and
etc.
The evaluation of the results of treatment was
made as described by El-On et al.  (1986) but partially
modified as follows: 1) rapidly effective (grade 1), no
parasites detected in cutaneous lesions, followed by
total healing within 1-3 weeks after the commence-
ment of treatment; 2) less rapidly effective (grade 2),
the same process (no parasites and total healing) occur-
ring within 4-6 weeks after the commencement; 3)
effective (grade 3), no parasites detected but healing
within 7-8 weeks; 4) ineffective (grade 4), parasites
still present in lesions and/or no clinical healing after
9 or 10 weeks of the commencement of treatment.
In the present subjects, species of Leishmania  are
not identified precisely, but our previous work indi-
cates that L. (Viannia) panamensis  is the most fre-
quently identified organism by zymodeme and
serodeme analyses, followed by L. (V.) guyanensis
in and around the study area (unpublished data).
Results
The number of cutaneous lesions per person ranged
from 1 to 4 with different size of lesions, ranging from
3 x 3 mm to 30 x 30 mm in diameter (Table 6.1.1).
All the present patients had ulcerative lesions; the
majority of these lesions were located on the exposed
body surface, such as forearm, foot and face.  The
duration time of infection varied from one to 12
months (average: 3.6 weeks) at the time of the com-
mencement of mefloquine treatment.  Nine (56.3%)
of the 16 patients healed within 3 weeks after the com-
mencement of oral treatment of mefloquine, show-
ing grade 1 category (see Fig. 6.1B-D), and other 6
cases took 4-6 weeks (grade 2) for healing. Only one
case (patient No. 3) took 8 weeks for complete heal-
ing, because of Tunga penetrans infection in the cuta-
neous lesion which had been at the late phase of
healing (4 weeks after the commencement of meflo-
quine treatment).  No ineffective case was found in
this study using mefloquine; the cure rate showed
100%.  In the present trial of treatment with meflo-
96
Figure 6.1.1. A, dwelling site of inhabitants in an endemic area (Manta Real) surrounded by a dense for-
est where the present patients (volunteers) came from.  B-D, A cutaneous leishmaniasis lesion located on
the lower extremity of a 22 years old female patient (No. 14).  B, An ulcer (34 x 26 mm) with typically ele-
vated border and marked induration around the lesion, before mefloquine treatment.  C, After 1 week of the
commencement of oral administration of mefloquine, the lesion reduced slightly in size and showed a grad-
ual disappearance of the ulcer border and induration. A marked epidermidalisation was observed on the sur-
face of the lesion.  D, After 3 weeks of mefloquine treatment; the lesion was completely covered by epidermis
without induration.
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Figure 6.1.2 A-D. A cutaneous leishmaniasis lesion located on the upper extremity of a 14 years old male
patient.  A, A lesion (20 x 17 mm) showing a typical ulcer border, before artesunate treatment.  B, After 2
weeks of the oral administration of artesunate, the lesion showed a marked granulation and reduced ulcer
border.  C, The cured lesion completely covered by epidermis without induration, after 6 weeks of arte-
sunate treatment.  D, The lesion (arrow) after 5 months of the treatment, showing a typical scar.
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Table 6.1.1. Clinical data on the parasitologically-positive patients with cutaneous leishmaniasis who received
Mephaquin® therapy
Patient
No. Age Sex
No. of
lesions
Size of
lesions (mm)
Site of
lesions
Type of
lesions
Duration time
of infection
Times (wks)
for healing
1 41 ? 1 35?25 forearm ulcer 2M* 6
2 16 ? 2 20?15 nose ulcers 12M 3
5?5 cheek
3 8 ? 2 30*30 foot ulcers 3M 8
10*5
4 12 ? 2 5?5 forearm ulcers 3M 5
5?5
5 19 ? 1 20?10 forearm ulcer 3M 5
6 81 ? 4 20?10 forearm ulcers 2M 4
15?15 shoulder
10?10
10?10
7 26 ? 3 20?20 forearm ulcers 1M 4
10?10
10?10
8 17 ? 1 15?10 neck ulcer 1M 2
9 4 ? 4 10?10 face ulcers 5M 2
5?5
5?5
4?4
10 22 ? 1 20?10 forearm ulcer 1M 2
11 3 ? 2 4?4 face ulcers 8M 2
3?3
12 13 ? 1 15?5 forearm ulcer 2M 3
13 22 ? 1 4?3 forearm ulcer 3M 3
14 22 ? 1 30?10 foot ulcer 8M 3
15 31 ? 1 20?10 front ulcer 2M 2
16 14 ? 1 34?26 foot ulcer 3M 6
quine, age or sex of the patients, number and size of
the lesions and duration time of the infection did not
show any influence against the efficacy of drug.
However, heavy bacterial infections and other infec-
tion such as Tunga penetrans were fully influential for
the healing time, especially in lesions located on the
lower extremities.
In a patient (14 years old male) treated with arte-
sunate (Plasmotrim®), an ulcer (20 x 17 mm) on the
forearm healed within 6 weeks after the commence-
ment of treatment (Fig. 6.1.2A-C) and no recurrence
was found after 5 months (Fig. 6.1.2D).  In compar-
ison with mefloquine, however, artesunate showed a
slow effectiveness on the healing of the dermal lesion,
especially in the early phase (1 week later) of oral
treatment.
All the present patients treated with mefloquine or
artesunate lived and worked in a rural and humid area
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with hygienically bad conditions.  There is no speci-
fied adverse reaction in the patients treated with the
drugs,  including skin eruptions or pruritus.  Therefore,
none of the subjects treated were withdrawn from the
study because of adverse reactions.
Discussion
For the treatment of most forms of New and Old
World leishmaniasis, pentavalent antimonial com-
pounds are still remain as the drugs of choice.  These
drugs are given intramuscularly or intravenously, and
generally cause serious adverse reactions, such as
renal and liver disfunctions, nausea, headache and
arthragia, in addition to pain at the injection site.  For
the treatment of Old World cutaneous leishmaniasis,
El-On et al.  (1986) reported topical application of
paromomycin ointment, obtaining satisfactory cure
rate as good as any currently used therapy.  Recently,
the therapy was also used for New World cutaneous
leishmaniasis in Ecuador (Nonoka et al., 1992;
Krause et  al., 1994) and Belize (Weinrauch et al.,
1993), confirming the results reported by El-On et
al. (1986).   However, such a topical treatment using
ointment has limitations in its usage even in cuta-
neous leishmaniasis cases. Application of ointment
would be only useful for relatively mild and simple
lesions which are caused by L. (L.) mexicana groups.
It is however not feasible for cutaneous disease forms
caused by L. (V.)  braziliensis (Weinrauch et al.,
1993) and mucocutaneous or visceral forms caused
by other Leishmania agents.
To date, various oral antileishmanial drugs, such
as metronidazole, rifampicin, levamizole, ketokon-
azole, co-trimoxazole, dapsone and etc., have been
used for different disease forms with variable results.
In the present study, antimalarial drugs, mefloquine
and artesunate were selected for clinical trials in
the continuing search for oral antileishmanial drugs.
These drugs were found to be effective against malar-
ial parasites in the Old and New World.  Mefloquine,
a long-acting quinine analogue is a schizonticide and
destroys the erythrocytic, asexual forms of the
Plasmodium  parasites in man, and the mean elimi-
nation half-life of the drug is culculated as 21.4 days
ranging from 15 to 33 days (Desjardins et al., 1979;
Schwartz et al.,  1980, 1982).  According to Schwartz
et al. (1980, 1982), maximum plasma concentrations
are reached 2-12 hours after a single oral dose and
plasma concentrations approaching 1?g/ml are pre-
sent after a dose of 1,000 mg of mefloquine.  They
also showed that similar maximum concentrations are
present in the steady state after administration of 250
mg (1 Lactab®) weekly; the concentration in the ery-
throcytes is almost twice as high. 
In this study, using mefloquine, almost all cuta-
neous lesions healed within 6 weeks after the com-
mencement of treatment showing 100% cure rate,
in spite of a relatively low daily dosage (250 mg/day)
of the drug compared with the dosage used in  malar-
ial cases.  The precise mode of action of mefloquine
against Leishmania has not been determined, although
it has been shown that more than 98% of the active
substance against Plasmodium schizonts is bound
to plasma proteins (Schwartz et al., 1982).  To some
extent, the mode of action of mefloquine against
Leishmania parasites might be similar to that found
in malarial cases, affecting amastigote-macrophage
interactions.
In oral treatment using artesunate, only one case
was experienced in this preliminary trial, suggesting
that the drug might remain as a candidate for future
study.  Artesunate, a preparation for the killing of
erythrocytic stage of Plasmodium asexual form,
reacts with intraparasitic heme in its mechanism of
anti-malarial action (Meshrick et al., 1991), but its
mode of action against Leishmania parasites is still
unknown precisely.  According to Jiang et al. (1982),
an advantage of artesunate administration is the speed
of onset of action and inhibitory effect on the mat-
uration of malarial parasites.  On the other hand, in
the present leishmaniasis case, it is likely that the
drug has a tendency to act slowly as compared with
mefloquine, especially at the early phase of treat-
ment.
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The current treatment with mefloquine or arte-
sunate was done in the subjects who made their nor-
mal daily activities without admission.  When a similar
treatment using these drugs was performed in well-
controled subjects under admission, more rapidly heal-
ing would be found.  Furthermore, a rapid healing
might occur when antibiotics are used as complemental
treatment to eliminate bacterial infections of cutaneous
lesions. With regard to oral administration of the pre-
sent drugs used, more suitable and effective dosage
should be examined, in addition to their precise mech-
anism(s) of antileishmanial action.
In conclusion, the significant efficacy of anti-
malarial drugs, mefloquine and artesunate against
Leishmania  following the oral delivery, suggests that
the novel antileishmanial activities of these drugs
should be investigated further, and their potential as
drugs for various clinical forms of leishmniasis includ-
ing visceral forms needs more study.
Eduardo A. Gomez L.,
Milorad Andrial,
Atsushi Hosokawa,
Shigeo Nonaka,
Yoshihisa Hashiguchi
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Introduction
Antimonials have been for a long time the drug of
choice for the treatment of leishmaniasis in Ecuador,
like in many other countries.  However, the difficult
parenteral administration of antimonials, the toxici-
ty, high cost and specially the usual lack of this drug
in the country have required for investigators to search
for alternative treatments, similar or better on terms
of efficiency but specially, of easier administration.
Several new treatments have been tried by us in recent
years, specially some ointments prepared with dif-
ferent drugs (Nonaka et al., 1992; Hosokawa et al.,
1994).  In 1994, we started treatment of cutaneous
leishmaniasis with antimalarial drugs, mainly with
mefloquine hydrochloride (Mephaquin®) and secon-
darily with artesunate (Plasmotrim®).  The idea of try-
ing this drugs came from the information we had on
the treatment of leishmaniasis with chloroquine, done
by American doctors during World War Two for
infected soldiers, with relative success.  We thought
that mefloquine, a much more effective antimalarial
drug could also work in some manner.  Interesting
results showing probable antileishmanial action of
these drugs (mefloquine and artesunate) obtained in
the mentioned prior trial, encouraged us to do a larg-
er study to obtain more detailed information about
such interesting event.
Materials and Methods
Study areas
This study was carried out in three different
endemic areas of Ecuador: Zhucay in Province of
Cañar; Mamey in Province of Esmeraldas and El
Carmen in Province of Manabi.
Selection of subjects
We know mefloquine (Mephaquin®) is a drug of
low toxicity, but because of ethical procedure and
security of patients as insured by our protocol, we were
very careful to choose patients to be under treatment
in this trial.  Admission discernments to include a
patient were: active cutaneous lesion(s); recent evo-
lution; parasitological confirmation; no prior specif-
ic treatment; good general condition; consent by patient
or relatives; no pregnancy; no breast feeding; no severe
or chronic diseases.  An additional selection was done
2.  Further Studies on the Oral Treatment of Cutaneous 
Leishmaniasis with Antimalarial Drug Mefloquine 
(Mephaquin®) in Ecuador
ABSTRACT. Since 1994, because of the lack of antimonials in that year, we tried for the first time
antimalarial drugs, mefloquine and artesunate, to treat cutaneous leishmaniasis, and got quite surprised
by their probable efficiency.  This paper follows the prior one, with the main purpose to study a
larger number of patients with a new dosage of mefloquine first, and in a further work, of artesunate,
to obtain more evidence on such cure capacity.  A group of seventy-two selected patients (groups A,
B and C) and a randomized group (D) of 16, were treated with mefloquine, 100 mg after breakfast
and supper for ten days, for adults or children with more than 45 kg, and a total dose of 50 mg/kg
given as one or two oral intakes of 50 mg after breakfast and supper during ten days, for children (or
adults) with less than 45 kg.  A group (E) was also treated with Glucantime® for comparison.  Obtained
results are quite interesting, with a high percentage of cure rate (clearance of parasites) and normal-
ly variable times for healing in the patients.  Side effects were carefully evaluated, and confirmed to
be mild, in most cases, when present.
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among excluded patients to conform 2 comparative
study groups: one to be treated with Glucantime® and
the other with mefloquine as a randomized group.
Management of subjects
Medical histories were elaborated; clinical exam-
ination was done.  Cutaneous lesions were evaluated
by type (ulcerous, nodular, verrucous etc) and size
(small: <1cm; medium: >1- 2.5cm; big: > 2.5cm).  The
parasite was isolated when possible.  Biopsies were
taken before, during and after treatment.  Density of
parasites was evaluated before, during and after treat-
ment (No. of parasites / 100 microscopic fields).
Treatment was administered according to protocol.
Contaminated lesions were treated with antibiotics
(cefalexine) inocuous for Leishmania before starting
administration of mefloquine.  All patients were fol-
lowed-up for a minimun of one year, after healing time
of lesions.
Drug administration
Used therapeutical scheme was the following:
adults or children with more than 45 kg: 100 mg (1
tablet of 100 mg) after breakfast and supper for 10
days;  children with less than 45 kg: 50 mg/kg as a
total dose, with oral intakes of 50 mg once or twice
a day after meals to complete the total dose.  This
treatment could be repeated after 7 days in case of
severe leishmaniasis (big lesions with high density
of parasites).
Follow-up of treated subjects 
Clinical and parasitological examination and pho-
tographic record were done on the first day and every
15 days until cure, and then, every 30 days to com-
plete one year of follow-up.
Results
Under our selective procedure, 155 patients with
cutaneous lesions from the three mentioned endemic
areas were examined, of which, 118 were found infect-
ed with Leishmania amastigotes; 72 were selected for
the study, 15 for comparative study group treated with
Glucantime® (usual dosage) and 16 to comform a spe-
cial randomized  group treated with mefloquine
(Mephaquin®) with same dosage than the principal
group. This randomized group was not under selec-
tion protocol.
Only 16 (22%) patients had small lesions and con-
formed group A; 56 (78%) had medium and big lesions
and were included in groups B and C.  In group A,
18% of lesions were nodules, and 82% were ulcers;
in groups B and C (56 subjects), 26.7% were nodules,
3.5%, verrucous and 69.8%, ulcers. Parasites species
isolated in Zhucay are Leishmania (Viannia) guya-
nensis and L. (V.) panamensis; in Mamey, L.
(Leishmania) mexicana and L. (V.) panamensis; in
El Carmen, L. (V.) panamensis.  Among selected
patients (groups A, B and C), 41 (56%), cleared par-
asites in 15 days; 31 (44%) did it in 30 days.  In ran-
domized group (D: also treated with mefloquine), 5
persons (31.2%) cleared parasites in 15 days; 10
(62.5%) dit it within 30 days and 1 (6.3%) never did
it.  In group (E) treated with Glucantime®, all patients
took 30 days for total parasite clearance.  Healing time
for 16 patients with small cutaneous lesions (group A)
treated with mefloquine (Mephaquin®) is shown in
Fig. 6.2.1.  The minimun healing time was 15 days,
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Figure 6.2.1. Healing time for subjects with small
lesions (less than 1 cm in diameter) of cutaneous
leishmaniasis (group A) treated with Mephaquin®.
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Figure 6.2.2. Healing time for subjects with medi-
um and larger lesions (1.1 cm to 2.4 cm) of cutaneous
leishmaniasis (group B) treated with Mephaquin®.
Figure 6.2.4. Healing time for subjects in random-
ized group (D) treated with Mephaquin®.  A patient
(No. 5) in this group showed no healing during the
present trial.
Figure 6.2.5. Healing time for subjects in random-
ized group (E) treated with Glucantime®.
Figure 6.2.3. Healing time for subjects with larger
lesions (2.5 cm or more) of cutaneous leishmaniasis
(group C) treated with Mephaquin®.
maximun, 40 days, and average, 27.2 days.  Results
on healing time for 24 patients with medium and large
cutaneous lesions (group B) treated with mefloquine
is shown in Fig. 6.2.2.  The minimum time was 13;
maximum  was 60; and average, 35.5 days.  Results
on healing time for last group of selected patients (32)
with medium and large cutaneous lesions (group C),
treated with mefloquine are shown in Fig. 6.2.3.  The
minimum time was 15; maximum, 50; and average,
28.2 days. In addition, the result on healing time for
randomized group of 16 patients with cutaneous leish-
manial lesions, treated with mefloquine is shown in
Fig. 6.2.4.  The minimum time was 15; maximum, 40;
and average, 24.8 days. For comparison of drug effi-
cacy, healing time for randomized group of cutaneous
leishmaniasis patients treated with Glucantime® is
shown in Fig. 6.2.5.  The minimum healing time was
18; maximum, 45; and average, 27 days.
Forty two (58.3%) of patients in groups A-C pre-
sented side effects. Of these, only 2 (2.7%) had a clin-
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Figure 6.2.6. A patient (8-year-old male) treated orally with mefloquine (Mephaquin®) and his dwellings.
A: before treatment (14 Aug., 1996), B: 2 weeks after reatment (28 Aug., 1996), C: 4 weeks after treatment
(11 Sept., 1996), D: dwellings of the patient.
ical symptom which may be considered important,
because it was kind of moderate paresis; loss of sen-
sibility in both legs for about 3 hours, after which it
disappeared.  Other side effects presented by the
remaining subjects treated with Mephaquin® were:
mild somnolence, 15 (21%);  mild headache, 8
(11.1%); moderate headache, 7 (9.7%);  severe
headache, 2 (2.7%); mild somnolence and headache,
5 (6.9%); mild dizziness (on fast movements), 2
(2.7%); and moderate abdominal pain, 1 (1.3%).  The
rest of patients in groups A-C, 30 (41%) did not com-
plain of any side effect.  In randomized group D (Fig.
6.2.6), 9 (56.2%) complained of some symptoms as
follows: moderate headache, 3 (18.7%); mild nausea,
3 (18.7%); mild dizziness, 2 (12.5%); and mild weak-
ness, 1 (6.2%).  The rest of patients in this group, 7
(43.8%) did not complain of anything.
In the group E treated with Glucantime®, side
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effects were shown by 9 patients (60%) as follows:
moderate headache, 3 (20%); moderate nausea, 4
(26.6%); and mild dizziness, 2 (13.3%).  The rest of
patients in this group, 6 (40%) did not have any prob-
lem.
Discussion
Different clinical features of leishmaniasis are not
always severe.  Many times, benign or small lesions
cure spontaneously or with conservative treatments.
Although antimonials are very effective to kill the par-
asite,  parenteral administration of such drugs remains
being a problem because of the multiple complications
it may have, like painful muscles, inflamation, bac-
terial infections (Chlostridia, Staphylococcus,
Streptococcus etc), viral infections (hepatitis, AIDS
etc), several  and serious adverse reactions (headache,
nausea, arthralgia, liver and renal disfuctions etc) and
so on, besides the necessity of experimented person-
al to apply the shots and high cost of the drug in mar-
ket. Moreover, in Ecuador, we must add something
else to all these problems, for example, the frequent
lack of antimonials in this country, for many differ-
ent reasons.
Like many other research groups, we have been
looking for an alternative good treatment for several
years, and recently in a previous paper we presented
the first treatment done with antimalarial drugs, meflo-
quine (Mephaquin®) and artesunate (Plasmotrim®) in
this country.  Results obtained in the present work,
with a larger number of patients, represent, in our opin-
ion the confirmation of the real possibility of using
this drugs for the treatment of cutaneous leishmaniasis
caused by the mentioned species of parasites isolat-
ed in our study areas.
In carefully selected group (A-C), all of them
(100%) cleared parasites.  Cure rate was 100%; how-
ever it does not represent the real rate to be obtained
in routinary treatment, because patients were care-
fully selected. That is why we also tried a random-
ized group (D) with the same treatment, where 93.7%
cleared parasites, and cure rate was 93.7%.  One
patient of this group did not clear neither heal his
lesion during 45 days he was under control but did not
come again.  So, we may suppose that cure rate for
patients treated with mefloquine is between 90 and 93
%.  Cure rate for patients (group E) treated with
Glucantime® was 100%.  Times for clearance of par-
asites were similar but did not show no relationship
with times taken for healing of lesions in this study.
Parasites are cleared by the drug (rate of efficiency),
but healing is an individual biological process depend-
ing on many individual  factors such as age, nutritional
state, peripheral blood perfusion, chronic diseases (dia-
betes), contamination and etc.  In the other hand, we
must consider the fact that our patients were not hos-
pitalized, kept doing usual activities and no comple-
mentary topical care was done, so if medical care is
taken at a hospital (hygiene, topical care, rest and good
nutrition), healing time should improve.
Detected side effects in patients treated with meflo-
quine (Mephaquin®) are in general mild, and kind of
similar to those found with Glucantime®.  Mefloquine
should be tried against other types of leishmaniasis
caused by different parasites.  The possibility of com-
bining these two drugs should be taken into consid-
eration and tried in further studies to treat resistant
species of Leishmania.  Oral administration of meflo-
quine is quite convenient and combining drugs would
decrease the dosage of antimonials to be used.
Eduardo A. Gomez L.,
Atsushi Hosokawa,
Motoyoshi Maruno,
Shigeo Nonaka,
Setsuo Suguri,
Roberto Sud A.,
Yoshihisa Hashiguchi
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Introduction
In general terms, only two clinical forms of
leishmaniasis have been confirmed to exist in Ecuador,
so far.  Studies on the epidemiological aspects of
leishmaniasis and its mode of transmission have been
continuously done in this country, and among a lot
of information obtained since 1982, when the research
work started, cutaneous and mucocutaneous forms are
the only two clinical manifestations of leishmaniasis
found in Ecuador (Hashiguchi and Gomez, 1991).
Among cutaneous cases, there is one case, complete-
ly confirmed and described, of the diffuse type of cuta-
neous leishmaniasis, DCL (Reyna et al., 1994).
Cutaneous leishmaniasis is the most important and fre-
quent clinical form in the country, and it is found in
the three principal natural geographic regions of
Ecuador (Hashiguchi and Gomez, 1991).  Mucocutaneous
leishmaniasis is mostly found, not so often, in the
Amazonian region (Amunarriz, 1982), but some cases
have been described from other areas.
There is a great variety of types of cutaneous
leishmaniasis, regarding to size, morphology, clini-
cal evolution, and response to treatment, probably due
to virulence of different Leishmania strains and/or
immunological and physiological conditions of humans
(hosts).  Antimonials are still drugs of the first choice
for the treatment of leishmaniasis in Ecuador, but, we
have found, when visiting several endemic areas, that
treatment with antimonials is not available for most
patients living in remote, rural areas; that some peo-
ple may get antimonials, after paying certain high
amount of money, but do not find a qualified person
to apply the injections and, that sometimes persons
with small or benign lesions received an excessive
dosage of antimonials.  For these reasons, we have
been looking for a good alternative treatment for cuta-
neous leishmaniasis, including ointments, lotions and
lately oral treatment with antimalarial drugs meflo-
quine and artesunate (Gomez et al., 1995).  In this
paper we present the results of a clinical trial done
with artesunate lactabs 200 mg (Plasmotrim®) to treat
15 patients with cutaneous leishmaniasis, and the
experimental use of artesunate ointment in other one,
which could not be given oral treatment because of
breast feeding.
3. Studies on Oral Treatment of Cutaneous 
Leishmaniasis with an Artemisinin Derivative, 
Artesunate (Plasmotrim®) in Ecuador 
ABSTRACT. Our previous work revealed that antimalarial drugs, mefloquine (Mephaquin®) and arte-
sunate (Plasmotrim®), had an efficacy when they were used as oral therapy of cutaneous leishman-
iasis patients.  In order to clarify if both antimalarial drugs have similar or different effects, it is
necessary to carry out more detailed investigation based on additional cases of the treatment especially
with artesunate.  For this purpose, 15 patients with cutaneous leishmaniasis were treated with arte-
sunate.  The following dosage of the drug was used in the treatment: 1) adults with 45-59 kg body
weight (b. w.) or children with more than 45 kg b.w. and/or older than 12 received 100 mg of
Plasmotrim® (half tablet) after breakfast and supper for 10 days; and 2) adults with more than 60 kg
b. w. received 200 mg of the drug (1 tablet) after breakfast and supper for 10 days.  In both cases,
the treatment could be repeated if  necessary.  Time for clearance of parasites was 15 days in 26.6%
of patients and 30 days in 73.4%.  The clearance times are quite similar to those obtained with
Mephaquin®.  Average time for clinical healing of cutaneous lesions was 34.5 days.  Topical trial using
1% ointment of artesunate against cutaneous lesions was also done, and it showed a good result.
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Materials and Methods
All patients came from the same endemic area,
Canton El Carmen in Province of Manabi, Ecuador.
Individuals were carefully selected, following our usual
criteria for admission and requirements of our proto-
col.  Those requirements were: active cutaneous lesion,
recent evolution, parasitologically confirmed to be
leishmaniasis, no prior antileishmanial treatment, good
general condition, without severe or chronic diseases,
no pregnancy or breast feeding, good nutritional con-
dition and consent by the patient or relatives.
After selection of patients, clinical histories were
taken.  Cutaneous lesions were evaluated by number,
type and size.  When evident contamination was
detected, patients received antibiotic treatment with
a known inocuos for Leishmania drug, cefalexine.
Parasite was isolated when possible, and isolates kept
for further identification.  Tissue smears and biop-
sies were taken before, during and after treatment to
evaluate density of parasites and future electron micro-
scopic studies.  Density of parasites was determined
by counting the number of parasites in 100 scope
fields.  Artesunate was given as follows: adults with
45-60 kg or children with more than 45 kg and older
than twelve: 100 mg (half tablet) after breakfast and
supper for ten days; adults with more than 60 kg: 200
mg (1 tablet) after breakfast and supper for ten days.
This treatment could be repeated after 5 - 7 days if
necessary.  Clinical evaluation to detect side effects
and photograph secuence was done before, during and
after treatment (follow-up).  Minimum time for fol-
lowing patients up was 1 year, with periodic evalua-
tions every 30 days after cure.
Results
A total of 50 patients were examined, of which,
35 had cutaneous leishmaniasis.  Among these 35, only
15 patients were admitted in the study, and treated
with artesunate.  A comparative group of patients treat-
ed with Glucantime® with usual dosage, was also struc-
tured.
Regarding to cutaneous clinical evaluation, 3
(20%) patients presented multiple (2-5) lesions,  12
(80%) presented only one; 4 (26.6%) had small lesions
(<1cm), 11 (73.3%) had medium or big lesions (>1.1
- 2.4 cm; >2.5); 3 (20%) had nodules and 12 (80%)
had ulcers.
Parasite species isolated in El Carmen is
Leishmania (Viannia) panamensis.  This species has
a wide distribution in the north and central part of
Manabi Province.  About clearance of parasites, 4
patients (26.6%) cleared them within 15 days and 11
(73.3%) did it within 30 days.  In comparative group
(Glucantime®) all patients cleared parasites within 30
days.  About healing time for patients treated with
artesunate (Plasmotrim®) lactabs, the minimum was
15 days; maximum, 45 days; and average, 34.5 days
as shown in Figures 6.3.1 and 6.3.2.
Average healing time for patients treated with
Glucantime®, in the comparative group was 45 days.
The only patient (EC, No. 9) treated with 1 % oint-
ment of artesunate in vaseline base was a breast feed-
ing young female, who had a 2-month-old baby.  She
had two ulcerous lesions in her right thigh and two
in her right arm which healed within 30 days and mul-
tiple  nodules on her left elbow which healed within
60 days (Fig. 6.3.3).
Parasitological examinations after treatment per-
Figure 6.3.1.  Healing time for patients with cuta-
neous leishmaniasis treted with artesunate (Plasmotrim®).
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Figure 6.3.2. A male patient (EC-No. 12) with a large ulcer lesion on his knee.  Above: before oral treat-
ment with artesunate (Plasmotrim®) (13 Aug. 1996).  Below: 45 days after the oral treatment (27 Sept. 1996).
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Figure 6.3.3. A female patient (EC-No.9; 22-year-old) with a 2-month-old breast feeding baby  was treat-
ed with 1% ointment of artesunate (Plasmotrim®).  She had 2 each of ulcerous lesions on her right thigh
and right arm which healed within 30 days.  However, multiple nodular type lesions on her left elbow took
about 2 months for healing as shown in this figure.  A: before the treatment (13 Aug. 1996), B: 27 days
after the treatment (9 Sept. 1996), C: 42 days after the treatment (24 Sept. 1996), D: 60 days after the treat-
ment (12 Oct. 1996).
BB
AA CC
DD
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mitted us to observe interesting changes in the struc-
ture of parasites after 15 days, which might be the
result of the direct action of artesunate. Differences
are evident when comparing the morphological char-
acteristics of parasites on smear specimens taken
before and after treatment.  Cytoplasm of the few par-
asites is hardly seen, kinetoplast has disappeared in
all of the parasites, nuclear granules are disorderly
grouped and usual shape of the nucleus is gone. In
smears taken before treatment, these figures are never
seen, and parasites inside and outside of the
macrophages were seen normaly and clearly.  In
smears taken  after treatment, parasites are complete-
ly gone within 15 days in patients with low density of
amastigote, but in those with high densities, more than
80% of parasites disappear but some may be still seen,
showing the apparent morphological changes.  Within
30 days every subject showed a complete clearance of
amastigotes on smear specimens.
Discussion
Cure rate for patients treated with artesunate
(Plasmotrim®) was 100%, but this rate may show any
variation when a larger numbers of patients are stud-
ied.  Clearance of parasites seems to have some direct
relationship with the parasite density; the higher den-
sity of parasites, the longer time is required for clear-
ance, but not with the size of the ulcer, which should
be more related with healing time, in normal systemic
health conditions.
Patients with short times for clearance were also
those with low parasite densities; on the contrary, those
with long clearance times had always high densities.
If compared with antimonials (Glucantime®), arte-
sunate (Plasmotrim®) seems to take a shorter time
for clearing parasites, so far; however, this must be
completely clarified when doing further research
works.
Like in our prior work (Gomez et al., 1995;
Chapters 6.1 and 6.2 in this text) done with meflo-
quine (Mephaquin®), times taken for healing lesions
showed a variation difficult to analyze regarding to
the effect of the drug which is really represented by
the times taken for parasite clearance. Individual bio-
logical factors have an undoubtful participation in heal-
ing process, therefore healing must not be taken as
indicator of drug efficiency.  Many cases of reacti-
vation of leishmaniasis are due to the fact that ones
consider a patient as cured, based on healing with-
out confirming if parasite clearance was completed.
On the other side, patients who have cleared their
lesions very fast, continue under treatment with anti-
monials because healing does not occur, due to other
so many factors.  As an example of the importance
of this aspect, we insist the followings: during this
work we selected a total of 16 patients for the treat-
ment with artesunate.  Few weeks after treatment we
noticed that one of the patients who cleared parasites
within 15 days, did not show any sign of healing.
There was no contamination, and his clinical history
did not show any helpful information.  We asked the
patient about the possibility of diabetes and he denied
it.  A blood sample was taken and diabetes was con-
firmed later on.  Thus the patient confessed he did not
tell us about his problem, to avoid to be excluded.  He
was cured of leishmaniasis, but his ulcer was never
going to heal, without additional treatment for dia-
betes.  The treatment was stopped and the patient was
excluded.
About any relationship between the type of lesion
and clearance of parasites, we think that if any, it will
be determined for further studies with a larger num-
ber of patients.  Perhaps the most important aspect
of the treatment of cutaneous leishmaniasis with arte-
sunate is the almost total abscence of undesired side
effects.  Only one patient complained of moderate
headache, which easily responded to a weak analgesic.
The interesting results obtained with our female
patient treated with artesunate ointment opens a new
possibility to be investigated.  If effective, the oint-
ment could be combined with oral treatment with anti-
malarials mefloquine and artesunate, or, with parenteral
antimonials, to decrease in both cases, the total dosage
of those drugs, and to diminish risk of undesired side
effects for the patients.
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The way of action of artesunate against Leishmania
parasites is the big question.  Efficiency of topical
ointment, if confirmed, would suggest the direct action
of the drug against amastigotes.  So far, we may sup-
pose there is a direct action. We have observed very
clear changes in smear taken after treatment.  Besides
the spectacular reduction of parasites density, lasting
elements show alterations which might be considered
the effect of the drug.  However, more sophisticated
techniques will have the good answer. In the mean-
while, careful observation of the smears taken before
and after treatment should be done, to make sure,
unless, that those alterations are not seen before treat-
ment.
Eduardo A. Gomez L.,
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Introduction
There are various forms of treatments for cuta-
neous leishmaniasis (Koff et al., 1994).  Antimonial
therapy is still well used in the world.  But, this drug
has side effects and it is very difficult to use this drug
to the patients with pregnancy or small children.
Previously, we undertook an evaluation of topical treat-
ment for cutaneous leishmaniasis using paromomycin
ointment and meglumine antimonate solution with mer-
cury chrome (Nonaka et al., 1992).  An evaluation
of topical treatment for cutaneous leishmaniasis is not
easy.  The first problem is natural healing.  Guderian
et al. (1991) confirmed untreated cures on nine pait-
ents during their therapeutic study for cutaneous
leishmaniasis in Ecuador.  The second is a reactivation
of the lesions.  The third is a possibility to transfer
to mucocutaneous or visceral forms.  In general, par-
asites of mucocutaneous and visceral leishmaniasis in
New World are Leishmania (Viannia) braziliensis com-
plex and L. (Leishmania) chagasi, respectively.  We
performed our therapeutic study in the areas infected
by L. (L.) mexicana complex.  Five years follow up
study were performed in this study.
4.  Clinical Observation of Topical Treatment for 
Cutaneous Leishmaniasis for 
5 Years in Ecuador
ABSTRACT. We tried to evaluate the topical treatment of several drugs for 5 years in Ecuador.
The total number of patients treated with topical ointment and solution was 162, 82 males and 80
females.  The mean age of patients was 17.60 (?1.19)-year-old in total, 17.11 (?1.87)-year-old in
male and 18.09 (?1.47)-year-old in female.  Young aged patients less than 20-year-old occupied more
than 60 per cent of all the patients treated.  In this study, healing process was divided into 4 grades
according to the reaction against topical treatments employed as follows: 1) excellent, 2) good, 3) fair,
and 4) no reactions.  The treatment with meglumine antimonate solution produced excellent reaction
in 13 patients, good reaction in 5 patients, fair reaction in 6 patients and no effect in one patient.
The effective rate more than good reaction of this treatment was 75.0% in male, 69.2% in female
and 72.0% in total.  The treatment with paromomycin ointment showed the results of excellent reac-
tion in 38 patients, good reaction in 19 patients, fair rection in 11 patients and no reaction in 4 patients.
The effective rate more than good reaction of this treatment was 70.0% in male, 85.7% in female
and 79.2% in total.  The treatment with 10% paromomycin ointment showed excellent reaction in 10
patients, good reaction in 6 patients, fair reaction in 5 patients and no reaction in one patient.  The
effective rate more than good reaction of this treatment was 72.7% in total.  The treatment with 2%
paromomycin ointment showed the result of excellent reaction in 25 patients, good reaction in 13
patients, fair reaction in 6 patients and no reaction in 2 patients. The effective rate more than good
reaction of this treatment was 66.7% in male, 92.9% in female and 82.6% in total.  Topical treatment
using low concentrations of paromomycin ointment and meglumine antimonate with mercury chrome
solution was effective to 80% of cutaneous leishmaniasis patients. There was a low irritation to the
wet ulcers of patients with cutaneous leishmaniasis. But, it was less effective to the non-ulcered lesions
of the patients. Topical treatment to cutaneous leishmaniasis should be done carefully to the patients,
who do not have any concern to mucocutaneous and visceral types of leishmaniasis.
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Materials and Methods
Subjects
A total of 162 patients with cutaneous leishman-
iasis with informed concert were recruted in this study
(Table 6.4.1).  All the subjects continued their daily
activity during the treatment without hospitalization.
Follow-up of the treatment was performed from 1991-
1995.  Thirty-nine patients were treated with meglu-
mine antimonate solution plus mercury chrome
solution (Table 6.4.2).  One hundred eleven patients
were treated with paromomycin ointment (Table 6.4.3).
Preparation for topical ointment and solution
Paromomycin ointment was prepared in tow con-
centrations, 10% and 2%.  Petrolatum was used for
ointment base.  Meglumine antimonate solution was
prepared as follows: 250 ml of 30% meglumine anti-
monate, 750 ml of physiological saline and 1,000 ml
of mercury chrome solution.  This mixed solution was
then divided into 25 ml each in small bottles.
Application procedure of topical ointment and
solution
The patients were given a guide to apply the oint-
ment or solution two or three times a day using a
cotton applicator.  The applications were completely
done by the patients themselves or their family mem-
bers in their houses.  Before the topical application,
cleaning of the lesions using a soap and water was rec-
ommended.
Efficacy criteria for the topical treatments
The effect of topical application was judged pri-
marily by the clinical features.  Photographs of the
lesions were taken at each one week to two weeks,
and the size and conditions of lesions were carefully
observed and recorded.  Especially, the ulcer sizes and
indurations were measured at each clinical observa-
tion.  The effects were graded into four criteria as fol-
lows: 1) no effect; no change of the eruption during
treatment, 2) fair; slight improvement of the eruptions,
3) good; definite improvement of the eruptions; and
4) excellent; marked improvement or complete cure
of the lesions.
Results
The results are summarized in Tables 6.4.1 to
6.4.5.  The total number of patients treated with top-
ical ointment and solution was 162, 82 males and 80
females (Table 6.4.1). The mean age of patients was
17.60 (?1.19)-year-old in total, 17.11 (?1.87)-year-
old in male and 18.09 (?1.47)-year-old in female.
Young aged patients less than 20-year-old occupied
more than 60 % of all the patients treated.  The treat-
ment with meglumine antimonate solution produced
excellent reaction in 13 patients, good reaction in 5
patients, fair reaction in 6 patients and no effect in one
patient (Table 6.4.2).  The effective rate more than
good reaction of this treatment was 75.0% in male,
69.2% in female and 72.0% in total.  The four patients
who showed excellent reaction are described as fol-
lows.  The case of No. 139 was a 4-year-old boy.  The
patient had many insect bites on the face and extrem-
ities.  Four months earlier, his mother had noticed red
papules and nodules on the same place, then these
lesions increased gradually and some of them became
ulcerated.  When the patient visited our clinic, 7 lesions
were observed on the right arm (Fig. 6.4.1A), right
thigh and face.  The smear from the elbow showed
positive for the parasites, and the skin test also showed
positive (18x18/22x23).  The meglumine antimonate
with mercury chrome solution was given to him.  The
nodules with ulcer changed to the lesion with crusts
after 3 weeks of the treatment (Fig. 6.4.1B).  Two
month later, all the lesions healed completely.  One
year later, the lesions healed with slight scar and there
was no recurrence (Fig. 6.4.1C).  The case of No. 140
was a 6-year-old boy.  Three lesions appeared on the
elbow and face 4 months ago.  The erythematous
plaque with small ulcers on the left elbow was the
largest lesion (Fig. 6.4.2A).  The skin test showed pos-
itive (10x10/12x15).  The meglumine antimonate solu-
tion was given to him.  The ulcer disappeared after
three weeks of the treatment (Fig.6.4.2B).  The lesions
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Table 6.4.1. Age of patients with cutaneous leishmaniasis
Age (year) Male (%) Female (%) Total (%)
00?05 11? 13.41? 12? 15.00? 23? 14.20?
06?09 17? 20.73? 16? 20.00? 33? 20.37?
10?19 25? 30.49? 27? 33.75? 52? 32.10?
20?29 17? 20.73? 10? 12.50? 27? 16.67?
30?39 6? 7.32? 4? 5.00? 10? 6.17?
40?49 4? 4.88? 6? 7.50? 10? 6.17?
50?59 0? 0.00? 2? 2.50? 2? 1.23?
60?00 2? 2.44? 3? 3.75? 5? 3.09?
total 82?100.00? 80?100.00? 162?100.00?
Table 6.4.2. The effects of meglumine antimonate with mercury chrome solution
Effects Male (%) Female (%) Total (%)
Excellent 6? 50.00? 7? 53.85? 13? 52.00?
Good 3? 25.00? 2? 15.38? 5? 20.00?
Fair 3? 25.00? 3? 23.08? 6? 24.00?
No effect 0? 0.00? 1? 7.69? 1? 4.00?
Subtotal 12?100.00? 13?100.00? 25?100.00?
Unknown 9? ? 5? ? 14??
Total 21? ? 18? ? 39??
were completely healed after six months (Fig. 6.4.2C).
The case of No. 145 was a 14-year-old girl, who com-
plained of a nodule with ulcer on her right cheek for
8 months (Fig. 6.4.3A).  The skin test was positive
(12x13/18x22).  The lesion became dry after two
weeks of the topical treatment (Fig. 6.4.3B), and the
lesion healed with a slightly elevated scar after 3 weeks
(Fig. 6.4.3C).  The scar became flatter after one year
(Fig. 6.4.3D).  The case of No. 146 was a 9-year-old
girl, who complained of indurated scar with ulcers for
6 months.  The lesion was a scar with indurated ery-
thema and ulcers sized 50 mm by 30 mm on her right
leg (Fig. 6.4.4A).  The skin test was positive
(25x22/35x40).  The topical treatment was continued
for 2 weeks, the lesion became dry (Fig.6.4.4B).  One
month later, the lesion was healed with slight crust
(Fig. 6.4.4C), and that was completely healed after
one year (Fig. 6.4.4D).
The treatment with paromomycin ointment showed
the results of excellent reaction in 38 patients, good
reaction in 19 patients, fair rection in 11 patients and
no reaction in 4 patients (Table 6.4.3). The effec-
tive rate more than good reaction of this treatment was
70.0% in male, 85.7% in female and 79.2% in total.
The treatment with 10% paromomycin ointment
showed the results of excellent reaction in 10 patients,
good reaction in 6 patients, fair reaction in 5 patients
and no reaction in one patient (Table 6.4.4). The effec-
tive rate more than good reaction of this treatment was
72.7% in total. The treatment with 2% paromomycin
ointment showed the result of excellent reaction in 25
patients, good reaction in 13 patients, fair reaction
in 6 patients and no reaction in 2 patients (Table 6.4.5).
The effective rate more than good reaction  of this
treatment was 66.7% in male, 92.9% in female and
82.6% in total.  The four patients showed excellent
reaction are described as follows.  The case of No. 27
was a 40-year-old male, who complained of indurat-
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ed nodule with an ulcer for 5 months.  The lesion was
a indurated ulcer with dirty crust sized 25 mm by 15
mm on his right wrist (Fig. 6.4.5A).  The skin test was
positive (16x22/30x35). When the 10% paromomycin
ointment was applied for 2 weeks, the lesion became
dry and it's size was decreased (Fig. ??????).  One
month later, the lesion was healed with slight crust
(Fig. 6.4.5C), and that was completely healed after
one year (Fig. 6.4.5D).  The case of No. 36 was a
14-year-old boy, who complained of an indurated ulcer
on his right forearm since 2 months (Fig. 6.4.6A).  The
skin test was positive (20x20/38x32).  The topical
treatment with 2% paromomycin ointment was carried
out.  The lesion became dry after three weeks
(Fig.6.4.6B), and it healed with a slightly elevated scar
after 2 months.  The scar became flatter after one year
Table 6.4.3. The effect of paromomycin ointment
Effect Male (%) Female (%) Total (%)
Excellent 13? 43.33? 25? 59.52? 38? 52.78?
Good 8? 26.67? 11? 26.19? 19? 26.39?
Fair 7? 23.33? 4? 9.52? 11? 15.28?
No effect 2? 6.67? 2? 4.76? 4? 5.56?
Subtotal 30?100.00? 42?100.00? 72?100.00?
Unknown 23? ? 16? ? 39??
Total 53? ? 58? ? 111??
Table 6.4.4. The effect of 10% paromomycin
Effect Male (%) Female (%) Total (%)
Excellent 4? 36.36? 6? 54.55? 10? 45.45?
Good 4? 36.36? 2? 18.18? 6? 27.27?
Fair 3? 27.27? 2? 18.18? 5? 22.73?
No effect 0? 0.00? 1? 9.09? 1? 4.55?
Subtotal 11?100.00? 11?100.00? 22?100.00?
Unknown 5? ? 3? ? 8??
Total 16? ? 14? ? 30??
Table 6.4.5. The effect of 2% paromomycin ointment
Effect Male (%) Female (%) Total (%)
Excellent 8? 44.44? 17? 60.71? 25? 54.35?
Good 4? 22.22? 9? 32.14? 13? 28.26?
Fair 4? 22.22? 2? 7.14? 6? 13.04?
No effect 2? 11.11? 0? 0.00? 2? 4.35?
Subtotal 18?100.00? 28?100.00? 46?100.00?
Unknown 10? ? 7? ? 17??
Total 28? ? 35? ? 63??
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Figure 6.4.1. Case No. 139, a 4-year-old boy.  A, before topical treatment with antimoniate lotion; B, 3
weeks later; C, 1 year later without recurrence.
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Figure 6.4.2. Case No. 140, a 6-year-old boy.  A, before treatment with the lotion;  B, 3 weeks later;  C,
6 months later.
AA
BB
CC
120
Figure 6.4.3. Case No. 145, a 14-year-old girl.  A, before treatment with the lotion; B, 2 weeks later; C,
3 weeks later; D, 1 year later.
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Figure 6.4.4. Case No. 146, a 9-year-old girl.  A, before treatment with the lotion; B, 2 weeks later; C, 1
month later; D, 1 year later.
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Figure 6.4.5. Case No. 27, a 40-year-old male.  A, before topical treatment with paromomycin ointment;
B, 2 weeks later; C, 1 month later; D, 1 year later.
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Figure 6.4.6. Case No. 36, a 14-year-old boy.  A, before treatment with the ointment; B, 3 weeks later; C,
1 year later.
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Figure 6.4.7. Case No. 55, a 13-year-old boy.  A, before treatment with the ointment; B, 3 weeks later; C,
2.5 months later; D, 4 months later.
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Figure 6.4.8. Case No. 70, a 9-year-old boy.  A, before treatment with the ointment; B, 1 month later; C,
2 months later; D, 1 year later.
AA CC
BB DD
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(Fig. 6.4.6C).  The case of No. 55 was a 13-year-old
boy, who complained of a large ulcer on his right lower
leg for 2 months (Fig. 6.4.7A).  There was a large ulcer
with dirty crust sized 70 mm by 45 mm and small
red papules were scattered surrounding the ulcer. The
skin test was positive (25x21/28x25).  The topical
treatment with 2% paromomycin ointment for 3 weeks
changed, the lesion dry (Fig. 6.4.7B), then meglumine
antimonate solution was added to the lesions. The
lesion was covered with epidermis after 2 and half
months (Fig. 6.4.7C). Four months later, the lesion
was completely healed (Fig. 6.4.7D).  The case of No.
70 was a 9-year-old boy.  The patient had complained
of an ulcer on his face since 3 months.  When the
patient visited our clinic, there was an indurated ulcer
sized 30 mm by 30 mm on the left cheek (Fig. 6.4.8A).
The skin test showed positive (24x14/33x22). The 2%
paromomycin ointment was given to the patient.  The
ulcer changed to the dry lesion with crusts after one
month (Fig. 6.4.8B).  Two months later, the lesion was
healed completely with slight scar (Fig. 6.4.8C); the
scar was diminished after one year (Fig. 6.4.8D).
Discussion
A 15% paromomycin sulfate and 12% methyl-
benzethonium ointment was effective to the patients
with cutaneous leishmaniasis in Old World (El-On,
1986, 1992).  The concentration of paromomycin was
relatively high and the ointment was combined with
paromomycin and methylbenzethonium.  We used
lower concentrations of paromomycin in Ecuador.
Even a low concentration of 2% was effective in 80%
of the patients in this study.  There was no differ-
ence in effectiveness between the 10% and 2% of paro-
momycin ointments.  Meglumine antimonate with
mercury chrome solution was also effective.  The
effective rate of the solution showed similar tenden-
cy to paromomycin ointment.  However, drug resis-
tance of antimonial drugs to the cutaneous
leishmaniasis is increasing (Grogl, 1992).  Therefore,
topical use of meglumine antimonate will have the
same problem.  We need a study how to avoid this
drug resistance in the future.  Chemotherapy for killing
the parasites has always a similar contradiction.
Immunotherapy may be necessary for the treatment of
leishmaniasis.
Topical treatment using low concentrations of
paromomycin ointment and meglumine antimonate
with mercury chrome solution was effective to 80%
of cutaneous leishmaniasis patients in this study.
There was a low irritation to the wet ulcers of patients
with cutaneous leishmaniasis.  But, it was less effec-
tive to the non-ulcered lesions of the patients.  Topical
treatment against leishmaniasis should be done care-
fully to the patients, who do not have any concern to
mucocutaneous and visceral types of the disease.
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Introduction
Leishmania parasites are transmitted by the bites
of infected female sandflies to the vertebrate hosts. In
sandflies the parasites as a promastigote form devel-
op only in the gut and in vertebrate hosts they as an
amastigote form develop in the macrophages.
Although female sandflies feed on the blood meal from
the vertebrates for oviposition, their common diets are
plant-derived foods termed sugar meals.  Leishmania
infections are permanently in the gut of sandfly where
they are exposed to these meals and are apparently
affected by the components of these meals. Schlein
and Jacobson (1994) reported some plant diets of
Phlebotomus papatasi, which is the vector of L.
(Leishmania) major in Israel, impair L. (L.) major
infectons in the sandflies.  Since the sandflies in the
New World also feed on plants, the composition of
plants may influence Leishmania infections in their
gut.  In this study, effects of the composition of plants
which are distributed in Leishmania endemic area of
Ecuador on growth of Leishmania promastigotes in
culture were investigated.
Materials and Methods
Plants used in this study
Leaves of an agave (Amaryllidace sp.) (Agave)
and two bean-plants (Leguminosae) (Mame 1 and
Mame 2) were collected from Huigra in the Province
of Chimborazo.  Leaves of piñon, fruits of naranja
(Citrus sp.) (Piñon and Naranja) and mandarina (Citrus
sp.) (Mandarina) were collected from San Sebastian
in the Province of Los Rios which is an endemic area
of L. (Viannia) panamensis.  In addition, nuts of
mamei (Mamei) were collected from La Esmeralda
Chapter 7
Experimental Studies on Antileishmanial Effect 
in Vitro and in Vivo
1. Effect of Plant Juices on the Growth of Leishmania 
Promastigotes in Culture 
ABSTRACT. In this study, effects of crude components of plants which are distributed in Leishmania
endemic area of Ecuador on the growth of Leishmania promastigotes in culture are investigated.
Promastigotes cultured in medium 199 with the samples from mandarina and naranja showed a better
development as compared with the control at 48 hours in culture.  Although the samples from piñon
and agave promoted the development of promastigotes until 24 hours in culture, the number of pro-
mastigotes in the medium with these samples were smaller than the controls at 72 hours in culture.
In all experiments, flagellum length of promastigote extended with the lapse of time. At 72 hours in
culture, flagellum length was about twice in length as compared with flagellum at the commence-
ment of the culture.  It was clear that naranja and mandarina contain some components which pro-
mote the growth of promastigotes in culture and agave and piñon enhance the growth of promastigotes
during early cultivation period (~ 24 hours).  On the other hand, mamei and the two Leguminosae plants
used in this study inhibited the development of promastigotes.  Those plants apparently contain some
components which can adversely affect the growth of promastigotes in culutre.
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the remaining culture medium was used.
Morphological mesurements of cultured pro-
mastigotes
Promastigotes from 6, 12, 24, 48, and 72 hours
cultures were put on a slide glass, air-dried, fixed with
methanol, and stained with Giemsa solution.  The
lengths of the body and the flagellum were determined
by measuring 30 randomly selected culture forms.
Results
Growth patterns 
Promastigotes cultured without any plant samples
(the control) increased in number with the lapse of
time until 72 hours from 1 x 105 to 5.69 x 105 /ml
(Table 7.1.1).  Promastigotes cultured with the sam-
ples from mandarina and naranja showed about two-
fold development (6.77 x 105 and 7.52 x 105 /ml,
respectively) as compared with the control (4.01 x 105
/ml) at 48 hours in culture.  Although the samples from
piñon and agave promoted the development of pro-
mastigotes (3.37 x 105 and 2.34 x 105 /ml, respec-
tively) until 24 hours in culture, the number of
promastigotes in medium 199 with these samples were
smaller than the control's at 72 hours in culture.  The
two Mame and Mamei controlled the development of
promastigotes in culture.
Morphological changes during growth in medi-
in the Province of Los Rios. 
Leishmania parasite
The WHO reference strain, L. (V.) panamensis
(MHOM/PA/71/LS94), which is a major species in the
endemic area from where plant samples were obtained,
was maintained in the culture medium, tissue culture
medium 199, with 10% heat inactivated fetal calf
serum, penicillin (100 U/ml) and streptomycin (100
?g/ml) at 24?.
Preparation of plant samples 
The plant materials were kept at -80? until use.
The plant samples were squeezed and then at tem-
perature of 4?, centrifuged at 12000 rpm for 15 min-
utes.  The supernatant (plant juice) was used for the
experiment after filtration through a 0.22?m pore
membrane filter (MILLEX-GS, MILLIPORE Co., Ltd.,
U.S.A.).
Growth curves
Ten to the fifth of promastigotes (105)/ ml in log-
arithmic-phase were seeded in 96-well cell culture
plate (Cluster Dishes, Coster, U.S.A.) with the tissue
culture medium 199.  The plant samples of one hun-
dredth volume of the medium were added to the wells
individually and then incubated at 24?.  At 6, 12, 24,
48, and 72 hours after starting the culture, 50?l of the
culture was collected and the number of parasites ???
counted using a cell count chamber. For observations
of morphological shapes of cultured promastigotes,
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Table 7.1.1. Growth of promastigotes in culture 
Control Agave Mame 1 Mame 2 Piñon Naranja Mandarina Mamei
00 time 1.00
06 hours 1.44 1.07 1.01 1.93 2.04 2.98 2.78 1.64
12 hours 1.62 1.93 1.96 1.62 2.38 3.23 2.34 1.58
24 hours 2.49 2.34 1.35 2.30 3.37 3.82 3.18 1.98
48 hours 4.01 5.07 2.29 2.02 5.34 7.52 6.77 2.35
72 hours 5.69 4.24 1.38 1.52 4.83 6.56 7.55 1.79
* No. is shown as x 105 promastigotes/ml.
** Agave; Leaves of an agave (Amaryllidace sp.), Mame 1 and Mame 2; two bean-plants (Leguminosae),
Piñon; Leaves of piñon, Naranja; fruits of naranja (Citrus sp.), Mandarina; mandarina (Citrus sp.).
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Table 7.1.2. Morphology of parasites in culture
0 time control 29.2 11.1 18.1 0.37?0.067
Control, 6 hours 35.6 15.2 20.4 0.42?0.064
12 hours 35.8 15.3 20.5 0.42?0.066
24 hours 40.1 20.4 19.7 0.50?0.079
48 hours 44.1 22.5 21.6 0.51?0.047
72 hours 43.8 23.2 20.6 0.53?0.072
Agave 6 hours 29.8 11.4 18.4 0.37?0.094
12 hours 29.3 12.4 16.9 0.42?0.071
24 hours 31.2 13.7 17.5 0.43?0.064
48 hours 47.7 24.0 23.7 0.50?0.044
72 hours 43.6 23.5 20.1 0.53?0.063
Mame 1 6 hours 37.6 16.2 21.4 0.42?0.074
12 hours 34.1 14.3 19.8 0.42?0.040
24 hours 33.6 14.7 18.9 0.43?0.075
48 hours 39.0 20.7 18.3 0.55?0.076
72 hours 39.8 24.5 15.3 0.62?0.123
Naranja 6 hours 33.0 13.6 19.4 0.41?0.071
12 hours 33.1 14.5 18.6 0.43?0.081
24 hours 32.1 14.9 17.2 0.46?0.054
48 hours 47.4 24.0 23.4 0.50?0.060
72 hours 49.3 26.5 22.8 0.53?0.044
Mandarina 6 hours 31.6 12.5 19.1 0.39?0.076
12 hours 29.8 12.6 17.2 0.42?0.058
24 hours 35.0 16.6 18.4 0.47?0.058
48 hours 51.7 26.0 25.7 0.50?0.041
72 hours 41.3 22.0 19.3 0.53?0.046
Full
length
Flagellum
length
(?m)
Plant juice? and 
culture medium
Body
length
(?m)
F/B??
* Agave, Leaves of an agave (Amaryllidace sp.); Mame 1, bean-plants (Leguminosae); Naranja, fruits
of naranja (Citrus sp.); Mandarina, mandarina (Citrus sp.).  ?? Flagellum/body length.
um 199 with/without plant samples
In all experiments, flagellum of promastigote
increased in length with the lapse of time (Table 7.1.
2).  At 72 hours in culture, flagellum length was about
twice as long (from 11.1?m to 23.2?m) as flagel-
lum at the commencement of the culture.  Some lit-
tle growth of the body length was recognized in culture
with the plant samples from Agave, Naranja and
Mandarina (20.1?m, 22.8?m and 19.3?m, respec-
tively).  In contrast, the body length of promastig-
otes reduced from 18.1?m to 15.3?m, with those from
Mame 1.
Discussion
Sandfly vectors do not only feed on blood meals
from vertebrates but also feed on sugar meals from
juices of plants in the field.  Honeydews consist main-
ly of various sugars and amino acids of plant saps
(Brown  1975) and these compositions might be use-
ful for the development of promastigotes in the gut of
the sandfly.  Honeydews lack many of the components
of plant tissues.  Although in the wild, feeding of sand-
flies only on juices has been confirmed, in the labo-
ratory, they can feed by biting into plant tissues
(Schlein and Warburg, 1986).  Therefore, plant food
may give a wide range of influence on the Leishmania
parasites in the sandflies.
In this study, we investigated the effects of com-
ponents of plants collected from endemic areas of
leishmaniasis in Ecuador on Leishmania promastig-
otes in culture.  It was clear that naranja and manda-
rina contain some components which promote the
growth of promastigotes in culture and agave and
piñon enhance the growth of promastigotes during
early cultivation period (~ 24 hours).  On the other
hand, mamei and the two Leguminosae plants used
in this study inhibited the development of promastig-
otes. Those plants apparently contain some compo-
nents which can adversely affect the growth of
promastigotes in culture.  Although it is not confirmed
that sandflies feed on those plants in the field, it may
be considered that if sandflies infected with
Leishmania feed above mentioned plants, the deve-
lopment of the parasites in the sandflies are either
accelerated or hindered.
Sugar meals from juices of plants affect infectiv-
ity of Leishmania promastigotes in the gut of the sand-
flies (Schlein, 1993, Young et al., 1980).  However,
plant feeding of the sandflies is not only beneficial but
also impaire the development of the parasites in the
gut. Feeding on Ricinus communis, Capparis spin-
osa and Solanum luteum cause more than 50% mor-
tality and deformation of promastigotes (Schlein and
Jacobson, 1994).  In the present study, measurements
of para ites showed a marked tendency to diminish
in flagellum/body (F/B) length ratios due to an increase
in the length of the flagellum on successive days in
culture.  The round-shaped cell body of promastigotes
in the early culture period became spindle-shaped in
all of experiments except in cultures with the plant
samples from two Leguminosae.  In those cases, the
development of promastigotes was hindered and about
40% of the promastigotes showed rounding of the cell
body, which died by 72 hours in culture.
Since the plants used in this study affected the
development of promastigotes in culture, they may
also affect activity of promastigotes in the sand flies
(Rey et al., 1990).
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number of amastigotes was counted per 500 liver
nuclei in Giemsa-stained liver stamp preparations and
multiplied by liver weight in mg to express the para-
site load as Leishman-Donovan Units (LDU) (Bradley
and Kirkley, 1977).
Treatment of infected mice with mefloquine
For in vivo experimental chemotherapy, we used
Mephaquin® Lactab® (Mepha Ltd., Aesch-Basle,
Switzerland); each tablet contains mefloquine
hydrochloride corresponding to 250 mg mefloquine
base.  The mefloquine tablet was ground in a pestle
and mortar with sterile saline and resultant drug sus-
pension was inoculated into the mouse stomach by
stomach tube.  A group of four infected mice were
given the drug at a dose of 75 mg/kg for 2 days before
infection (days -1 and 0 ) and the other group of six
infected mice were given at the same dose at 7 and
8 days after infection (days +7 and 8 ).  Six infected
mice remained untreated as a control group.
In vitro drug susceptibility test
For in vitro drug susceptibility test, we used meflo-
quine hydrochloride powder which was supplied by
M. Andrial, Mepha Ltd. Promastigotes of L. (L.) dono-
vani were harvested from the stationary phase cultures
and suspended in Medium 199 with 20% HIFCS at a
concentration of 4 x 105 per ml.  The organisms (4 x
104) in a volume of 100?l were added to each well
of 96-well flat-bottomed microplates (Nunc, Denmark)
as described before (Katakura et al., 1992, 1994).
Two-fold dilutions of mefloquine hydrochloride in a
volume of 100?l were added to duplicate rows of the
plate.  The plate was incubated at 26? for 4 days until
Introduction
Recently we found that antimalarial drugs, meflo-
quine hydrochloride (Mephaquin®) and artesunate
(Plasmotrim®), had an effect when they were used
as oral therapy of cutaneous leishmaniasis patients
at endemic areas of Ecuador (Gomez et al., 1995).
The patients treated with the oral administration of a
total dosage of 1500 mg mefloquine or 4.2 mg/kg/day
for 6 days showed healing of almost all skin lesions
within 6 weeks. These clinical trials raised a ques-
tion whether the same drugs were also effective against
visceral leishmaniasis. Here we report results of oral
administration of Mephaquin® to mice experimental-
ly infected with Leishmania (Leishmania) donovani.
Materials and Methods
Parasites
A virulent clone of L. (L.) donovani 2S-25M-C2
(Katakura and Kobayashi, 1985, 1988) was used in
this study. Promastigotes of the clone have been main-
tained in Medium 199 containing 20% heat-inactivated
fetal calf serum (HIFCS) and 100?g/ml gentamycin
at 25-26?.
Infection of mice and determination of parasite
burden in the liver
As described previously (Katakura and Kobayashi,
1985, 1988), female BALB/c mice of 8 weeks of age
were inoculated intravenously via the tail vein with
1 x 108 promastigotes harvested from the stationary
phase cultures. Two weeks after the infection, the
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2.  Effect of Mefloquine on Visceral Leishmaniasis in Mice
ABSTRACT. We evaluated an effect of oral administration of mefloquine on experimental visceral
leishmaniasis in mice inoculated with Leishmania (Leishmania) donovani.  Mice orally received meflo-
quine at a dose of 75 mg/kg for 2 days before infection showed a 50% reduction in number of para-
sites in the liver. However, administration of drug at the same dose for 2 days after infection had no
therapeutic effect on elimination of parasites in the liver of infected mice.
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control cultures with no drug reach to the maximum
growth. The number of parasites in each well was
counted on a hemocytometer.  Initial cell density was
subtracted from the final cell density and the resultant
difference was expressed as a percentage of the con-
trol growth.  Effective drug concentration which inhib-
ited parasite growth by 50% (EC50) was then
determined.
Results
Effect of Mephaquin® on experimental visceral
leishmaniasis in mice
We assessed LDU in the liver of infected mice
at 2 weeks of infection because a peak of number of
parasites in the liver was seen at 2 weeks of infec-
tion in our murine model using BALB/c mice and L.
(L.) donovani 2S-25M lines (Katakura, 1986).  Infected
BALB/c mice received 75 mg/kg mefloquine for two
days before infection had an average of 575 LDU in
the liver, showing about a 50% reduction in number
of amastigotes compared to that in untreated control
infected mice (Table 7.2.1).  However, infected mice
received the drug at 7 and 8 days after infection exhib-
ited no substantial reduction in number of parasites in
the liver.
Antipromastigote activity of mefloquine hydro-
chloride in vitro
The susceptibility profile of L. (L.) donovani pro-
mastigotes to mefloquine hydrochloride was monopha-
sic.  Few proliferating parasites were seen in the
presence of 2.5?g/ml mefloquine and the ED50 value
was about 1.35?g/ml (Fig.7.2.1).
Discussion
Chemotherapeutic drugs for leishmaniasis have
been extensively examined by in vitro drug suscepti-
bility test against promastigotes in cell-free cultures
and amastigotes in cultured mammalian cells as well
as by in vivo animal models for cutaneous and visceral
leishmaniasis (reviewed by Neal, 1987).  We still need,
however, to make an effort to search for rational drugs
which are orally applicable for different types of
leishmaniasis.
In Ecuador, we tried oral treatment of cutaneous
leishmaniasis patients with mefloquine, an antimalar-
ial drug.  Surprisingly we found that almost all cuta-
Mefloquine LDU ? SD in the liver on day 14 
(No. of mice examined)
Non-treated 1170 ? 284 (6)
75 mg/kg/day (days -1 and 0) 575 ? 211 (4)
75 mg/kg/day (days +7 and +8 ) 1120 ? 279 (6)
Table 7.2.1. Effect of mefloquine on L. (L.) donovani infection in mice
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Figure 7.2.1. Susceptibility of L. (L.) donovani pro-
mastigotes to mefloquine hydrochloride in vitro.
Promastigotes were cultured in the presence of vari-
ous concentrations of mefloquine hydrochloride and
inhibitory effect of the drug on parasite growth was
expressed as a percentage of the control growth.
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neous lesions of the patients healed within 6 weeks
(Gomez et al., 1995).  Mefloquine, a quinine analogue,
destroys asexual erythrocytic forms of Plasmodium
species and has been used for chemotherapy of malar-
ia patients.  Possible mechanisms of action of meflo-
quine against malarial parasites are explained as
follows.  Mefloquine binds to lipid membranes of ery-
throcytes with high affinity and may inhibit the inva-
sion of erythrocytes by merozoites (Mu et al., 1975).
The action of mefloquine appears to be linked to hemo-
globin digestion by the parasites which produces fer-
riprotoporphyrin IX, a membrane lytic compound.
Mefloquine strongly binds to ferriprotoporphyrin IX
to form a complex which is toxic to the parasites while
Plasmodium hem polymerase detoxifies this metabo-
lite by catalyzing formation of an inert malarial pig-
ment, hemozoin (Goldberg and Slater, 1992; Wellems,
1992).  In addition, ionisable nitrogens of the side
chains of mefloquine may be important to increase
P. falciparum vesicle pH and inhibit parasite growth
(Krogstad et al., 1985).  Although the precise mode
of action of mefloquine against Leishmania parasites
is unknown, it is possible that mefloquine also acts
for increasing lysosome pH in Leishmania and inhib-
it metabolic pathways of the parasites.
Peters et al.(1980a, b) reported that mefloquine
was more effective against experimental cutaneous
leishmaniasis than visceral leishmaniasis. Against mice
infected with L. (L.) major or L. (L.) amazonensis,
they subcutaneously injected a total dose of 350 mg
mefloquine by giving 70 mg/kg/day for five consec-
utive days from the day of infection. The drug activ-
ity was recorded as a moderate level for both
Leishmania species because the mean size of the skin
lesions developed at the base of the tail was reduced
by 1/3 to 2/3 of that in untreated control infected mice.
In addition, they also examined the activity of meflo-
quine against visceral leishmaniasis in mice.  The same
amounts of mefloquine were subcutaneously admin-
istered into the L. (L.) infantum-infected mice from
5th or 6th day after infection for five consecutive days.
As a result, they concluded that the drug activity was
scored as a low level because the number of para-
sites in the liver of mice treated with mefloquine
remained 50-90% of that in untreated control infect-
ed mice.  The reasons why dermotropic Leishmania
spp.  are more sensitive to mefloquine than vis-
cerotropic species remain to be elucidated
In this study we also detected that mefloquine was
not effective against visceral leishmaniasis in mice
when the drug was given after infection.  However,
when the drug was administrated before infection, a
moderate level of prophylactic effect of mefloquine
against visceral leishmaniasis was evident.  This effect
may be due to the direct antipromastigote activity of
the drug.  We speculated that mefloquine concentra-
tions in the plasma of mice infected with L. (L.) dono-
vani were probably higher than 1.35?g/ml, the ED50
against promastigotes of this species in vitro, because
the mice were given a total dose of 150 mg/kg meflo-
quine and it has been reported that mice received 8
mg/kg mefloquine showed the maximum drug con-
centration of 1.55?g/ml in the plasma at 24 hr after
the drug administraion (Rozman et al., 1978).
Furthermore, administration of a total dose of 1000
mg mefloquine for healthy volunteers resulted in the
maximum drug concentration of about 1?g/ml in the
plasma and the mean half life of the drug is calcu-
lated as 21.4 days ranging from 15 to 33 days.
(Schwarts et al., 1980, 1982).
In conclusion, therapeutic effect of mefloquine on
visceral leishmaniasis is unlikely, whereas some pro-
phylactic effect of the drug against various types of
leishmaniasis may be expected when malaria patients
residing in endemic areas of both malaria and
leishmaniasis are treated with mefloquine.
Ken Katakura,
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Eduardo A. Gomez L.,
Yoshihisa Hashiguchi
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Chapter 8
Leishmaniasis and its Related Skin Diseases 
1.  Clinical Comparison of Cutaneous Changes of
Patients with Diffuse Cutaneous Leishmaniasis
and Leprosy in Ecuador
ABSTRACT. The cutaneous changes of a patient with diffuse cutaneous leishmaniasis who had
been mistreated for lepromatous leprosy were reported.  The patient was a 24-year-old male, born in
Province of Esmeraldas in Ecuador. Diffuse type of cutaneous leishmaniasis was not detected by the
screenings of family members, the relatives and the neighbouring people. The eruptions observed in
this case were similar to those of leprosy, lepromatous leprosy and borderline group leprosy.  However
there were some differences in dermatological findings, such as types of eruptions and their distribu-
tion, between these two infectious diseases.
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Introduction
Clinically, patients with cutaneous leishmaniasis
have  various cutaneous manifestations such as insect
bite-like papules, nodules, ulcers and erythematous
plaques.  Therefore, differential diagnosis between
cutaneous leishmaniasis and other skin diseases includ-
ing leprosy is very important, especially in Ecuador
where those infectious diseases are relatively common.
It is reported that early nodular lesions of cutaneous
leishmanisis are similar to those of lepromatous lep-
rosy (LL) (Jopling, 1984). 
The purpose of the assignment given to us in our
medical team from 1992 until 1995 was to compare
the lesions between cutaneous leishmaniasis and lep-
rosy.  We, therefore, have been investigated and sum-
marized cutaneous changes observed on the skin
lesions of patients with cutaneous leishmaniasis
(Nonaka et al., 1990; Hosokawa et al., 1994).  In this
report, the cutaneous changes of a patient with diffuse
cutaneous leishmaniasis who had been previously treat-
ed for LL are reported.  Though the eruptions of this
case were similar to those of leprosy, there were some
differences in clinical and dermatological findings
between these two diseases.  Furthermore, based on
the observation of the cutaneous manifestations of this
case, we will add a brief comment on a possibility
of ulcer formation on the lesion and non-specific
immunodeficiency against leishmaniasis.
Case report
A 24-year-old male, born in Province of
Esmeraldas, Ecuador, visited our clinic in August of
1994.  He grow up in San Ignacio (Muisne), a rural
and mountainous area far from Esmeraldas city, where
his family actually lived.  There were no patients with
a diffuse cutaneous leishmaniasis in his family mem-
bers and neighbouring people.  When the patient was
16-year-old, papules appeared on his left knee and
right cheek.  The eruption  gradually increased in size
and in number.  For about two years, he received var-
ious medications without confirmed diagnosis.  About
half a month prior to his visit to an outpatient clinic
in Guayaquil city, he was diagnosed clinically as lep-
rosy and started receiving medication for it.  In 1989,
after clinical and laboratory examinations, he was diag-
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nosed as a diffuse cutaneous leishmaniasis at the clin-
ic. Physical examinations revealed pea to rice-grain-
sized reddish papules on both the ear lobes and the
auricles.  Induration of the lesions was palpable (Fig.
8.1.1). Miliary to pea-sized reddish papules were
observed on the face (Fig. 8.1.2).  Miliary to pea-sized
reddish papules and nodules were also observed on
the left shoulder. Many miliary to hen-egg-sized
papule, nodule, erythema, infiltrated erythema and
brownish colored fleckles were observed on the upper
extremities (Fig. 8.1.3).  The surfaces of some of the
nodules were scaly and crusted (Fig. 8.1.4).  Rice-
grain to thumb-sized reddish papules  grouped on the
brownish colored fleckle lesion on the lower back were
observed.  Miliary-sized papules were scattered show-
ing satellite lesions around the plaque-like lesions (Fig.
8.1.5).  Thumb to palm-sized erythemas were observed
on the thigh showing no loss of sensation (Fig. 8.1.6).
Various kinds of eruptions, such as papules, nodules,
infiltrated erythemas, brownish colored fleckles, were
observed also on the lower extremities (Figs. 8.1.7,
8.1.8 and 8.1.9).  There were no eruptions on the
hands, the feet, the scalp, the axillary, epigastric,
inguinal, perineal and anal regions, except a few ver-
ruca vulgaris  lesions on the dorsal aspect of the left
hand (Fig. 8.1.3).  There was no sensory loss on all
over the body surface and no hypertrophy of periph-
eral nerve.  Leishmanin skin test showed negative.
Numerous Leishmania amastigotes were observed in
the stained smears from the skin lesion though no acid
fast bacilli were observed in the skin slit smear mate-
rials with Ziehl-Neelsen staining method.  The para-
sites were isolated in culture both in vivo and in vitro.
Zymodeme and karyodeme analysis revealed that they
were L. (Leishmania) mexicana  (Katakura et al.,
1994).  Histological findings of the specimen taken
from nodule on the thigh showed  hyperkeratosis and
mild acanthosis of the dermis.  There was dense cel-
lular infiltration in the dermis (Fig. 8.1.10).
Proliferations of blood vessels were also visible.  In
the foamy cells, numerous Leishmania amastigotes
were observed (Fig.8.1.11).  There was no such epithe-
liod cell granuloma as seen in leprosy.  No acid fast
bacilli were observed in the dermis.  From these result
of various examinations, the patient was diagnosed as
a diffuse cutaneous leishmaniasis (Reyna et al., 1994).
Comments
Lepromatous leprosy is similar to diffuse cuta-
neous leishmaniasis in that the disease is generalized;
the skin tests negative for their specific and patho-
genic organisms, Lepromin test and Leishmanin test;
there are many organisms in the lesions; it progress-
es chronically during several years; and it is resis-
tant to specific treatment (Convit et al., 1972).  In the
present case of a diffuse cutaneous leishmaniasis, the
similar cutaneous manifestations to those of leprosy,
especially multi-bacillary leprosy, were observed.  As
the patient had various kinds of eruption similar to
various type of leprosy (Jopling, 1984.; Hidano, 1968;
Walter, 1983), it might be convenient to summarize
some points for making differential diagnosis between
these two diseases as follows.  Examination of sen-
sory function is the most important test for diagno-
sis of leprosy. In LL, especially in its early stage,
as sensory loss sometimes is not clear or unfold, this
examination should be done carefully at the wide
region on all over the body surface including normal
colored skin regions.  Palpation of peripheral nerves
is also important.  But in multi-bacillary leprosy, espe-
cially in LL, sometimes hypertrophy of peripheral
nerves is not observed or they show only mild changes
without pressure pain and irradiation pain.
Bacteriological examinations such as acid fast stain-
ing for diagnosis and classification  should be per-
formed in all patients suspected with leprosy.
Ziehl-Neelsen staining method is easy and simple.
In some prefectures in  Ecuador, we saw the indeter-
minated leprosy case which had been misdiagnosed
and medicated as LL. The distribution of the eruptions
in this case was relatively bilaterally symmetric and
similar to borderline lepromatous leprosy (BL).  The
distribution of  the skin lesions of this case was sim-
ilar to that of leprosy.  That is, the eruptions were
139
Figure 8.1.1. Rice to pea sized papules on the right ear.
Figure 8.1.2. Various sized papules on the face.  On the right cheek, rice grain sized papules grouped and
make plaque-like lesion.
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Figure 8.1.4. Keratoachantoma-like nodule on the elbow.  Scaly and crusted shal-
low ulcer is observed.
Figure 8.1.3. Various kinds of eruption on the right upper extremity. Verruca vul-
garis scattered on the dosal aspect ot the hand.
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Figure 8.1.6. Thumb to palm sized infiltrated erythemas,
partially annular, and brownish colored fleckles on the right
thigh.
Figure 8.1.5. Various sized papules and nodules grouped on the lower back.
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Figure 8.1.7. Various kinds of eruptions on the
left thigh.
Figure 8.1.8. Nodules grouped on the left knee.
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observed on the ear lobes, the auricles, the face and
the all extremities except on the hands and feet.
Furthermore, no eruptions were observed on the scalp,
the axillary, epigastric, inguinal and perineal regions.
As ulceration is not always observed on the lesions of
leprosy, it can not be a ground for differential diag-
nosis between the two.  In LL, papules  are multiple
and their size is monotone, distributed bilaterally and
symmetrically.  In this case, although  papules were
multiple, their distribution was not bilaterally sym-
metric over all the affected region and their size var-
ied from miliary-sized to pea-sized.  Although the
thumb-sized nodules were observed on the extremi-
ties in this case, in LL and BL the size of nodules is
not so big.  The plaques in this case resembled those
of tuberculoid leprosy (TT) and borderline group lep-
rosy in appearance, but could be differentiated by the
fact that sensory loss exists in the lesion of leprosy.
Annular erythema usually observed in TT and bor-
derline group leprosy was not observed in this case.
The  brownish pigmentation  probably caused by the
inflammation or caused by taking clofazimin, resem-
bled to that of leprosy in appearance, but could  be
also differentiated by examination of sensory func-
tions.  Although Leon et al. ???????reported that dif-
fuse cutaneous leishmaniasis form non-ulcerated
nodules, crusted lesions were observed on the nodules
in our case.  The crusted lesion on the relatively large
nodules might have been caused by ulceration, exu-
date and bleeding.  Therefore, it is suspected  that
ulceration occured in the lesions of the disease.  From
this point of view, the case of Ecuadorian diffuse cuta-
neous leishmaniasis reported by Zerega (1961), in
which immunlogical and parasitological examinations
had not been performed, should be reexamined for the
true diagnosis.  In leprosy, clinical and histological
findings show various features caused by some fac-
tors, such as site of biopsy, choice and stage of erup-
tions (new, old, lepra reaction, medicated, cured or
spontanously healed eruption etc.), and especially
Figure 8.1.9. Brownish colored fleckles and infiltrated erythema on the extensor aspect of the both legs.
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Figure 8.1.10. Numerous foamy cells are  observed in the dermis stained with H&E (x100).
Figure 8.1.11. Leishmania amastigotes are observed in the foamy cells stained with H&E (x1000).
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immunological relation between hosts and parasites.
It has been speculated that host-parasite immuno-
logical relationships may modify cutaneous manifes-
tations of such diseases as tuberculosis, candidiasis,
dermatophytosis, chromomycosis, sporotrichosis and
other infectious diseases (Hosokawa et al., 1996).  If
the similar features to those in leprosy are observed
in diffuse cutaneous leishmaniasis, they might be
caused by some of the above mentioned immunolog-
ical factors.  In other respects of the dermatological
findings of this case, no eruptions were observed  on
the scalp, the axillary, epigastric, inguinal, perineal
and anal regions, where the temperature of the body
surface was relatively high.  This fact is usually
observed in the patients with leprosy (Hosokawa et
al., 1996; Hosokawa et al., 1994).  It was speculated
from this fact that the causative agents might clini-
cally prefer low temperature of the body surface
(Sheperd, 1965). In this case, leishmanin (Montenegro)
skin test showed negative reaction and tuberculin, can-
didine and trichophytine tests showed positive reac-
tions, demonstrating the existence of specific anergy
against Leishmania antigen (Reyna et al., 1994). On
the other hand, the existence of verruca vulgaris  on
the forearm of the 24-year-old  patient suggests that
he might suffer from some immunodeficiency  besides
the above mentioned specific immunodeficiency
against Leishmania.  In consideration of the differ-
ential diagnosis of diffuse cutaneous leishmaniasis,
it may be difficult to diagnose it only by cutaneous
manifestations.  Therefore, during the investigation of
this case, we re-recognized that sensory test and bio-
logical examinations by simple skin slit smear for dis-
covering the organisms were very important for correct
diagnosis and prevention of misdiagnosis of the dis-
eases.
Atsushi Hosokawa,
Motoyoshi Maruno,
Shigeo Nonaka,
Eduardo A. Gomez, L.,
Yoshihisa Hashiguchi
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Introduction
Fungal infections still remain a frequent health
care problem in Latin American countries including
Ecuador (Rios-Fabra et al., 1994).  In the current study,
one of the purposes is to make a differential diagno-
sis about the skin lesions found in the patients with
cutaneous leishmaniasis, leprosy and various skin dis-
oders including fungal infections.  We found a case
of chromomycosis in an endemic area for cutaneous
leishmaniasis in Ecuador.  Cutaneous manifestations
in chromomycosis sometimes showed a similarity to
those of cutaneous leishmaniasis.  Both diseases have
a chronic infectious, granulomatous findings
histopathologically.  The clinical  feature of our case
was thought  to be similar to that of verrucous type of
cutaneous  leishmaniasis.  Initially, as the screlotic
cells were found  in the epidermal scrapings from the
surface of the nodule of the patient, the case was con-
sidered to be rare with concominant cutaneous
leishmaniasis  and chromomycosis.  Several exami-
nations proved that the lesion had been caused only
by chromomycosis.  This paper deals in detail with
the case of chromomycosis caused by Fonsecaea
pedrosoi and we consider a differential diagnosis
between cutaneous leishmaniasis and chromomycosis.
The patient gave  an informed consent to  participate
to every examination.
Case report
The patient (File No. Baba 6) was a 60-year-old
male,  farmer, living  in rural area of Babahoyo city,
Province of Los Rios, Ecuador.  None of his family
members had the similar cutaneous symptoms.  He
denied any history of local traumatic injury prior to
the development of skin lesion.  He did not receive
any topical treatment of corticosteroid.  About a year
earlier, the patient noticed a rice-grain-sized, scaly
papule on the dorsal aspect of his right hand.  The
scaly papule gradually increased in size to form a
superficial nodule. He visited our clinic, the Multin  y
Casa Hospital in Babahoyo city, for diagnosis and
treatment. 
Physical examination revealed an irregular, scaly,
crusted,  verrucous, firm, nontender, brownish, hen-
egg-sized nodule on the dorsal aspect of his right hand
(Fig. 8.2.1).  The nodule was non-pedunculated, whose
top was nearly flat, and raised about 1 cm.  The sur-
face was rough and irregular with cauliflower-like
apprearance.  There was no associated regional lym-
2.  A Case Report of Chromomycosis from an Endemic Area for
Cutaneous Leishmaniasis in Ecuador: a Differential Diagnosis 
between Leishmaniasis and Chromomycosis
ABSTRACT. A patient with chromomycosis was seen in an area endemic for cutaneous leishman-
iasis, Babahoyo city, Province of Los Rios, Ecuador.  The patient was a 60-year-old male who daily
worked outdoors as a farmer.  The cutaneous manifestation on the dorsal aspect of the right hand in
this case was similar to  that of verrucous type of cutaneous leishmaniasis.  Mitochondrial DNA analy-
sis for Fonsecaea pedrosoi cultured from this case proved to be type 4 of F. pedrosoi, which is usu-
ally detected in South, Central and North America.  It is well known that chromomycosis, cutaneous
leishmaniasis and leprosy have a number of common clinical characteristics.  Therefore it is impor-
tant to perform mycological, parasitological and bacteriological examinations using epidermal scrap-
ings or skin slit smears, and to perform sensory tests on the wide area of the body surface when the
differential diagnosis of the three diseases needed.
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phadenopathy.  The differential diagnoses included
chromomycosis, cutaneous leishmaniasis, paracoc-
cidiomycosis, skin cancer and tuberculosis verrucosa
cutis. 
Laboratory examinations
Smear specimens of the lesion revealed neither
acid-fast bacilli nor Leishmania amastigotes.
Epidermal scrapings from the lesion were collected
for mycological evaluation.  Under direct microscop-
ic examination of the specimens using 15% potassi-
um hydroxide (KOH) solution, the fungal elements
found  in the scales were dark brown in color and were
in the forms of sclerotic cells and hyphae (Fig. 8.2.2).
Epidermal scrapings from the lesion were cultured on
Sabouraud-dextrose agar at room temperature.  Tissue
sample taken from the lesion was also cultured on
blood agar medium for detection of Leishmania pro-
mastigotes.  About two weeks later, a black colored,
heaped colonies were observed on the both culture
media (Figs. 8.2.3 and 8.2.4).  The colony showed
three kinds of conidation: Cladosporium-like (Figs.
8.2.5 and 8.2.6), Rhinocladiella and Phialophora
conidation (Figs. 8.2.7 and 8.2.8).  They were iden-
tified to be F. pedrosoi.  Mitochondrial DNA analy-
sis for F. perosoi showed that this strain was included
in group 4 (Fig. 8.2.9 and Table 8.2.1).  Mitochondrial
DNA analysis was perfomed by the method of
Kawasaki et al. (1993).
Histopathological study of the skin biopsy speci-
men from the border of the lesion revealed features of
chromomycosis.  Biopsy of the nodule revealed
marked irregular hyperkeratosis and acanthosis and
pseudocarcinomatous hyperplasia (Fig. 8.2.10) of the
epidermis with papillomatosis.  The dermis and epi-
dermis showed a granulomatous infiltration consist-
ing admixture of epitheloid cells, giant cells of both
Langhans and foreign  body types, plasma cells, lym-
phocytes, eosinophils and polymorphonuclear leuco-
cytes forming microabscesses.  A small number of
dark-brown, rounded, thick walled, and septate fungal
cells, that is sclerotic cells, were seen both within
the giant cells (Fig. 8.2.11) and in the microabscess-
es. Culture of biopsy specimen taken from the surface
Figure 8.2.1. Verrucous lesions of the patient caused  by F. pedrosoi.
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Figure 8.2.2. Brownish colored sclerotic cells (left) and hypha (right) observed by microscopic direct exam-
ination of a tissue fragment in KOH (original magnification, x1000).
Figure 8.2.3. Culture of the scales taken from the surface of the nodule, in Sabouraud-dextrose agar revealed
growth in about 2 weeks.  Heaped up dark colonies with a brown velvety surface of F. pedrosoi is observed.
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Figure 8.2.4. Culture of the tissue taken from the border of the nodule. Morphology of F. pedrosoi colony,
heaped up dark colonies with a brown velvety surface, on blood agar after about a month incubation.
Figure 8.2.5. Slide culture of F. pedrosoi detected from this case.  Forms of Cladosporium conidation (orig-
inal magnification, x1000).
151
Figure 8.2.6. Cladosporium-like conidation of F. pedrosoi detected from this case is demonstrated cleary
by the scanning electron microscope.
Figure 8.2.7. Slide culture of F. pedrosoi detected from this case.  Rhinocladiella-type structure is  observed
(original magnification, x1000).
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Figure 8.2.8. Phialophora fructification of F. pedrosoi is observed by slide culture of the fungus taken from
the lesion of this case (original magnification, x1000).
Figure 8.2.9. Mitochondrial DNA analysis for the present strain showing F. pedrosoi group 4.  Restriction
fragment length polymorphism of the mtDNA digested  with Hae? and MspI. M, size marker; Baba, the
present case; IFM46421, control.
M
Msp?
Hae?
Baba
IFM46421
Baba
IFM46421


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Figure 8.2.10. Biopy of the nodule revealed marked  irregular hyperkeratosis and acanthosis and pseudo-
carcinomatous hyperplasia of epidermis with papillomatosis.  Dermis and epidermis showed a granuloma-
tous infiltration consisting admixture of  epitheloid cells, giant cells of both Langhans and  foreign body types,
plasma cells, lymphocytes, eosinophils and collections of polymorphonuclear leucocytes forming microab-
scesses (original magnification, x100).
Figure 8.2.11. A small number of dark brown rounded thick-walled and septate fungal cells 'sclerotic
cells' were seen within the giant cells and in the microabscesses (original magnification, x400).
of blastomycosis.  They lack sharply raised borders
containing minute abscesses, the fairly rapid lateral
spread and central healing with flat and thin scar, all
of which are present in the former.  In older lesions
of chromomycosis with widespread or confluent flat
verrucous lesions and concurrent lymph stasis, the
diagnosis of "mossy foot" must be excluded by demon-
strating the fungi in crusts or tissues.  Only in the clas-
sic type of raised or pedunculated lesion, the clinical
diagnosis can be made with considerable confidence
(Chester, 1970).  It is well known that clinical find-
ings of cutaneous leishmaniasis sometimes resemble
to those of sporotrichosis and other infectious diseases
(Nonaka, 1990).  In the current survey in Ecuador, one
of the purpose was to make a differential diagnosis
about the lesions found in the patients with cutaneous
leishmaniasis, leprosy and other skin diseases.  The
lesions of chromomycosis must be also differentiat-
ed from those of cutaneous leishmaniasis, cutaneous
tuberculosis, tertiary syphilis, yaws and leprosy, espe-
cially from tuberculoid leprosy, borderline tubercu-
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Table 8.2.1. Mitochondrial DNA analysis for F. pedrosoi (Kawasaki et al., 1993)
Strain Origin Type Strain Origin Type Strain Origin Type
TIMM 530 Japan ?
TIMM 533 Japan ?
TIMM 606 Japan ?
TIMM 622 Japan ?
TIMM 634 Japan ?
TIMM 637 Japan ?
TIMM 639 Japan ?
TIMM 642 Japan ?
TIMM 656 Japan ?
TIMM 661 Japan ?
TIMM 664 Japan ?
TIMM 666 Japan ?
TIMM 669 Japan ?
TIMM 671 Japan ?
TIMM 676 Japan ?
TIMM 677 Japan ?
TIMM 683 Japan ?
TIMM 684 Japan ?
TIMM 685 Japan ?
TIMM 686 Japan ?
TIMM 687 Japan ?
TIMM 688 Japan ?
TIMM 689 Japan ?
TIMM 690 Japan ?
Yakou Japan ?
TIMM 532 USA ?
IFM 4915 Mexico ?
IFM 4916 Mexico ?
IFM 4917 Venezuela?
IFM 4918 Venezuela?
IFM 41517 Venezuela?
IFM 41518 Venezuela?
IFM 41519 Venezuela?
IFM 41520 Venezuela?
IFM 1415A Colombia ?
IFM 41867 Colombia ?
IFM 41868 Colombia ?
IFM 41705 China ?
IFM 41706 China ?
MMC 42 Thailand ?
IFM 4886 USA ?
IFM 41704 China ?
IFM 41934 ? ?
(F. compacta)
TIMM: Research Center for Medical Mycology, Teikyo University, Tokyo, Japan.
IFM: Research Center for Pathogenic Fungi Microbial Toxicoses, Chiba University, Chiba, Japan.
MMC: School of Medicine, Chiang Mai University, Chiang Mai, Thailand.
of the nodule, in Sabouraud-dextrose agar (Slant-N)
also revealed a growth of colonies in about two weeks
at room temperature.  The fungus in the colony was
also identified to be F. pedrosoi.
Slit-skin smear from the lesion, as above men-
tioned, did not show acid fast bacilli with Ziehl-
Neelsen staining method, though screlotic cells  and
hyphae were stained clearly dark blue with methyl-
eneblue (Fig. 8.2.12).
Comments
Chromomycosis is a localized chronic mycosis
of skin and subcutaneous tissues.  It is characterized
by verrucous, ulcerated and crusted lesions which may
be nearly flat and or may be raised 1 to 3 centimeters.
Many of the  raised lesions are pedunculated and have
surfaces so rough and irregular that they looks like a
cauliflower (Chester, 1970).  In general, early lesions
of chromomycosis must be differentiated from those
ication for cutaneous leishmaniasis was started.
Though this tentative diagnosis was considered ini-
tially, the lesion was found to be caused only by chro-
momycosis on repeated examinations finally.  Though
its association with cutaneous leishmaniasis has not
been reported, the examination, especially detection
of the microorganism, should be performed for con-
firming the diagnosis and adequate treatment.
Histopathological study of the nodule revealed all the
features characteristic of chromomycosis.  No Leishmania
amastigotes were seen in the smear materials and the
biopsy specimen.  These were further confirmed by
the culture of biopsy specimen in Sabouraud dextrose
agar.  Culture of the tissue of the dermis taken from
the lesion's border by a syringe in blood agar medium
for Leishmaia promastigotes further strengthened this
diagnosis.
Lesions of chromomycosis are usually localized
to the lower leg but may be occur on the skin surfaces
at the sites of cutaneous injuries (Zaror et al., 1987).
Satellite lesions arise by autoinoculation, by lymphatic
spread to adjacent areas  and rarely by hematogenous
loid leprosy and chronic discoid lupus erythemato-
sus (Torrealba et al., 1995).  Though it is stated that
leprosy may be rarely associated with other systemic
granulomatous diseases of infectious origin (Pavithran,
1988) including chromomycosis and cutaneous
leishmaniasis, one case of chromomycosis has been
misdiagnosed as tuberculoid leprosy (Pavithran, 1992;
Torrealba, 1995) and eight patients with concomitant
leprosy and cutaneous leishmaniasis in Ethiopia
(Barnetson, 1978) had been reported. As chromomy-
cosis, cutaneous leishmaniasis and leprosy have a num-
ber of similar clinical characteristics, it is important
that  skin slit smears should be taken from several
lesions and that sensory test should be performed on
the wide area of the body surface when the coexis-
tence of the three infections is suspected.
At first, when we observed the eruption of our
patient, we suspected that of verrucous type of cuta-
neous leishmaniasis.  Even after the demonstration
of the sclerotic cells in the crusts from the surface
of the nodule, the lesion was suspected to be induced
by the two infectious microorganisms and the med-
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Figure 8.2.12. Slit-skin smear from the lesion did not show acid fast bacilli with Ziehl-Neelsen staining
method, though screlotic cells and hyphae were stained dark blue with methyleneblue.
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spread to the brain (Lever, 1983). There is a pre-
dominance of infection in males, probably because
they have greater opportunity for soil contact and pre-
disposition to injury while working in the field. The
majority of the patient are between the age of 0 and
50 years.  As above mentioned, the feet and the legs
are the most frequented sites of infection, except
Venezuela (Rios-Fabra et al., 1994) where the more
frequently involved sites are the shoulders, chest and
trunk, and in Cuba, the upper extremities.  The most
common agent is F. pedrosoi, which is found in humid
tropical zones or wet areas within torrid zones (Rios-
Fabra et al., 1994; Londero et al., 1976).  In Ecuador,
95% or more of the cases were caused by F. pedrosoi
(Londero et al., 1976).
Recently mitochondrial DNA (mtDNA) analysis
for various fungi was considered as one of the use-
ful methods for identification of the species
(Kozlowski, 1982; Taylor, 1986; Corby, 1987; Helga,
1988; Suzuki, 1988; Takeda, 1991; Nishio, 1992;
Kawasaki, 1993).  As shown in Table 8.2.1, mtDNA
analysis for F. pedrosoi shows that all strains dis-
covered in North, Central and South  America  are
group 4 (Yamagishi et al., 1994).  Our analysis proved
that  the agent of this case is also included in the group
4 of F. pedrosoi.
Our patient was a 60-year-old male farmer living
in a rural area in Babahoyo city.  The site of lesion
was dorsal aspect of the right hand.  Though he denied
a history of traumatic injury locally prior to the deve-
lopment of the lesion, we suspected that he had had
many opportunities to be exposed to the causal agent
of chromomycosis.  Because he worked daily in the
field.  The agent of his disease was F. pedrosoi (type
4).  Nishimoto et al.  (1984) stated that more than 300
cases of chromomycosis had been repored in the
Japanese literature and they were noted to have sev-
eral characteristics different from those found in the
cases in tropical or  subtropical areas of Central and
South America.  The cutaneous manifestations of chro-
momycosis observed in our case were not common
in Japan.  Although the lesion did  not show typical
pedunculated form in our case, we consider that this
case is relatively  typical of chromomycosis in
Ecuador.  We consider that direct microscopic exam-
ination in potassium hydroxide (KOH) solution is very
important for diagnosis of fungal diseases.
Atsushi Hosokawa,
Shigeo Nonaka,
Masako Kawasaki,
Hiroshi Ishizaki,
Eduardo A. Gomez L.,
Yoshihisa Hashiguchi
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Introduction
During our survey for cutaneous leishmaniasis in
an endemic area, Zhucay, Province of Cañar, two
patients with cutaneous myiasis visited our clinic for
group examination.  When the eruption of cutaneous
myiasis was observed, it was first suspected that the
lesion might be the furuncle, folliculitis, bacterially
caused traumatic lesion or some rare type of cutaneous
leishmaniasis similar to Andean type.  Clinically,
patients with cutaneous leishmaniasis have various
types of cutaneous changes such as insect bite-like
papules, nodules, ulcers, sporotrichosis-like lesion,
chromomycosis-like verrucous lesion and erythema-
tous plaques.  It is therefore important to differentiate
leishmaniasis from these dermal changes.  On the other
hand, myiasis is the invasion of intact tissues by lar-
vae of certain species of flies.  The flies are found
in coastal areas as well as on the inland plains and
in the jungles (Zumpt, 1973).  Two main forms are
recognized, (a) external or dermal, and (b) internal
myiasis.  Cutaneous myiasis in man usually results
from the invasion of skin, mucous membrane, nose,
mouth and anus, or conjunctiva by the fly larvae
(Edington, 1969).  The current paper deals with the
two cases with cutaneous myiasis in detail.  The
patients gave an informed consent to participate to the
examination and treatment.
Case report
Case 1 (File No. Zhucay 24): A 70-year-old male
visited our rural clinic in Zhucay, Province of Cañar,
Ecuador on August 26, 1995, with a complaint of nod-
ule of a few months duration on the extensor aspect
of left elbow.  The patient was a farmer and worked
usually outdoors.  He had not noticed any insect bite
on the lesion site.  A few months earlier, however,
he noticed a reddish papule.  The lesion gradually
incresed in size.  He regarded the furunculous lesion
as cutaneous leishmaniasis and came to the clinic to
get a specific treatment.  The reddish nodule was 1.5
x 1.0 cm in diameter and a small fistula, 2-3 mm in
diameter, was open at the center of the nodule (Fig.
8.3.1). In the fistula, the spiracle (mouth) of the fly
larva moving for respitration was observed.  Swellings
of the axillary and inguinal lymph node were not pal-
pable.  The patient complained of a mild pressure pain.
A public health nurse of the clinic diagnosed clini-
cally the lesion as cutaneous myiasis on the basis of
the cutaneous appearance.  At first, we tried to extract
larva by a forceps with application of gentle pres-
sure to both sides of the lesion (Fig. 8.3.2).  As it was
relatively large, it was extracted by a surgical proce-
dure using a small incision under local anaesthesia
(Figs. 8.3.3 and 8.3.4).  After removal of the larva
(maggot), oral antibiotics and antiseptic solution were
3. Case Reports of Cutaneous Myiasis due to 
Dermatobia hominis  from an Area Endemic for 
Cutaneous Leishmaniasis in Ecuador
ABSTRACT. Two cases of patients with cutaneous myiasis, due to Dermatobia hominis (myiasis-
producing fly), were seen in an area endemic for cutaneous leishmaniasis, Zhucay, Province of Cañar,
Ecuador.  These cases were diagnosed during a survey for cutaneous leishmaniasis in the area.  Clinical
manifestations of cutaneous myiasis showed a similar appearance to those of furuncle and other skin
diseases.  One case of 70-year-old male had a furunculous lesion with mild pain on the right elbow
and another case of 7-year-old male had the folliculitis-like lesion with itching  on the scalp.  Cutaneous
myiasis is a rare disease  in Japan, and therefore it is difficult for Japanese doctors to diagnose it
correctly.  The incidence of myiasis will augment following increased air travels in recent years.
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prescribed for the lesion.  It was identified  as the third
instar larva of Dermatobia hominis.  The larva was 21
mm in length and 5 mm in width (Fig. 8.3.5).  There
were many small spines lined around the body.  Nine
rows of spines and a few oblique rows behind them
were counted on the surface from the mouth to the end
of the body (Figs. 8.3.6 and 8.3.7).  In the mouse, two
small pharyngeal skeletons were observed and around
the spiracle, numerous small tiny spines were observed
(Fig. 8.3.8).
Case 2 (File No. Zhucay 22): A 7-year-old male
schoolboy visited the same clinic in Zhucay on August
26, 1995 with a complaint of papule of a few weeks
duration on the scalp. In  addition, the patient suffered
from a nodule and an ulcer of a few months duration
on the dorsal aspect of right forearm.  The crusted red-
dish nodule was 1.5 x 1.3 cm in diameter (Fig. 8.3.9)
and the ulcer with induration at the margin was 1.3
x 0.5 cm in diameter (Fig. 8.3.10).  These eruptions
were diagnosed as cutaneous leishmaniasis clinically
and parasitologically.  Besides these eruptions, a few
weeks earlier, an eruption appeared on his scalp  and
gradually increased in size (Fig. 8.3.11).  He regard-
ed the eruption as cutaneous leishmaniasis as he had
done with the eruptions on the forearm.  He came to
the clinic to receive a specific treatment.  He had not
noticed any insect bite  on the scalp.  On physical
examination, the indurated erythema of 1 cm in diam-
eter without tenderness was crusted slightly. A small
sized fistula, about 1 mm in diameter, was opened at
the center of the eruption (Fig. 8.3.10).  In the fistu-
la, the mouth of the fly larva moving for respiration
was observed.  Axillary and inguinal lymphnode
swellings were not palpable.  Again, the public health
nurse diagnosed clinically the lesion as cutaneous myi-
asis.  After she applied an insecticide on the lesion,
surgical extraction was performed by tweezers.  After
the removal of the larva, ointment of antibiotics was
prescribed on the lesion.  It was identified as second
instar larva  of D. hominis. The length of the larva
was 16 mm and width, 2mm.  There were many small
spines lined around the body.  Four rows of spines and
a few oblique rows behind them were counted on the
surface from the mouth  to the end of the body.  In
the mouth, two small pharyngeal skeletons  were
observed.  Around the spiracle, many small tiny spines
were observed.  These two cases were  summarized in
Table 8.3.1.
Comments
Though cutaneous myiasis is not a relatively rare
disease in developing countries, the incidence of myi-
asis will increase especially in tourist following
increased air travel in recent years.  We should add
cutaneous myiasis to the list of differential diagnosis
for leishmaniasis when we enter into the area endem-
ic for the disease and when we examine a patient who
has an experience to have visited an endemic area.  In
Japan, for example, 13 cases of cutaneous myiasis due
Table 8.3.1. Two cases of myiasis from the endenic area of cutaneous leishmaniasis, Zhucay, Province of
Cañar, Ecuador.
Case 1 (File No. 24) Case 2 (File No. 22)
Age 70 7
Sex male male
Site of lesion extensor aspect of left elbow scalp (vertex)
Size of lesion 10?15 mm 13??5 mm
Symptom of 
lesion
reddish furunculous subcutaneous nodule
with mild pain
crusted slightly elevated erythema with
mild itching
application of insecticides on the lesion and
of gentle pressure to both sides of the
lesion
surgical extraction under local anaesthesiaTreatment
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Figure 8.3.1. Thumb sized reddish furunculous nodule on the extensor aspect of left elbow.  Small size
fistula was opened at the center of the nodule.  In the fistula, the spiracle (mouth) of the fiy larva moving
for respiration was observed.
Figure 8.3.2. The larva was tried to extract by a forceps under application of gentle pressure to both sides
of the lesion.
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Figure 8.3.3.  As the larva was relatively large, it was not extracted by the treatment mentioned in the expla-
nation for Figure 8.3.2.
Figure 8.3.4. The larva was extracted  by a surgical procedure using a small incision under local anaes-
thesia.
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Figure 8.3.5. The larva extruded from the elbow of Case 1. There are many small spines lined around the
body.  Nine rows of spines and a few oblique rows  behind the mare counted on the surface from the mouth
to the end of the body.
Figure 8.3.6. The anterior end of the larva.  Rows of spines are seen.
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Figure 8.3.7. A scanning electron microscopic feature, showing the structure of the anterior end of the larva.
Figure 8.3.8. The posterior end of the larva.  Two small pharyngeal skeletons were observed in the openn-
ing.  Around the spiracle, numerous small tiny spines existed.
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Figure 8.3.9. A cutaneous leishmaniasis lesion located at proximal site of the right forearm of Case 2.
Figure 8.3.10. An ulcer, with induration at the margin, of cutaneous leishmaniasis located at distal site  of
the right forearm of Case 2.
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Figure 8.3.11. On  the scalp of Case 2, crusted slightly indurated pea sized erythema without tenderness.
A small size fistula was opened at the center of the eruption. In the fistula, the mouth of the fly larva mov-
ing for respiration was observed.
Figure 8.3.12. The public health nurse of the clinic, Zhucay, Department of Cañar, applied the insecti-
cides  on the lesion to extract the maggot.
to D. hominis have been reported from 1974 to 1996
by Taniguchi (1996).  They reported  the number of
patients  and countries  of infestations.  Out of 13, 7
(53.8%) cases were from Brazil, 2 (15.4%) cases were
from Mexico, one case from Paraguay, one case from
Belize (Central America), one case from Honduras
(Taniguchi et al., 1996). 
Dermatological findings of cutaneous myiasis
1) Papular or furunculoid lesions: The opening at
the summits of the lesions,  through which the larva
breathes and which may be diagnostic, is character-
istic of the human or tropical bot, i.e., D. hominis,
in the American tropics (Miller, 1978).  The lesions,
produced after the larva has penetrated, are usually,
but not necessarily, on exposed parts of the body, and
are single-grouped, or widely separated.  They com-
monly contain one larva, but sometimes several.
Symptoms progress from minor itching and pain to
local tenderness and severe pain as the lesions  increase
in size (to 20 mm or more) over a period of usually
several weeks.  Open lesions may produce a serious
discharge, but there is little pus unless secondary bac-
terial  infection and abscess formation occur after death
or escape of the larva (Miller, 1978).
2) Migratory lesions: These lesions induce itch-
ing and serpentine, superficial, red tunnels caused by
the young larvae of botflies.  D. hominis does  not
produce such lesions, because it does not migrate into
the skin. 
3) Traumatic cutaneous lesion: The lesion origi-
nates in the open wounds where the flies deposit eggs
or larvae, they may be caused by over 50 different
species of flies including D. hominis. 
Thomas et al. (1995) reported that five out of six
patients with cutaneous myiasis due to D. hominis had
complained of pain, sometimes severe, at the lesions.
A furunculous, often painful lesion was formed, in
which the larvae had remained for up to 90 days
(Arellano et al., 1985).  The duration of the symptoms
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before referral was markedly long in this group, com-
pared with the patients infected with Cordylobia
anthropophaga of whom only two out of six had com-
plained of pain.  In Case 1, the lesion had had no pus
and patient complained of only mild pressure pain.  In
Case 2, the lesion showed minor itching on the scalp
without pus, and was relatively clean. The patient
did  not complain of pain  at all.  From these clini-
cal findings and the reports in their references, it was
considered that the severity of pain at the lesions might
be induced by the secondary bacterial infection. 
Myiasis producing fly (D. hominis) and its vec-
tors
Most common infestation of cutaneous myiasis
is due to D. hominis (Fig.8.3.12) and C. anthro-
pophaga (Thomas et al., 1995).  D. hominis is endem-
ic in the American tropics. D. hominis fly, which
shows a  neotropical distribution from the Gulf coast
of Central Mexico to  Argentina, is a member of war-
ble  or botfly group, which includes  the sheep nasal
bot (Oesrus ovis), the cattle bots (Hypoderma spp.),
the horse bots (Gasterophilus spp.), the Russian gad-
fly (Rhinoestrus purpureus), and other species which
generally less parasitize humans.  The flies are found
in the coastal areas as well as on the inland plains and
in the jungles of tropical America, frequently near
forests (Zumpt, 1973). 
It is considered  that both Dermatobia and  its vec-
tors seem to be forest insects, though Dermatobia will
occasionally leave the forests accompanying a host
(Bates, 1942).  The adult fly does not seek its host
directly, but almost always utilizes some other species
of insects for the transmission of its eggs.  The adult
female D. hominis acts in the daytime and seeks
insects of moderate size and moderately active habits
on which it deposits its eggs.  The Dermatobia female
usually captures the mosquitoes or other blood-suck-
ing arthropods in flight and, while hovering, manages
to fasten some 14 to 25 whitish elongated-ovoid eggs
to its abdomen without causing any injury.  Their
common vectors are several species of Psorophora
(subgenus Janthinosoma) in Central America and
northern South America, Culex among the mosquitoes,
Stomoxys calcitrans of the blood-sucking  muscoids
Siphona sp.  (biting flies) in Brazil, Fannia spp. of the
Figure 8.3.12. Dermatobia hominis, female (myi-
asis-producing fly) (from James, 1947).
Figure 8.3.13. Dermatobia hominis, maturing larva
in human skin.  The posterior end of the larva is at the
outer end of the tunnel, so that breathing may occur
through the posterior spiracles (from Faust et al., 1970)
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nonblood-sucking muscoids, and the tick, Ambllyomma
cajennense (Paul, 1984; Taniguchi, 1996).  When the
favorite vectors of the Dermatobia-eggs alights on a
warm-blooded host, the young larvae, stimulated by
the warmth of the host's body and ready to hatch,
emerge from the egg-membranes through a small oper-
cular opening, and in less than an hour invade the skin
frequently through the puncture wounds made by the
vector and/or by their own mouth parts.  Within the
host's skin layers, the larva feeds, grows, and moults
twice. Each larva penetrates independently in the skin
and forms a boil-like pouch in the subdermis.  It com-
municates with  the exterior through a small fistula
(Fig. 8.3.13).  Near the anterior of the second and third
thoracic segments, are short, stout, posteriorly direct-
ed spines or hooklets that anchor the larva in the skin
and the larva does  not migrate  within the skin.  The
duration for larvae development requires from about
46-50 days (Dunn, 1930; Taniguchi et al., 1996) to as
long as 3 months, after which the larva  works its way
out of the skin  of the hosts, falls  to the ground, and
pupates in the soil, and then develops into adult fly.
Hosts of the myiasis
Domestic and wild mammals, humans, cattle, dogs
and birds are most commonly parasitized by the lar-
vae.  The Dermatobia population may differ from
forests to forests  with no obvious relation to the pop-
ulation of cattle, usually the chief host, in the vicin-
ity (Bates, 1942).  Humans are usually infested when
associated with domestic animals (Paul, 1981).
Medical treatment
It is stated that larvae should be removed from the
skin, because they can lead to abscess formation.
Several methods of removal have been known.  One
of them is to remove them by forceps or a needle under
application of gentle pressure to both sides of the
lesion. Application of mineral oil onto the opening
of the lesion, injection of lidocaine into the larvae, use
of insecticide spray, placement of vaseline, bacon fat,
butter onto the lesion, and various other methods have
been proposed to ease the larvae out (Rawlsins, 1988;
Omar, 1992; Loong, 1992; Brewer, 1993; Nunn, 1994;
Taniguchi, 1996; Thomas, 1995).  These materials cut
off the larval air supply by blocking the spiracle and
stimulate extrusion.  Other method is to extract them
by a surgical procedure using a small incision under
local anaesthesia.  That is, larvae may be removed
by slightly widening the already present opening under
local anaesthesia, and then  gently squeezing out the
larva.  Cleansing and use of antiseptics and antibiotics
are indicated to combat secondary infection. Generally,
surgical excision is unnecessary unless larvae are alive,
but it has been used for removal of dead or decayed
larvae (Arosemana, 1993).  In Case 1, the larva was
removed by the surgical treatment using  a small inci-
sion  under local anaesthesia and under application  of
gentle pressure to both sides of the lesion.  In Case
2, after the application of the insecticides onto the
opening of the lesion, the larva was removed by for-
ceps under application of gentle pressure to both sides
of the lesion.  On the other hand, it was reported that
spontaneous extraction was seen in four patients out
of 13 Japanese patients with cutaneous myiasis due to
D. hominis in Japan, and it was speculated that appli-
cation of ointment containing vaselin and antibiotics
onto the treated lesions might have caused the spon-
taneous extrusion of lavae.  In 1995, when we visit-
ed Guayaquil city in Ecuador, we encountered a
woman, a city dweller who had travelled in the rural
areas, suffering from cutaneous myiasis on the leg.  In
this case, the larva moved out from the furunculous
lesion spontaneously (unpublished data).  In general,
oral medicines are not applied to the patients with cuta-
neous myiasis due to D. hominis. It is reported that
the oral application of ivermectin is not a standard pro-
cedure in the treatment of infection with Hypoderma
lineatum but might be of value in individual cases
(Thomas,1995). We have the same opinion as theirs
and generally the oral application of ivermectin may
not be needed.
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In this text, the results obtained from field surveys
in different endemic areas of cutaneous leishmaniasis
in Ecuador, and those obtained from laboratory works
based on the materials collected during 1994 and 1996
were mainly compiled, from the parasitological, mol-
ecular biological, dermatological and pharmacologi-
cal points of view.  During the present investigation,
special emphasis was given on the evaluation of dif-
ferent types of drugs which would be suitable for oral
or topical treatment of the disease.  In addition, cur-
rently available molecular biological techniques are
also evaluated briefly, in order to have good diagnostic
tools which are especially applicable for  field surveys
at endemic areas of developing countries in tropical
and subtropical regions.  The results obtained are sum-
marized as follows.
A note on Leishmania-HIV co-infection
Recently, leishmaniases, especially its visceral
forms are noticed as one of the important opportunistic
infections of acquired immunodeficiency symdrome
(AIDS) in several areas of the world where both dis-
eases distribute sympatrically. Since the mid-1980s
there has been a dramatic increase in the number of
Leishmania infections in human immunodeficiency
virus (HIV) positive patients concurrent with the
spread of the viral epidemic to areas traditionally
endemic for leishmaniasis in the world.  In southern
Europe, for example, especially in Spain, Italy and
France, leishmaniasis is a growing problem with sev-
eral hundreds of HIV co-infection cases. Similar prob-
lems are also reported from Asian countries.
Therefore, in the present text, such cases of
Leishmania-HIV co-infections were briefly reviewed,
in order to give an attention to inhabitants living in
areas endemic for both diseases, leishmaniasis and
AIDS.
Molecular parasitological findings
DNA karyotype of Leishmania isolates from cuta-
neous leishmaniasis patients at endemic areas of
Ecuador was analyzed by pulsed field gel elec-
trophoresis.  From the results obtained, it is worth to
note that DNA karyotyoe variation was evident among
Leishmania (Viannia) panamensis isolates in the
Pacific coastal regions while karyotype homogeneity
was detected previously in L. (Leishmania) mexicana
isolates in the Andes mountain regions.  Leishmania
isolates collected during the period from 1990 to date
at 13 provinces of leishmaniasis-endemic areas of
Ecuador were also analyzed by ELISA, based on more
than 100 isolates, and their geographical distribution
was shown.
Ultrastructural studies on leishmaniasis
A comparative electron microscopic observation
was made between the skin biopsy materials taken
from diffuse cutaneous (DCL) and localized cutaneous
leishmaniasis (LCL) patients in Ecuador.  Large par-
asitophorous vacuoles and disconnected cell mem-
branes of Leishmania amastigotes were observed only
in DCL. From the results obtained, it was suggested
that proteo-high molecular weight phosphoglycan (pro-
teo-HMWPG) was released from the disconnected site
of the membranes of the amastigotes, and that pro-
duction of proteo-HMWPG was accelerated in DCL
more than in LCL.  Pathological difference between
DCL and LCL was also investigated immunohisto-
chemically by using anti-T cell, CD45RO antibody
and anti-lysozome antibody.  The results obtained
showed that the macrophages may not play their role
as antigen presenting cells in the DCL case.
Microscopic studies on patients treated orally with an
antimalarial drug, Mephaquin®, was carried out by
examining skin biopsy materials from the patients.
After the oral treatment, inflammatory cell infiltration
was remarkably decreased in H-E staining specimens,
and the activity and cytotoxicity of macrophages were
remarkably diminished in anti-asialo GM1 antibody
staining specimens. 
Summary
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Diagnostic trials using molecular techniques
A trial to detect Leishmania parasites in paraf-
fin-embedded skin biopsies of Ecuadorian cutaneous
leishmaniasis patients, using polymerase chain reac-
tion (PCR).  In the study, a specifically amplified DNA
by PCR using genomic DNA extract from Leishmania
organisms was confirmed, and specific DNA was
detected in some of the formalin-fixed and paraffin-
embedded skin specimens.  A comparative study of
conventional and PCR-based diagnosis of cutaneous
leishmaniasis in Ecuador was made.  The results
showed that PCR was consistently more sensitive than
any of the 3 conventional diagnostic methods, micro-
scopic examinations of 1) smear specimens, 2) in vitro
culture materials and 3) histological specimens. In the
other trial, template DNAs were prepared by boiling
for 10 min in 5% Chelex solution, and Leishmania
amastigotes in skin biopsy materials were detected by
PCR using primers designed from minicircle (13A and
13B) and mini-exon gene (S-1629 and S-1630).  The
latter primer never amplified non-specific products
even in human template, and enabled the subgenus
level identification of the genus Leishmania. 
Clinical and epidemiological studies
During 5 years from 1991 to 1995, a total od 348
cutaneous leishmaniasis patients were examined clin-
ically and parasitologically in epidemiological surveys
at different endemic areas of cutaneous leishmaniasis;
the study sites distributed into 4 provinces, Manabi,
Los Rios, Azuay and Esmeraldas, Ecuador. In this ret-
rospective study, clinical and epidemilogical features
of cutaneous leishmaniasis, such as age-composition
of patients and clinical forms of the disease, and num-
ber, size, location and duration time of lesions, were
thoroughly analyzed. From the clinical and epidemi-
ological analysis of data, it was recommended that
control and/or treatment of the disease in Ecuador
should be done based on not only clinical knowledges
but also entomological, ecological, environmental and
anthropological knowledges.  A retrospective study
was also made in an endemic area of the Pacific coastal
region, Province of Manabi, Ecuador.  Clinical cases
registered during 1985 and 1996 in a public hospital
were briefly evaluated, in order to get an informa-
tion on the global situation of the disease.  In this study
area, the following preliminary trials of chemothera-
py of patients with antimalarial drugs were done.
Oral and topical treatment using antimalarial
drugs and others
Antimalarial drugs such as mefloquine hydrochlo-
ride (Mephaquin®) and artesunate (Plasmotrim®) which
are currently being used for malaria cases were eval-
uated for their antileishmanial activities.  Almost all
of cutaneous leishmaniasis patients were highly sen-
sitive for both drugs, showing a high cure rate.  The
healing time of lesions tended to depend on the size
and/or secondary infections of lesions, including other
health conditions of each patient.  Topical treatment
using 2 preparations, a low concentration of paro-
momycin ointment and a meglumine antimonate lotion
with mercury chrome was also effective against 80%
cutaneous leishmaniasis patients.  These  topical treat-
ment used showed a low irritation agaist patients with
ulcer lesions, and less effective against those with non-
ulcered lesions. Naturally, such a topical application
of drugs should be tried in the areas where no risk
of mucocutaneous or visceral types of the disease
exists.
A laboratory assay of plant juices and meflo-
quine for antileishmanial activity in vitro and
in vivo
Crude components of plants which are distrib-
uted in leishmaniasis-endemic areas of Ecuador are
evaluated on their antileishmanial effects of pro-
mastigotes in vitro.  From the results obtained it was
suggested that naranja and mandarina contain some
components which promote the growth of promastig-
otes in culture, and agave and piñon enhance the
growth of the parasites during early cultivation time
within 24 hours.  On the other hand, mamei and the
two Leguminosae plants used in this study inhibited
the development of promastigotes; these plants appar-
ently contain some components which can adversely
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affect the parasite growth in culture.  An antileish-
manial effect of mefloquine (Mephaquin®) was eval-
uated using Leishmania donovani-infected visceral
leishmaniasis model mice.  The animals were treated
orally with the drug at a dose of 75 mg/kg for 2 days
before infection showed a 50% parasite reduction in
the live, while no parasite reduction was found when
the same dose was given after infection. 
Related diseases
A clinicl comparison of cutaneous chages between
patients with diffuse cutaneous leishmaniasis and lep-
rosy was done based on dermatological findings, such
as types of eruptions and their distribution.
Furthermore, case reports of chromomycosis and myi-
asis due to Dermatobia hominis were reported from
areas endemic for cutaneous leishmaniasis, and a dif-
ferential diagnosis between these diseases and cuta-
neous leishmaniasis was briefly mentioned in the text. 
APPENDIX
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1. An Epidemiological Study of Leishmaniasis in a Plantation
"Cooperativa 23 de Febrero" Newly Established in Ecuador
Yoshihisa Hashiguchi, Vicenta Vera De Coronel and Eduardo A. Gomez L. 
ABSTRACT. An epidemiological study was performed on leishmaniasis in September 1982, in a plan-
tation "Cooperativa 23 de Febrero" newly established in the region of Andean slope in Ecuador. The
first immigration of inhabitants in this plantation started from August 1977.  Fifteen (15.8%) of the
95 inhabitants examined were diagnosed as positive for leishmaniasis with ulcers (active leishmanial
lesions) on the skin.  During the period between 1977 and 1982, a total of 57 (60.0%) of 95 exami-
nees have suffered from the disease.  Regardless to age and sex, leishmanial infections occurred almost
evenly.  The result indicated that the transmission of leishmaniasis had been occurring in a wide
range of working and housing areas in the plantation.  In most of the active patients, the onset occurred
in July or August.  The length of time between immigration and the onset of leishmaniasis ranged  from
3 to 59 months, mostly 9 to 36 months in those with active leishmanial lesions.  A large number of
leishmanial lesions were located on the upper parts of the body exposed.
Revista Ecuatoriana de Higiene y Medicina Tropical, 34, 1984, 1-20
2.  Infección Natural de Phlebotomus con Promastigotes de 
Leishmania braziliensis en una Area Endemica de 
Leishmaniasis en Ecuador
Vicenta Vera De Coronel, Yoshihisa Hashiguchi, Eduardo A. Gomez L., Tatsuyuki Mimori
and 
Masato Kawabata
ABSTRACT. En el curso de nuestro estudio sobre el mecanismo de transmisión de la leishmaniasis
en areas endemicas del Ecuador, las primeras fases de la investigación se canalizaron hacia  las  busque-
da de las especies de flebotominós que estarian desempeñando el papel de vectores de la enfermedad
(Lutzomyia spp.), por medio de la disección de especimenes capturados picando al hombre en la flo-
resta.  Hasta la fecha, en el Ecuador, se han realizado algunos trabajos de investigación sobre las
manifestaciónes clinicas de la enfermedad en los pacientes, y sobre los aspectos taxonomicos y eco-
logicos de los insectos sospechosos de ser los vectores de la endemia.  Sinembargo no se han hecho
intentos para determinar definitivamente al vector o vectores principales de la enfermedad, mediante
el hallazgo de la infección natural en los insectos incriminados potencialmente.  Cuando la investi-
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gación se encamina a conocer el  mecanismo de transmisión como paso previo a la adopción de prob-
ables medidas de control, lo mas importante o prioritario sera siempre  conocer a los principales vec-
tores en cada area endemica.
En el presente trabajo, usando cebos humanos, los flebotomus capturados fueron el nucleo de nues-
tra atención, desde Julio a Octubre de 1983, en siete diferentes sitios del area endemica de leishman-
iasis escogida por nosotros, la zona de Ocaña, Provincia del Cañar.  Solo encontramos dos especies
antropofilicas del genero Lutzomyia, en esta area de estudio; ellas fueron identificadas  como Lu. trapi-
doi, y Lu. hartmanni, basandonos en las caracteristicas morfologicas de su espermateca y armadura
cibarial.  Un total de 1,452 flebotominós de ambas especies capturadas, fueron sistematicamente dis-
ecados y examinados en busqueda de la infección natural, y el resultado fue que las dos resultaron
positivas con promastigotes.  Los flagelados observados fueron identificados al momento como
pertenecientes al complejo Le. braziliensis, de acuerdo a su aspecto morfologico y comportamiento
en el vector, especialmente su ubicacion en el tubo digestivo del huesped invertebrado.
Al examinar los ejemplares recolectados a diferentes alturas sobre el nivel del mar, 350 m, 600
m, 950 m, 1,200 m y 1,500 m, Lu. trapidoi resulto ser la especie predominante en los sitios mas
bajos, mientras que Lu. hartmanni lo fue en los lugares mas altos.  De todos estos puntos, encontramos
flebotomus naturalmente infectados con promastigotes de Leishmania, hasta los 1,200 m de altura.
La transmisión de la enfermedad, por tanto, se extiende hasta esta altitud, en el area de estudio.  Ambas,
Lu. trapidoi y Lu. hartmanni, visitaron al cebo humano durante toda la noche, para alimentarse.  La
mayoria de los picos de actividad de los vectores, se encontraron entre las 19:00 y 24:00 hs.  Al
disecar a Lu. trapidoi y Lu. hartmanni, encontramos que los naturalmente infectados, siempre fueron
capturados entre las 18:00 y 24:00 hs, no encontrandose ninguno positivo a partir de esa hora.  Este
hecho es atribuible al desarrollo del ciclo gonotropico, es decir flebotomus paridas y nuliparas, deducien-
do que las paridas concurren a picar temprano.  Por otra parte este fenomeno no pudo observarse en
Lu. hartmanni, a los 600 m, ya que a dicho nivel la captura del mismo fue escasa.
Asi, el resultado de este trabajo de investigación ha sido el descubrimiento de la infección natur-
al con promastigotes del complejo, Le. braziliensis, en especies de Lutzomyia ecuatorianas, pro vez
primera, lo que nos ha  permitido automaticamente incriminarlas fundamentalmente como los vec-
tores principales de la leishmaniasis en una zona endemica ecuatoriana.  Ademas una de estas especies,
Lu. hartmanni, no ha sido antes señalada como vector en estudios previos realizados en Centro y
Sudamerica, ni conocida con anterioridad en nuestro pais, todo lo cual debera confirmarse minu-
ciosamente antes del veredicto definitivo, como parte del largo camino que nuestro grupo debera
aun recorrer revelando uno a uno los extraños secretos que la naturaleza guarda todavia sobre los com-
plejos mecanismos de transmisión de las artropozoonosis, y entre ellas, la leishmaniasis tegmentaria
americana.
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3. Natural Infections with Promastigotes in Man-biting Species of 
Sand Flies in Leishmaniasis-endemic Areas of Ecuador
Yoshihisa Hashiguchi, Eduardo A. Gomez L., Vicenta Vera De Coronel, Tatsuyuki Mimori
and 
Masato Kawabata
ABSTRACT. In order to determine the vectors of leishmaniasis  in Ecuador, 1,054 man-biting sand
flies from the Department of Cañar were dissected and examined for promastigotes.  There were 2
man-biting species, Lu. trapidoi and Lu. hartmanni in this endemic area of the disease.  The infec-
tion rates were 7.7% in the former and 3.9% in the latter species, demonstrating the different rates
in various localities and altitudes of the study areas.  There was an association between infection
rates and the time of day, suggesting some connection with biting activity of sand fly species.  In
collections using human bait at 7 study areas in 5 Departments, 6 man-biting species were recog-
nized,  indicating different dominant species in each area.  It was assumed that the dominant species
would play an important role as the principal vector of  leishmaniasis in each endemic area.  As to
species  determination of the present Leishmania promastigotes, suffice it to say that the parasites
are Leishmania  sp., presumably L. braziliensis s.l., until the isolates have been typed.
Annals of Tropical Medicine and Parasitology, 79(5), 1985, 533-538
4. Biting Activity of Two Anthropophilic Species of Sandflies,
Lutzomyia, in an Endemic Area of Leishmaniasis in Ecuador
Yoshihisa Hashiguchi, Eduardo A. Gomez L., Vicenta Vera De Coronel, Tatsuyuki Mimori
and 
Masato Kawabata
ABSTRACT. The biting patterns of Lutzomyia trapidoi and Lu. hartmanni, vectors of leishman-
iasis, were studied using a human bait in an endemic area on the Pacific slope of the Andes in Ecuador.
The results suggest that Lu. trapidoi is primarily an early biter at dusk, with the first peak at 20:00-
21:00 hours and the second at 03:00-04:00 hours; and that Lu. hartmanni bites more constantly through-
out the night, with a pronounced peak between 23:00 and 24:00 hours.  The biting activity, however,
shows a marked variation at each site and between different collections at the same site.  The activi-
ty and the biting places on man are discussed in relation to human infection with leishmaniasis in the
area and the location of lesions on patients.
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5.  Leishmania Isolated from Wild Mammals Caught in 
Endemic Areas of  Leishmaniasis in Ecuador
Yoshihisa Hashiguchi, Eduardo A. Gomez L., Vicenta Vera De Coronel, Tatsuyuki Mimori
and 
Masato Kawabata
ABSTRACT. In total, the following 48 wild mammals were caught and examined for Leishmania
infections in the two localities, Naranjal (N) and Ocaña (O): Didelphis marsupialis, nine in N and  five
in O; Tamandua tetradactyla, one and nil; Choloepus hoffmani didactylus, one and nil; Sylvilagus
braziliensis, one and nil; Dasypus novemcinctus, one and one; Sciurus granatensis, four and one; Rattus
espinosus, six and nil; R. rattus, one and nil; Coendou bicolor, two and nil; Agouti paca, two and
nil; Dasyprocta punctata, two and nil; Potos flavus, eleven and nil.  Of these animals, only three
were positive for the parasite, namely, one Choloepus hoffmani didactylus, one of four Sciurus granaten-
sis and one of 11 Potos flavus from Naranjal.  Only cultures from the liver of these three animals
were positive for Leishmania, those from the spleens being negative.  In the light of future planning
of control measures of the disease in Ecuador, it is thought to be important to make a search for the
reservoir hosts in endemic areas.  To determine the principal host in this country, however, more detailed
such a work should be performed.
Japanese Journal of Tropical Medicine and Hygiene, 13(3), 1985, 205-2453
6. A Review of Leishmaniasis in the New World with Special Reference
to its Transmission Mode and Epidemiology
Yoshihisa Hashiguchi
ABSTRACT. Leishmaniasis is a widespread protozoan disease in the New World from southern US
at the north to northern Argentina at the south.  The disease is principally divided into three forms,
i.e., cutaneous, mucocutaneous and visceral leishmaniasis, mainly based on the clinical manifesta-
tions in patients and on the species of the causative agents, Leishmania.  The leishmaniases are well
known as a considerable public health problem in endemic areas of the disease in the New World,
except for Canada, Chile and Urguay where no such a disease occurs.  In this review, an attempt was
made to understand a global situation of the epidemiology of the New World leishmaniasis, laying
an emphasis on the pick-up of known endemic areas, vectors and reservoir  hosts of different species
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of the genus Leishmania in each country.  From the information published hitherto, it was found that
an intensive leishmaniasis research has been made in Central and South American countries, such as
Belize, Panama, Venezuela and Brazil.  The study, however, was poorly done in many other coun-
tries of the New World, without limiting endemic areas or deciding vectors and reservoir hosts of the
disease.  In the present  text, the author emphasized on a future research importance of epidemiolog-
ical characteristics including the transmission mode of New World leishmaniases, in order to search
for suitable control  measures in each endemic area of different countries.  Most of the transmission
of leishmaniasis in the New World have  been  found  in dense  tropical rain forests with various species
of Leishmania, sand  flies and mammals.  In such circumstances of endemic  areas of leishmaniasis
in the New World, the difficulty of the prophylaxis and control has frequently been pointed out by
several investigators.  At the present situation of leishmaniasis research without a suitable vaccine
and sufficient epidemiological data,  ones have commented that the only control measure for  New
World leishmaniasis is to remove all the inhabitants of communities from regions at risk of the dis-
ease, or to perform thoroughly deforestrations around dwelling areas or working places.  Past trials
of several control measures, such as the spraying of insecticides, destruction of reservoir hosts, appli-
cation of some vaccines  and etc., were also briefly reviewed in the text. (In Japanese with English
summary)
Revista Ecuatoriana de Higiene y Medicina Tropical, 36, 1986, 3-8
7.  Primera Generacion de Phlebotomus de Laboratorio en el Ecuador:
el Metodo de Crianza, Mantenimiento y su Contribucion al Futuro 
de la Investigacion Cientifica  en Epidemiologia Nacional 
Eduardo A. Gomez L.
ABSTRACT. Dada la importancia que tiene el estudio de la transmisión de la leishmaniasis se proyec-
to y desarrollo este trabajo, encaminado a la cria de phlebotomus en el laboratorio para trabajos de
experimentación.  Se capturo un buen numero de "progenitoras silvestres", y en frascos adecuadamente
preparados con yeso humedo, se las traslado al laboratorio conjuntamente con machos de la misma
especie escogida (Lu. trapidoi), para encerrarlos en una camara especial para la alimentación y cop-
ula.  Las hembras gravidas fueron conservadas en frascos igualmente acondicionados hasta la oviposi-
ción, quedando luego los huevos depositados en los mismos recipientes, y guardados en camara humeda
durante el tiempo de realización de la metamorfosis completa.  A partir de 50 hembras gravidas obtu-
vimos 1,022 huevos, 706 larvas, 510 pupas y 498 adultos, quedando despues de seis semanas com-
pletamente estudiado el ciclo evolutivo in vitro de Lu. trapidoi.  A partir de  la eclosión de los
huevos las larvas fueron alimentadas con heces de conejo secas y pulverizadas.
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8. Leishmaniasis in Different Altitudes on Andean Slope of Ecuador
Yoshihisa Hashiguchi, Eduardo A. Gomez L., Vicenta Vera De Coronel, Tatsuyuki Mimori
and 
Masato Kawabata
ABSTRACT. An epidemiological survey was performed in a leishmaniasis-endemic area along
highway which was established about 15 years  ago on the Andean slope of Ecuador; the area  ranged
from 300 m to 1,500 m above sea level.  In general survey, 64 (14.3%) of the 446 subjects examined
were positive for leishmanial signs.  In order to know leishmanial infections in relation to the altitudes
of dwelling sites of subjects, analysis was made on 224 children with 5 to 15 years of age.  At 4 dif-
ferent sites with 500 m, 1,000 m, 1,300 m and 1,500 m above sea level, the infection  rates of the
subjects from the individual sites were 17.4, 18.8, 5.6 and 8.8%, respectively.  A statistically  signif-
icant difference was recognized between the altitudes, 500-1,000 m and 1,300-1,500 m (0.01<p<0.05,
?2 = 5.314), but not between 500 m and 1,000 m and between 1,300 m and 1,500 m.  Leishmanial
infec tions of the children who came from forest and highway areas were compared in each altitude.
But no significant difference was found between forest and highway dwellers at any study sites.
Annals of Tropical Medicine and Parasitology, 81(6), 1987, 681-685
9.  The Relationship between Severity of Ulcerated Lesions and 
Immune Responses in the Early Stage of 
Cutaneous Leishmaniasis in Ecuador
Tatsuyuki Mimori, Yoshihisa Hashiguchi, Masato Kawabata, Eduardo A. Gomez L. 
and 
Vicenta Vera De Coronel
ABSTRACT. The relationship was examined between the severity of ulcerated lesions and immune
responses in 19 Ecuadorian  patients in the early stages of New World cutaneous leishmaniasis.  As
an  immunological assay, the humoral immune response was assessed by enzyme-linked  immunosor-
bent assay (ELISA) and the cell-mediated response by delayed type skin test for leishmanial antigen
(leishmanin test).  There was a statistically significant correlation (r = 0.61, p<0.01) between the
total area of ulcerated lesions and the reciprocal titre of ELISA in identical subjects.  However, no
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significant difference was observed in the ELISA titre between patients with a single lesion and
those with multiple lesions (?2 = 7.06, df = 5, p>0.01).  These results suggest that the severity of ulcer-
ated lesions relates to the  activation  of both the humoral and cell-mediated immune systems in the
early stage of New World cutaneous leishmaniasis.
Kochi, Japan: Kyowa Printing, ????????????????Series, No. 1, 1987, 1-174
10. Studies  on New World Leishmaniasis and  its Transmission, with
Particular Reference to Ecuador
Yoshihisa Hashiguchi (ed.)
ABSTRACT. In the present text, results of field studies on several aspects of leishmaniasis epi-
demiology in Ecuador are  presented.  These aspects include parasite isolation and characterization,
detection of natural infections of sand flies and mammalian hosts with Leishmania, and evaluation of
immunological tools in the epidemiological survey.  In addition, current knowledge of Ecuadorian
leishmaniasis and its endemicity were reviewed.  The following points were extracted from each chap-
ter of this text. 
Leishmaniasis investigations in Ecuador
Prior to 1982 the principal leishmaniasis research activity in Ecuador was limited to case reports
and/or the treatment of patients in medical centers or hospitals, although some studies of vector
entomology had been done by several investigators.  Thereafter, transmission studies were initiated
by the present  workers, who detected natural infections of sand flies and wild mammals with leish-
manial parasites in endemic areas.  According to the articles published in Ecuador to date, there may
be three or four clinical forms of the disease: cutaneous cases (CL), ca. 93% of the total; mucocuta-
neous (MCL), ca. 6 or 7%; and visceral (VL) and diffuse cutaneous ones (DCL).  The last two forms
have not yet been parasitologically proven in the country.  Analysis of the data accumulated in med-
ical institutions revealed that the disease had a country-wide distribution in Ecuador.
Ecology of areas endemic for leishmaniasis
The Andes divide the country into three natural regions: the Pacific  coast including the Andean
slope, the Andean and the Amazonian regions.  The majority of leishmaniasis cases  reported were
from the Pacific coast, followed by the Amazon.  A few cases were also observed in the Andean
highland or the mid-Andes.  In the text, ecological features of each region  relating to the mam-
malian and sand fly fauna, are taken into special consideration in discussion of disease transmission.
Parasite isolation and their characterization
We have isolated eight stocks, five from humans and three from wild mammals, in the present
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study.  Identifications based on results of serodeme typing using monoclonal antibodies revealed
that  three of the five from humans are Le. b. panamensis (MHOM/EC/87/G05, MHOM/EC/87/G06
and MHOM/EC/87/G07) and all three from wild mammals are Le. m. amazonensis (MSCI/ EC/87/G02,
MPOT/ EC/87/G03 and MTAM/EC/87/G04).  The remaining stocks from humans require further inves-
tigation until they are fully characterized.  Results of this will be reported elsewhere. 
Natural infections of sand flies and wild mammals
One species of Lutzomyia, Lu. gomezi, was added to the list of Ecuadorian leishmaniasis vectors,
in addition to the two known vector species, trapidoi and hartmanni.  With regard to reservoir hosts,
one species, Tamandua tetradactyla, was newly implicated.  Of these other mammalian species,
Potos flavus, Sciurus vulgaris and Choloepus h. didactylus, which had already been listed as leishman-
iasis reservoirs, the first two mammalian species were also positive for leishmanial parasites in the cur-
rent study.  A search for leishmaniasis reservoir hosts was also made by the immunological method
using counter immunoelectrophoresis (CIE) in this study.  The CIE technique revealed that the tissue
extracts (antigen) of three arboreal species, Didelphis marsupialis, Caluromys lanatus and Choloepus
h. didactylus, reacted immunologically with anti-leishmanial serum, producing precipitin lines.  In
the first two mammalian species, no natural infections with leishmanial parasites have parasitologi-
cally been observed.  It was, however, suggested that these immunologically positive mammals  play
an important role as reservoirs of the disease in endemic areas of Ecuador.
Immunological diagnosis of the disease
The  present immunological tools, skin test and ELISA,  were highly sensitive and specific for cuta-
neous  and mucocutaneous  leishmaniasis in Ecuador.  From the results  obtained, it was concluded
that these diagnostic method could be very useful in screening of the disease in epidemiological sur-
veys.
Epidemiological findings
Andean  leishmaniasis (uta) in Ecuador was first described from the mid-Andes (2,300 to 2,500
m above sea level).  The  suspected sand fly vector is Lu. peruensis, which was the only species col-
lected during our field survey.  No Leishmania-positive fly was found among 51 specimens dissect-
ed.  In order to clarify epidemiological features such as human, reservoir and vector infections in
this mid-Andes endemic area, a further investigation will be conducted by the present workers.  Bacterial
flora was isolated from highland and lowland leishmanial ulcers, in an attempt  to determine the
effect of bacterial concomitant infection on the development of the distinct skin manifestations.  The
prevalence rate of Gram-negative rods, but not Gram-positive cocci or anaerobic bacilli was apparently
different between two types of ulcer, occurring in 18.2% of highland as opposed to 37.5% of low-
land infections.  Gram-negative rods were composed of such enterobacteria as Escherichia, Serratia,
Klebsiella and Enterobacter.  Histological examination showed inflammatory cell infiltrations most-
ly composed of small lymphocytes throughout the dermis in highland ulcers, while those from lowland
cases restricted to the deep dermis.  When the parasitologically-proven prospective leishmaniasis cases
were reviewed, the most important  period for transmission of the disease in Ecuador was considered
to be during the rainy season, from October to April.  Most of the findings presented here can be
considered as preliminary results of the investigation.  Based on these basic data obtained, however,
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we hope to further elucidate the epidemiological features of leishmaniasis in the New World, with par-
ticular reference to Ecuador, in future studies.
Japanese Journal of Tropical Medicine and Hygiene, 15(2), 1987, 97-104
11.  The Fate of Leishmania braziliensis, L. donovani and 
Trypanosoma cruzi in Diffusion Chambers Implanted 
into Hamsters and Mice -a Preliminary Study-
Yoshihisa Hashiguchi, Masato Furuya  and Yoshisuke Okamura 
ABSTRACT. Leishmania braziliensis and L. donovani were  investigated for the transformation
and survival in intraperitoneal (IP), subcutaneous (SC) and intrascrotal (IS) diffusion chambers  implant-
ed into hamsters and mice.  For a comparison, Trypanosoma cruzi was also examined by using the
same procedure.  The 2 Leishmania species revealed an unexpectedly short survival time, and no trans-
formation was observed in the parasites in chambers implanted into hamsters or mice.  IS chambers
seemed to provide a better condition for L. donovani, L. braziliensis and T. cruzi, as compared with
IP and SC chambers in hamsters.  In the study, no IS chambers were examined in mice because of
too small size of the scrotum to insert the diffusion chamber.  T. cruzi showed a considerably longer
period of survival than L. donovani or L. braziliensis in mice, but not in hamsters.  The trypanosome,
T. cruzi, transformed from epimastigote to trypomastigote and amastigote in IP and SC chambers in
mice.  These results seemed to suggest that the factors responsible for the transformation and sur-
vival of the organisms might be greatly different between the 2 genera, Leishmania and Trypanosoma,
and also between the 2 host animals, hamsters and mice.
American Journal of Tropical Medicine and Hygiene, 40(2), 1989, 154-158
12.  Identification, using Isoenzyme Electrophoresis  and 
Monoclonal Antibodies, of Leishmania Isolated from 
Humans and Wild Animals of Ecuador
Tatsuyuki Mimori, Gabriel Grimaldi, Jr., Richard D. Kreutzer,  Eduardo A. Gomez L., 
Diane McMahon-Pratt, Robert B. Tesh and Yoshihisa Hashiguchi
ABSTRACT. Six strains of Leishmania isolated from wild mammals and humans on the Pacific Coast
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of Ecuador were identified by isoenzyme electrophoresis and by their reactivity patterns to  a cross-
panel of specific monoclonal antibodies using a radioimmune  binding  assay.  Single isolates from
Sciurus vulgaris, Potos flavus, and Tamandua tetradactyla were identified as Leishmania amazonen-
sis.  Three other strains, isolated from  cutaneous  lesions of humans, were identified as Leishmania
panamensis.
Japanese Journal of Tropical Medicine and Hygiene, 17(2), 1989, 149-155
13.  Observations on the Validity of the Ovarian Accessory 
Glands of Seven Ecuadorian Sand Fly Species 
(Diptera: Psychodidae) in Determinating 
Their Parity
Hiroyuki Takaoka, Eduardo A. Gomez L., John B. Alexander 
and 
Yoshihisa Hashiguchi
ABSTRACT. Females of seven sand fly species caught on man  in several leishmaniasis-endemic foci
in Ecuador were examined to assess the value of the accessory gland secretions as an  indicator of par-
ity.  It was found that parous females could be distinguished from nulliparous by the presence of
granular secretions in the accessory glands in Lutzomyia ayacuchensis, probable vector of Leishmania
in the Andean highlands of southern Ecuador.  Examination of the female accessory glands was not
a reliable method for determining parity in six other sand fly species caught in lowland areas, includ-
ing Lu. trapidoi, Lu. hartmanni, and Lu. gomezi, three proven vectors of Leishmania, since glanular
secretions were found in both parous and nulliparous females.
Nettai, 22, 1989, 68-82
14.  A Brief Review of Central and South American Leishmaniasis, 
with Special Reference to Ecuador
Yoshihisa Hashiguchi
ABSTRACT. A brief review is given of  recent  developments in leishmaniasis research worldwide,
including details of the transmission of the three clinical forms of the disease, viz., cutaneous, muco-
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cutaneous, and visceral.  Current knowledge of  leishmaniasis in Leishmania-endemic regions of Ecuador
is described, for  each  of  the three geographical regions of the country, i.e., Pacific coastal, Amazonian
and Andean plateau. Particular  emphasis is given to Andean leishmaniasis and its endemic area, a
focus of the disease discovered by our field survey in 1986.  Current leishmaniasis treatment meth-
ods such as perilesional administrations of antimonials and topical treatments such as thermotherapy
and cream application are discussed, together with progress in the development of vaccines and new
drugs.  The continued importance of field studies in Leishmania-endemic areas is noted, these being
necessary in understanding leishmaniasis epidemiology and in application of control measures. (In
Japanese) 
Nihon Iji Shinpo, No. 33397, 1989, 59-60
15.  Leishmaniasis Research in Central and South America 
-Why is it Necessary to Study Parasitic Diseases
Which are not Prevalent in Japan ?-
Yoshihisa Hashiguchi
ABSTRACT. In the article an attempt is made to stimulate the interest of Japanese investigators in
the field of parasitic  and other infectious diseases.  The author developed an understanding of the
importance of leishmaniasis research in the third world, through his own research experience on the
disease in Ecuador and wanted to help promote a general understanding among medical workers on
the necessity of international medical  (research) collaboration in tropical regions of the world.  In
Japan, parasitic diseases have largely erradicated through the application of efficient control mea-
sures and sanitary  improvements.  This has resulted in a tendency for Japanese researchers to have
little interest in parasitology and the control of  parasitic diseases, at a time when research on these
topics is urgently  required in the third world countries. (In Japanese)
Japanese Journal of Tropical Medicine and Hygiene, 17(4), 1989, 331-338
16.  Epidemiological Survey of Leishmaniasis using Skin Test and
ELISA in Ecuador
Masato Furuya, Tatsuyuki Mimori, Eduardo A. Gomez L., Vicenta Vera de Coronel, 
Masato Kawabata and Yoshihisa Hashiguchi
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ABSTRACT. The present study was designed to evaluate the intradermal skin test (ST) and the ELISA
as diagnostic tools  in  the screening for Ecuadorian cutaneous and mucocutaneous  leishmaniasis.  The
antigen for skin testing was prepared from ruptured promastigotes of Leishmania braziliensis.  The
ST and ELISA positive rates among 72 subjects with active dermal lesions were 81.1% (36/44) and
81.3% (52/64), respectively, while parasites were observed in 31 (44.9%) of 69 subjects presenting
active lesions.  In the parasites positive cases, all subjects proved to be positive for the two tests except
for one in ST and two in ELISA.  In 35 healed cases, the ST and ELISA positive rates were 86.2%
(25/29)  and 72.4% (21/29), respectively.  On the other hand, the positive rate in subjects without clin-
ical signs was only 3.8% in ST and 8.2% in ELISA.  An epidemiological survey in Selva Alegre,
Esmeraldas, revealed that among 115 inhabitants  38 were positive for the clinical signs, 10 active
and 28 healed cases.  Of these subjects 33 (86.8%) showed positive  reactions against ST and/or ELISA.
Based on the results obtained, therefore,  we  concluded that the present skin testing antigen and ELISA
were very useful for the screening of leishmaniasis in the endemic areas of Ecuador.
Boletin de la Oficina Sanitaria Panamericana, 108(4), 1989, 296-307
17.  Las Investigaciones sobre la Leishmaniasis en el Ecuador, 1920-1989
Yoshihisa Hashiguchi y Eduardo A. Gomez L.
ABSTRACT. Se examina brevemente el estado actual de los conocimientos sobre la leishmaniasis
en el Ecuador, basandose en gran parte en la bibliografia publicada entre 1920 --el año en que se
describio el primer caso humano-- y 1989.  La enfermedad es endemica en 14 de los 20 departamen-
tos del pais.  De 260 casos notificados, 239 (91.9%) eran de la forma cutanea, y 18 (6.9%), de la muco-
cutanea.  Durante los 67 años transcurridos de 1920 a 1987, solo se registro un caso de la forma visceral
y otro de la cutanea difusa.  Tambien se analizan los conocimientos  actuales sobre los vectores y los
huespedes reservorios.  En la acutualidad, se estan estudiando muchas cepas de Leishmania aisladas
durante 1982 y 1988 por los autores.  Hasta la fecha, mediante la electroforesis de isoenzimas y el
empleo de anticuerpos monoclonales, una parte de ellas ha sido identificada como Leishmania ama-
zonensis, procedente de animales salvajes, y Leishmania panamensis, originaria de seres humanos. 
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Journal of Medical Entomology, 27(4), 1990, 701-702
18.  Natural Infections with Leishmania Promastigotes in 
Lutzomyia ayacuchensis (Diptera: Psychodidae) in 
an Andean Focus of Ecuador
Hiroyuki Takaoka, Eduardo A. Gomez L., John B. Alexander and Yoshihisa Hashiguchi
ABSTRACT. In the Andean town of Paute, Ecuador, 2 of 97 (2%) Lutzomyia ayacuchensis Caceres
and Bianchi were found to be naturally infected with Leishmania promastigotes.  The parasites were
confined to the midgut of the sand fly, indicating they did not belong to the subgenus Leishmania
(Viannia).
Memorias del Instituto de Investigaciones en Ciencias de la Salud, 14, 1990, 128-133
19.  Phlebotomes of Paraguay: Species Identification in Three Endemic
Areas (Diptera, Psychodidae, Phlebotominae)
Alba Inchausti, Yoshihisa Hashiguchi and Antonieta De Arias
ABSTRACT. Sand fly catch was performed in four sites of three leishmaniasis-endemic areas of
Paraguay, using shannon trap and protected human bait collections.  A total of 606 females of the genus
Lutzomyia were dissected to examine the natural  infections with Leishmania promastigotes; only
one of Lu. whitmani was positive for the parsite.  The following 8 sand fly species were identified
(% shows species composition): Lu. migonei (11.0%), Lu. shannoni (13.6%), Lu. intermedia (20.3%),
Lu. walkeri (0.2%), Lu. whitmani (51.4%), Lu. fisheri (2.6%), Lu. longispinosa (0.7%) and Lu. cortelezzi
(0.2%).
Kochi, Japan: Kyowa Printing, Research Report Series, No. 2, 1990, 1-238
20. Studies on New World Leishmaniasis and its Transmission, 
with Particular Reference to Ecuador
Yoshihisa Hashiguchi (ed.)
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ABSTRACT. The present text dealts with the results obtained from surveys carried out in different
leishmaniasis-endemic areas of Ecuador, from epidemiological, vector entomological,  immunologi-
cal  and dermatological point of view.  Particular emphasis was given to a recently discovered  autochtho-
nous Andean highland leishmaniasis, and comparison of this disease form with others in the Pacific
coast and Amazonian lowland Ecuador. Moreover, currently available  techniques in molecular biol-
ogy was briefly reviewed and evaluated on their application to future studies of leishmaniasis epi-
demiology in Ecuador.  Potential control measures against the disease in the country were also considered.
The results obtained are summarized as follows. 
Leishmaniasis and its endemic area of Ecuador
In the text the relationship between human  activities and ecological factors in each of the endem-
ic areas was discussed in terms of the disease transmission.  American cutaneous  leishmaniasis  is
highly prevalent in the Pacific coast and Amazonian lowland regions, although mucocutaneous forms
are more frequent in  the latter than the former.  In the Andean highland of Ecuador, a recently dis-
covered new type of the disease was found, and its  ecology was compared with that of the both
lowland disease forms.  
Leishmania isolates from humans and animals and their characterization     
In the present study 18 Leishmania strains from the  Pacific coast and Amazonian lowland patients
and 11 from Andean highland were isolated.  The isolates were precisely characterized employing
serodeme, zymodeme and schizodeme analysis.  The Andean parasites were identified as Le. pifanoi,
while in  the  Pacific coast region Le. panamensis was found and in the Amazon, Le. braziliensis.
A part of the present strains isolated, however, still remained unknown.  In distinct human leishman-
iasis-endemic areas, 194 wild and domestic animals were examined, by performing liver  punctures,
of which 14 or 7.2% of the total were  positive for  protozoans.  A strain from Andean domestic
dogs was identified as Le. pifanoi but the majority still remained unidentifiable in spite of a precise
characterization method.  Leishmania isolates  from humans and wild animals were examined by restric-
tion enzyme analysis of kinetoplast DNA (kDNA).  From the results of fragment patterns, three iso-
lates from cutaneous lesions of patients from the Pacific coast lowland region were identified as Le.
panamensis.  On the other hand, the isolates from three wild mammals from the same region were iden-
tified as Le. amazonensis. 
Sand fly fauna and human leishmaniasis vectors in Ecuador
In eight Departments of Ecuador where human leishmaniases are endemic, the phlebotomine sand
fly was sampled.  A total of 40 species  was collected, of which at least 11 represented new records
for Ecuador.  This record increased the number of sandfly species of Ecuador to 56.  In the country,
three sand fly species of the genus Lutzomyia, trapidoi, hartmanni and gomezi, hitherto, had  been
recorded as Leishmania-vectors.  In the present  study, Lu. ayacuchensis from Andean plateau, Paute,
Department of Azuay was found to be positive for Leishmania promastigotes.  These Andean parasites
were confined to the midgut of the fly, suggesting  that they did not belong to a Le. braziliensis
complex  species.  Monthly examination of the natural infection with Leishmania and the biting
activity of the sand fly, Lu. ayacuchensis was performed in Andean leishmaniasis-endemic area, Paute.
The results revealed that there is a marked monthly variation in both natural infections and biting activ-
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ity, of the flies in the  area suggesting a high transmission intensity during the rainy season.  The valid-
ity of the ovarian accessory glands of seven  sandfly species from both the lowland and highland
Ecuador was examined.  It was found that in highland species parous females could be distinguished
from nullipars by the presence of granular secretions in the gland but the feature is of no value in deter-
mining parity of lowland species.
Immunological findings
Partially purified skin test antigen prepared from Le. panamensis promastigotes was evaluated in
17 Ecuadorian patients with active cutaneous lesions caused by Le. braziliensis complex. Based on the
results obtained, it was concluded that crude antigen and two fractions (FA-1 and FA-2) were useful
for diagnosis of cutaneous leishmaniasis in Ecuador.  Moreover, it was estimated that at least 5 anti-
gens, approximately 66, 55, 45, 28, and 26 kilodalton polypeptides, were related to a specific  delayed-
type hypersensitivity in the New World disease.  Skin test using the crude antigen was performed in
two endemic areas of Ecuador, lowland and highland regions.  The intradermal responses  of the
subjects  from  the two regions were compared each other.
Recently discovered Andean leishmaniasis and its ecology 
During studies made in 1986 and 1988, 25 patients less than 10 years of age were found to be
positive for Leishmania parasites,  demonstrating abundant amastigotes in smears taken from small
cutaneous lesions.  The disease symptoms were clinically similar to those exhibited by cases of uta
caused by Le. peruviana reported from Peru.  However, the causative agent and vectors of the Ecuadorian
form were completely different; the former is Le. pifanoi and the latter, Lu. ayacuchensis, though the
reservoir seems to be rats and domestic dogs in the endemic area.  From examination of our prelimi-
nary data, it appears that the transmission cycle of Andean leishmaniasis involves variable overlapping
of two sets of biological entities, with the degree of overlap governed by climatic conditions.  Changes
in the incidence and frequency of human cases of Andean leishmaniasis in this endemic area are
considered to be the result of migrations of sand flies and rodents (principal reservoir host) among  the
three habitat categories.  
Clinical findings of leishmaniasis in Ecuador
Cutaneous changes due to leishmaniasis were thoroughly examined dermatologically, histopatho-
logically and parasitologically in different endemic areas of Ecuador.  Special emphasis was given to
the comparison between the lowland and highland disease in the country.  The most common mani-
festation in lowland cases was a large wet-ulcer which was clearly demarcated, had an indurated periph-
ery and a wet base.  On the other hand, the highland patients had a small papule with dry crust  resembled
the primary lesion (eschar) seen in tsutsugamushi disease.  Mean age of patients was 20.47 years in
lowland, while it was 1.96 years in highland.  In the lowland disease, the longest duration of the
eruption in our cases was 15 years, but almost all the cases healed within one year.  Lymphnode swelling
was frequently seen; the swelling was easy to palpate on the upper extremities and asymptomatic.  The
histological findings in lowland cases coincided with the granulomatous phase.  Thus, the present study
revealed a marked difference in clinical findings of leishmaniasis  patients between  the lowland and
highland of Ecuador.
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Comments on combating leishmaniasis in Ecuador
Presently available perilesional administrations of antimonials and topical treatments are discussed,
together with current progress in the research into vaccine and new antileishmanial drugs.  In future
application of control measures, moreover, it is important to better understand the epidemiological fea-
tures of the disease in each endemic area, because the New World form of the disease manifest them-
selves in a variety of cycles in different endemic areas.  In additon to individual protections such as
use of mosquito net and repellents, sanitary education through community campains for people in
endemic areas of Ecuador is also important for prophylaxis and/or partial protection. 
Strategies for future molecular epidemiology in Ecuador
A series of procedures for the preparation of specific DNA probes which may be applied for future
epidemiological survey on leishmaniasis in Ecuador have been briefly summarized in the text. 
Bulletin of the Pan American Health Organization,  25(1), 1991, 64-76 
21.  A Review of Leishmaniasis in Ecuador
Yoshihisa Hashiguchi and Eduardo A. Gomez L.
ABSTRACT. The current state of knowledge on Ecuadorian leishmaniasis was briefly reviewed, large-
ly from  previous literature reported during the period from 1920 when the first human case was
described in Ecuador, to the present.  Of the 20 Departments of the Republic of Ecuador, 14 are endem-
ic for the disease.  Out of 260 cases reported, 239 (91.9%) were cutaneous (CL) forms, while 18 (6.9%)
were mucocutaneous (MCL) ones.  Only one case each of visceral (VL) and diffuse cutaneous (DCL)
forms was  reported during 67 years from 1920 to 1987.  In the text current knowledges  of the vec-
tors and reservoir hosts reported are also reviewed.  Many strains of Leishmania isolated during
1982  and 1988 by the authors are currently under study.  Up to date only a part of them was identi-
fied as Le. amazonensis from wild  animals and Le. panamensis from humans by using isoenzyme elec-
trophoresis and monoclonal antibodies. 
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22.  Evaluation and Characterization of Partially Purified 
Skin Test Antigens Prepared from Leishmania 
panamensis Promastigotes
Masato Furuya, Shigeo Nonaka, Eduardo A. Gomez L. and Yoshihisa Hashiguchi
ABSTRACT. The present study was designed to evaluate skin test preparations prepared from
Leishmania panamensis promastigotes in 30 active cutaneous leishmaniasis patients.  The crude  anti-
gen preparation (CA) used was 10,000 g supernatant of the parasites homogenate.  The soluble extract
was further resolved into 4 preparations (FA-1 to -4) with the aid of a Sephacryl S-200 gel filtration.
There was no significant difference in the  positive ratio and the average induration size between CA
(10 mg protein /test) and Montenegro's antigen (MA; 5 x 106 parasites/test).  The reactivity of the
delayed-type hypersensitivity to 10 mg dose of CA was shown with much the same intensity in the
25 mg dose of CA.  In FAs (10 mg protein dose, except for 7.5 mg in FA-4), the positive ratio was
as follows: 90.0% in FA-1, 77.8% in FA-2, 75.0% in FA-3 and 37.5% in FA-4.  The positive ratio  and
the intensity of skin test response in FA-4 were remarkably low in comparison with those in CA or
MA. Significant difference was found in the intensity of response  between FA-3 and CA or MA.  Based
on these results, therefore, we concluded that 10 mg protein dose of CA of L. panamensis and same
dose of the fractionated preparations, FA-1 and -2, were very suitable for the diagnosis of cutaneous
leishmaniasis in endemic areas of the New World.  Furthermore, it was estimated that at least some
or all of the 5 proteins, approximately 66, 55, 45, 28, and 26 kD, were related to a specific delayed-
type hypersensitivity in cutaneous leishmaniasis of the New World.
American Journal of Tropical Medicine and Hygiene,  44(2), 1991, 205-217
23. Andean Leishmaniasis in Ecuador Caused by Infection with
Leishmania mexicana and L. major-like Parasites
Yoshihisa Hashiguchi, Eduardo A. Gomez L., Vicenta V. De Coronel,  Tatsuyuki Mimori,
Masato Kawabata, Masato Furuya, Shigeo Nonaka,  Hiroyuki Takaoka, J. Bruce Alexander,
Aida M. Quizhpe, Gabriel Grimaldi Jr., Richard D. Kreutzer and Robert B. Tesh 
ABSTRACT. Between 1986 and 1988, epidemilogic studies were carried out in a small rural com-
munity in an Andean region of Ecuador, where  cutaneous leishmaniasis is highly endemic.  A total
of 25 human cases, positive for Leishmania parasites by culture and/or smear, were examined.  Fourteen
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of the cases were in infants less than one year of age, suggesting intradomiciliary transmission of
the disease.  Clinically, many of these cases were similar to descriptions of "uta," a form of cuta-
neous leishmaniasis which occurs in Andean regions of Peru and is reportedly caused by L. peruviana.
Of the 11 positive cultures obtained from human cases in the present study, eight were identified  by
molecular characterization as L. mexicana and three were identified as L. major-like.  Two addition-
al isolates of L. mexicana were also made from an infected dog and from a sand fly, Lutzomyia
ayacuchensis, living in the region, thus implicating the latter species as possible reservoir and vec-
tor, respectively, of L. mexicana in this highland community.  The significance and validity of recent
isolates of L. major-like parasites from  the New World are also discussed.
Transactions of the Royal Society of Tropical Medicine and Hygiene, 85(5), 1991, 592-594
24. Cutaneous Leishmaniasis in South-eastern Paraguay: 
a Study of an Endemic Area at Limoy
Yoshihisa Hashiguchi, Ofelia Arias, Domingo Maciel, Julio Mansur, Masato Furuya 
and 
Masato Kawabata
ABSTRACT.  An epidemiological study was performed on leishmaniasis in a newly established com-
munity in south-eastern Paraguay.  149 persons, of 172 inhabitants, were thoroughly examined  by clin-
ical, parasitological and immunological (leishmanin  skin test) examinations.  88 of those examined
(59%) were clinically positive for dermal and nasal (mucosal) lesions or dermal scars, while 74
(50%) were positive by the leishmanin test.  Of the 88 persons, 66 (75%) were positive for both
leishmanial (dermal and nasal) signs and skin test; these subjects were therefore considered  to be
leishmaniasis patients.  Most of the patients (60%) had a single dermal lesion. Among the 66 leishman-
iasis  patients, serious mucosal (nasal septum) lesions were observed in the 41 subjects: 2 had destruc-
tion of the septum, 8 had ulceration and 31 had erythema.  In this community the persons with dermal
and/or nasal problems had been treated with meglumine antimonate (Glucantime®), without any pre-
cise diagnosis having been made by parasitological or immunological examination.  The socio-eco-
nomical and socio-medical points of view aspects are discussed.
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25. Monthly Variation in Natural Infection of the Sandfly 
Lutzomyia ayacuchensis with Leishmania mexicana 
in an endemic focus in the Ecuadorian Andes
Eduardo A. Gomez L. and Yoshihisa Hashiguchi 
ABSTRACT. In order to collect information on the role of Lutzomyia ayacuchensis in the transmis-
sion of leishmaniasis in a newly discovered Andean endemic focus in Ecuador, a longitudinal field
study was carried out over 13 months.  Monthly dissections were made of a minimum of 200 anthro-
pophilic sandflies, collected at night during the month.  A total of 2600 flies was separated from a
small number of Lu. osornoi, another anthropophilic species in the area, and dissected; 95 (3.65%)
were naturally infected with Leishmania mexicana promastigotes.  The parasites were always located
in the sandfly midgut.  The current study revealed a marked monthly variation both in natural infec-
tions with Leishmania and in biting activity of sandflies in the endemic area, demonstrating a high
transmission rate during the period from the early rainy season to the early or mid dry season  (February
to July).
Memorias do Instituto Oswardo Cruz,  87(2), 1992, 221-228
26.  Description of Leishmania equatorensis sp.n. (Kinetoplastida:
Trypanosomatidae), a New Parasite Infecting Arboreal 
Mammals in Ecuador
Gabriel Grimaldi, Jr., Richard D. Kreutzer, Yoshihisa Hashiguchi, Eduardo A. Gomez L., 
Tatsuyuki Mimori and Robert B. Tesh
ABSTRACT. Characterization is given of a new parasite, Leishmania equatorensis sp. n., which
was isolated from the viscera of a sloth (Choloepus hoffmanni) and a squirrel (Sciurus granatensis),
captured in humid tropical forest on the Pacific Coast of Ecuador.  Data based on biological and
molecular  criteria, as well as numerical zymotaxonomical analysis, indicate that this parasite is a
new species of the L. braziliensis complex.  L. equatorensis is clearly distinguishable from all other
known species within this complex, using the following molecular criteria: reactivity patterns with spe-
cific monoclonal  antibodies, isoenzyme electrophoresis, and restriction endonuclease fragment pat-
terns of kinetoplast DNA (k-DNA).
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27.  New Records of Phlebotomine Sand Flies (Diptera: Psychodidae)
from Ecuador
J. Bruce Alexander, Hiroyuki Takaoka, Yuki Eshita, Eduardo A. Gomez L. 
and 
Yoshihisa Hashiguchi
ABSTRACT. The phlebotomine sand fly fauna of Ecuador was  surveyed  in two 3-month collect-
ing trips made in 1988 and 1990.  A total of 12 provinces were visited, including three (Bolivar,
Loja and Morona Santiago) from which no previous records of phlebotomines existed.  Forty-six species
were collected, 13 of which, together with 1 subspecies and 1 genus (Warileya) represented new records
for the country.  This survey  increases the known  number of species in Ecuador to 60.  The distri-
bution of Ecuadorian sand flies is discussed in the light of these new findings.
Japanese Journal of Tropical Medicine and Hygiene, 20(1), 1992, 11-21 
28. Ultrastructural Studies on Cutaneous Leishmaniasis in Ecuador
Abdul Mannan Bhutto, Shigeru Okada, Shigeo Nonaka, Eduardo A. Gomez L. 
and 
Yoshihisa Hashiguchi
ABSTRACT. Ultrastructural observations were made of lesions of three Ecuadorian patients with
cutaneous leishmaniasis. Parasites were located both within the macrophages, either inside the intra-
cytoplasmic vacuoles (parasitophorous vacuoles) or free in cytoplasm and outside host cells.  Amastigotes
were  rounded or oval with a mean length of 2.62 nm (±0.17 s.d.) and mean width of 2.18 nm (±0.28
s.d.).  Parasites showed degeneration  intracellularly both within the vacuoles and in the cytoplasm
of  macrophages.  Lymphocytes were seen in close contact with parasitized macrophages as well as
directly attached to the parasites. Furthermore, spongiotic vesicle was observed in the epidermis where
Leishmania parasites were found, surrounded by lymphocytes and other mononuclear cells.  Amastigotes
attached to mononuclear cells were also observed inside and between the keratinocytes.  Mononuclear
cells containing melanin granules showed amastigotes in their cytoplasm.
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29. Phlebotomine Sandfly Species and Examinations of 
their Infection with Leishmania in Paraguay
Yoshihisa Hashiguchi, Tom Chiller, Alba Inchausti, Antonieta De Arias, Masato Kawabata
and 
John Bruce Alexander
ABSTRACT. Nine species of sandflies, Lutzomyia (Nyssomyia) whitmani (Antunes and Countinho),
Lutzomyia (Nyssomyia) intermedia (Lutz and Neiva), Lutzomyia (Psathyromyia) shannoni (Dyar),
Lutzomyia migonei (Franca), Lutzomyia (Pintomyia) fischeri (Pinto), Lutzomyia (Pintomyia) pessoai
(Countinho and Barretto), Lutzomyia cortelezzii (Brethes), Lutzomyia walkeri (Newstead) and Lutzomyia
(Trichopygomyia) longispinus (Mangabeira), were caught, by human bait and Shannon trap, in four
areas of Paraguay hyperendemic for human leishmaniasis. L. whitmani and L. intermedia were the  pre-
dominant species.  All the species collected were found to be anthropophilic.  Hindgut infections
with  leishmanial promastigotes were observed in only one (0.38%) of the 266 L. whitmani dissect-
ed.  No L. intermedia were found infected, giving an overall infection rate of one (0.16%) of 615
flies dissected. The results indicate a very low rate of natural infection  in endemic areas of Paraguay.
Kochi, Japan: Kyowa Printing, Research Report Series, No. 3, 1992, 1-182
30.  Studies on New World Leishmaniasis and its Transmission, 
with Particular Reference to Ecuador
Yoshihisa Hashiguchi (ed.)
ABSTRACT. The current text dealts with the results of field  and laboratory studies derived from sur-
veys conducted during 1990 and 1991 in the Pacific lowlands and Andean highlands of Ecuador.  All
the data and materials obtained were analyzed from the view of parasitological, entomological,  immuno-
logical, molecular biological, clinical and pathological points.  In addition, information on the epi-
demiological and entomological features of Paraguayan leishmaniasis has been given briefly.  The
results mentioned are summarized as follows.
Findings on Andean leishmaniasis and its ecology 
Until more recently, the only form of leishmaniasis in the Andes was considered to be Peruvian
uta caused by Leishmania peruviana.  However, in 1986, we have discovered another type of leishman-
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iasis in the Ecuadorian Andes which has a completely different species of causative agents and vec-
tors from those of Peruvian uta.  In this text, we briefly reviewed Andean leishmaniasis including
uta and revised an ecological model of the disease in the Andean plateau.  Furthermore, in this  text
autochthonous Andean leishmaniasis cases were reported from two regions of Ecuador, Huigra (1,300
m above sea level) and Alausi (2,300 - 2,500 m a.s.l.), Department of Chimborazo.  In the areas school
children, domestic dogs as reservoir host and vector sandflies were examined: 18.9% of the 122 chil-
dren from Alausi showed positive for both leishmanin skin test and dermal scars; 32.8% of the 58 dogs
from the same site revealed a high ELISA value; and Leishmania parasites were isolated from Lutzomyia
ayacuchensis caught in both sites, Alausi and Huigra.  The parasites were also isolated from two
children (one- and two-year-old females) living in Huigra. 
Molecular biological findings
Karyotypes of L. mexicana, L. panamensis and L. major-like parasites from Ecuador were analyzed
by a turn-table type pulsed field gel electrophoresis (PFGE) apparatus.  A total of 18-21 chromo-
somes from 200 kb to over 1,100 kb were resolved, depending on the Leishmania isolates. The PFGE
revealed  species-specific DNA karyotypes.  The observed karyotype variations among isolates from
distinct regions appear to reflect the species diversity of Leishmania in the New World.  Polymerase
chain  reaction (PCR) techniques have been applied for detection of Leishmania DNA, using synthe-
sized oligonucleotide primers derived from L. braziliensis.  The primers used differentiated L. brazilien-
sis complex from L. mexicana complex or Trypanosoma spp. 
Vector entomological findings 
Biting activity and Leishmania infection of sandfly, Lutzomyia spp.  collected by four different
methods were examined, especially in relation to parous rates.  The higher parous rates produced the
higher Leishmania infection rates.  Sandflies caught during/after dawn tended to possess more suck-
like ovarian follicles than those collected during/after dusk.  A strong possibility of transmission of
L. panamensis to man by the bite of Lu. hartmanni or Lu. trapidoi was discussed, based on the infec-
tion of one (J. B. A.) of our research members during a sandfly collecting trip.  The sandfly fauna of
each of nine sites endemic for Leishmania was sampled using a variety of collection methods.  A
total of 30 species were collected and three of them, recorded for the first time in the country.  The
genus Warileya was also recorded in the country for the first time, represented Wa. phlebotomanica.
The known  ranges  of 23 species were increased by 36 new province records.
Clinico-epidemiological findings on the disease of lowlands
A total of 1,296 leishmaniasis cases diagnosed at the outpatient facility of the national institute
were thoroughly reviewed.  All the cases were from rural areas of the Department of Manabi, the Pacific
coastal region endemic for cutaneous leishmaniasis.  The majority of cases occurred between 1989 and
1990.  A markedly high rate of onset time was found in the period from August to October, just
before the beginning of rainy season; the period was estimated as the main time of transmission of
the disease in the area.  An epidemiological and clinical study was conducted in a leishmaniasis-endem-
ic area, San Sebastian (Ciento Tres), Department of Manabi.  Clinical forms of the disease in the
area were described in detail; lymphnode swellings were seen in half of the 143 subjects examined,
showing a more frequent occurrence in male than in female.  Bacterial and fungal floras in suspected
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Leishmania ulcers of patients from the endemic area were also studied preliminary, in order to eval-
uate their  influence against the natural course of cutaneous leishmaniasis. 
Light and electron microscopical findings
Specimens of both the nose and footpads of golden hamsters infected experimentally with L.
mexicana from Ecuador showed large numbers of amastigotes with extensive infiltration of histiocytes,
lymphocytes and some extent of neutrophils, eosinophils and plasma cells.  A number of mast cells
were prominent in the upper and lower dermis of granulomatous lesions.  Amastigotes were  found
in the macrophages inside the large parasitophorous vacuoles, mostly at the central part of the  lesion.
Regular destruction of parasites was observed within macrophages in all the cutaneous and visceral
sections indicating the phagocytizing role of these cells against the Leishmania parasites.  Ultrastructural
observations on the cutaneous lesions of three patients with leishmaniasis was also performed.
Lymphocytes were in close contact with parasitized macrophage as well as directly attached with the
parasites.  Amastigotes were confirmed in the epidermis where lymphocytes and other mononuclear
cells were present near the parasites.  Amastigotes were also observed in and between the keratinocytes,
and were attached with lymphocytes. 
Findings on the treatment of cutaneous leishmaniasis
Leishmanicidal activity of paromomycin, meglumine antimonate and  mercury chrome was eval-
uated in vitro and in vivo for the purpose of the topical applications to American cutaneous leishman-
iasis.  The result obtained showed that paromomycin and mercury chrome are potent chemotherapeutic
agents for the disease.  However, in this experiment no obvious synergistic inhibitory effect of meg-
lumine antimonate on the promastigote proliferation in vitro was observed.  In San Sebastian (Ciento
Tres), Department of Manabi, Ecuador, a total of 132 cutaneous leishmaniasis patients were recruit-
ed for the topical  treatment with two types of medications, viz., paromomycin ointment and meglu-
mine antimonate plus mercury chrome solution.  The result indicated that paromomycin ointment
may be quite useful for ulcerative lesions, but not so effective against non-ulcerative lesions.  Meglumine
antimonate plus mercury chrome solution seemed to be also effective for ulcerative lesions, showing
more marked early dryness of the ulcers compared with the ointment.
Findings on the Paraguayan leishmaniasis
A study was performed of the epidemiology of  leishmaniasis in a newly established community
in south-eastern Paraguay (Limoy, Department of Alto Parana). 59.1% of the 149 subjects examined
revealed clinically positive for dermal and nasal (mucosal) lesions or dermal scars, while 49.7% showed
positive for leishmanin skin test. Serious mucosal (nasal septum) lesions were  observed in the fol-
lowing 41 subjects including two with loss of nasal septum; eight with ulceration; and 31 with ery-
thema.  In the community visited, the persons who had dermal and/or nasal problems had been treated
with Glucantime®, without precise diagnosis.  The socioeconomical and sociomedical aspects of
Leishmania infection was also discussed in the text.  In Paraguay, nine species of sand flies, Lutzomyia
spp. were caught by protected human bait and Shannon trap, in four areas hyperendemic for leishman-
iasis.  By the dissection of 615 sandflies in total, a hind-gut infection with promastigotes indistigu-
ishable from Leishmania was found in one (0.4%) out of 266 Lu. whitmani, suggesting a very low
infection rate of vectors even in a hyperendemic area. 
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31.  Histopathological Observations of Golden Hamsters Infected with
an Ecuadorian Isolate of Leishmania mexicana
Abdul Manan Bhutto, Shigeo Nonaka, Eduardo A. Gomez L., Yoshihisa Hashiguchi 
and 
Masato Furuya
ABSTRACT. An experimental study was performed to investigate the Leishmania mexicana infec-
tion in golden hamsters.  The animals were infected with L. mexicana from Ecuador. At the autopsy
6 months after inoculation, the inoculated sites were shallow, ulcerative and covered with thick
crusts.  No cutaneous metastasis was observed on other exposed parts of the body.  Histologically,
specimens of both the nose and footpads showed large numbers of amastigotes with extensive infil-
tration of histiocytes and lymphocytes and, to some extent, of neutrophils, eosinophils and plasma cells.
Large numbers of mast cells were evident in the upper and lower dermis of granulomatous lesions.
Amastigotes were found in the macrophages inside the large parasitophorous vacuoles, mostly at the
central part of the lesion.  Amastigotes were also observed in the liver and spleen by electron micro-
scope but the number was fewer in visceral than in cutaneous sections.  Regular destruction of para-
sites was observed within macrophages in all the cutaneous and visceral sections indicating the
phagocytizing role of these cells against parasites.
Nishi Nihon Hihuka, 55(4), 1993, 638-642 
32.  The Successful Treatment of Intralesional Injection of Meglumine
Antimonate for Cutaneous Leishmaniasis
Motoi Takenaka, Taro Ohgami, Hikotaro Yoshida, Yoshihisa Hashiguchi 
and 
Shigeo Nonaka 
ABSTRACT. A 35-year-old male patient had a walnut-size erythema with induration on his left upper
arm.  There was a nut-size ulcer  at the center of the erythema.  He had been interned at a desert in
southern Iraq from August to November 1990.  In November, he noticed an insect-bite-like eruption
on his left arm.  The eruption had, gradually gotten worse despite of therapy.  The patient visited our
hospital on April 23rd, 1991.  A huge  amount of  amastigote-like  leishmaniae were recognized in
the  smear specimen, taken from the edge of the ulcer.  A biopsy of the skin lesion revealed many
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histiocyte-like cells that had many granules in the upper dermis.  We successfully cultivated leishmania
parasites isolated  from the skin lesion which were identified as Leishmania major by a zymodeme
analysis.  Initially, an external remedy consisting of meglumine antimonate and povidone iodine was
used, but was not effective.  Therefore, an intralesional  injection of meglumine antimonate was
done.  After 10 times injections, the ulcer and erythema eventually healed leaving only a pigmenta-
tion.  The side-effects were limited to some localized pain  following injection.  Thus, intralesional
injections with meglumine antimonate proved to be highly effective against the ulcerative lesion, while
demonstrating no serious side effects. (In Japanese with English summary)
American  Journal of Tropical Medicine and Hygiene, 48(5),  1993, 707-715 
33.  Molecular Karyotype Characterization of Leishmania panamensis, 
Leishmania mexicana, and Leishmania major-like Parasites: 
Agents of Cutaneous Leishmaniasis in Ecuador
Ken Katakura, Yoshitsugu Matsumoto, Eduardo A. Gomez L., Masato Furuya, 
and 
Yoshihisa Hashiguchi
ABSTRACT. Molecular karyotypes of Leishmania isolates from patients with cutaneous leishman-
iasis in Ecuador were analyzed by pulsed-field gel electrophoresis (PFGE) and Southern blot  hybridiza-
tion.  The DNA karyotypes of L. major-like parasites were similar between two human isolates from
a lowland coastal and a highland Andean region, but were apparently different from those of eleven
World Health Organization reference strains  including L. major.  The smallest chromosome of 240
kilobases in L. major-like parasites was found to belong to the  715-class of small linear chromoso-
mal DNAs, which have been shown to appear in some lines of Leishmania.  Chromosome banding pat-
terns of L. mexicana isolates exhibited a novel, ordered, chromosomal ladder, and were identical among
four human isolates and one canine isolate from a restricted  geographic region in the Andes.  On the
other hand, minor chromosome size polymorphisms were observed among three L. panamensis isolates
from different endemic regions near the Pacific Coast.  Chromosomal locations of dihydrofolate reduc-
tase-thymidylate synthetase and P-glycoprotein genes revealed further differences in chromosomal orga-
nizations among these Leishmania species in Ecuador.  These results indicate that karyotype analysis
by PFGE is useful for epidemiologic studies of leishmaniasis in Ecuador.
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34.  Histopathological and Electron Microscopical Features of Skin
Lesions in a Patient with Baltonellosis in Ecuador
Abdul M. Bhutto, Shigeo Nonaka, Eduardo A. Gomez L. and Yoshihisa Hashiguchi
ABSTRACT. Chronic verruga nodules taken from a patient with verruga peruana were studied.
Histopathologically, specimens of all the lesions that showed extensive infiltration of various types
of cell along with the proliferation of capillaries.  The sections were predominantly infiltrated with
neotrophils and endothelial cells, while histiocytes, plasma cells, lymphocytes and mast cells were also
visible in some extent.  The blood vessels were  dilated and many endothilial cells were located periph-
erally that were rounded and swollen, while the huge number of neutrophils was invaded inside the
vessels.  Electron microscopically, large number of organisms was found and seen under different
stages of life cycle in stroma.  Furthermore, organisms were regularly seen either close contact or being
existed inside the cytoplasm of neutrophils, suggesting the phagocytic role of these cells against organ-
isms.  No organism was found inside the endothelial cells and histiocytes.
Journal of Pakistan Association of Dermatologists, 3,  1994, 17-32
35.  Comparative Observations of Golden Hamsters Infected with 
Leishmania (Leishmania) mexicana from Ecuadorian Patient 
with Diffuse and Localized Type of Cutaneous Leishmaniasis
Abdul M. Bhutto, Shigeo Nonaka, Masato Furuya and Yoshihisa Hashiguchi
ABSTRACT. In order to search for factors relating to different disease forms caused by Leishmania
strains or species, histopathological and ultrastructural comparisons were made.  For this purpose, ham-
sters were infected experimentally with promastigotes of Leishmania (Leishmania) mexicana (=L. mex-
icana mexicana) strains isolated from patients with two types of clinical forms, diffuse cutaneous (DCL)
and localized cutaneous leishmaniasis (LCL).  No histopathological and ultrastructural findings pro-
viding clear differentiation between DCL and LCL strains were recognized.  The experimental animals
used were divided into the following two groups.  Hamsters in group A were infected with L. (L.) mex-
icana, isolated from a patient with DCL, and the  remaining animals in group B were infected with
the parasite, L. (L.) mexicana, isolated from patients with LCL.  Macroscopically, no remarkable
difference in the inoculated sites was noticed  after the 1st month of promastigote inoculation.  After
the 2nd and 4th month of inoculation, small and large nodules were observed on the inoculation site
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of animals in both groups.  The large nodules were found relatively more numerous in the animals of
group A than those of group B. No cutaneous dissemination  and/or metastasis was noted in the ani-
mals from both groups.  Histopathologically, granulomatous changes were observed in all the micro-
scopical sections of the nose and footpads of hamsters infected experimentally.  In the nose and footpad
sections, a large number of neutrophils were observed in the animals of group A, while, histiocytes
and lymphocytes were dominant in those of group B. In ultrathin sections amastigotes were located
in the dermis extracellularly and intracellularly.  Degeneration of parasites was  observed inside the
macrophages in group B sections only. Morphologically, no clear differentiation was found in light-
and ultra-microscopical observations between the amastigotes of L. (L.) mexicana from the two groups
of experimental animals.
Japanese Jaunal of Parasitology, 43(3), 1994, 173-186
36.  New World Leishmaniasis and its Transmission, with Particular
Reference to Andean Type of the Disease, Uta
Yoshihisa Hashiguchi
ABSTRACT. In the text, New World leishmaniases were geographically divided into lowland and
Andean highland forms, and were briefly reviewed.  As to Peruvian uta, its short research history
and more recent information on the taxonomic problem of the causative agent, Leishmania (Viannia)
peruviana, were briefly discussed.  From 1982 to 1993, the author and his co-workers worked with
leishmanisis in Ecuador, in order to disclose the transmission mechanism(s).  During the study, a
new type of leishmaniasis was found in three endemic areas of Andean highlands, Paute (2,300 m 
-1,500 m above sea level), Alausi (2,300 m -2,500 m a.s.l.) and Huigra (1,200 m -1,500 m a.s.l.).
Clinically, the disease forms in Ecuador were found to be very similar to those in Peru.  However,
the parasites and vectors were completely different between the two countries.  In Ecuador, the
organisms isolated from humans, sandflies (Lutzomyia ayacuchensis) and dogs (Canis familiaris) were
identified as L. (Leishmania) mexicana by zymodeme, serodeme, schizodeme and karyodeme analysis.
In addtion, another species of the genus Leishmania, was also isolated from humans living in Paute,
Ecuador, and characterized as L. (L.) major-like, by molecular techniques mentioned above.  Thus, the
current review pointed out that Andean leishmaniases would have more complicated features of the
epidemiology and ecology in different endemic areas than were previously considered.  Besides, a
model to show how local conditions affect transmission of the disease in the Andes was also shown.
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37.  Case Report of Leprosy and a Trial of Screenings for the Family
Members in Ecuador
Atsushi Hosokawa, Shigeo Nonaka, Juan J. Alava P., Eduardo A. Gomez L., Hugo M.
Jurado S. and Yoshihisa Hashiguchi
ABSTRACT. Four cases of patients with leprosy were seen in an area endemic for cutaneous leishman-
iasis, Los Ranchos, Department of Manabi, Ecuador.  Two cases of them (borderline lepromatous
leprosy and indeterminate one) in a single family and result of screenings for the family members were
reported.  It was suggested that family examination of leprosy patient might be useful for early detec-
tion of leprosy in a low endemic areas for leprosy, such as Department of Manabi.  A nine banded
armadillo kept by the family was examined, but no acid-fast bacilli was observed in the liver materi-
als.
Japanese Journal of Tropical Medicine and Hygiene, 22(4), 1994, 179-184
38.   Seroepidemiological Surveys for Leprosy in Ecuador
Atsushi Hosokawa, Shigeo Nonaka, Miguel H. Jurado, Masato Furuya, Yuki Eshita,
Tatsuyuki Mimori, Ken Katakura, Eduardo A. Gomez L., Shinzo Izumi 
and 
Yoshihisa Hashiguchi
ABSTRACT. Serological examination of leprosy in endemic areas of cutaneous leishmaniasis were
carried out using the sera collected during a survey for cutaneous leishmaniasis and  several parasitic
diseases in Ecuador.  There was no correlation between prevalence rates for leprosy and seropositive
rates of the antibodies (anti-PGL-I and LAM-B antibodies) in the subjects living in several provinces
in Ecuador.  Seropositive rates of anti-PGL-I antibodies of the leprosy patients and their families in
Los Ranchos, Department of Manabi, were relatively high (84.6%, 11/13) in comparison with the aver-
age seropositive rates (42.4%, 154/365) of the subjects from other areas of Ecuador.  It was suggest-
ed that serological survey of families of leprosy patients might be useful for screening of household
contacts in a low endemic area, such as Department of Manabi, Ecuador.
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39. Studies on New World leishmaniasis and its Transmission, 
with Particular Reference to Ecuador 
Yoshihisa Hashiguchi (ed.)
ABSTRACT. The present issue was mainly designed to compile the results of the field works car-
ried out during the period from 1992 to 1993 at different areas endemic for leishmaniasis in Ecuador.
Using materials collected in the field, furthermore, laboratory investigations were made in Ecuador and
Japan, and the data  were also mentioned in this text.  The results obtained are summarized as fol-
lows.
Molecular biological and immunological findings
DNA karyotype of 12 Leishmania isolates, from three different areas of the Ecuadorian Andes, was
examined by pulsed field agarose gel electrophoresis.  A marked karyotype similarity was observed
in all the isolates examined.  Chromosomal DNA banding pattern of these isolates was characterized
by an ordered  chromosomal ladder, by the presence of four low molecular weight chromosomes of
220, 250, 280 and 325  kilobases.  The results obtained suggested that L. (Leishmania) mexicana strain
with a defined karyotype is widely distributed and a major agent of cutaneous leishmaniasis in the
Ecuadorian Andes regions.  Monoclonal antibodies were raised against promastigotes of newly described
L. (Viannia) equatorensis.  Fusions of immunized spleen cells of BALB/c mice with P3-X63-Ag8,6.5.3.
myeloma cells resulted in the production of six monoclonal antibodies (MAbs) against the parasite.
Among these, five MAbs 9F4, 7H6, 3A7, 8C1, and 1G5 were found to be species-specific for L. (V.)
equatorensis.  By indirect immunofluorescent antibody (IFA) test, MAbs 9F4, 7H6, and 7A6 appeared
to bind the surface and cytoplasm of promastigotes of the parasite, while MAbs 3A7 and 1G5 bound
only to flagellum.  On Western blot analysis, MAb 3A7 recognized set of bands ranging from 110 to
170 kDa, MAb 1G5, however, recognized a different set of molecules ranging from 200 to 250 kDa.
Experimental findings using the Ecuadorian Leishmania isolates
In order to make a search for some factors relating to different disease forms caused by Leishmania
strains or species, histopathological and ultrastructural comparisons were made.  For this purpose, ham-
sters were infected with promastigotes of L. (L.) mexicana isolated from patients with two different
types of clinical forms, viz., diffuse cutaneous (DCL) and localized cutaneous (LCL) leishmaniasis.
However, no clear difference was found between the two animal groups infected with DCL and LCL
strains of the parasite, except the following points.  In the nose and footpad sections of hamsters, a
large number of neutrophils were observed in animals infected with DCL strains, while histiocytes and
lymphocytes were dominant in those infected with LCL strains.  In ultrathin sections amastigotes were
located in the dermis extracellularly and intracellularly.  Degeneration of parasites was observed inside
the macrophages in animals infected with LCL strains only.  No morphological difference was observed
light- and ultra-microscopically in amastigotes of the parasites from animals infected with DCL and
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LCL strains. In order to check lot variation of Glucantime® used in Ecuador, in vitro anti-promastigote
activity was examined, by using three manufacturing lots of meglumine antimonate.  A minimum twice
difference in the activity was detected among the lots tested.  Effective concentration of the drug which
inhibited promastigote proliferation by 50% (EC50) varied with different Leishmania species, and EC50
values of the most effective lot were in a range of 20-38 mg/ml Glucantime® or 5.7-10.8 mg/ml anti-
mony.
Vector entomological findings
Biological features of several man-biting  sandfly species were examined in two areas endemic
for leishmaniasis, the Andean slope (site I) and the Pacific coast (site II).  In site I, the data obtained
in 1991/1993 were compared with those in 1983; a marked difference was recognized in species
composition of sandflies and natural infections with Leishmania, between the two study periods.  In
study site II, six man-biting species were collected in the primary and secondary forest.  Among
these, some were also captured inside the house, suggesting a possibility of the role of vectors of
leishmaniasis in the area.  In this  study site, however, a total of 2,530 flies were dissected, no nat-
ural infections with the parasite was found to date. Parity of sandflies, Lutzomyia spp., was exam-
ined at different endemic areas of leishmaniasis.  Some of Lu. gomezi showed the developmental  stage
II or III of follicles without any blood meals,  suggesting an existence of autogeny individuals.  To
know a susceptibility of snadflies against fenitrothion (Sumithion), a preliminary study was conduct-
ed.  Based on the results obtained, residual sprays of the insecticide were briefly discussed from the
view point of reducing biting chance of endophilic sandflies, especially in Andean leishmaniasis-endem-
ic areas of Ecuador.  A bibliographical review was also made briefly on the application of insecti-
cides for the control of endophilic sandflies.
Seroepidemiological findings
To evaluate enzyme-linked immunosorbent assay (ELISA) as a diagnostic method in leishmaniasis-
endemic areas of Ecuador, 95 sera of the patients were examined.  Based on clinical manifestations,
these sera were divided into four groups and subjected to ELISA; the antigens were prepared from pro-
mastigotes of L. (V.) panamensis and L. (V.) guyanensis.  From the results obtained, it was found
that the ELISA used could be very useful for both the diagnosis and the evaluation of treatment in
endemic areas of the disease in Ecuador.  In order to know endemy of leishmaniasis in domestic
dogs as a reservoir host of human leishmaniasis in the country, a serological survey was performed.
Thirty-seven sera from the Pacific lowland (Palm Junta) and the Andean highland (Alausi) were exam-
ined by ELISA, using two Leishmania antigens mentioned above.  Although positive rate of dogs in
Alausi was higher than in Palm Junta, the average OD value of positives was higher in the latter;
older dogs showed higher positive rates.  A further epidemiological study of Andean leishmaniasis in
Ecuador was carried out, especially in Huigra (1200-1500 m above sea level), Department of Chimborazo.
The results obtained were compared to those in Alausi (2,300-2,500 m), Department of Chimborazo
and Paute (2,300-2,500 m), Department of Azuay.  The disease forms in these foci were found to be
similar to each other.  It was suggested, however, that in Huigra the ecological features, including vec-
tor and reservoir biology, were quite different from other endemic areas. 
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Clinical findings of leishmaniasis in Ecuador
In the text, a typical case of parasitologically confirmed diffuse cutaneous leishmaniasis was reported
for the first time in the country.  The patient was anergy to Leishmania antigen but not for other antigens,
such as PPD and BCG, and was refractory against chemotherapy by Glucantime®.  The parasite isolated was
identified as L. (L.) mexicana by zymodeme and karyotype analyses.  A rare case of generalized cutaneous
leishmaniasis with 308 crusty ulcers was also reported.  The clinical picture of this patient showed some
controversies, showing herpes zoster, and resulted in a difficult diagnosis.  However, microscopical exami-
nations of lesions revealed abundant Leishmania amastigotes.  Finally, it was concluded that coexistence of
herpes zoster might have partly supported dissemination of lesions all over the body surface, though the infec-
tion by multiple biting of infected sandflies could not still be ruled out.  A preliminary trial of chemothera-
py using an anticancer drug, fluorouracil (5FU), was made against localized cutaneous leishmaniasis. From
the trial, it was considered that 2% 5FU ointment would be useful for a relatively small sized, shallow ulcer-
ative lesion, but not so effective against non-ulcerative lesions; no patients revealed burning sensation and
other side effects by 2% 5FU ointment applications.
Related skin diseases
Chronic verruga nodules taken from a Ecuadorian patient with bartonellosis was examined electron-micro-
scopically; the disease was known to be transmitted by sandflies, Lutzomyia spp, vectors of leishmaniasis.
Large numbers of organisms were found in different stages of the life cycle in the stroma. Furthermore,
these organisms were regularly seen either in close contact or existing inside the cytoplasm of neutrophils,
suggesting the phagocytic role of these cells against the organisms.  No organism was found inside the endothe-
lial cells or histiocytes.  Skin diseases found in endemic areas of cutaneous leishmaniasis in Ecuador were
investigated whether there would exist any skin disease and cutaneous changes that might need to make dif-
ferential diagnosis for  leishmaniasis.  No marked difference on the incidence of cutaneous changes was found
between rural and urban areas of the country.  In an area endemic for cutaneous leishmaniasis, seven lep-
rosy patients were found.  The disease should be considered as a possibility of misdiagnosis and therefore
properly examined.  For leprosy, a serological survey was also performed using sera collected during sur-
veys for leishmaniasis and other parasitic diseases.  No correlation between prevalence rates and sero-posi-
tive rates was observed in the current study.  Two cases of leprosy, a borderline lepromatous leprosy and an
indeterminate one, in a single family were reported in detail, with their pedigree.  Fungi from patients were
also examined, in relation to the evolution of leishmaniasis lesions.
Japanese Journal of Tropical Medicine and Hygiene, 23(3), 1995 151-157
40.  Oral Treatment of New World Cutaneous 
Leishmaniasis with Anti-malarial Drugs in Ecuador: 
a Preliminary Clinical Trial
Eduardo A. Gomez L., Milorad Andrial, Atsushi Hosokawa, Shigeo Nonaka 
and 
Yoshihisa Hashiguchi
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ABSTACT. The current study was designed to evaluate anti-leishmanial activity of mefloquine
hydrochloride (Mephaquin®) and artesunate (Plasmotrim®) which are currently being used as malaria
drugs. A total of 17 patitents (volunteers) with cutaneous leishmaniasis were treated with these durgs
in this study.  Of these subjects, 16 were treated by the oral administration of a total dosage of 1,500
mg (1 Lactab® each for 6 days) mefloquine, 4.2 mg/kg/day for 6 days, and if necessary the dosage was
repeated with 3 weeks intervals.  The majority of cutaneous lesions healed within 2 to 3 weeks after
the commencement of mefloquine treatment, showing an average of 3.6 weeks of healing times with
100% cure rate.  One slowly healing within  8 weeks after the commencement was observed; this
case grew worse because of infection with Tunga penetrans at the late healing phase of leishman-
iasis.  The remaining one patient with an ulcer lesion was treated by the oral administration of a
total dosage of 1,200 mg (2 Lactab® each for 3 days) artesunate, i, e., 6.7 mg/kg/day for 3 days, and
the same dosage was repeated 2 weeks later.  The lesion healed within 6 weeks after the commence-
ment of artesunate treatment.  In the present study, all the patients received mefloquine or artesunate
were treated without admission, performing their normal daily activities.  No specified adverse reac-
tion was noticed.
Okinawa Medical Journal, 33, 1995, 44-47
41. A Trial of Topical Treatment using 2% Fluorouracil (5FU) Ointment 
for Cutaneous Leishmaniasis at the Pacific Coastal 
Lowland of Ecuador 
Atsushi Hosokawa, Shigeo Nonaka and Yoshihisa Hashiguchi
ABSTRACT. ????????????????????????????????????????????????????????????????????????????????????????
????????????????????????????????????????????????????????????????????????????????????????????????????????
village of Guayabales, Department of Manabi, Ecuador, were recruited for the study.  5FU ointment
was prepared at the concentration of 2%.  Among 7 patients treated with 2% 5FU ointment, one had
a good improvement; two showed a slight improvement; and four showed no reaction.  In addition,
of these 77 cases, no complete cure was found within a month of treatment.  It is reported that burn-
ing sensations were caused by the application of 10% paromomycin ointment.  In this research, no
patient with ulcerative lesions complained of burning sensation during the application of 2% 5FU oint-
ment.  It is concluded that 2% 5FU ointment may be useful for the relatively small sized shallow ulcer-
ative lesions, but not so effective against non-ulcerative lesions. (In Japanese)
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42. Cutaneous Leishmaniasis
Yoshihisa Hashiguchi
ABSTRACT. Leishmaniases distribute widely in tropical and subtropical countries of the New and
Old World; and 350 million people are at risk.  The causative agents of the disease belong to the genus
Leishmania parasitic to reticuloendotherial cells, especially macrophages, of mammals including
man.  The genus Leishmania which are divided into 2 subgenus, Leishmania and Viannia, includes
about 20 species parasitic to human in the New and Old World.  In human case the clinical forms
are very variable, depending on the causative species of Leishmania, host immunological and physi-
ological conditions and characteristics of each endemic area.  Clinically, the disease forms are large-
ly classified into 3 categories, cutaneous (CL), mucocutaneous (MCL) and visceral (VL) types in
general.  In this text, however, they are devided into 6 categories in order to compare their clinical fea-
tures in detail as follows: 1) CL including simple and self-healing type, leishmaniasis recidivans
type and sporotricoid type; 2 ) DCL (diffuse cutaneous leishmaniasis); 3) DICL (disseminated cuta-
neous leishmaniasis); 4) MCL; 5) VL;  6) PKDL (post-kala-azar dermal leishmaniasis). Furthermore,
a brief review was also done on the infection  mechanism(s) and the clinical classification of the dis-
ease based on histopathological findings reported.  In addition, clinical and immunological features
of leishmaniasis are compared among DCL, DICL and CL.  Finally, the vector sand flies, reservoir
hosts, diagnosis, treatments and control measures of the disease are discussed briefly. (In Japanese)
Japanese Journal of Dermatology, 106(12), 1996, 1471-1481
43.  Leishmaniases
Yoshihisa Hashiguchi
ABSTRACT. Leishmaniases are caused by a unicellular organism of the genus Leishmania, and trans-
mitted by phlebotomine sandflies, the genus Phlebotomus in the Old World and the genus Lutzomyia
in the New World.  There are at least 21 different species Leishmania that cause human infections.
The protozoan parasites, Leishmania spp., produce a wide range of clinical infections in both humans
and vertebrate aminals as zoonosis.  In humans, clinical leishmaniasis ranges from a simple, often
self healing cutaneous form to those producing destructive mucocutaneous ulcers of the nasopharyn-
ges, uncurable diffuse cutaneous lesions, and a visceral form known as kala-azar, a severe chronic
infection of the reticuloendothelial system which is often fatal if left untreated.  The disease is
endemic in many tropical and subtropical regions and is classified as one of the six tropical diseases
targeted by the World Health Organization (WHO) for study by the Tropical Disease Research Program
(TDR).  It is estimated that there may be some 12 million infected people in the world and 370 mil-
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lion at risk, of whom some 0.4 to 1 million will be infected each year in the 67 countries affected.
Some 90% of the visceral leishmaniasis cases are reported from two regions, a wide zone from north-
east India and Bangladesh to southern Nepal and Sudan; and 90% of cutaneous cases including muco-
cutaneous and diffuse ones are found in Afganistan, Iran, Saudi Arabia and Syria in the Old World,
and Brazil and Peru in the New World.  (In Japanese with English summary)
Internal Medicine, 35(6), 1996, 434-435
44.  Leishmaniasis: its Changing Pattern and 
Importance as an Imported Disease
Yoshihisa Hashiguchi
ABSTRACT. During the past few decades, the parasitic diseases such as leishmaniasis, malaria and
trypanosomiasis have not been considered priority public health problems or to be of medical impor-
tance in Japan and in other developed countries.  Therefore, such diseases were sometimes relegated
to the status of simply an academic curiosity in these countries, and few physicians or parasitologists
felt the need to understand the details of the diagnostic procedures and treatment regimens associat-
ed with these parasitic infections.  Recently, however, increasing worldwide travel has raised the num-
bers and a variety of parasitic diseases have been imported into non-endemic areas of the diseases.
In such a circumstance, imported cases of a variety of parasitic diseases should be adequately diag-
nosed and treated by knowledgeable medical personnel. Here, the changing pattern of leishmaniasis
and its importance as an imported disease are briefly discussed in order to stimulate the interest of
medical personnel in the field of parasitic diseases.
